page
montreal
canada
protein
societi
premier
intern
societi
dedic
support
protein
research
announc
winner
protein
societi
award
award
confer
st
annual
symposium
protein
societi
juli
montreal
canada
carl
en
award
sponsor
rigaku
corpor
honor
outstand
protein
scientist
also
made
except
contribut
area
educ
andor
servic
field
recipi
award
dr
billi
hudson
vanderbilt
univers
dr
hudson
work
tirelessli
develop
aspirnaut
stem
pipelin
divers
program
provid
internship
untap
pool
talent
highschool
student
encourag
work
stem
field
go
colleg
hudson
outstand
research
accomplish
includ
semin
discoveri
structur
chemistri
collagen
iv
scaffold
extracellular
basement
membran
led
potenti
treatment
diabet
kidney
diseas
dorothi
crowfoot
hodgkin
award
sponsor
genentech
grant
recognit
except
contribut
protein
scienc
profoundli
influenc
understand
biolog
award
present
year
two
deserv
nomine
first
dr
juli
feigon
univers
california
lo
angel
feigon
structur
studi
protein
larg
evolv
around
protein
interact
dna
rna
reveal
interact
crucial
understand
dna
repair
regul
gene
express
feigon
recent
accomplish
structur
analysi
tetrahymena
telomeras
complex
multisubunit
riboprotein
complex
respons
mainten
telomer
structur
provid
new
mechanist
knowledg
telomer
function
associ
age
cancer
corecipi
dorothi
crowfoot
hodgkin
award
dr
manajit
hayerhartl
max
planck
institut
biochemistri
past
decad
dr
hayerhartl
investig
mechan
groel
cofactor
groe
work
led
insight
chaperonin
addit
prevent
aggreg
profoundli
influenc
freeenergi
landscap
protein
acceler
fold
entrop
destabil
unfold
state
confin
environ
fold
cage
mechan
consid
specif
chaperonin
han
neurath
award
sponsor
neurath
foundat
seek
honor
individu
made
recent
contribut
except
merit
basic
protein
research
han
neurath
awarde
dr
kazuhiro
nagata
kyoto
sangyo
univers
nagata
made
fundament
discoveri
advanc
understand
protein
qualiti
control
endoplasm
reticulum
dr
nagata
research
focus
function
analysi
collagenspecif
molecular
chaperon
function
analysi
mammalian
er
qualiti
control
erassoci
degrad
erassoci
degrad
misfold
protein
system
christian
b
anfinsen
award
sponsor
protein
societi
recogn
technolog
achiev
signific
methodolog
advanc
field
protein
scienc
recipi
award
dr
lewi
kay
univers
toronto
dr
lewi
kay
involv
develop
larg
number
groundbreak
tool
approach
revolution
nmr
spectroscopi
render
one
power
techniqu
protein
scienc
research
dr
kay
laboratori
focus
develop
nmr
techniqu
studi
macromolecular
structur
dynam
applic
nmr
techniqu
problem
biolog
clinic
import
emil
thoma
kaiser
award
recogn
recent
highli
signific
contribut
applic
chemistri
studi
protein
recipi
dr
thoma
muir
princeton
univers
muir
known
innov
work
develop
semisynthet
approach
known
express
protein
ligat
manipul
coval
structur
protein
combin
tool
organ
chemistri
biochemistri
cell
biolog
muir
develop
suit
new
technolog
make
protein
defin
posttransl
modif
enabl
function
studi
protein
work
would
otherwis
possibl
chemistrydriven
approach
pioneer
muir
lab
wide
use
chemic
biologist
around
world
stein
moor
award
name
nobel
laureat
dr
william
stein
dr
stanford
moor
award
vener
emin
leader
protein
scienc
made
sustain
high
impact
research
contribut
field
recipi
dr
john
kuriyan
univers
california
berkeley
kuriyan
major
scientif
contribut
understand
regul
eukaryot
cell
signal
phenomenon
process
dna
repair
contribut
includ
semin
studi
structur
basi
regul
protein
interact
molecular
mechan
associ
cancer
insight
come
work
protein
kinas
srcfamili
kinas
abelson
tyrosin
kinas
epiderm
growth
factor
receptor
kinas
ii
protein
scienc
young
investig
award
name
academ
journal
societi
recogn
scientist
gener
within
first
year
independ
career
made
import
contribut
studi
protein
recipi
dr
david
pagliarini
univers
wisconsin
madison
earliest
point
career
pagliarini
made
substant
last
contribut
understand
mitochondri
protein
function
take
interdisciplinari
approach
pagliarini
reveal
larg
number
mitochondri
protein
establish
function
mani
associ
human
diseas
goal
use
rang
techniqu
connect
orphan
protein
mitochondri
pathway
process
begin
year
two
best
paper
select
articl
publish
protein
scienc
preced
month
junior
author
typic
first
author
design
award
winner
invit
give
talk
follow
annual
protein
societi
symposium
recipi
charlott
miton
zach
schaefer
charlott
miton
alreadi
someth
world
travel
follow
complet
master
degre
franc
particip
research
project
mexico
itali
undertak
phd
cambridg
dr
f
hollfeld
hyvonen
charlott
narrat
follow
phd
work
join
dr
nobuhiko
tokuriki
ubc
vancouv
share
passion
track
elucid
mechan
behind
function
transit
mutat
interact
conform
chang
result
evolutionari
select
work
togeth
time
cambridg
felt
mani
potenti
pathway
abstract
could
explor
led
core
motiv
behind
paper
protein
scienc
base
data
gener
field
singl
evolutionari
trajectori
preval
trend
observ
laboratori
degre
could
use
inform
make
infer
protein
structur
felt
gener
consensu
role
mutat
epistasi
ie
nonaddit
interact
mutat
base
quantit
survey
type
preval
remain
establish
abl
gather
analys
compar
complet
mutat
data
nine
evolutionari
trajectori
curat
literatur
analysi
reveal
epistasi
play
major
albeit
hidden
role
constrain
evolutionari
trajectori
half
mutat
fix
nine
trajectori
neutral
detriment
origin
wt
background
becam
posit
later
round
evolut
follow
prior
fixat
permiss
mutat
second
best
paper
awarde
zach
schaefer
work
toni
kossiakoff
describ
zach
nutshel
follow
zach
undergrad
reed
graduat
decid
take
year
two
find
mean
life
sound
reedlik
get
pictur
appli
lab
technician
see
whether
scienc
thing
usual
nt
like
part
type
experi
mentor
reed
thought
good
bet
good
bet
spent
coupl
year
put
number
hard
project
interestingli
work
describ
protein
scienc
paper
complet
initi
zach
postdoc
luke
bailey
work
togeth
mainli
background
thing
work
project
requir
fab
coupl
bival
format
found
best
fab
applic
actual
becam
highli
aggreg
put
form
develop
polar
ring
import
step
lead
abil
make
bival
fab
construct
protein
scienc
best
paper
award
winner
research
read
articl
protein
scienc
editorinchief
brian
w
matthew
protein
scienc
best
paper
award
charlott
miton
zach
schaefer
depend
pathway
also
associ
autoimmunechron
inflammatori
diseas
mav
transmembran
mitochondri
peroxisom
protein
form
prionlik
selfperpetu
fiberlik
polym
addit
function
mav
aggreg
atyp
differ
amyloid
fiber
instead
exhibit
sixhelix
bundl
structur
compos
three
ahelic
insid
surround
three
extern
compel
evid
support
role
reactiv
oxygen
speci
ro
regul
mavsdepend
pathway
first
mav
local
organel
strongli
involv
metabol
ro
addit
recent
work
laboratori
other
unveil
ro
deriv
nadph
oxidas
mitochondria
activ
essenti
mavsdepend
respons
includ
aggreg
molecular
mechan
action
ro
remain
poorli
understood
redox
posttransl
modif
protein
oxptm
notabl
cystein
cy
residu
recent
emerg
key
process
regul
protein
structur
function
use
maleimidederiv
switch
method
label
cy
oxptm
found
mav
possess
cy
undergo
oxid
furthermor
analysi
mav
behavior
oxid
stress
condit
strongli
support
role
mav
cy
oxptm
regul
polym
format
structurefunct
analys
current
perform
character
redox
regul
mav
activ
format
prionlik
selfperpetu
fiberlik
polym
amyloid
protein
depositionha
domin
role
differ
neurotox
aggreg
relat
disord
like
alzheim
diseas
parkinson
diseas
system
amyloidosi
etcth
presentstudi
emphas
amyloid
inhibitori
well
disaggreg
action
promethazin
prm
neurolept
antihistamin
drug
human
lysozym
hl
fibril
associ
cytotoxicityexploit
biophys
biochem
microscop
cytotox
assay
reveal
prmi
effectivein
inhibit
disaggreg
hl
amyloid
fibril
display
cytoprotect
action
amyloid
associatedcytotox
biophys
techniqu
like
rayleigh
scatter
rl
tht
ansfluoresc
measur
circular
dichroism
cd
dynam
light
scatter
dl
measurementsrev
inhibitori
action
prm
inhibit
constant
ki
valu
prm
estim
x
mm
respect
addit
microscop
techniqu
tem
fm
display
nonexist
fibrillar
speci
hl
co
incub
prm
cytotox
assay
accomplish
neuron
cell
line
confirm
decreas
cytotox
presenc
prm
prm
establish
potent
hl
pre
form
fibril
valu
depolymerizationconcentr
evalu
mm
likewis
lessen
cytotox
disaggreg
speci
well
consequ
prmmightwork
favorabletherapeut
inhibitor
design
amyloid
relat
diseas
energi
landscap
insight
motiv
multiscal
comput
algorithm
simul
fibril
growth
larg
number
short
atomist
simul
perform
comput
system
diffus
tensor
reaction
coordin
space
predict
analyt
theori
ensembl
aggreg
pathway
growth
kinet
comput
markov
state
model
msm
trajectori
algorithm
deploy
understand
fibril
growth
mechan
kinet
three
mutant
order
growth
rate
wildtyp
two
singl
mutat
peptid
predict
msm
trajectori
consist
experiment
result
simul
also
correctli
predict
doubl
mutat
would
reduc
fibril
growth
rate
even
though
degre
rate
reduct
respect
either
singl
mutat
estim
artifact
may
attribut
simplist
implicit
solvent
model
trend
growth
rate
appar
inspect
rate
constant
individu
bond
lifetim
misregist
state
primari
kinet
trap
emerg
ensembl
trajectori
gener
msm
maria
soria
silvia
cervant
thalia
bajakian
ansgar
siemer
mrna
bind
protein
translat
regul
found
melanogast
abl
form
function
amyloidlik
aggreg
fruit
fli
brain
isoform
b
found
aggreg
isoform
thought
initi
aggreg
process
mechan
must
regul
avoid
toxic
amyloidrel
speci
occur
amyloid
diseas
previou
data
suggest
might
abl
bind
lipid
membran
membran
bind
affect
aggreg
mani
amyloidform
protein
investig
potenti
membran
bind
well
lipid
membran
bind
affect
amyloid
aggreg
use
circular
dichroism
electron
paramagnet
reson
epr
identifi
bind
lipid
vesicl
also
use
transmiss
electron
microscopi
epr
track
amyloid
format
time
without
lipid
vesicl
present
show
bind
anion
small
unilamellar
vesicl
suv
use
ntermin
amphipath
helix
charg
import
vesicl
bind
well
high
degre
membran
curvatur
also
show
presenc
anion
suv
inhibit
amyloid
format
open
door
regulatori
role
membran
format
function
amyloid
fibril
neurotransmitt
noradrenalin
bind
asynuclein
modul
structur
aggreg
properti
priyanka
singh
rajiv
bhat
jawaharl
nehru
univers
parkinson
diseas
pd
character
deterior
dopamin
da
neuron
substantia
nigra
par
compacta
along
substanti
loss
noradrenalin
na
neuron
locu
coeruleu
major
sourc
na
brain
thu
investig
interact
na
asynuclein
asyn
major
protein
constitu
lewi
bodi
patholog
hallmark
pd
tissu
express
noredrenalin
report
high
hippocampu
neocortex
striatum
thalamu
cerebellum
region
brain
site
asyn
predominantli
express
suggest
na
might
interact
asyn
possibl
na
could
bind
asyn
modul
aggreg
propens
kinet
could
affect
onset
parkinson
diseas
evalu
thermodynam
paramet
bind
na
asyn
use
isotherm
titrat
calorimetri
steadi
state
fluoresc
investig
conform
aggreg
aspect
use
circular
dichroism
dl
fluoresc
spectroscopi
bind
isotherm
na
asyn
observ
exotherm
natur
appar
bind
constant
millimolar
rang
suggest
weak
interact
na
significantli
suppress
asyn
aggreg
concentr
depend
manner
promot
alpha
helic
structur
format
speci
form
smaller
size
differ
morpholog
shown
tem
speci
also
observ
toxic
human
neuroblastoma
cell
studi
mtt
cytotox
assay
studi
signifi
role
noradrenalin
pd
could
help
develop
altern
strategi
cure
parkinson
diseas
numer
studi
report
glycosaminoglycan
gag
acceler
amyloid
assembl
peptid
protein
whose
aggreg
associ
amyloidrel
diseas
gag
unbranch
polysaccharid
abund
cell
surfac
extracellular
matrix
sulfat
polysaccharid
associ
virtual
amyloid
extract
analyz
patient
afflict
protein
misfold
diseas
strikingli
gag
mediat
amyloid
assembl
aggregationpron
polypeptid
also
fibrilis
numer
nonamyloidogen
protein
mechan
gag
favor
peptid
selfassembl
howev
still
matter
activ
debat
use
nonamyloidogen
highli
solubl
peptid
model
investig
mechan
neurohormon
nonpathogen
stabl
solut
nonaggreg
presenc
low
molecular
weight
heparin
lmwh
readili
form
amyloidlik
fibril
interestingli
rapidli
adopt
ahel
structur
upon
bind
sulfat
gag
conform
observ
lag
phase
amyloid
reaction
prolong
incub
secondarystructur
transit
conform
observ
amyloid
natur
assembl
confirm
atom
forc
microscopi
transmiss
electron
microscopi
circular
dichroism
spectroscopi
thioflavint
fluoresc
studi
whether
ahel
structur
essenti
gagmedi
amyloidogen
pathway
two
synthet
variant
reduc
helic
fold
propens
design
conform
restrict
peptid
abl
form
amyloid
fibril
despit
increas
resist
ahelix
format
lag
phase
kinet
observ
reduc
variant
suggest
format
helic
structur
presenc
gag
obligatori
step
mechan
amyloid
fibril
format
tyrosin
nitrat
histidin
carbonyl
modul
immunoglobulin
light
chain
structur
stabil
amyloidogenec
ximena
zottig
steve
bourgault
universit
e
du
qu
ebec
montr
eal
uqam
light
chain
amyloidosi
al
common
form
system
amyloidosi
origin
plasma
cell
prolifer
lethal
diseas
primarili
character
overproduct
immunoglobulin
light
chain
lc
follow
patholog
deposit
amyloid
fibril
extracellular
space
vital
organ
caus
organ
dysfunct
nonenzymat
posttransl
modif
ptm
profoundli
affect
protein
properti
shown
contribut
pathogenesi
sever
protein
misfold
diseas
howev
known
ptm
effect
lc
amyloidogen
investig
impact
oxid
ptm
particularli
carbonyl
hydroxynonen
hne
oxid
nitrat
structur
thermodynam
stabil
aggreg
wil
lc
variabl
domain
germlin
initi
identifi
residu
prone
oxid
chemic
modif
lcmsm
analysi
perform
pepsin
digest
subsequ
note
hnecarbonyl
specif
residu
nitrat
precis
tyr
side
chain
modul
wil
propens
selfassembl
form
thtposit
fibrillar
aggreg
nitrat
appear
acceler
format
aggreg
low
crosssheet
quaternari
structur
effect
associ
decreas
thermodynam
stabil
contrast
hneconjug
specif
imidazol
group
affect
structur
stabil
although
alter
conform
convers
drive
aggreg
process
effect
lc
wil
aggreg
structur
stabil
note
oxid
wil
ptm
thu
thermodynam
stabil
physicochem
structur
properti
consid
concomitantli
evalu
amyloidogen
propens
lc
variabl
domain
context
al
preeclampsia
pregnancyspecif
disord
share
typic
pathophysiolog
featur
protein
misfold
disord
includ
alzheim
diseas
despit
much
progress
understand
protein
aggreg
process
factor
govern
aggreg
rate
stabil
oligom
fulli
understood
work
perform
allatom
explicit
solvent
simul
forc
field
reveal
relationship
aggreg
rate
mechanost
bind
energi
amyloidogen
peptid
studi
two
model
peptid
oligom
compos
fvflm
peptid
overrepres
urin
women
preeclampsia
klvff
peptid
beta
amyloid
simul
demonstr
mechanost
peptid
oligom
strongli
correl
bind
energi
larger
mechanost
stronger
bind
energi
extent
superior
mechanost
fvflm
compar
klvff
quantifi
subject
steer
molecular
dynam
bind
free
energi
fvflm
klvff
system
calcul
potenti
mean
forc
curv
obtain
extens
umbrella
sampl
simul
clearli
establish
fvflm
better
binder
klvff
studi
indic
oligom
format
time
strongli
correl
stabil
faster
aggreg
rate
peptid
stronger
note
mechan
stabil
bind
free
energi
studi
show
peptid
bind
affin
might
accur
predict
use
either
mechan
stabil
oligom
format
rate
refer
univers
waterloo
mutat
human
cu
znsuperoxid
dismutas
link
fatal
neurodegen
diseas
amyotroph
later
sclerosi
al
increas
evid
suggest
al
onset
andor
progress
may
due
toxic
misfold
aggreg
mutant
protein
overexpress
e
coli
result
format
insolubl
intracellular
protein
aggreg
refer
inclus
bodi
ib
undergo
multipl
posttransl
modif
vivo
includ
bind
one
cu
one
zn
ion
per
monom
format
intramonom
disulfid
bond
dimer
form
matur
holo
protein
find
gener
less
stabl
immatur
nonmetal
form
increas
propens
aggreg
vitro
wide
rang
extent
ib
format
alslink
mutant
differ
condit
temperatur
ad
metal
ib
format
decreas
growth
condit
low
temperatur
addit
zn
indic
protein
may
partial
rescu
bind
zn
consid
implic
find
role
mutant
aggreg
diseas
polyamin
enhanc
aggreg
fold
protein
case
studi
bovin
carbon
anhydras
polyamin
pa
ubiquit
express
cellular
hydrocarbon
contain
one
aamino
group
particip
multipl
cellular
mechan
includ
cell
divis
protein
synthesi
etc
pa
physiolog
level
tightli
regul
low
level
could
inhibit
cell
progress
higher
concentr
aid
carcinogenesi
howev
conform
diseas
level
known
escal
aggrav
diseas
condit
increas
rate
protein
aggreg
sinc
pa
normal
cell
low
concentr
cancer
cell
high
concentr
never
report
induc
protein
aggreg
specul
disord
protein
aggreg
enhanc
pa
verifi
investig
effect
human
pa
aggreg
bovin
carbon
anhydras
bca
fulli
fold
protein
use
variou
probe
includ
uvvi
fluoresc
cd
spectroscopi
electron
microscopi
etc
surprisingli
found
pa
enhanc
bca
aggreg
indic
protein
structur
integr
play
role
pa
mediat
aggreg
modul
intrigu
curios
understand
mechan
employ
pa
enhanc
protein
aggreg
firstli
investig
import
pa
charg
state
aid
aggreg
enhanc
properti
evalu
bca
aggreg
profil
presenc
pa
ph
condit
greater
pk
pa
aamino
group
secondli
analys
differ
extent
aggreg
promot
propens
measur
term
final
aggreg
rate
aggreg
lag
time
pa
differ
hydrocarbon
chain
length
putrescin
spermidin
spermin
see
tabl
result
analysi
reveal
charg
state
hydrophob
residu
pa
enhanc
proteinprotein
interact
aggrav
protein
aggreg
find
believ
open
novel
therapeut
target
modul
protein
aggreg
thu
conform
diseas
amyloidogenesi
associ
diseas
mechan
involv
remain
larg
unknown
de
novo
design
protein
favor
conform
form
amyloidlik
fibril
west
et
al
proc
natl
acad
sci
usa
tendenc
differ
depend
subcellular
local
eukaryot
cell
olzscha
et
al
cell
woerner
et
al
scienc
moreov
difficult
express
purifi
e
coli
due
pronounc
tendenc
aggreg
make
difficult
studi
experiment
aim
investig
whether
ntermin
mutant
domain
nt
spider
draglin
silk
protein
spidroin
kronqvist
et
al
nat
commun
press
use
solubl
tag
prevent
aggreg
express
purif
enabl
control
aggreg
fusion
protein
nt
recombinantli
produc
e
coli
level
solubl
protein
analyz
sdspage
fibril
format
secondari
structur
determin
kinet
assay
use
thioflavin
tht
report
circular
dichroism
spectroscopi
respect
result
sdspage
reveal
high
amount
monomer
solubl
fusion
protein
obtain
proteolyt
releas
nt
tag
allow
control
aggreg
support
tht
kinet
assay
furthermor
structur
studi
show
adopt
ph
depend
conform
find
support
nt
prevent
aggreg
allow
structur
studi
perform
method
may
facilit
investig
amyloid
format
protein
could
aid
identif
potenti
antiamyloid
strategi
preval
devast
patholog
associ
amyloidogen
disord
prompt
search
compound
could
inhibit
fibrillogenesi
diseas
associ
protein
mitig
toxic
associ
onpathway
intermedi
fibril
polyphenol
resveratrol
exhibit
potent
amyloidmodul
properti
toward
number
amyloidogen
protein
present
studi
effect
investig
amyloid
fibril
format
human
lysozym
hul
associ
nonneuropath
system
amyloidosi
use
rang
biophys
techniqu
shown
resveratrol
interfer
earli
event
fibril
pathway
hul
potent
inhibit
amyloid
fibril
format
bind
weak
moder
affin
conform
popul
earli
stage
pathway
alongwith
stabil
conform
molecular
dock
approach
reveal
bind
resveratrol
aggregationpron
region
hul
combin
hydrogen
bond
hydrophob
interact
without
perturb
activ
margin
decreas
hul
lifetim
observ
presenc
resveratrol
timeresolv
fluoresc
measur
indic
involv
complex
format
hul
resveratrol
structur
activ
analys
show
retent
nearn
conform
hul
presenc
resveratrol
an
bind
analysi
seed
experi
mtt
cytotox
analysi
reveal
presenc
resveratrol
fibril
pathway
modul
toward
lesshydrophob
lesstox
offpathway
aggreg
result
demonstr
potenti
resveratrol
remark
modul
hul
aggreg
toxic
suggest
potenti
possibl
therapeut
agent
lysozym
amyloidosi
endocytosi
essenti
process
requir
nutrient
uptak
regul
plasma
membran
composit
signal
despit
knowledg
accumul
along
year
process
mechan
mediat
spatialtempor
recruit
protein
endocyt
site
still
fulli
understood
howev
project
aim
chang
situat
introduc
concept
prionlik
behavior
forc
drive
assembl
endocyt
complex
evid
collect
lab
indic
similar
prion
yeast
homolog
endocyt
protein
epsin
oligomer
vitro
display
cooper
bind
biolog
membran
vitro
vivo
b
interestingli
contain
polyglutamin
stretch
prion
form
domain
pfd
shown
display
prionlik
aggreg
presenc
wellknown
prion
conformationinduc
support
idea
link
prionlik
behavior
endocytosi
chaperon
respons
break
prioncomplex
also
wellknown
factor
involv
disassembl
endocyt
machineri
summari
project
introduc
concept
priondriven
interact
process
endocyt
site
assembl
addit
experiment
result
led
develop
quantit
mathemat
model
base
final
found
mammalian
epsinfamili
member
well
adaptor
protein
also
show
pfd
suggest
prionlik
behavior
play
evolutionari
role
vesicl
traffick
monom
neurotox
oligom
fibril
plaqu
aggreg
preced
misfold
step
monom
difficult
gather
experiment
evid
elucid
mechan
hypothes
exist
consist
structur
featur
despit
peptid
assum
intrins
disord
structur
dynam
studi
base
start
structur
multipl
replic
use
standard
anneal
molecular
dynam
simul
mdss
aqueou
solut
combin
cluster
princip
compon
analysi
cartesian
coordin
secondari
structur
analysi
frequenc
contact
matric
identifi
common
characterist
monom
although
disord
peptid
consist
secondari
structur
propens
close
interact
termini
amphipath
natur
includ
sampl
simul
also
construct
rel
freeenergi
landscap
captur
conform
space
monom
studi
intrins
disord
structur
use
md
challeng
problem
demonstr
work
possibl
extract
insight
wide
sampl
even
though
solut
made
set
highli
divers
tertiari
structur
engag
distinct
tau
speci
differ
inhibitori
effect
amyloid
format
reaction
recent
develop
comput
biolog
abl
investig
divers
via
conserv
analysi
regard
function
import
region
enzym
first
enzym
studi
class
ribonucleotid
reductas
rnr
class
rnr
divid
sever
subclass
accord
chemic
mechan
figur
potenti
altern
mechan
perform
sequenc
conserv
analysi
site
around
activ
center
queri
annot
class
rnr
protein
databas
compar
sequenc
pattern
wellcharacter
subclass
success
identifi
set
variant
distinct
pattern
structur
model
analysi
one
set
variant
term
nrdf
suggest
novel
chemic
mechan
differ
canon
one
complement
test
nrdf
ecoli
confirm
vivo
enzymat
activ
detail
mechanist
studi
perform
addit
rnr
appli
pipelin
examin
feakgdepend
enzym
superfamili
well
base
conserv
pattern
propos
critic
site
might
respons
altern
chemistri
perform
differ
subgroup
strategi
leverag
structur
biolog
bioinformat
exhibit
power
identifi
altern
mechan
class
rnr
priorit
list
novel
rnr
candid
also
appli
method
enzym
system
identifi
critic
sitespattern
associ
certain
specif
reaction
brett
jani
michael
menz
univers
louisvil
comput
conform
late
embryogenesi
abund
lea
protein
belong
three
lea
classif
group
analyz
use
sever
bioinformat
program
protein
found
anhydrobiot
life
without
water
cyst
crustacean
artemia
franciscana
anim
known
express
lea
protein
one
classif
group
lea
protein
hypothes
limit
function
hydrat
state
undergo
conform
transit
desicc
activ
order
confer
desicc
toler
anhydrobiot
organ
result
suggest
group
intrins
disord
hydrat
state
may
undergo
conform
shift
termini
respons
desicc
increas
morf
potenti
toward
cterminu
group
lea
protein
afrleai
show
structur
varieti
expect
within
singl
lea
group
afrleai
may
form
amphipath
ahelix
bundl
interact
phospholipid
bilay
andor
monolay
contrast
unusu
high
mean
net
charg
compar
lea
protein
contain
repeat
amino
acid
sequenc
group
lea
protein
contain
sever
repeat
seed
matur
protein
smp
domain
acid
long
region
enrich
prolin
suggest
limit
conform
flexibl
studi
suggest
high
degre
structur
variabl
within
lea
group
indic
lea
classif
group
may
correspond
potenti
function
protein
bioinformat
tool
may
provid
insight
individu
role
anhydrobiosi
work
fund
nsf
last
twenti
year
static
view
natur
protein
base
sole
tertiari
quaternari
structur
complet
chang
shown
protein
structur
determin
fluctuat
dynam
dynam
key
element
protein
perform
function
one
interest
manifest
protein
dynam
allosteri
bind
effector
molecul
one
site
often
result
longrang
conform
chang
protein
structur
alloster
commun
mechan
wide
use
natur
regulatori
purpos
recent
attempt
deciph
characterist
residu
constitut
alloster
commun
path
studi
annot
protein
alloster
databas
asd
belong
four
differ
class
kinas
nuclear
receptor
peptidas
transcript
factor
tri
deciph
consist
pattern
inher
alloster
commun
subsystem
acss
graphtheoret
approach
acsss
unveil
interest
pattern
term
individu
collect
effect
residu
along
physic
effect
present
studi
took
step
tri
learn
pattern
represent
exhibit
acss
resid
use
deep
convolut
neural
network
use
learn
represent
aim
classifi
given
residu
belong
acss
preliminari
data
obtain
us
encourag
show
deep
learn
improv
predict
residu
constitut
alloster
commun
path
method
improv
futur
growth
size
asd
identif
structur
determin
transglycosyl
function
alphaamylas
enzym
famili
residu
contact
analysi
rodrigo
arreolabarroso
gloria
saabrinc
institut
biotechnolog
unam
mexico
mani
drug
contain
sugar
moeiti
howev
attach
sugar
molecul
cumbersom
process
tradit
chemistri
requir
mani
step
ensur
regio
chemo
stereospecif
reaction
enzym
perform
task
singl
step
although
usual
need
nucleotid
activ
substrat
alphaamylas
famili
employ
readili
avail
starch
substrat
member
break
starch
smaller
glucos
chain
hydrolyisi
reaction
other
abl
transfer
sugar
unit
sugar
chain
transglycosyl
even
differ
hydroxyl
acceptor
capabl
perform
reaction
within
famili
open
opportun
identifi
structur
determin
transferas
reaction
work
analyz
residu
contact
alphaamylas
famili
identifi
possibl
mutat
site
far
catalyt
center
modifi
prefer
transfer
measur
transfer
glucos
unit
butanol
hydrolysi
alphaamylas
enzym
elliott
stollar
tom
brown
raj
shevagani
nick
brown
eastern
new
mexico
univers
usa
need
develop
bioinformat
predict
protein
function
especi
member
domain
famili
share
common
fold
yet
may
uniqu
function
illustr
approach
investig
member
yeast
domain
famili
figur
encod
specif
inform
bind
uniqu
peptid
target
approach
identifi
import
specif
residu
show
littl
conserv
within
align
yeast
domain
famili
member
paralog
yet
conserv
align
given
domain
nonredund
ancestor
ortholog
unlik
sequenc
align
approach
make
distinct
domain
ortholog
domain
paralog
instead
group
domain
famili
sequenc
togeth
lose
critic
insight
approach
find
yeast
domain
famili
member
evolv
uniqu
amino
acid
conserv
pattern
suggest
bind
peptid
target
high
intrins
specif
minor
predict
less
divers
bind
surfac
like
requir
addit
factor
bind
target
specif
predict
consist
previous
determin
protein
structur
recent
evolutionari
spot
bind
data
furthermor
import
secondari
bind
site
alloster
pathway
structur
extens
identifi
within
famili
approach
use
probe
intrins
bind
specif
interact
domain
famili
maintain
evolut
recent
conceiv
implement
new
approach
call
scratch
explor
protein
structur
sequenc
space
scratch
combin
two
method
attract
recent
attent
use
small
modular
protein
tertiari
structur
motif
describ
build
protein
structur
rich
inform
provid
deep
multiplesequ
align
msa
method
decompos
protein
structur
ppi
interfac
small
modular
overlap
structur
tertiari
motif
term
residu
queri
databas
singlechain
protein
structur
msa
correspond
structur
match
region
obtain
pfam
databas
use
learn
sequenc
prefer
term
use
multivari
normal
distribut
mnd
statist
framework
fragment
stitch
togeth
use
statist
score
scratch
benchmark
method
independ
protein
bind
affin
test
set
contain
data
point
preliminari
result
show
predict
power
compar
known
structurebas
method
sever
benefit
approach
first
requir
allatom
model
thu
rapidli
evalu
huge
sequenc
space
model
target
structur
deriv
second
method
provid
intuit
way
visual
entir
sequenc
landscap
associ
given
fold
complex
final
formal
make
easi
look
landscap
chang
constraint
impos
ident
certain
residu
structur
flexibl
enzym
upon
bind
ligand
activ
site
use
estim
entropi
ensembl
contact
matric
zaahirah
qazi
christian
blouin
stephen
l
bearn
contact
map
wide
use
repres
protein
structur
extend
concept
aggreg
contact
matric
across
homolog
sampl
defin
frequenc
contact
matric
fcm
fcm
encod
frequenc
contact
side
chain
homolog
site
sinc
contact
site
constant
possibl
deriv
sitewis
contact
entropi
data
use
tool
analyz
gener
sitewis
contact
entropi
set
protein
structur
without
ligand
bound
work
specif
investig
effect
ligand
bind
side
chain
contact
residu
close
activ
site
structurefunct
linkag
databas
sfld
use
defin
dataset
enzym
enolas
superfamili
divid
subgroup
calcul
shannon
entropi
residu
contact
across
fcm
measur
side
chain
freedom
residu
result
show
contact
entropi
residu
buri
insid
protein
higher
compar
entropi
residu
locat
peripheri
result
also
show
ligandbound
protein
subgroup
degre
freedom
residu
close
bind
site
similar
protein
ligandbound
activ
site
nichola
newel
beta
turn
constitut
quarter
protein
structur
commonli
classifi
central
ramachandran
angl
small
set
type
provid
lowresolut
pictur
varieti
turn
geometri
favor
conform
import
amino
acidspecif
featur
work
address
limit
appli
beta
turn
method
author
recent
use
map
helixtermin
structur
bmc
bioinformat
leastsquar
cartesianspac
backbon
cluster
algorithm
partit
turn
desir
resolut
find
bestfit
repres
exemplar
structur
cluster
distribut
turn
across
conform
depict
heat
map
display
set
exemplar
color
width
set
proport
turn
abund
correspond
cluster
statist
featur
detect
appli
sequenc
turn
cluster
detect
signific
amino
acidspecif
featur
involv
one
two
three
residu
distribut
abund
overrepresent
featur
across
conform
depict
individu
heat
map
featur
width
color
cluster
exemplar
global
turn
map
provid
unifi
highresolut
pictur
turn
structur
cartesian
space
determin
detail
conform
prefer
previous
known
unknown
aminoacid
specif
featur
includ
involv
asp
asn
glu
pro
gli
aid
understand
structur
consequ
diseaseinduc
mutat
result
helix
termini
studi
alreadi
done
use
protein
design
small
heat
shock
protein
shsp
famili
molecular
chaperon
broadli
employ
across
mani
organ
prevent
aggreg
partial
unfold
protein
substrat
defin
featur
shsp
abil
form
dynam
polydispers
oligom
exhibit
subunit
exchang
certain
condit
physiolog
relev
oligomer
mode
chaperon
function
remain
undetermin
shsp
contain
canon
acrystallin
domain
acd
domain
flank
nand
ctermin
region
ntr
ctr
respect
vari
length
sequenc
believ
particip
substrat
quaternari
interact
previou
studi
identifi
minichaperon
fragment
acd
demonstr
chaperon
activ
interact
substrat
protein
prevent
aggreg
order
identifi
function
region
shsp
purifi
rel
unstructur
ntermin
sequenc
human
use
two
model
substrat
malat
dehydrogenas
mdh
citrat
synthas
cs
identifi
sequenc
exhibit
chaperon
activ
solut
determin
import
oligomer
organ
multival
interact
chaperon
activ
construct
gold
nanoparticl
aunp
append
ntr
shspaunp
exhibit
chaperon
activ
efficaci
vari
substrat
excit
result
observ
shspaunp
activ
chaperon
citrat
synthas
unconjug
shsp
ntr
final
result
indic
import
ntr
chaperon
activ
demonstr
therapeut
potenti
shspaunp
steven
johnson
sanofar
abde
trent
kunkl
nilshad
salim
andrew
ambros
eli
chapman
iu
school
medicin
indiana
usa
ua
colleg
pharmaci
arizona
usa
prolong
use
misus
antibiot
led
emerg
drug
resist
bacteria
effect
therapi
sever
lack
illustr
rise
multidrugresist
staphylococcu
aureu
mrsa
strain
kill
peopl
us
year
counter
rise
bacteri
superbug
requir
develop
new
antibiot
target
previous
unexploit
biolog
pathway
toward
goal
object
research
identifi
antibacteri
candid
target
bacteri
groel
chaperonin
system
groel
chaperonin
system
distinct
class
molecular
chaperon
essenti
cell
viabil
molecular
machin
assist
proper
fold
function
numer
cellular
protein
block
chaperon
function
lead
multipathway
collaps
death
bacteria
previous
identifi
sever
hundr
inhibitor
escherichia
coli
groel
chaperonin
system
highthroughput
screen
campaign
counterscreen
subset
groel
inhibitor
seri
chaperoninmedi
biochem
cellviabl
assay
recent
identifi
hit
inhibitor
cytocid
gramposit
bacteria
includ
mrsa
subsequ
medicin
chemistri
derivat
initi
hit
scaffold
identifi
analog
exhibit
submicromolar
antibacteri
effect
therapeut
window
compar
human
liver
kidney
cell
toxic
groel
inhibitor
function
uniqu
mechan
appear
ultim
prevent
groel
engag
groe
cochaperon
therebi
block
refold
cycl
promis
vitro
result
encourag
continu
optim
novel
groelestarget
antibacteri
candid
efficaci
test
vivo
bacteri
infect
model
androgen
receptor
ar
transcript
factor
activ
androgen
regul
express
male
phenotyp
regul
androgen
prostat
cell
depend
ar
activ
prolifer
thu
ar
import
therapeut
target
prostat
cancer
prior
activ
androgen
receptor
bound
molecular
chaperon
cytosol
androgen
bind
caus
dissoci
complex
lead
format
activ
state
ar
capabl
transloc
nucleu
studi
molecular
interact
transactiv
domain
ntd
ar
high
resolut
use
solut
nmr
found
stabil
inact
form
ar
recogn
specif
ntermin
motif
also
interact
ctermin
ligand
bind
domain
lbd
upon
androgen
activ
result
reveal
act
holdas
inact
state
ar
prevent
interact
n
ctermin
domain
characterist
activ
state
import
drug
target
dynam
membran
proteinchaperon
interact
particl
small
atpindepend
chaperon
necessari
suffici
prevent
revers
aggreg
lightharvest
chlorophyllbind
protein
lhcp
class
membran
protein
involv
photosynthesi
object
explor
natur
substratechaperon
interact
elucid
role
conform
chang
complex
format
use
combin
mutagenesi
light
scatter
fluoresc
anisotropi
establish
interact
site
chaperonesubstr
complex
moreov
mutat
bridg
helix
bh
domain
help
establish
cofactor
role
modul
conform
electron
paramagnet
reson
epr
analysi
illumin
natur
conform
chang
ankyrin
repeat
bh
region
substrat
bind
domain
sbd
chaperoneproteas
clpxp
recogn
degrad
ftsz
polym
multival
recognit
strategi
escherichia
coli
marissa
viola
jodi
camberg
univers
rhode
island
rhode
island
usa
atpdepend
chaperoneproteas
clpxp
degrad
tubulin
homolog
ftsz
cell
divis
promot
subunit
exchang
divis
septum
clpxp
compris
hexamer
clpx
ring
recogn
unfold
transloc
substrat
clpp
serin
proteas
degrad
ftsz
polym
assembl
ringlik
structur
midcel
divis
ftsz
contain
globular
polymer
domain
residu
disord
linker
residu
structur
cterminu
residu
clpx
recogn
ftsz
disord
linker
residu
extrem
cterminu
residu
purifi
ftsz
contain
mixtur
monom
dimer
determin
recognit
site
util
degrad
monom
engin
chimer
protein
contain
gfp
fuse
ctermin
residu
ftsz
gfpz
contain
linker
cterminu
monitor
degrad
loss
fluoresc
gfpz
degrad
inhibit
xb
peptid
contain
residu
import
direct
interact
sspb
adaptor
clpx
ndomain
known
impair
ftsz
degrad
incub
xb
peptid
gfpz
contain
mutat
linker
degron
also
prevent
degrad
clpxp
chimera
lack
ctermin
degron
gfpz
degrad
clpxp
result
suggest
ndomain
depend
clpx
substrat
linker
degron
dispens
degrad
ftsz
monom
contrast
degrad
fluoresc
ftsz
polym
impair
linker
degron
significantli
reduc
suggest
linker
degron
import
polym
recognit
data
suggest
clpxp
use
two
site
enhanc
recognit
ftsz
polym
wherea
ftsz
monom
util
one
escherichia
coli
modul
assembl
ftsz
tubulin
homolog
e
coli
anuradha
balasubramanian
monica
markovski
sue
wickner
laboratori
molecular
biolog
nation
cancer
institutenih
usa
heat
shock
protein
highli
conserv
atp
depend
molecular
chaperon
involv
remodel
activ
stabil
client
protein
client
protein
identifi
sever
client
e
coli
homolog
identifi
function
unknown
howev
overexpress
cell
becom
filament
filament
exhibit
distinct
nucleoid
indic
overexpress
affect
chromosom
segreg
assess
overexpress
interf
cell
divis
machineri
test
ftsz
tubulin
homolog
essenti
cell
divis
assembl
ringlik
structur
futur
site
cell
divis
cell
overexpress
unabl
detect
ftsz
ring
overexpress
cell
observ
ftsz
present
normal
level
cell
overexpress
test
hypothesi
prevent
ftsz
polymer
use
purifi
protein
fluoresc
label
ftsz
observ
fluoresc
microscopi
ftsz
form
polym
absenc
presenc
addit
show
light
scatter
ftsz
polym
inhibit
ad
prior
polymer
clientbind
defect
mutant
exhibit
reduc
abil
inhibit
ftsz
polymer
summari
data
show
overexpress
inhibit
divisom
assembl
vivo
prevent
ftsz
polymer
vitro
result
suggest
modul
cell
divis
interact
hold
ftsz
possibl
slow
cell
divis
heat
stress
stress
ravaviaa
chaperonelik
system
modul
activ
respiratori
chain
complex
vaibhav
bhandari
keith
wong
protein
moxr
famili
propos
chaperonelik
activ
modul
protein
assembl
insert
cofactor
substrat
protein
genet
analysi
group
reveal
gene
encod
moxr
atpas
often
found
close
proxim
protein
contain
von
willebrand
factor
vwa
domain
order
gain
insight
relationship
among
group
protein
function
analysi
perform
escherichia
coli
moxr
repres
protein
rava
vwa
domain
partner
viaa
experiment
found
rava
viaa
function
associ
anaerob
respir
e
coli
express
analysi
rava
viaa
gene
show
coexpress
sever
anaerob
respiratori
gene
mani
regul
anaerob
transcript
regul
fnr
inde
express
rava
viaa
found
depend
fnr
anaerob
grown
cell
furthermor
viaa
found
physic
interact
frda
flavincontain
subunit
anaerob
electron
transport
complex
fumar
reductas
frd
rava
fescontain
subunit
frd
complex
frdb
regul
interact
importantli
frd
activ
observ
increas
absenc
rava
viaa
indic
rava
viaa
modul
activ
frd
complex
signifi
potenti
regulatori
function
ravaviaa
bacteri
anaerob
respir
fumar
termin
electron
acceptor
bricho
molecular
chaperon
activ
decoupl
abil
inhibit
amyloid
fibril
format
gefei
chen
axel
abelein
axel
leppert
simon
tambaro
henrik
jenni
presto
jan
johansson
karolinska
institutet
sweden
bricho
domain
contain
amino
acid
associ
neurodegen
amyloid
diseas
eg
alzheim
diseas
ad
vitro
vivo
studi
bricho
much
effici
prospc
bricho
inhibit
peptid
fibril
recent
data
show
prospc
bricho
abl
effici
suppress
destabil
model
protein
aggreg
hypothes
differ
quaternari
structur
prospc
bricho
underli
differ
abil
work
molecular
chaperon
method
human
bricho
protein
recombinantli
produc
e
coli
analyz
chromatographi
mass
spectrometri
western
blot
thioflavin
assay
nmr
spectroscopi
cd
spectroscopi
chaperon
activ
assay
found
bricho
dimer
assembl
larger
polydispers
oligom
partli
link
interchain
disulfid
bridg
interestingli
bricho
oligom
effici
inhibit
aggreg
thermodenatur
citrat
synthas
cs
wherea
monom
dimer
ineffici
convers
small
size
speci
much
effici
larg
oligom
suppress
fibril
format
block
secondari
nucleat
elong
process
furthermor
incub
isol
monomer
bricho
presenc
mous
serum
result
format
larger
oligom
even
number
subunit
oligom
potent
inhibit
cs
aggreg
abil
prevent
fibril
format
reduc
decoupl
molecular
chaperon
activ
antiamyloid
abil
bricho
domain
vitro
suggest
activ
vivo
regul
environment
condit
chaperoneclientinteract
basic
principl
role
health
diseas
sebastian
hiller
orn
burmann
irena
burmann
roland
riek
silvia
campioni
juan
gerez
pratibha
kumari
stefan
udig
biozentrum
univers
basel
switzerland
eth
zurich
switzerland
utrecht
univers
netherland
molecular
chaperon
essenti
cellular
protein
homeostasi
central
aspect
chaperon
function
still
well
understood
atom
level
includ
chaperon
recogn
client
conform
state
client
bound
employ
highresolut
nmr
spectroscopi
main
method
address
question
initi
work
periplasm
holdas
skp
provid
first
atomiclevel
descript
natur
fulllength
chaperonecli
complex
extens
model
system
reveal
chaperon
spi
select
recogn
flexibl
local
frustrat
region
partial
fold
client
highli
dynam
fashion
interact
site
ident
chaperon
highlight
gener
principl
govern
client
recognit
util
mechanist
insight
investig
role
chaperon
parkinson
diseas
parkinson
common
neurodegen
disord
patholog
manifest
intracellular
accumul
aggreg
protein
asynuclein
systemat
investig
array
chaperon
identifi
gener
interact
motif
asynuclein
aminoterminu
interact
preserv
insid
live
mammalian
cell
incel
nmr
experi
show
target
knockdown
chaperon
cell
trigger
membraneinteract
asynuclein
concomit
aggreg
format
posttransl
modif
asynuclein
methionineoxid
specif
tyrosinephosphoryl
known
hallmark
parkinson
diseas
destroy
chaperon
interact
data
establish
molecular
chaperon
domin
interactor
asynuclein
healthi
cell
mechanist
demonstr
regul
function
provid
novel
therapeut
avenu
treatment
parkinson
diseas
refer
chaperon
famili
engag
mani
biolog
process
import
proteostasi
fold
polypopetid
nativ
state
prevent
aggreg
refold
misfold
protein
metazoan
cell
stress
condit
protein
aggreg
frequent
form
must
effect
elimin
order
avoid
potenti
patholog
condit
understand
disaggreg
process
human
import
sinc
activ
cellular
defens
sever
neurodegen
disord
caus
deposit
aggreg
inform
metazoan
cope
accumul
aggreg
limit
sinc
organ
express
aaa
disaggregas
found
yeast
bacteria
howev
recent
studi
shown
class
b
dnaj
protein
form
machineri
disaggreg
activ
moreov
shsp
yeast
seem
play
role
disaggreg
process
therefor
main
object
investig
system
role
human
shsp
disaggregas
activ
first
analys
abil
phosphorylationmim
mutant
tripl
prevent
luciferas
aggreg
measur
light
scatter
incub
observ
tripl
mutant
effici
bind
luciferas
maintain
solubl
also
perform
vitro
disaggreg
assay
use
aggreg
luciferas
show
tripl
mutant
import
disaggreg
luciferas
ubiquit
express
molecular
chaperon
assist
protein
fold
disaggreg
atp
depend
process
requir
jdomain
protein
stimul
atp
hydrolysi
nucleotid
exchang
displac
adp
also
upregul
mani
cancer
import
cancer
surviv
therefor
small
molecul
inhibitor
show
strong
promis
eventu
clinic
use
current
character
novel
alloster
inhibitor
cell
compound
decreas
refold
solubl
heatdenatur
luciferas
vitro
use
purifi
protein
compound
slow
atp
bind
furthermor
pulldown
assay
show
inhibitor
increas
luciferas
bind
suggest
compound
impair
releas
substrat
insight
mechan
action
inhibitor
provid
tool
understand
biolog
role
cancer
proteostasi
diseas
context
role
chaperonemedi
disaggreg
mammalian
system
kipunsam
lee
jason
young
yogita
patel
michael
wong
protein
aggreg
toxic
cell
number
neurodegen
diseas
result
accumul
mutant
misfold
protein
aggreg
molecular
chaperon
key
manag
misfold
protein
cell
cochaperon
mediat
protein
refold
direct
protein
degrad
either
ubiquitinproteasom
system
up
autophagi
howev
disaggreg
protein
mammalian
cell
well
understood
recent
disaggreg
complex
human
chaperon
assist
yeast
small
heat
shock
protein
observ
pure
protein
assay
studi
aim
demonstr
disaggreg
activ
elucid
mechan
core
disaggreg
machineri
mammalian
cell
thu
far
result
show
involv
disaggreg
cell
therefor
hypothes
import
role
mammalian
disaggreg
system
examin
mechan
involv
knockout
cell
line
mutant
abolish
interact
chaperon
gener
addit
also
address
disaggreg
relat
degrad
via
up
autophagi
studi
disaggreg
system
cell
allow
us
better
understand
protect
mechan
mammalian
cell
use
toxic
aggreg
thiago
seraphim
walid
houri
central
complex
modul
cellular
process
drive
cell
cycl
protein
genom
homeostasi
also
involv
chromatin
remodel
phosphatidylinositol
kinas
signal
apoptosi
tumorigenesi
group
discov
complex
interact
molecular
chaperon
assist
assembl
box
cd
small
nucleolar
ribonucleoprotein
snornp
core
snornp
factor
yeast
form
four
protein
member
superfamili
protein
kda
phosphopeptidebind
protein
kda
tetratricopeptid
motifcontain
protein
connect
despit
studi
regard
import
cellular
complex
lack
inform
structur
complex
interact
snornp
complex
order
fill
gap
use
structur
techniqu
determin
assembl
interact
snornp
use
combin
electron
microscopi
small
angl
xray
scatter
nuclear
magnet
reson
pulldown
experi
determin
structur
interfac
drive
assembl
found
assembl
hexamer
ring
altern
subunit
elong
heterodim
solut
identifi
two
heterocomplex
interact
via
rvb
insert
domain
ntermin
domain
also
found
ntermin
domain
also
bind
cterminu
propos
model
assembl
mechan
complex
bind
protect
aggreg
subsequ
load
onto
snornp
complex
christoph
wood
rachel
klevit
hallmark
life
abil
toler
withstand
stressor
varieti
sourc
includ
ischemia
oxid
acidosi
advers
cellular
condit
promot
local
unfold
protein
potenti
lead
aggreg
format
small
heat
shock
protein
shsp
among
first
respond
cellular
stress
function
atpindepend
chaperon
delay
format
aggreg
maintain
client
protein
solubl
refold
compet
state
shsp
share
domain
architectur
character
structur
central
conserv
acrystallin
domain
acd
nand
ctermin
sequenc
extens
variabl
length
conserv
amino
acid
ident
evid
indic
extens
heterogen
larg
disord
shsp
protom
small
kda
human
shsp
exist
larg
polydispers
oligom
kda
defi
tradit
method
structur
determin
missens
mutat
gene
encod
prototyp
human
shsp
also
known
abcrystallin
associ
autosom
domin
inherit
diseas
includ
cataract
myopathi
compar
contrast
effect
mutat
structur
function
character
three
diseaseassoci
mutat
locat
within
conserv
acrystallin
domain
nuclear
magnet
reson
nmr
heteronuclear
singl
quantum
coher
spectroscopi
hsqc
negativestain
electron
microscopi
vitro
function
assess
although
mutant
form
expand
oligom
effect
observ
acd
structur
chaperon
function
vari
substanti
current
work
model
relationship
structur
chaperon
function
present
report
new
famili
reagent
select
coval
derivat
hexahistidinetag
recombin
protein
reaction
involv
revers
format
ternari
metal
complex
reagent
imidazol
function
hexahistidin
tag
bival
metal
cation
follow
additionelimin
reaction
baylishillman
ester
function
reagent
noncoordin
imidazol
ring
hexahistidin
tag
reagent
use
introduct
fluoresc
label
click
cycloaddit
function
biotinyl
recombin
protein
use
equimolar
amount
reagent
protein
dilut
neutral
aqueou
solut
start
nm
concentr
methodolog
success
extend
derivat
surfac
nanoparticl
protein
approach
appear
gener
protein
bioconjug
techniqu
suitabl
derivat
hexahistidinetag
recombin
protein
use
simpl
uniform
procedur
xiaohua
zhang
david
kwan
glycosaminoglycan
serv
import
role
cell
commun
keratan
sulfat
exampl
glycosaminoglycan
exhibit
vari
biolog
function
neuron
develop
mainten
corneal
matrix
structur
also
known
restrict
neural
regener
injuri
format
glial
scar
overexpress
cancer
elucid
mechan
keratan
sulfat
mediat
signal
determin
interact
ligand
bind
protein
specif
keratan
sulfat
substructur
lead
therapeut
may
valuabl
treat
chronic
diseas
like
neural
damag
form
cancer
homogen
structur
keratin
sulfat
discret
length
defin
pattern
sulfat
synthes
use
glycosynthas
engin
keratanas
ii
mutat
activesit
glutam
aspart
residu
involv
catalyz
format
oxazolin
intermedi
sequenc
align
analysi
sever
candid
among
glutam
aspart
residu
conserv
among
enzym
reveal
six
residu
could
replac
alanin
preliminari
result
show
three
six
mutant
inact
react
natur
substrat
keratan
sulfat
activesit
inact
mutant
could
work
glycosynthas
synthes
homogen
keratan
sulfat
oligoand
polysaccharid
defin
length
sulfat
pattern
thu
use
probe
signal
interact
specif
keratan
sulfat
structur
determin
biolog
role
focus
neurolog
function
patholog
includ
cancer
hebrew
univers
jerusalem
israel
major
protein
form
oligom
rotat
symmetri
despit
mani
function
advantag
symmetr
pack
vast
major
protein
oligom
nearli
symmetr
key
question
field
protein
structur
therefor
symmetri
advantag
protein
stop
shi
perfect
symmetri
answer
question
appar
multiparametr
involv
minim
free
energi
dynam
protein
effect
surround
paramet
mechan
oligomer
first
step
address
question
convers
current
use
vagu
qualit
descript
languag
nearsymmetri
accur
quantit
measur
develop
quantit
method
capabl
analyz
whole
protein
backbon
select
portion
capabl
visual
variou
level
symmetri
deviat
form
symmetri
map
second
step
analyz
variou
paramet
affect
symmetri
distort
explor
enthalp
effect
prove
order
minim
enthalpi
aminoacid
interact
contact
zone
oligomer
subunit
give
away
symmetri
requir
also
look
oligomer
mechan
paramet
found
import
role
affect
final
oligom
symmetri
protein
oligom
memor
restrict
evolutionari
pathway
creation
translat
symmetri
distort
regul
gene
express
critic
cell
develop
function
lysin
methyl
histon
protein
wellrecogn
mean
epigenet
control
dysregul
lysin
methyl
implic
multipl
cancer
protein
interpret
methyl
state
lysin
refer
reader
protein
human
reader
util
cage
aromat
residu
interact
nmethyl
group
methyl
lysin
menk
residu
surprisingli
cationpi
interact
implic
major
contributor
menk
recognit
dougherti
cowork
first
studi
cationpi
interact
use
unnatur
amino
acid
uaa
expand
dougherti
approach
use
vivo
uaa
mutagenesi
trimethyllysin
reader
protein
two
tyrosin
residu
aromat
cage
heterochromatin
protein
drosophila
melanogast
mutat
uaa
variou
electronwithdraw
donat
group
k
recognit
monitor
isotherm
titrat
calorimetri
correl
bind
electrostat
potenti
uaa
rgroup
observ
residu
protein
crystallographi
confirm
chang
bind
due
chang
structur
one
posit
appear
exhibit
pronounc
effect
bind
like
due
orient
peptid
within
pocket
provid
knowledg
first
exampl
differenti
residuespecif
cationpi
effect
observ
reader
protein
current
investig
cationpi
interact
contribut
recognit
dimethyllysin
ligand
appli
methodolog
reader
protein
implic
human
diseas
protein
structur
initi
result
structur
genom
sg
protein
structur
deposit
pdb
mani
structur
incorrect
put
function
assign
unknown
biochem
function
addit
better
function
predict
sg
protein
add
substanti
valu
alreadi
accumul
structur
inform
approach
incorpor
structurebas
comput
chemic
properti
local
site
predict
follow
local
structur
match
first
partial
order
optimum
likelihood
pool
use
comput
predict
catalyt
import
residu
protein
structur
next
structur
align
local
site
activ
salsa
analyz
superfamili
develop
spatiallyloc
consensu
signatur
protein
known
function
function
famili
base
poolpredict
residu
function
character
residu
import
final
poolpredict
residu
sg
protein
compar
consensu
signatur
align
score
determin
degre
similar
local
activ
site
research
focus
two
enzym
superfamili
crotonas
superfamili
cs
glycosidas
superfamili
cs
comput
determin
function
mani
sg
protein
current
misannot
provid
better
put
function
assign
addit
assay
number
sg
protein
verifi
function
predict
correct
comput
demonstr
method
distinguish
substrat
specif
within
function
famili
main
goal
research
project
provid
valid
approach
function
annot
wider
applic
commun
includ
drug
discoveri
biofuel
product
support
dysregul
transcript
observ
nearli
human
diseas
thu
better
understand
transcript
regul
could
open
new
avenu
drug
develop
therapeut
intervent
sever
coactiv
creb
bind
protein
cbp
mediat
complex
util
kix
domain
interact
surfac
transcript
activ
kix
domain
contain
two
activ
interact
surfac
shown
vitro
commun
alloster
mani
question
still
remain
howev
includ
alloster
network
modul
transcript
activ
vivo
address
question
use
kix
domain
subunit
fungal
mediat
complex
model
system
develop
toolbox
probe
modul
kix
interact
librari
mutant
contain
nonn
cystein
residu
screen
use
tether
sitedirect
screen
strategi
identifi
ligand
kix
activ
bind
surfac
identifi
ligand
character
accord
rel
abil
act
chemic
cochaperon
stabil
uniqu
conform
kix
modul
activ
bind
orthoster
alloster
suit
chemic
cochaperon
use
saccharomyc
cerevisia
evalu
function
consequ
alloster
modul
activ
bind
transcript
activ
assay
anticip
result
studi
clarifi
role
allosteri
activatorkix
interact
expand
understand
activatorcoactiv
interact
regul
control
eukaryot
gene
transcript
enzym
aminoglycosid
phosphotransferas
aph
inactiv
aminoglycosid
antibiot
phosphoryl
therebi
confer
bacteri
resist
aph
inhibitor
could
potenti
resensit
resist
bacteria
therefor
clinic
interest
enzym
kinet
studi
aph
suggest
substrat
atp
requir
bind
first
follow
aminoglycosid
product
phosphoaminoglycosid
dissoci
rapidli
adp
dissoci
slowli
previou
studi
suggest
accumul
adp
might
compet
atp
enzym
activ
site
howev
inhibit
process
studi
commonli
use
coupl
assay
method
product
adp
isconvert
atp
pyruv
kinasew
therefor
develop
new
method
use
isotherm
titrat
calorimetri
itc
studi
kinet
mechan
aph
product
inhibit
adp
demonstr
first
time
adp
potent
competit
inhibit
aph
determin
kiadp
via
multipl
inject
itc
assay
give
unexpect
result
aph
iiia
bind
tightli
adp
atp
use
engin
oil
toxic
fauna
flora
alter
natur
process
accord
us
environment
protect
agenc
gallon
use
engin
oil
contamin
million
gallon
freshwat
toxic
oil
remain
constant
threat
manag
problem
phoenix
environ
qu
ebec
ca
recov
use
motor
oil
compon
could
recov
decontamin
biolog
project
identifi
class
molecul
present
repres
stock
wast
oil
proport
gcm
ftir
rmn
tga
analys
also
isol
screen
microorgan
found
phoenix
screen
bacteria
base
abil
grow
cultur
media
contain
use
motor
oil
microorgan
genet
identifi
subsequ
expos
bacteria
media
contain
use
engin
oil
expos
use
oil
fluoresc
compound
metabol
certain
bacteria
suggest
exist
metabol
pathway
potenti
involv
oilderiv
fluoresc
molecul
process
bacteria
also
abil
produc
green
bioproduct
bioplasticsbiopolym
use
use
engin
oil
nutrient
sourc
ftir
analysi
show
one
biopolym
produc
extracellularli
belong
petrochem
biopolym
sever
industri
applic
moreov
bacteria
show
abil
produc
polyhdroxyalkano
pha
intracellularli
base
preliminari
result
hope
identifi
biolog
avenu
could
help
better
manag
use
engin
oil
wast
work
establish
partnership
phoenix
could
lead
bioplast
product
use
engin
oil
androgen
receptor
ar
hormoneactiv
transcript
factor
ar
ntermin
domain
ntd
intrins
disord
function
recruit
basal
transcript
machineri
order
express
gene
relat
develop
male
phenotyp
gelmann
ep
arntd
recruit
basal
transcript
machineri
directli
interact
subunit
rnapolymeras
ii
mcewan
ij
found
short
motif
arntd
fold
alphahelix
conform
bound
affin
chemic
modifi
peptid
span
ar
interact
motif
measur
solut
nuclear
magnet
reson
cell
proximitylig
assay
order
low
micro
molar
affin
two
protein
arntd
high
helic
content
phosphoryl
specif
serin
residu
demol
e
manuscript
prepar
ar
activ
main
driver
prostat
cancer
pc
castrationresist
prostat
cancer
crpc
inhibit
arntd
proteinprotein
interact
ppi
gelmann
ep
could
repres
novel
therapeut
approach
treatment
pc
crpc
poster
show
biophys
cellular
characteris
arntd
ppi
ii
first
result
drug
discoveri
process
aim
find
small
molecul
hit
abl
disrupt
aforement
interact
northeastern
univers
massachusett
usa
dna
damag
constant
threat
endogen
exogen
sourc
damag
repair
unrepair
damag
bypass
yfamili
dna
polymeras
process
call
transles
synthesi
yfamili
dna
polymeras
e
coli
dinb
human
pol
kappa
specif
bypass
minor
groov
adduct
posit
deoxyguanin
block
major
groov
adduct
previous
shown
singl
point
mutat
activ
site
loop
dinb
elimin
discrimin
major
groov
adduct
work
creat
chimer
polymeras
swap
loop
region
adjac
activ
site
use
sitedirect
mutagenesi
assess
import
loop
damag
specif
activ
use
primer
extens
assay
dna
substrat
contain
minor
groov
adduct
major
groov
adduct
ethenoda
well
undamag
templat
found
loop
region
dinb
pol
kappa
near
catalyt
site
import
damag
bypass
specif
accuraci
nucleotid
incorpor
specif
human
pol
kappa
toler
substitut
activ
site
loop
dinb
creat
loop
swap
increas
understand
preferenti
bypass
major
groov
adduct
dinb
human
pol
kappa
accomplish
optim
lignocellulos
biomass
process
novel
high
throughput
approach
xylan
polysaccharid
track
surfac
fiber
vinay
khatri
fatma
meddebmouelhi
univers
quebec
troisrivieri
canada
background
xylan
identifi
physic
barrier
limit
cellulos
access
cover
outer
surfac
fiber
interfibrillar
space
therefor
track
xylan
prerequisit
understand
optim
lignocellulos
biomassbas
process
biofuel
product
result
studi
develop
novel
xylan
track
approach
use
twodomain
probe
call
consist
fusion
cellvibrio
japonicu
carbohydratebind
domain
fluoresc
protein
new
probe
specif
bind
xylan
affin
similar
sensit
detect
approach
compar
standard
method
xray
photoelectron
spectroscopi
xp
chemic
composit
analysi
three
approach
use
analyz
variat
xylan
content
lignocellulos
biomass
fiber
xp
allow
surfac
analysi
fiber
clearli
indic
chang
xylan
content
chemic
composit
analysi
respond
chang
xylan
content
give
specif
inform
relat
fiber
surfac
interestingli
probe
enabl
highli
sensit
detect
xylan
variat
surfac
fiber
varianc
method
probe
use
high
throughput
format
conclus
develop
rapid
high
throughput
approach
detect
chang
xylan
exposur
surfac
lignocellulos
fiber
introduct
method
lignocellulos
biomassbas
industri
revolution
understand
optim
sustain
altern
fuel
technolog
matthew
bienick
indraneel
ghosh
sean
campbel
david
lasanski
univers
arizonachemistri
biochemistri
usa
select
modul
activ
desir
enzym
vivo
major
goal
protein
design
aid
develop
method
understand
rewir
cellsign
pathway
protein
kinas
phosphatas
complementari
enzym
catalyz
addit
remov
phosphat
group
upon
substrat
protein
respect
kinas
phosphatas
implic
almost
everi
signal
pathway
deregul
implic
diseas
cancer
neurodegener
high
structur
homolog
kinas
phosphatas
present
challeng
design
select
inhibitor
understand
cellular
role
though
power
genet
knockdown
knockout
tool
exist
suscept
compensatori
cellular
mechan
address
problem
design
potenti
gener
alloster
approach
gate
kinas
phosphatas
activ
util
wellstudi
proteinprotein
interact
domain
protein
small
molecul
inhibitor
design
system
specif
peptid
insert
enzym
predetermin
nonhomolog
posit
domain
bad
unstructur
adopt
rigid
ahel
conform
upon
addit
protein
bind
partner
bclxl
thu
system
bclxl
act
poison
alloster
inhibit
function
badinsertedenzym
subsequ
addit
small
molecul
inhibitor
bind
displac
bclxl
act
antidot
thu
restor
enzymat
activ
shown
method
allow
control
activ
kinas
phosphatas
small
molecul
dose
depend
fashion
vitro
cellulo
investig
function
variou
nucleotid
ishankumar
soni
kevin
dagbay
jeann
hardi
univers
massachusett
amherst
usa
dimer
cystein
aspart
proteas
involv
multipl
biolog
pathway
includ
apoptosi
neurodegener
result
variou
research
conduct
understand
regul
biolog
well
chemic
synthes
molecul
research
focus
direct
interact
nucleotid
fulllength
zymogen
form
well
activ
cleav
form
preliminari
result
atp
gtp
acyl
probe
bind
motiv
us
investig
atp
bind
atp
modul
function
nucleotid
deriv
modul
function
use
site
direct
mutagenesi
demonstr
residu
present
dimer
interfac
put
bind
site
atp
acyl
probe
well
atp
gelbas
vitro
activ
assay
establish
exogen
atp
attenu
selfproteolyt
activ
last
use
gelbas
vitro
activ
assay
deriv
function
effect
datp
adp
amp
gtp
diadenosin
tetraphosh
identif
optim
inhibitor
dihydrofol
reductas
b
trimethoprimresist
enzym
chromosom
dihydrofol
reductas
dfr
select
pressur
produc
tmp
result
emerg
altern
famili
tmpresist
plasmidborn
dfrb
littl
knowledg
preval
dfrb
gene
librari
hundr
tmpresist
sampl
clinic
e
coli
infect
screen
silico
seven
known
dfrb
gene
rel
new
gene
found
mobil
genet
element
plasmid
multipl
resist
gene
previous
report
first
gener
select
inhibitor
toward
bastien
et
al
complex
symmetr
bisbenzimidazol
inhibitor
inhibit
low
micromolar
rang
ki
mm
built
upon
previou
work
develop
second
gener
inhibitor
demonstr
toler
varieti
linker
composit
increas
potenc
optim
length
inhibitor
remain
constant
crystal
one
inhibitor
help
uncov
mode
bind
order
circumv
risk
associ
take
two
drug
screen
class
folatelik
compound
call
bisubstr
bisubstr
known
inhibitor
bacteri
enzym
found
folat
pathway
found
bisubstr
inhibitor
low
micromolar
rang
mm
amino
acid
sequenc
highli
similar
ident
base
similar
success
inhibitor
test
potenti
inhibitor
object
research
develop
sensit
screen
method
base
portabl
surfac
plasmon
reson
spr
devic
emerg
technolog
target
enzym
dihydrofol
reductas
dhfr
confer
bacteri
resist
antibiot
trimethoprim
target
enzym
link
thin
gold
surfac
specif
plasmon
optic
properti
proport
mass
bound
molecul
allow
monitor
bind
event
surfacelink
dhfr
thu
permit
identif
inhibitor
howev
mass
typic
inhibitor
ie
gmol
low
result
signific
spr
signal
therefor
competit
assay
develop
gold
nanoparticl
carri
substrat
analog
bind
surfaceimmobil
dhfr
give
strong
spr
signal
due
high
mass
upon
screen
potenti
inhibitor
bound
nanoparticl
displac
target
enzym
molecul
provid
suffici
affin
thu
possibl
indirectli
monitor
bind
inhibitor
target
project
aim
firstli
test
valid
spr
screen
approach
appli
dhfr
appli
methodolog
screen
new
inhibitor
drive
bcell
develop
thu
dnabind
pair
domain
hotspot
diseas
mutat
link
carcinogenesi
use
nuclear
magnet
reson
nmr
spectroscopi
combin
molecular
dynam
md
simul
character
dna
bind
mechan
solut
pair
domain
compos
two
helic
bundl
subdomain
join
flexibl
linker
upon
bind
dna
ntermin
fold
entir
domain
includ
linker
becom
rigid
protect
amid
hydrogen
exchang
hx
subdomain
contribut
specif
dna
bind
result
equilibrium
dissoci
constant
three
order
magnitud
lower
exhibit
separ
subdomain
nm
versu
mm
isol
ntermin
subdomain
high
dnabind
specif
dynam
evidenc
hx
md
simul
addit
use
isotherm
titrat
calorimetri
itc
found
interact
dna
driven
favor
enthalpi
chang
counteract
larg
loss
entropi
contrast
less
flexibl
ctermin
subdomain
associ
divers
rang
dna
sequenc
reli
nonspecif
electrostat
contact
distinct
physicochem
dnabind
properti
subdomain
point
mechan
ctermin
subdomain
provid
initi
lowaffin
nonspecif
contact
allow
associ
dna
rapidli
hand
dynam
ntermin
subdomain
respons
set
specif
cognat
site
overal
studi
indic
conform
plastic
need
form
high
affin
interact
cognat
dna
site
allow
protein
effici
scan
genom
dna
map
bind
site
naphthalenebas
inhibitor
trypanosoma
brucei
rna
edit
ligas
vaibhav
mehta
reza
salavati
xray
crystal
structur
trypanosoma
brucei
rna
edit
ligas
complex
atp
pave
way
discoveri
naphthalen
base
inhibitor
adenylyl
step
compet
atp
activ
site
durrant
et
al
plosntd
moshiri
et
al
jbc
compound
inhibit
vitro
adenylyl
step
recombin
protein
um
rang
interfer
editosomerna
interact
context
nativ
purifi
editosom
moshiri
et
al
jbc
unpublish
differ
observ
effect
compound
recombin
nativ
underscor
low
effici
fact
measur
inhibit
constant
ki
equilibrium
constant
time
larger
dissoci
equilibrium
constant
kd
atp
nm
suggest
lower
affin
one
reason
offtarget
work
vari
predict
bindingsit
residu
determin
residu
import
inhibitor
activ
appear
crucial
interact
ligas
import
bind
data
suggest
partial
overlap
bind
site
two
inhibitor
distinct
contribut
residu
surround
activ
site
result
provid
import
guidelin
design
potent
specif
inhibitor
genom
target
epigenet
probe
use
chemic
tailor
system
glen
liszczak
tom
muir
princeton
univers
usa
recent
advanc
field
programm
dnabind
protein
led
develop
facil
method
genom
local
genet
encod
entiti
despit
extens
util
tool
locusspecif
deliveri
synthet
molecul
remain
limit
lack
adequ
technolog
combin
flexibl
chemic
synthesi
specif
programm
dnabind
protein
use
protein
transsplic
ligat
synthet
element
nucleasedefici
vitro
subsequ
deliv
cargo
live
cell
versatil
technolog
demonstr
deliv
fusion
includ
either
smallmolecul
bromodomain
extratermin
famili
bromodomain
inhibitor
peptidebas
chromodomain
ligand
capabl
recruit
endogen
copi
cognat
bind
partner
target
genom
bind
site
expect
technolog
allow
genom
local
wide
array
small
molecul
modifi
proteinac
materi
intein
zymogen
condit
assembl
splice
split
intein
via
target
proteolysi
josef
gramespach
tom
muir
princeton
univers
usa
natur
split
intein
found
widespread
use
chemic
biolog
due
abil
ligat
separ
express
polypeptid
process
call
protein
transsplic
pt
howev
due
autocatalyt
natur
pt
signific
effort
gone
toward
engin
intein
requir
extern
input
trigger
initi
splice
reaction
studi
har
pt
render
associ
split
intein
fragment
condit
upon
presenc
userdefin
proteas
show
intein
zymogen
use
creat
protein
sensor
actuat
respond
presenc
variou
stimuli
includ
bacteri
pathogen
viral
infect
light
furthermor
show
design
strategi
compat
sever
orthogon
split
intein
pair
therebi
open
way
creation
multiplex
sensor
system
mitoneet
first
member
cdgsh
ironsulfur
domain
cisd
protein
famili
discov
two
addit
famili
member
later
discov
structur
mitoneet
strikingli
similar
sequenc
conserv
function
impact
knockout
model
quit
differ
plasmid
mitoneet
gene
antibiot
resist
gene
obtain
transform
escherichia
coli
strain
compet
cell
interestingli
consist
differ
isol
purif
note
rel
mitoneet
ph
environ
signific
impact
ironsulfur
protein
structurefunct
pkox
determin
spectroscop
method
within
ph
rang
techniqu
could
use
mitoneet
due
protein
instabl
fluoresc
spectroscopi
employ
character
bind
mitoneet
redox
cofactor
nadh
nadph
result
present
contribut
larger
trend
small
chemic
chang
larg
function
impact
biomolecul
select
inhibit
e
coli
dna
rna
topoisomeras
dev
arya
nihar
ranjan
clemson
univers
south
carolina
usa
dna
topoisomeras
import
class
enzym
help
regul
dna
topolog
involv
sever
cellular
function
remov
supercoil
strand
breakag
recombin
chromosom
condens
well
disentangl
intertwin
dna
eukaryot
dna
topoisomeras
ii
gain
signific
attent
drug
target
particularli
cancer
treatment
hand
bacteri
dna
gyras
topoisomeras
iv
target
establish
antibiot
therefor
control
dna
topoisomeras
function
envis
develop
new
anticanc
antibacteri
agent
emerg
resist
antibacteri
necessit
search
novel
molecul
could
help
tackl
issu
recent
report
hoechst
deriv
bisbenzimidazol
linker
contain
long
alkyl
group
show
excel
dna
topoisomeras
inhibit
present
discuss
bacteri
dna
rna
topoisomeras
poison
inhibit
bisbenzimidazol
systemat
vari
alkyl
chain
length
b
compar
antibacteri
topoisomeras
activ
bisbenzimdiazol
monobenzimidazol
explor
relationship
topoisomeras
poisoninginhibit
antibacteri
activ
dna
bind
compound
refer
oxid
stress
induc
carbonyl
biomolecul
protein
lipid
hallmark
diseas
cancer
diabet
serv
diseas
biomark
exist
methodolog
detect
biomolecul
carbonyl
endpoint
assay
requir
lengthi
downstream
process
cell
lysat
fix
immunocytochemistri
present
onestep
carbonyl
detect
visual
quantif
methodolog
perform
live
cell
three
synthet
hydrazinefunction
coumarin
synthes
shown
biocompat
sensor
enabl
real
time
analys
protein
lipid
cellular
milieu
fluorophor
readili
intern
live
cell
promptli
react
carbonyl
cellular
milieu
nontox
concentr
use
studi
fluoresc
deriv
distinct
photochem
properti
share
uniqu
turnon
abil
upon
conjug
carbonyl
sensor
exhibit
increas
fluoresc
conveni
detect
commonli
avail
instrument
demonstr
sensor
util
differ
oxid
stress
model
includ
serum
starvat
metal
catalyz
oxid
peroxid
induc
stress
intracellular
distribut
carbonyl
biomolecul
live
cell
model
visual
use
fluoresc
microscopi
quantit
analysi
cellular
carbonyl
use
plate
reader
live
cell
lysat
fluorophor
also
present
fluoresc
tag
remain
intact
sdspage
cellular
lysat
indic
probe
may
also
find
applic
proteom
eastern
illinoi
univers
illinoi
usa
univers
louisvil
univers
michigan
dearborn
usa
glutam
dehydrogenas
enzym
key
metabol
control
mammalian
cell
numer
molecul
exert
alloster
control
activ
identifi
includ
adp
gtp
leucin
palmitoylcoa
mitoneet
recent
discov
mitochondri
protein
bind
partner
antidiabet
drug
pioglitazon
mitoneet
contain
uniqu
three
cystein
one
histidin
ligat
metal
cluster
howev
cellular
function
mitoneet
current
unknown
put
proteinbind
partner
mitoneet
analyz
cellular
local
cofactor
function
order
elucid
function
mitoneet
one
result
pulldown
assay
evalu
proteinbind
partner
mitoneet
enzym
kinet
assay
use
studi
differ
bind
partner
protein
small
molecul
affect
function
alloster
regul
ad
enzym
compar
function
presenc
bind
partner
mitoneet
tzd
proteinoligonucleotid
conjug
poc
possess
uniqu
properti
broad
applic
rang
biomed
diagnost
assay
fundament
research
molecular
recognit
futur
class
molecul
bright
tool
make
far
gener
differ
approach
conjug
includ
noncoval
coval
attach
typic
requir
modif
protein
explor
cheap
univers
coval
label
approach
synthes
wide
rang
poc
nonmodifi
protein
use
heterobifunct
crosslink
success
attach
thiolmodifi
redoxlabel
singlestrand
dna
ssdna
lysin
residu
bacteri
fimbria
protein
use
care
choic
reaction
condit
eg
stoichiometri
time
buffer
show
synthes
rang
conjug
protein
contain
differ
number
dna
futur
effort
investig
sitespecif
label
differ
research
topic
lab
possibl
approach
achiev
goal
includ
kinet
control
use
ntalabel
noncoval
attach
polyhisdin
tag
protein
hybrid
esterfunction
react
spatial
proxim
lysin
protein
follow
displac
leav
covalentlyattach
posttransl
modif
ptm
import
regul
gene
express
acetyl
revers
ptm
modul
oppos
activ
histon
acetyltransferas
hat
histon
deacetylas
hdac
hdac
famili
enzym
includ
metaldepend
hdac
requir
activ
site
dival
metal
ion
catalysi
either
zn
ii
fe
ii
hdac
metalloenzym
best
biochem
character
isozym
yet
ident
vivo
dival
metal
speci
still
unclear
develop
metalspecif
inhibitor
one
promis
approach
may
help
elucid
vivo
metal
speci
bound
use
biochem
activ
assay
screen
fragment
librari
inhibitor
inhibitor
structur
base
parent
compound
discov
previou
screen
preferenti
inhibit
fe
ii
bound
activ
site
rather
zn
ii
demonstr
screen
compound
lower
inhibit
fe
ii
compar
parent
compound
still
maintain
specif
fe
ii
compar
zn
ii
work
provid
basi
develop
metalspecif
inhibitor
increas
affin
specif
may
use
identifi
metal
speci
bound
vivo
univers
michigan
ann
arbor
usa
histon
deacetylas
hdac
becom
attract
target
cancer
therapi
current
four
fda
approv
hdac
inhibitor
present
inhibitor
design
base
target
dival
metal
present
activ
site
hdac
function
around
hydroxam
acid
warhead
howev
hydroxam
moieti
poor
pharmacokinet
inhibitor
high
toxic
use
fragmentbas
metalloenzym
inhibitor
librari
focus
nonhydroxam
identifi
compound
novel
function
group
inhibit
subset
compound
addit
show
inhibit
depend
bound
metal
fe
ii
vs
zn
ii
fragment
show
promis
develop
hdac
inhibitor
mechan
inhibit
need
determin
three
like
mechan
compound
inhibit
chelat
metal
manner
similar
edta
strip
metal
directli
activ
site
act
competit
inhibitor
bind
activ
site
develop
method
determin
extent
metal
chelat
util
induct
coupl
plasmamass
spectrometri
icpm
measur
presenc
fe
ii
incub
inhibitor
sever
compound
identifi
competit
inhibitor
illicit
studi
refer
protein
geranylgeranyltransferasei
ggtasei
catalyz
attach
farnesyl
geranylgeranyl
moieti
respect
cystein
residu
near
cterminu
substrat
protein
end
caax
sequenc
proper
prenyl
subsequ
process
small
gtpase
known
import
correct
membran
local
cellular
function
recent
work
cell
indic
smggd
small
gprotein
gdp
dissoci
stimul
protein
bind
small
gtpase
regul
entri
cellular
prenyl
pathway
character
potenti
role
smggd
protein
regul
small
gtpase
prenyl
test
whether
smggd
splice
variant
could
inhibit
vitro
activ
ggtasei
ftase
small
gtpase
inhibit
activ
enzym
determin
occur
gtpase
substrat
sequestr
rather
direct
enzym
inhibit
nucleotidestatu
gtpv
gdpbound
known
alter
structur
small
gtpase
therefor
effect
interact
smggd
protein
protein
prenyl
test
reduc
vitro
geranylgeranyl
farnesyl
rhoagdp
significantli
rhoagtp
howev
could
still
bind
rhoagtp
albeit
weaker
affin
current
look
small
gtpase
kra
understand
smggd
protein
regul
protein
prenyl
increas
understand
smggd
protein
regul
traffick
prenyl
protein
may
offer
new
insight
target
prenyl
small
gtpase
treat
human
diseas
complex
odor
chemic
space
number
odor
receptor
or
make
understand
odor
code
enorm
challeng
specif
abl
predict
behavior
front
agonist
antagonist
nonagonist
remain
done
use
joint
approach
combin
molecular
model
experiment
data
sever
or
built
model
captur
activ
inact
state
protein
bound
ligand
differ
potenc
aim
comput
tool
combin
sitedirect
mutagenesi
predict
activ
human
strong
agonist
androstenon
androstadienon
inactiv
form
nonagonist
z
first
time
robust
comput
model
g
proteincoupl
odor
receptor
captur
differenti
activ
mechan
upon
ligand
bind
consist
vitro
data
suggest
unpreced
metric
activ
mechan
use
predict
activ
model
use
identifi
residu
respons
dynam
activ
bind
caviti
g
protein
coupl
site
residu
belong
highli
conserv
motif
suggest
result
valid
mammalian
mutat
site
confirm
crucial
function
role
power
approach
help
unravel
odorcod
nervou
system
facilit
understand
gener
rule
neuron
activ
induc
odor
refer
elev
wnt
signal
implic
number
diseas
specif
interest
role
retin
neovascular
well
elev
intraocular
pressur
lead
damag
trabecular
meshwork
dishevel
dvl
cytoplasm
protein
involv
wnt
signal
major
regul
develop
control
cell
prolifer
differenti
inhibit
abnorm
wnt
signal
target
pdz
domain
dvl
therapeut
potenti
howev
improv
bind
affin
specif
smallmolecul
inhibitor
challeng
purpos
studi
expand
upon
current
structureact
relationship
base
smallmolecul
peptid
ligand
dvl
specif
goal
determin
correl
amount
distort
activ
site
bind
affin
across
rang
ligand
use
inform
guid
futur
design
effort
molecular
dynam
simul
dvl
pdz
domain
free
ligandbound
state
perform
box
explicit
water
simul
reveal
increas
pairwis
distanc
c
posit
along
activ
site
bind
groov
upon
ligand
bind
observ
chang
backbon
dihedr
angl
support
distort
helix
toward
concav
activ
site
taken
togeth
repres
distort
structur
deviat
activ
site
pdz
domain
upon
bind
quantifi
rootmeansquar
deviat
correl
moder
well
bind
affin
explor
conform
space
antiapoptot
protein
famili
lui
carogomez
apoptosi
natur
process
requir
remov
redund
cell
develop
potenti
danger
cell
senesc
cell
death
dysregul
implic
varieti
human
diseas
cancer
autoimmun
neurodegen
disord
process
regul
sever
protein
belong
famili
member
famili
group
accord
homolog
particip
apoptot
mitochondri
pathway
proand
antiapoptot
protein
antiapoptot
protein
eg
bclxl
bclw
proapoptot
protein
eg
bax
bak
bok
domain
eg
bid
bin
bik
comput
studi
great
interest
describ
foldingunfold
properti
protein
explain
interact
properti
protein
small
ligand
use
ration
drug
design
aim
project
describ
structur
properti
protein
possibl
conform
chang
associ
interact
protein
methodolog
silico
use
molecular
dynam
simul
md
differ
temperatur
condit
inform
use
better
understand
contribut
domain
function
mention
protein
import
result
indic
fld
tm
contribut
maintain
overal
conform
protein
protein
thermal
stress
furthermor
stabil
effect
domain
addit
storeoper
calcium
entri
one
primari
mechan
calcium
influx
cell
mani
cell
type
mediat
activ
calcium
releaseactiv
calcium
crac
channel
plasma
membran
crac
channel
compos
stromal
interact
molecul
stim
orai
protein
orai
protein
form
pore
subunit
crac
channel
activ
stim
act
intracellular
calcium
sensor
although
believ
function
form
orai
channel
tetramer
thompson
shuttleworth
sci
rep
recent
crystal
structur
orai
hou
et
al
scienc
exhibit
hexamer
form
threefold
quasisixfold
axial
symmetri
around
pore
channel
studi
examin
stabil
hexam
tetram
assembl
orai
protein
perform
allatom
molecular
dynam
simul
explor
function
signific
form
orai
channel
analyz
contact
consequ
subunit
distribut
water
molecul
insid
ion
pore
stabil
pore
radiu
conform
chang
porelin
residu
involv
gate
mechan
investig
ion
select
gener
free
energi
profil
permeat
calcium
potassium
sodium
ion
use
umbrella
sampl
modest
success
chang
function
exist
protein
tradit
strategi
like
graft
make
evid
understand
degre
subtl
perturb
natur
interact
protein
drastic
effect
function
featur
reli
dynam
one
way
gain
insight
understand
conform
dynam
system
studi
comput
mean
perform
molecular
dynam
simul
md
studi
dynam
effect
mutat
site
laobp
pdb
id
periplasm
bind
protein
salmonella
typhi
natur
recogn
posit
aminoacid
nanomolar
rang
show
open
close
transit
presenc
ligand
evalu
effect
four
substitut
site
gener
structur
mutant
use
itass
server
simul
done
use
amber
suit
forcefield
water
total
simul
time
ns
obtain
protein
simul
analysi
routin
perform
use
cpptraj
r
librari
structur
analysi
call
found
chang
natur
occur
residu
posit
leucin
lysin
mutant
alter
dramat
behaviour
protein
make
possibl
sampl
close
state
without
ligand
addit
mutant
nt
show
alter
suggest
interact
make
possibl
spontan
mechan
close
could
explan
new
affin
gain
mutant
report
relat
experiment
work
group
proteinfold
pf
problem
aim
predict
physic
dynam
process
transform
unfold
protein
function
structur
todat
approach
obtain
inform
reli
timeconsum
molecular
dynam
md
simul
propos
novel
dynam
program
algorithm
combin
statist
ensembl
model
techniqu
evolutionarybas
sequenc
inform
comput
accur
coarsegrain
represent
conform
landscap
protein
represent
model
conform
ensembl
fulli
fold
structur
contain
set
interact
secondari
structur
interact
comput
use
boltzmannbas
energi
function
landscap
use
predict
domin
fold
pathway
present
predict
wider
biolog
comput
scienc
commun
also
develop
graphic
tool
convey
content
energi
landscap
interact
explor
network
data
propos
algorithm
appli
benchmark
protein
demonstr
excel
result
term
residuecontact
fold
pathway
predict
particularli
algorithm
averag
greater
precis
stateoftheart
contact
residu
algorithm
protein
without
homologybas
templat
predict
fold
rout
agre
pathway
elucid
experiment
studi
md
simul
propos
pf
method
repres
altern
high
computationalcost
approach
allow
largescal
studi
fold
dynam
annot
proteom
mechan
activ
nuclear
receptor
liver
receptor
synthet
agonist
peroxisom
proliferatoractiv
gamma
coactiv
transcript
coactiv
denis
okafor
suzann
may
richard
whitbi
devrishi
goswami
jozef
stec
autumn
flynn
michael
dugan
nathan
jui
patrick
griffin
emori
univers
georgia
usa
emori
univers
univers
southampton
uk
scripp
research
institut
california
usa
liver
receptor
homolog
orphan
nuclear
hormon
receptor
regul
divers
biolog
process
includ
metabol
prolifer
resolut
endoplasm
reticulum
stress
great
potenti
therapeut
target
metabol
diseas
cancer
develop
modul
difficult
chemic
scaffold
exist
capabl
activ
howev
mechan
activ
unknown
xray
crystallographi
structur
method
use
explor
receptorligand
interact
associ
activ
set
relat
agonist
similar
efficaci
dramat
differ
bind
mode
molecular
dynam
simul
elucid
import
role
pistack
polar
interact
mediat
differ
bind
mode
subsequ
differ
mechan
action
two
agonist
network
conserv
water
molecul
near
ligandbind
site
import
activ
agonist
explor
addit
mechan
coactiv
peroxisom
proliferatoractiv
gamma
coactiv
coactiv
explor
comparison
nuclear
receptor
bind
higher
affin
molecular
dynam
reveal
induc
correl
atom
motion
throughout
activ
function
surfac
induc
weaker
signal
activ
function
surfac
instead
promot
alloster
signal
helix
region
work
reveal
complex
associ
agonist
develop
ii
offer
insight
ration
design
strategi
iii
illumin
strategi
select
therapeut
target
depend
signal
pathway
human
phosphoglucos
isomeras
hpgi
import
glycolysi
catalyz
revers
isomer
shown
distal
amino
acid
residu
away
site
reaction
contribut
catalysi
singlesit
conserv
mutat
residu
result
signific
loss
catalyt
activ
shown
thirdshel
residu
indirectli
interact
catalyt
residu
variant
larger
effect
catalyt
effici
secondshel
residu
interact
directli
firstshel
catalyt
residu
dynam
variant
perspect
overal
structur
chang
show
minor
fluctuat
molecular
dynam
simul
wildtyp
pgi
variant
carri
compar
electrostat
hydrogen
bond
network
around
activ
site
determin
extent
contribut
structur
chang
togeth
electrostat
dynam
contribut
observ
decreas
catalyt
effici
result
suggest
involv
impart
necessari
chemic
electrostat
properti
catalyt
base
fi
protein
dnabind
protein
regul
two
hundr
gene
escherichia
coli
e
coli
regul
profil
gene
e
coli
cell
growth
follow
growth
phasedepend
regulatori
trend
fi
express
level
decreas
dramat
moleccel
earli
exponenti
phase
moleccel
stationari
phase
recent
experiment
studi
shown
dissoci
fi
protein
dna
acceler
increas
bulk
concentr
fi
protein
facilit
dissoci
suggest
import
dissoci
rate
understand
gene
regul
object
studi
therefor
understand
molecular
mechan
dissoci
fi
protein
dna
use
coarsegrain
proteindna
model
explor
bind
landscap
protein
dissoci
dna
simul
uncov
partial
dissoci
fi
conform
dna
singl
domain
remain
bound
dna
simul
support
threestat
sequenti
kinet
model
n
facilit
dissoci
n
refer
bound
state
intermedi
dissoci
state
respect
propos
kinet
model
explain
concentrationdepend
dissoci
conform
dynam
zinc
finger
nemo
diseasedassoci
mutant
freddi
salsburi
ryan
godwin
wake
forest
univers
north
carolina
usa
zincfing
protein
regul
critic
signal
pathway
variou
cellular
function
includ
apoptosi
oncogenesi
nemo
also
known
ikkg
one
zinc
finger
regulatori
abstract
portion
ijb
kinas
involv
celluar
respons
inflam
present
result
microsecond
scale
allatom
molecular
dynam
bind
site
proton
state
zinc
coordin
influenc
protein
conform
dynam
ultim
function
well
diseaseassoci
mutant
also
affect
dynam
conform
zinc
finger
nemo
analysi
focus
understand
conform
chang
dynam
via
sever
techniqu
incluldung
cluster
analysi
correl
analysi
network
analysi
hydrogen
bond
network
atom
coordin
obtain
singl
chain
divers
protein
train
fourlett
alphabet
c
n
design
atom
type
hydrogen
exclud
delaunay
tessel
perform
structur
wherebi
atom
treat
vertic
gener
convex
hull
enclos
hundr
spacefil
nonoverlap
irregular
tetrahedra
tetrahedron
identifi
four
vertic
one
possibl
type
interact
atom
quadruplet
rel
frequenc
occurr
fijkl
calcul
atom
quadruplet
type
j
k
l
use
observ
tetrahedra
rate
pijkl
expect
chanc
determin
multinomi
refer
distribut
energi
interact
score
given
sijkl
log
fijklpijkl
collect
defin
atom
fourbodi
potenti
subsequ
total
potenti
tp
protein
comput
ad
score
tetrahedr
interact
atom
quadruplet
deriv
structur
tessel
result
evalu
benchmark
set
decoy
ru
see
figur
compar
perform
physicsand
knowledgebas
potenti
base
nativ
rank
zscore
correl
coeffici
fraction
enrich
score
tie
surpass
amber
forc
field
potenti
use
similar
fourbodi
potenti
base
sixlett
alphabet
add
metal
x
nonmet
predict
bind
energi
known
proteaseinhibitor
complex
tpcomplex
tptarget
experiment
predict
correl
prove
robust
upon
identifi
addit
complex
result
suggest
accur
effici
atom
fourbodi
statist
potenti
protein
structur
predict
assess
apocarotenoid
form
famili
small
molecul
deriv
oxid
cleavag
larger
carotenoid
compound
classic
exampl
includ
vitamin
produc
oxid
cleavag
plant
hormon
abscis
acid
produc
cleavag
epoxycarotenoid
reaction
catalyz
famili
nonhem
ironcoordin
enzym
known
carotenoid
cleavag
oxygenas
cco
aim
elucid
factor
mediat
uniqu
divers
substrat
cleavag
specif
mediat
across
famili
enzym
bacteri
cco
homolog
biocontrol
agent
pseudomona
brassicacearum
pblsd
select
structur
function
character
vitro
enzymat
assay
highlight
strong
activ
lignostilben
resveratrol
weak
activ
carotenoid
lutein
subsequ
silico
dock
studi
use
recent
obtain
structur
pdb
id
predict
strong
bind
interact
substrat
howev
inspect
dock
molecul
crystal
structur
show
resveratrol
activ
site
singl
cleavabl
doubl
bond
coordin
directli
reactiveiron
center
unfavour
substrat
orient
observ
lutein
model
substrat
bind
pocket
residu
highlight
structur
featur
like
contribut
substrat
select
work
way
mutat
studi
perform
character
substrat
interact
import
catalyt
activ
work
support
nserc
dg
grant
mcl
jsa
nrc
biobas
specialti
chemic
program
mcl
noncoval
interact
cy
met
side
chain
phe
trp
tyr
contribut
protein
function
stabil
toward
understand
structur
energet
properti
saromat
interact
perform
ab
initio
quantum
mechan
calcul
full
p
level
theori
complex
mesh
aromat
model
side
chain
aromat
residu
result
reveal
stabl
conform
atom
mesh
bind
edgeon
fivememb
heteroaromat
ring
edgeon
enfac
phenyl
ring
complex
also
modul
ioniz
potenti
interact
fragment
geometri
complex
control
center
oxid
investig
bulk
water
allatom
addit
forc
field
ff
calibr
saromat
interact
implement
molecular
dynam
simul
aqueou
complex
stabl
bind
free
energi
kcalmol
stype
hbond
persist
simidazol
sphenol
structur
lesser
extent
meshindol
stabl
conform
adopt
enfac
geometri
except
meshimidazol
favor
intermedi
geometri
comprehens
investig
saromat
interact
ga
phase
water
provid
valuabl
data
set
studi
interact
protein
gapdh
oligomer
state
exhibit
distinct
moonlight
function
patholog
exampl
tetramer
gapdh
possess
dehydrogenas
activ
wherea
aggreg
monomericdimer
gapdh
associ
neurodegener
sinc
subunit
structur
ident
hypothes
dynam
dictat
gapdh
function
consist
known
behavior
tetram
dimer
dimer
normal
mode
analysi
reveal
one
domain
nbd
dimer
flexibl
nbd
flexibl
dimer
rel
tetram
monom
wherea
sloop
cover
dehydrogenas
activ
site
flexibl
monom
multivari
statist
analysi
molecular
dynam
simul
support
distinct
dynam
degre
oligomer
princip
compon
analysi
reveal
nbd
exhibit
differenti
flexibl
tetramer
dimer
gapdh
associ
neg
cooper
bind
unmask
high
fluctuat
sloop
monom
convers
sloop
intrins
disord
domain
monom
may
contribut
loss
glycolyt
activ
may
promot
bind
gapdh
multitud
protein
partner
includ
death
factor
consist
hypothesi
distinct
essenti
dynam
monomer
dimer
tetramer
gapdh
like
dictat
function
macromolecular
crowd
within
cell
shown
influenc
thermodynam
biomolecular
process
may
necessari
account
crowd
effect
model
process
build
comput
model
one
determin
optim
balanc
accuraci
effici
question
hand
seek
explor
tradeoff
appli
crowd
effect
molecular
recognit
particular
focu
electrostat
effect
driven
crowd
one
extrem
use
theoret
interact
toy
molecul
highli
simplifi
model
crowd
extract
gener
principl
physic
properti
interact
molecul
crowder
affect
bind
energet
extrem
use
molecular
dynam
simul
consid
atomist
represent
dnapeptid
system
particular
protein
crowder
allow
us
directli
evalu
model
experiment
preliminari
result
sampl
model
within
accuracyeffici
continuum
show
gener
systemspecif
effect
crowd
molecular
recognit
effect
trimethylaminenoxid
tmao
conform
peptid
miniprotein
cristiano
dia
zhaoqian
su
new
jersey
institut
technolog
usa
trimethylaminenoxid
tmao
organ
compound
affect
osmosi
cell
protect
nativ
state
protein
present
discuss
comput
studi
understand
tmao
protect
effect
molecular
level
particular
show
result
allatom
molecular
dynam
simul
homopeptid
polyglycin
polyalanin
polyvalin
polyleucin
trpcage
miniprotein
explicit
solvent
polyglycin
model
protein
backbon
wherea
polyalanin
polyvalin
polyleucin
repres
peptid
small
larg
nonpolar
side
chain
respect
find
tmao
favor
compact
conform
polyglycin
monom
consist
natur
protect
osmolyt
littl
effect
polyalanin
howev
tmao
favor
expand
conform
polyvalin
polyleucin
effect
tmao
polyalanin
polyvalin
polyleucin
agre
studi
show
tmao
littl
effect
interact
small
nonpolar
residu
wherea
weaken
hydrophob
interact
larg
nonpolar
molecul
result
rais
question
tmao
collaps
effect
backbon
model
ie
polyglycin
overcompens
effect
hydrophob
interact
caus
peptid
swell
molecul
stabil
compact
nativ
state
protein
answer
question
show
result
peptid
replica
exchang
molecular
dynam
simul
trpcage
miniprotein
comput
model
interfac
multijunct
dna
motif
endonucleas
biolog
process
includ
repeatdirect
dna
modif
chromosom
segreg
error
segreg
may
caus
aneuploidi
result
infertil
birth
defect
prove
role
rihp
propos
design
antipx
ligand
templat
select
endonucleas
endoi
junctionresolv
enzym
first
step
design
model
interfac
endoi
px
everi
possibl
scissil
phosphat
px
use
pyrosetta
simul
interfac
px
endoi
structur
pdb
complex
holliday
junction
scissil
phosphat
px
superimpos
scissil
phosphat
holliday
junction
atompair
constraint
use
maintain
interfac
scissil
phosphat
activ
site
residu
endoi
gener
low
energi
configur
correspond
phosphat
endoi
determin
bind
experiment
structur
simul
interfac
use
construct
model
endoi
interfac
use
model
thymidyl
kinas
essenti
enzym
thymidin
triphosph
dttp
biosynthesi
pathway
henc
critic
dna
synthesi
thymidyl
kinas
wide
studi
due
role
prodrug
activ
also
exploit
drug
target
homolog
structur
thymidyl
kinas
exhibit
similar
topolog
structur
function
role
conserv
residu
present
around
activ
site
remain
unclear
present
studi
thymidyl
kinas
thermu
thermophilu
use
model
protein
distinct
conform
obtain
nativ
ligand
bound
crystal
structur
reveal
correl
motion
activesit
residu
ploop
lid
region
requir
bind
posit
substrat
tmp
addit
bind
substrat
atp
tmp
activ
site
found
follow
random
bibi
mechan
function
import
movement
residu
studi
molecular
dynam
simul
conserv
arginin
drx
motif
act
hub
suboptim
path
present
atp
tmp
function
structur
import
residu
present
suboptim
path
assess
use
enzymat
thermal
stabil
assay
mutat
conserv
residu
either
result
loss
activ
affect
thermal
stabil
protein
molecular
dynam
analys
mutant
provid
insight
mechan
phosphoryl
transfer
reaction
insilico
identif
expos
dimer
interfac
bind
novel
comput
design
bind
protein
al
mutant
amyotroph
later
sclerosi
al
devast
motor
neuron
diseas
result
paralysi
death
usual
within
year
diagnosi
misfold
cuznsuperoxid
dismutas
emerg
mechan
underli
motor
neuron
degener
individu
amyotroph
later
sclerosi
al
carri
mutant
gene
al
sod
molecular
agent
specif
bind
neutral
misfold
toxic
mutant
protein
may
help
attenu
diseas
progress
famili
al
fal
promiscu
natur
human
iggbind
domain
hyperthermophil
variant
protein
g
convert
highli
specif
aggreg
inhibitor
design
two
falslink
mutant
display
high
bind
specif
toward
mutant
inhibit
amyloid
aggreg
vitro
prevent
accumul
misfold
protein
live
cell
reduc
cytotox
express
motor
neuronlik
cell
comput
model
identifi
specif
recognit
site
surfac
monom
bind
via
ahel
domain
involv
engin
mutat
eg
recogn
conform
nativ
dimer
disrupt
misfold
therebi
expos
hydrophob
dimer
interfac
henc
mechan
mutant
engag
interact
via
dimer
interfac
stabil
monomer
form
may
lead
enhanc
solubl
monom
thu
prevent
intermolecular
interact
andor
redirect
aggreg
nonamyloid
path
propos
mechan
detail
aminoacid
bind
interact
basi
futur
design
therapeut
candid
research
tool
character
substrat
specif
proteas
enzym
critic
illumin
molecular
basi
divers
complex
role
wide
array
biolog
process
rapid
accur
predict
extend
substrat
specif
would
also
aid
design
custom
proteas
capabl
select
control
cleav
biotechnolog
therapeut
relev
target
catalyt
drug
program
proteas
would
sever
advantag
bindingbas
moieti
antibodi
proteas
multispecif
enzym
cleav
multipl
substrat
dispar
sequenc
cleav
sequenc
therebi
show
sign
posit
neg
select
thu
specif
landscap
proteas
determin
function
key
use
design
therapeut
proteas
ensur
proper
target
minim
sideeffect
develop
specif
model
design
framework
combin
silico
structurebas
model
use
rosetta
macromolecular
model
approach
machin
learn
experiment
vivo
assay
deep
sequenc
elucid
predict
modul
specif
landscap
proteas
larg
scale
framework
ten
thousand
substrat
experiment
evalu
inform
use
guid
comput
design
approach
make
predict
entir
landscap
million
sequenc
describ
framework
applic
uncov
design
specif
landscap
hepat
c
viru
proteas
drugresist
mutant
object
develop
project
collect
expos
current
inaccess
protein
product
inform
reduc
effort
establish
new
recombin
protein
product
system
develop
webbas
recombin
proteom
data
resourc
allow
entri
divers
set
recombin
protein
product
data
explor
target
configur
new
protein
product
system
biomed
research
requir
highli
engin
protein
sampl
investig
biolog
structur
function
detail
recombin
protein
product
inform
routin
collect
research
varieti
lab
data
format
extrem
difficult
scientist
share
inform
use
convent
rout
public
databas
submiss
research
show
proteom
inform
remain
invis
outsid
parti
believ
protein
research
econom
greatli
improv
hidden
proteom
data
expos
manner
prevent
wast
unnecessari
retread
trialanderror
protein
product
effort
order
tackl
issu
built
onlin
recombin
proteom
data
resourc
enabl
research
easili
upload
exist
data
find
compar
experiment
detail
yield
product
unproduct
nevertheless
instruct
protein
product
result
show
compon
search
explor
configur
new
genetoprotein
experiment
plan
discuss
tool
help
open
door
much
improv
communitywid
protein
research
effici
design
experi
higher
likelihood
success
protein
product
je
us
banda
alejandro
sosapeinado
sooruban
shanmugaratnam
birt
ocker
rogelio
rodr
nation
autonom
univers
mexico
mexico
univers
bayreuth
germani
known
comput
design
ligand
bind
solv
problem
sinc
gener
approach
succeed
everi
case
studi
present
work
use
salmonella
typhimurium
typhimurium
lao
protein
scaffold
bind
protein
abl
bind
posit
amino
acid
llysin
larginin
lornithin
lhistidin
combin
two
design
approach
led
us
find
simpl
solut
achiev
novel
lglutamin
bind
lao
protein
result
approach
bind
pocket
graft
statist
coupl
base
strategi
one
mutat
possibl
lao
sequenc
allow
refin
second
round
mutat
point
mutat
actual
lao
sequenc
proper
experiment
protein
express
ligand
bind
measur
need
high
throughput
mutat
analysi
direct
evolut
gene
librari
approach
conclus
possibl
upon
experiment
mutat
comparison
two
design
approach
taken
find
solut
achiev
desir
ligand
bind
lao
protein
new
mutant
contain
one
point
mutat
accord
wild
type
scaffold
sequenc
present
radic
distinct
bind
profil
lglutamin
one
ligand
bound
highest
affin
accord
isotherm
titrat
calorimetri
itc
determin
dissoci
constant
order
magnitud
known
wild
type
escherichia
coli
e
coli
lglutamin
bind
protein
design
array
engin
amyloid
protein
fernanda
bononi
fernanda
bononi
michael
toney
depart
chemistri
uc
davi
usa
amyloid
fibril
extens
studi
due
role
develop
diseas
alzheim
type
ii
diabet
recent
high
strength
exploit
develop
nanomateri
recent
present
gener
approach
synthesi
amyloid
structur
natur
occur
protein
antifreez
protein
three
differ
type
amyloid
fibril
obtain
natur
nonamyoloidogen
antifreez
protein
assembl
mild
condit
contrast
amyloid
fibril
possess
high
stabil
toward
environment
stress
follow
design
synthesi
strong
resist
fibril
work
focus
engin
surfac
creat
fibrilbas
higherord
structur
scaffold
order
proteinbas
rug
scaffold
use
materi
applic
nanoparticl
order
photovolta
thermoelectr
applic
search
variou
polymer
condit
led
partial
order
fibril
assembl
agreement
design
strategi
advanc
partial
success
engin
new
interfac
sophist
approach
henc
current
work
focus
util
new
approach
protein
fusion
well
wellestablish
approach
rosetta
design
engin
metal
bind
site
creat
new
protein
interfac
allow
assembl
high
order
structur
natur
provid
rich
sourc
lightrespons
protein
serv
power
optogenet
tool
studi
biolog
system
howev
mani
known
bind
partner
optogenet
control
proteinprotein
interact
current
restrict
welldefin
natur
system
engin
system
base
aslov
protein
addit
affin
kinet
nativ
interact
often
suboptim
difficult
engin
absenc
structur
inform
present
gener
approach
discov
de
novo
synthet
light
switchabl
proteinprotein
interact
use
combinatori
protein
engin
techniqu
use
phage
librari
base
small
disulfidefre
domain
novel
codon
optim
scheme
gener
divers
bind
interfac
abl
gener
wellfold
monomer
bind
partner
specif
recogn
either
lightstat
darkstat
aslov
protein
well
photoact
yellow
protein
pyp
bacteri
photoprotein
known
bind
partner
de
novo
bind
partner
form
complex
rang
affin
onoff
rate
success
approach
impli
combinatori
librari
use
gener
bind
partner
lightswitch
protein
therebi
creat
palett
lightswitch
proteinprotein
interact
easili
customiz
differ
optogenet
applic
biocatalysi
thought
sustain
benign
complement
organ
synthesi
past
effort
tailor
enzymat
function
toward
desir
reaction
face
signific
knowledg
gap
present
two
distinct
combin
comput
experiment
protocol
predict
conform
catalyticallyrelev
enzym
ligand
complex
reveal
substrat
access
channel
even
absenc
ligandbound
structur
appli
adapt
bias
forc
abf
method
broadli
applic
predict
mutat
hotspot
substratespecif
manner
potenti
drastic
reduc
experiment
screen
effort
tailor
enzym
new
substrat
interest
start
ligandfre
crystal
structur
success
identifi
residu
known
involv
palmit
acid
bind
cytochrom
bind
trajectori
also
reveal
new
bind
residu
confirm
experiment
map
substrat
access
channel
protein
repres
signific
challeng
like
mani
biocatalyst
contain
numer
channel
thought
popul
substrat
product
solvent
gase
identifi
predict
correctli
multipl
ligand
migrat
channel
two
bacteri
use
implicit
ligand
sampl
il
free
molecular
dynam
simul
furthermor
calcul
free
energi
ga
migrat
channel
reveal
evid
evolut
toward
bind
conjunct
protect
inhibitori
co
exclus
result
significantli
enhanc
understand
ga
migrat
protein
provid
insight
evolut
gasutil
enzym
protein
oligom
complex
allow
precis
regul
mechan
dimer
monom
domin
lauzon
alexi
vall
eeb
elisl
protein
mutat
million
year
human
enzym
list
evolv
multimer
complex
alreadi
know
protein
complex
improv
biolog
input
exampl
increas
activ
enzym
help
regul
combin
specif
allosteri
activ
inhibit
hand
less
known
thermodynam
advantag
cost
relat
use
protein
complex
assembl
may
regul
function
studi
employ
synthet
biochemistri
approach
compar
perform
monomer
dimer
trimer
complex
design
simpl
dna
structur
threeway
junction
form
use
one
two
three
dna
strand
dna
repres
materi
choic
enabl
control
everi
thermodynam
paramet
structur
simpl
mutat
eg
modifi
trimer
affin
without
affect
dimer
affin
contrast
protein
system
impact
mutat
often
unpredict
use
mathemat
simul
experiment
studi
show
trimer
complex
exhibit
much
larger
window
regul
mechan
compar
dimer
complex
monom
dna
trimer
illustr
bind
behavior
go
posit
neg
cooper
kob
cover
fold
magnitud
also
identifi
ratio
dimer
affin
trimer
affin
key
paramet
program
threshold
cooper
trimer
assembl
result
provid
studi
shine
new
light
possibl
regul
mechan
trimer
system
may
help
understand
protein
evolv
oligom
photocontrol
protein
activ
power
techniqu
biolog
one
method
obtain
photoswitch
protein
coupl
photoisomer
azobenzen
switch
conform
chang
protein
interest
appli
azobenzen
photoswitch
fynom
small
proteinbas
affin
reagent
base
domain
human
fyn
engin
bind
inhibit
activ
human
chymas
chymas
known
involv
cardiovascular
diseas
well
patholog
inflammatori
condit
introduc
two
cystein
residu
point
mutat
sequenc
chymasebind
fynom
subsequ
crosslink
inhibitor
azobenzen
residu
allow
ci
isom
azo
moieti
compat
wellfold
fynom
darkadapt
tran
azo
crosslink
fynom
partial
unfold
show
reduc
inhibitori
activ
upon
irradi
switch
light
nm
inhibitor
larg
fold
better
inhibit
activ
chymas
sinc
fyn
scaffold
broadli
use
phagedisplay
select
techniqu
gener
fynom
target
virtual
protein
result
demonstr
promis
azobenzen
vivo
function
studi
photopharmacolog
regul
biolog
process
requir
precis
tune
activ
deactiv
rate
biomolecular
switch
across
dozen
order
magnitud
regul
biomolecular
switch
typic
reli
two
distinct
structureswitch
mechan
activ
induc
fit
occur
ligand
bind
inact
state
induc
conform
chang
activ
conform
select
cs
requir
spontan
switch
biomolecul
activ
conform
prior
ligand
bind
despit
year
experiment
theoret
investig
distinct
kinet
perform
two
mechan
well
rational
behind
evolut
select
remain
unexplor
employ
synthet
fluoresc
dna
switch
system
abl
oper
either
mechan
allow
easi
tune
assess
thermodynam
paramet
well
straightforward
kinet
character
result
reveal
yield
activ
rate
sever
order
magnitud
faster
cs
due
increas
concentr
bindingcompet
switch
acceler
conform
chang
also
find
revers
produc
similarli
faster
deactiv
rate
final
result
reveal
cs
enabl
program
activ
deactiv
rate
respect
simpl
modul
conform
equilibrium
togeth
find
reveal
evolut
may
taken
advantag
cs
mechan
program
activ
deactiv
rate
biomolecular
switch
provid
new
structurekinet
relationship
key
applic
bioengin
trichomona
vaginali
protozoan
causal
agent
trichomoniasi
common
nonvir
sexual
transmit
infect
sti
spread
worldwid
trichomoniasi
associ
infect
genitourinari
tract
sex
provoqu
prematur
birth
year
treatment
trichomoniasi
provis
nitroimidazol
commonli
metronidazol
tinidazol
howev
patient
show
improv
treatment
highlight
need
new
therapeut
regimen
trichomoniasi
carbohydr
main
nutrient
sourc
vaginali
therefor
enzym
glycolyt
pathway
vaginali
like
triosephosph
isomeras
tim
potenti
therapeut
target
perform
molecular
interact
simul
set
compound
obtain
librari
trios
phosphat
isomeras
vaginali
subsequ
compound
higher
probabl
interact
assay
abil
inhibit
destabil
mention
glycolyt
enzym
compound
select
dock
strategi
abl
reduc
replic
viabil
vaginali
cultur
find
import
implic
develop
new
therapeut
strategi
trichomoniasi
final
propos
new
potenti
drug
trichomoniasi
northeastern
univers
massachusett
usa
enzym
engin
seek
creat
enzym
either
de
novo
modif
known
protein
new
desir
function
biocatalysi
advantag
convent
catalyt
process
alway
natur
enzym
desir
properti
activ
exampl
mani
dna
polymeras
replic
dna
accur
high
speed
inhibit
damag
base
common
oxid
lesion
special
polymeras
may
well
suit
bypass
damag
typic
less
accur
undamag
dna
hybrid
polymeras
retain
accuraci
speed
replic
polymeras
incorpor
specif
lesion
bypass
abil
would
use
biochem
tool
research
focus
develop
highfidel
damagetoler
dna
polymeras
forens
analysi
damag
dna
lesion
mutagen
resid
syn
conform
allow
format
hoogsteen
pair
adenosin
molecular
dynam
dock
util
understand
lesion
conform
rel
fidel
model
polymeras
engin
variant
comput
method
themat
identifi
function
residu
assess
whether
variant
retain
electrostat
properti
natur
polymeras
catalysi
combin
comput
method
use
identifi
specif
variant
biochem
character
includ
thermal
stabil
catalyt
activ
lesion
bypass
capabl
fidel
support
nation
institut
justic
thermostabil
vpr
cold
adapt
subtilas
prolin
substitut
surfac
loop
structur
factor
correl
increas
stabil
thermophil
protein
increas
number
prolin
residu
locat
surfac
loop
compar
homolog
adapt
lower
temperatur
increas
number
prolin
residu
locat
loop
may
increas
rigid
prolin
residu
would
limit
number
possibl
configur
loop
structur
structur
comparison
vpr
subtilisinlik
serin
proteinas
psychrophil
vibrio
sp
relat
subtilas
includ
aqualysin
aqui
close
homologu
thermophil
thermu
aquaticu
show
aqui
contain
five
addit
prolin
residu
compar
vpr
four
locat
surfac
loop
substitut
four
pro
residu
correspond
site
structur
vpr
attempt
confer
increas
thermal
stabil
cold
adapt
enzym
produc
variant
contain
mutat
singl
doubl
tripl
quadrupl
variant
contain
substitut
prolin
mutat
signific
effect
thermal
stabil
vpr
variant
singl
variant
contain
either
two
substitut
near
nterminu
largest
effect
combin
stabil
doubl
mutant
four
substitut
present
select
site
loop
vpr
variant
melt
temperatur
increas
compar
wild
type
enzym
pro
substitut
howev
significantli
affect
catalyt
properti
enzym
roberto
chica
jame
davey
adam
damri
natali
goto
protein
molecular
machin
life
carri
complex
physic
chemic
process
often
requir
concert
motion
local
protein
structur
element
previou
effort
design
new
protein
applic
research
industri
medicin
focus
creation
sequenc
stabli
adopt
singl
target
structur
ignor
potenti
impact
protein
dynam
function
although
comput
protein
design
enjoy
consider
success
creat
new
protein
use
approach
fail
match
effici
found
natur
standard
method
allow
design
exchang
necessari
conform
state
functionallyrelev
timescal
develop
broadlyapplic
comput
method
engin
protein
dynam
term
metamultist
design
use
methodolog
design
spontan
exchang
two
novel
conform
introduc
global
fold
streptococc
protein
g
domain
design
protein
name
dancer
dynam
nativ
conform
exchang
stabli
fold
exchang
predict
conform
state
millisecond
timescal
evidenc
nuclear
magnet
reson
structur
zzexchang
experi
success
introduct
defin
dynam
function
timescal
pave
way
new
applic
requir
protein
spontan
access
multipl
conform
state
domain
swap
mode
protein
selfassoci
dimer
higher
order
oligom
form
monomer
protein
exchang
secondari
tertiari
structur
element
even
though
domain
swap
offer
facil
way
induc
oligomer
protein
lack
sequenc
similar
protein
known
swap
imped
identif
sequenc
motif
induc
domain
swap
protein
ration
identifi
experiment
demonstr
use
xray
crystallograph
nmr
spectroscop
techniqu
five
amino
acid
motif
qxvxg
conserv
function
cystatin
superfamili
suffici
drive
domain
swap
protein
nt
otherwis
domain
swap
differ
part
protein
could
made
swap
use
stretch
depend
target
loop
engin
gener
new
differ
fold
start
monom
use
motif
could
first
time
demonstr
doubl
domain
swap
dimer
could
design
rather
simpli
phenomenon
add
complex
linear
polymer
achiev
domain
swap
propos
qxvxg
motif
use
simpl
trick
ration
design
oligom
simpl
monomer
protein
comput
cost
engin
de
novo
interfac
protein
huge
strategi
bypass
exploit
natur
evolv
proteinprotein
interact
interfac
high
specif
proteinprotein
interact
network
comput
design
ravit
netzer
sarel
j
fleishman
signal
metabol
process
depend
highli
orchestr
interact
among
protein
network
specif
multispecif
interact
play
import
role
state
art
method
comput
specif
design
still
accur
enough
gener
network
overcom
challeng
develop
design
method
control
molecular
element
observ
natur
highspecif
network
includ
backbon
conform
interact
protein
orient
sequenc
appli
method
bacteri
colicin
toxinantitoxin
famili
gener
hundr
uniqu
design
pair
select
experiment
test
form
desir
complex
vivo
vitro
design
show
divers
specif
pattern
highli
specif
bound
cognat
partner
order
magnitud
tighter
design
other
show
multispecif
bind
sever
design
partner
overal
cognat
noncogn
interact
span
biolog
relev
interact
affin
subnanomolar
millimolar
dissoci
constant
crystal
structur
highlyspecif
design
show
atom
accuraci
orient
backbon
conform
conform
design
sidechain
comput
analysi
show
specif
design
rich
polar
interact
rigid
interfaci
loop
design
algorithm
contrast
multispecif
design
flexibl
loop
interact
surfac
promot
promiscu
bind
result
suggest
control
backbon
conform
enabl
design
larg
network
interact
protein
high
specif
multispecif
open
way
engin
insul
crossreact
interact
network
desir
develop
red
light
switchabl
proteinprotein
interact
use
phage
display
jaewan
jang
g
andrew
woolley
optic
control
protein
enabl
precis
spatial
tempor
control
molecular
function
complex
live
system
photoact
protein
chang
conform
respons
irradi
certain
wavelength
light
core
optogenet
tool
use
whole
anim
photoact
protein
respond
near
ir
wavelength
would
ideal
engin
small
gaf
domain
cyanobacteria
monomer
solut
protein
bind
biliverdin
present
mammalian
cell
undergo
nearir
driven
conform
chang
revert
sever
minut
dark
new
photoswitch
domain
enabl
new
applic
optogenet
whole
anim
within
evolv
landscap
protein
engin
approach
vast
major
mutat
yield
neutral
deleteri
destabil
effect
demonstr
stabil
mutat
usual
achiev
random
mutagenesi
make
identif
improv
protein
variant
exhaust
ineffici
process
herein
present
semir
combinatori
approach
support
dock
simul
residu
interact
network
rin
design
smaller
smarter
librari
mutant
lipas
b
pseudozyma
antarctica
calb
select
industri
relev
model
system
sinc
calb
display
low
activ
toward
bulki
substrat
main
goal
project
develop
calb
variant
enhanc
synthet
activ
toward
aromat
substrat
like
cinnam
salicyl
acid
use
combin
approach
uncov
import
residu
calb
activesit
caviti
contribut
synthet
reaction
dock
addit
calcul
energet
contribut
upon
sitedirect
mutagenesi
rin
result
improv
synthet
activ
calb
total
substrateproduct
convers
ratio
strategi
allow
us
obtain
calb
variant
enhanc
activ
toward
two
bulki
substrat
two
round
direct
evolut
sequenti
incorpor
favor
mutat
increas
chanc
select
improv
calb
variant
reduc
screen
effort
use
bottomup
strategi
rin
allow
us
understand
effect
mutat
throughout
protein
structur
power
tool
protein
engin
purpos
convent
organ
synthesi
produc
industri
relev
compound
still
costli
time
money
environment
impact
enzym
ecofriendli
altern
achiev
reaction
howev
labor
intens
engin
therefor
constant
need
develop
faster
high
throughput
method
acceler
enzym
engin
tackl
problem
multiplex
approach
creat
screen
identifi
multipl
variant
time
proof
concept
use
transform
indol
indigo
enzym
enzym
part
larg
famili
abl
catalyz
challeng
regio
chemoand
stereoselect
oxid
nonactiv
carbon
atom
singl
step
reaction
great
industri
import
mutat
activ
site
posit
satur
base
semir
design
screen
librari
use
easi
colorimetr
plate
assay
plate
screen
reveal
new
posit
abl
produc
indigo
gradat
blue
coloni
indic
effici
variant
therefor
variant
pool
categori
white
light
blue
dark
blue
sent
nextgener
sequenc
rapid
cheap
massiv
identif
collabor
sebastian
pechmann
udem
wrote
script
pars
million
read
reveal
new
identifi
variant
pool
primari
analysi
second
round
screen
method
use
novel
convers
industri
import
express
marin
adhes
protein
repeat
use
yeast
surfac
display
kristina
reinmet
stephen
fuch
tuft
univers
usa
adhes
protein
marin
organ
capabl
withstand
varieti
harsh
environment
condit
provid
great
model
studi
design
improv
biolog
adhes
approach
util
wellestablish
protein
engin
method
yeast
surfac
display
express
mussel
adhes
protein
repeat
evalu
abil
mediat
adher
surfac
stainless
steel
surfac
display
adhes
peptid
allow
easi
detect
cell
present
peptid
desir
properti
wherea
previou
work
lab
shown
repetit
code
sequenc
offer
potenti
mechan
impart
genet
divers
yeast
preliminari
result
demonstr
express
adhes
peptid
cell
surfac
indic
express
repeat
yeast
surfac
mediat
adhes
stainless
steel
absenc
stabil
posttransl
modif
tyrosin
hydroxyl
futur
work
aim
direct
evolut
improv
adhes
peptid
use
inher
instabl
repetit
sequenc
conjunct
random
sitespecif
approach
incorpor
modifi
amino
acid
import
adhes
rochelin
dalangin
robert
campbel
jiahui
wu
robert
campbel
abnorm
neurotransmitt
dynam
implic
variou
neurolog
condit
shortag
tool
visual
neurotransmitt
releas
geneticallyencod
fluoresc
protein
fp
sensor
becom
power
tool
studi
neuron
circuit
due
specif
high
spatiotempor
resolut
one
practic
use
fpbase
sensor
neurotransmitt
membraneteth
green
glutam
sensor
iglusnfr
enabl
multicolor
imag
experi
red
light
allow
deeper
tissu
imag
develop
red
glutam
sensor
iglusnfr
show
threefold
decreas
fluoresc
presenc
glutam
howev
traffic
cellular
membran
neuron
effici
iglusnfr
hyaluronan
ubiquit
express
extracellular
matrix
ecm
make
adult
brain
volum
previou
work
shown
green
fp
fuse
hyaluronanbind
domain
use
imag
hyaluronan
inspir
investig
approach
secret
iglusnfr
varieti
red
protein
ecm
fusion
hyaluronanbind
domain
approach
provid
altern
approach
use
fpbase
indic
visual
neurotransmitt
releas
may
provid
larger
robust
signal
due
larger
volum
space
occupi
secret
indic
beyond
point
mutat
direct
evolut
tool
effici
systemat
explor
protein
function
space
pedro
tizei
emma
harri
vitor
pinheiro
univers
colleg
london
uk
birkbeck
univers
london
uk
loop
play
central
role
mani
protein
catalyst
highaffin
ligand
repeatedli
shown
high
affin
ligand
antibodi
natur
laboratori
set
chang
composit
well
loop
length
huge
impact
function
nevertheless
direct
evolut
strategi
access
divers
method
introduc
divers
focu
fixedlength
librari
case
chang
length
discard
make
analysi
output
select
possibl
insert
delet
indel
repres
vast
region
sequenc
space
explor
goe
undetect
use
oloop
effect
substrat
specif
model
system
present
novel
platform
dna
librari
assembl
gener
highli
customiz
librari
vari
length
composit
addit
present
alignmentfre
sequenc
analysi
strategi
maxim
inform
gain
select
librari
vari
composit
length
togeth
enabl
sequenc
space
effici
navig
demonstr
isol
oloop
variant
differ
length
wildtyp
unrel
sequenc
activ
noncogn
substrat
assembl
analysi
tool
repres
power
new
tool
direct
evolut
highli
relev
protein
loop
linker
optim
abhi
aggarw
robert
campbel
landon
zarowni
depart
chemistri
univers
alberta
edmonton
canada
geneticallyencod
fluoresc
calcium
indic
geci
modul
fluoresc
intens
respons
chang
calcium
ion
concentr
power
tool
investig
cell
biolog
fluoresc
indic
vital
come
cellular
imag
allow
noninvas
studi
cell
tissu
subcellular
structur
detail
previous
possibl
focu
project
engin
new
geci
exhibit
favour
characterist
increas
bright
higher
fold
chang
develop
new
geci
start
mneongreen
brightest
monomer
fluoresc
protein
current
avail
initi
prototyp
construct
made
use
ration
design
follow
preced
gcamp
seri
indic
construct
improv
use
direct
protein
evolut
colonybas
screen
librari
randomli
gener
variant
observ
bright
promis
new
variant
perform
test
see
new
mutat
affect
bright
fold
chang
variant
round
screen
latest
variant
mneongreengeci
exhibit
chang
compar
origin
construct
indic
appear
significantli
brighter
higher
contrast
state
direct
evolut
ongo
expect
produc
fluoresc
indic
use
vivo
imag
intracellular
dynam
microfocus
frontier
mx
beamlin
fmx
fulli
commiss
deliv
flux
ph
mm
spot
maximum
flux
densiti
surpass
current
mx
beamlin
two
order
magnitud
cover
wide
wavelength
rang
featur
next
gener
eiger
pixel
array
detector
hz
frame
rate
high
bright
microfocus
capabl
fmx
ideal
solv
difficult
crystallograph
problem
experiment
station
highli
flexibl
design
support
wide
rang
structur
determin
method
serial
crystallographi
sub
micron
size
crystal
raster
optim
diffract
crystal
complex
larg
unit
cell
rapid
sampl
screen
room
temperatur
data
collect
difficult
freez
crystal
associ
wide
varieti
sampl
includ
frozen
crystal
loop
mesh
singl
crystal
acoust
deposit
crystal
crystal
crystal
plate
lipid
cupic
phasepl
jet
special
sampl
holder
serial
crystallographi
base
microstructur
silicon
chip
current
fabric
bnl
center
function
nanomateri
new
beamlin
push
frontier
synchrotron
crystallographi
enabl
user
determin
structur
difficult
crystal
target
like
membran
protein
use
previous
untract
fewmicrons
crystal
obtain
higher
qualiti
structur
research
support
us
nation
institut
health
nigm
grant
de
novo
design
antivirul
therapeut
base
genet
encod
hyperst
constrain
peptid
christoph
bahl
david
baker
univers
washington
usa
hhmi
usa
organ
domain
life
produc
residu
disulfideconstrain
peptid
function
rang
signal
virul
immun
peptid
stabil
function
conform
disulfid
bond
possess
mani
benefici
pharmacolog
properti
small
molecul
drug
eg
high
stabil
tissu
penetr
retain
high
interact
specif
larger
biolog
drug
antibodi
thu
constrain
peptid
repres
larg
untap
class
drug
scaffold
genet
encod
develop
gener
comput
method
design
constrain
peptid
de
novo
provid
access
much
molecular
divers
current
avail
naturalist
observ
use
method
design
constrain
peptid
span
nine
differ
structur
topolog
sequenc
unrel
known
gene
design
peptid
contain
three
disulfid
bond
express
purifi
bacteria
exhibit
high
thermal
chemic
stabil
experiment
determin
xray
nmr
model
show
design
protocol
atomiclevel
accuraci
new
method
enabl
design
peptid
structur
customtailor
specif
applic
current
effort
incorpor
function
direct
toward
treat
infecti
diseas
antagon
virulencepromot
mechan
pathogen
microorgan
two
primari
target
biofilmregul
lap
system
gramneg
bacteria
superantigen
enterotoxin
secret
gramposit
bacteria
case
exist
structur
mechanist
inform
leverag
conjunct
comput
peptid
design
engin
sitespecif
proteinprotein
interact
intend
therapeut
effect
monash
univers
australia
univers
cambridg
uk
serin
proteas
inhibitor
serpin
one
protein
famili
fold
metast
conform
metast
crucial
function
inhibitor
render
suscept
misfold
aggreg
redesign
serpin
may
provid
insight
balanc
function
stabil
previous
use
protein
engin
develop
synthet
serpin
conserpin
enhanc
biophys
properti
serpin
high
thermal
stabil
tm
aggregationresist
activ
inhibitor
explor
balanc
function
stabil
serpin
graft
region
conserpin
vice
versa
engin
conserpin
mimic
mutat
residu
reactiv
centr
loop
rcl
creat
conserpinaatrcl
mutat
affect
stabil
xray
crystal
structur
serpin
conserpinaatrcl
possess
weak
inhibitori
activ
compar
surfac
potenti
conserpinaatrcl
differ
greatli
molecular
dynam
simul
show
rcl
dynam
conserpinaatrcl
factor
could
play
role
failur
conserpinaatrcl
match
inhibitori
activ
engin
stabil
aggregationresist
graft
region
conserpin
onto
circular
dichroism
thermal
unfold
analysi
show
graft
confer
increas
thermost
retain
activ
wild
type
taken
togeth
result
suggest
engin
increas
stabil
aggreg
resist
without
compromis
function
protein
promis
materi
creation
coat
magnet
nanoparticl
mnp
due
biocompat
protect
magnet
core
biolog
liquid
influenc
prevent
agglomer
dispers
magnet
target
nanosystem
protein
coat
consid
applic
differ
area
biolog
medicin
hyperthermia
magnet
reson
imag
immunoassay
cell
molecular
separ
smart
deliveri
drug
target
cell
studi
object
develop
free
radic
approach
creation
function
bicompon
protein
coat
magnet
nanoparticl
variou
size
adsorpt
group
blood
protein
includ
serum
albumin
immunoglobulin
g
mnp
studi
novel
approach
base
protein
liabil
free
radic
modif
lead
format
intermolecular
coval
cross
link
use
obtain
coat
assembl
protein
molecul
surfac
magnetit
nanoparticl
dispers
properti
coat
studi
help
dynam
light
scatter
dl
uvvi
spectrophotometri
antibodyantigen
test
method
spectralfluoresc
probe
protein
adsorpt
shown
depend
incub
time
proteinmnp
concentr
nanoparticl
curvatur
temperatur
ionic
strenght
buffer
characterist
etc
free
radic
link
thrombin
immunoglobulin
g
surfac
nanoparticl
shown
almost
complet
keep
nativ
properti
protein
molecul
potenti
therapeut
product
biovector
report
studi
fund
rfbr
moscow
citi
govern
accord
research
project
molamo
rfbr
accord
research
project
moladk
autocatalyt
matur
chromophor
green
fluoresc
protein
gfp
thought
requir
precis
posit
side
chain
surround
core
protein
mani
strongli
conserv
among
homolog
fluoresc
protein
studi
screen
green
fluoresc
exhaust
set
point
mutat
seven
residu
make
chromophor
microenviron
exclud
mutat
posit
previous
character
contrari
expect
nearli
amino
acid
toler
seven
posit
four
point
mutat
knock
fluoresc
entir
howev
chromophor
matur
found
slower
andor
fluoresc
reduc
sever
case
select
combin
mutat
show
nonaddit
effect
includ
cooper
rescu
result
provid
guidelin
comput
engin
gfp
biofuel
industri
use
break
cellulos
aglucos
bioethanol
product
howev
suffici
heat
gener
process
denatur
biofuel
industri
spend
billion
cool
techniqu
cloud
chamber
purpos
research
entitl
direct
evolut
paenibacillu
polymyxa
design
thermost
use
biofuel
industri
breakdown
cellulos
aglucos
without
need
cool
success
biofuel
industri
use
enzym
spend
littl
money
cool
techniqu
fuel
afford
error
prone
polymeras
chain
reaction
use
creat
librari
mutant
dna
sequenc
librari
transform
escherichia
coli
strain
lack
gene
coloni
screen
chromogen
substrat
xgal
oc
identifi
clone
activ
temperatur
wild
type
activ
coloni
screen
thermost
mutant
identifi
present
phenotyp
biochem
character
thermost
phenotyp
rhamnolipid
rl
glycolipid
compound
produc
bacteri
speci
especi
pseudomona
burkholderia
spp
compound
display
excel
surfact
properti
environment
advantag
nevertheless
high
product
cost
hamper
practic
use
industri
addit
bacteri
strain
produc
rl
gener
mixtur
congen
vari
lipophil
chain
length
therefor
affect
macromolecular
behavior
sinc
physicochem
characterist
rl
directli
influenc
molecular
structur
modif
improv
surfact
properti
achiev
control
length
alkyl
chain
rhla
act
key
enzym
rl
biosynthesi
pathway
enzym
catalyz
esterif
reaction
two
unit
hydroxyl
fatti
acid
form
dimer
alkano
acid
haa
dilipid
precursor
rl
haa
biosynthesi
ratelimit
step
rl
biosynthesi
present
semir
evolut
approach
engin
rhla
p
aeruginosa
increas
vivo
haa
product
modul
substrat
select
use
structur
homolog
model
enzym
predict
number
substrateinteract
residu
perform
intragen
suppressiontyp
mutagenesi
increas
catalyt
effici
rhla
also
employ
chimer
approach
identifi
protein
domain
involv
enzym
select
addit
perform
sitedirect
mutagenesi
residu
locat
substrat
bind
pocket
modul
rl
congen
biosynthesi
result
provid
evid
protein
engin
approach
effici
employ
improv
rl
product
p
aeruginosa
monom
contribut
overal
composit
activ
site
therefor
disrupt
dimer
interfac
could
use
inhibit
mtalr
activ
five
potenti
hotspot
residu
identifi
use
comput
alanin
scan
robetta
yeast
twohybrid
system
use
assess
contribut
dimer
mtalr
clone
two
plasmid
express
one
plasmid
confirm
yeast
western
blot
candid
residu
mutat
alanin
individu
combin
effect
dimer
determin
twohybrid
system
unbias
random
mutagenesi
also
carri
find
potenti
hotspot
residu
experiment
verif
key
residu
mtalr
dimer
lead
identif
potenti
ligand
bind
site
dimer
interfac
inhibitor
design
use
phagedisplay
peptid
librari
identifi
peptid
ligand
bind
bacteria
mean
character
gut
microbiota
shweta
shah
gururaj
rao
gregori
j
phillip
roy
j
carver
depart
biochemistri
biophys
molecular
biolog
iowa
state
univers
random
peptid
librari
provid
divers
peptid
combin
molecular
structur
recogn
bind
varieti
target
molecul
phage
display
one
power
well
establish
technolog
select
screen
desir
bind
peptid
combinatori
peptid
librari
work
use
phagemid
vector
pcantab
construct
random
amino
acid
librari
fuse
piii
coat
protein
achiev
divers
librari
valid
screen
antiflag
monoclon
antibodi
isol
peptid
match
known
flag
epitop
dykddddk
previous
success
use
librari
protein
current
effort
focus
explor
use
phagepeptid
librari
context
gastrointestin
gi
microbiota
ie
identifi
peptid
ligand
uniqu
specif
bacteria
colon
mammalian
gut
end
pilot
experi
screen
librari
commens
strain
escherichia
coli
yield
bind
peptid
contain
consensu
bind
motif
swlkr
mer
phage
librari
use
isol
bind
peptid
specif
lactobacillu
murinu
member
murin
gi
tract
one
futur
goal
also
util
techniqu
isol
identifi
peptid
distinguish
variou
bacteri
speci
new
tool
studi
structur
function
gi
microbiota
proteinbas
nanostructur
mani
potenti
applic
medicin
materi
scienc
describ
generaliz
method
use
short
coiledcoil
domain
assembl
protein
nanocag
variou
geometri
approach
requir
minim
alter
protein
henc
preserv
structur
function
properti
protein
strategi
reli
combin
rotat
symmetri
element
one
provid
natur
build
block
protein
bbp
provid
coil
coil
specifi
protein
cage
desir
geometri
oligomer
coiledcoil
bring
togeth
copi
bbp
togeth
lead
assembl
protein
cage
employ
bbp
coiledcoil
differ
rotat
symmetri
possibl
design
cage
variou
size
geometri
key
success
strategi
optim
linker
bbp
associ
strength
coiledcoil
strand
use
strategi
abl
success
design
octahedr
tetrahedr
protein
cage
current
focu
design
structur
challeng
icosahedr
protein
cage
well
elabor
structur
previous
design
octahedr
cage
addit
protein
domain
adam
steven
tom
muir
giridhar
sekar
david
cowburn
princeton
univers
usa
albert
einstein
colleg
medicin
usa
protein
splice
posttransl
autoprocess
event
interven
protein
intein
cleav
precursor
protein
simultan
ligat
adjac
residu
extein
form
nativ
peptid
bond
although
biolog
function
intein
remain
unclear
found
widespread
use
tool
chemic
biolog
protein
engin
special
interest
natur
split
intein
two
intein
fragment
separ
express
effici
undergo
associ
splice
tran
howev
applic
split
intein
limit
number
shortcom
includ
issu
express
yield
among
proteinintein
fusion
decreas
splice
rate
certain
extein
context
extein
depend
structur
mechanismguid
approach
engin
split
intein
increas
thermost
extein
promiscu
enhanc
split
intein
appli
number
protein
engin
method
gener
head
tail
cycliz
protein
modif
monoclon
antibodi
small
molecul
cargo
semisynthesi
cellular
chromatin
isol
nuclei
overal
expect
engin
protein
facilit
use
develop
protein
transsplic
base
technolog
method
heme
biosynthesi
well
character
final
step
occur
mitochondria
heme
transfer
hemedepend
protein
known
part
due
current
technic
limit
monitor
heme
load
specif
protein
cell
cytochrom
c
peroxidas
hemebas
mitochondri
sensor
labil
heme
occur
level
spike
respir
yeast
lead
activ
catalas
directli
indirectli
receiv
heme
fulli
understand
unpreced
heme
mobil
select
fuse
green
fluoresc
protein
probe
heme
load
live
cell
sinc
heme
effici
quench
gfp
fluoresc
monitor
fluoresc
lifetim
concentr
independ
unlik
fluoresc
intens
vitro
hemefre
recombin
exhibit
lifetim
ns
wherea
hemeload
display
long
ns
short
ns
lifetim
fraction
amplitud
short
lifetim
increas
linearli
expens
longlifetim
amplitud
bind
heme
result
allow
us
estim
flim
heme
statu
live
yeast
cell
studi
shed
light
heme
statu
vivo
also
suggest
novel
tool
unravel
intracellular
heme
traffick
cyanovirinn
cvn
antivir
lectin
potent
activ
envelop
virus
case
hiv
antivir
activ
cvn
postul
requir
multival
interact
oligomannos
envelop
protein
achiev
pseudorepeat
sequenc
adopt
two
nearident
glycanbind
site
possibl
involv
dimer
form
cvn
work
lab
shown
flexibl
dock
method
dissect
contribut
singl
amino
acid
bind
target
glycan
predict
mutat
increas
bind
affin
improv
antivir
activ
design
coval
dimer
cvn
increas
number
activ
glycanbind
site
two
nativ
repeat
separ
nest
coval
insert
two
addit
repeat
cvn
result
four
possibl
glycanbind
site
result
nest
cvn
fold
wildtypelik
structur
assess
circular
dichroism
nmr
spectroscopi
display
high
thermal
stabil
tm
ident
wt
four
glycanbind
domain
encompass
sequenc
function
demonstr
isotherm
titrat
calorimetri
reveal
two
set
bind
event
dimannos
dissoci
constant
kd
mm
mm
assign
domain
b
b
domain
respect
nest
cvn
display
fivefold
increas
activ
compar
wt
cvn
cellular
assay
fusion
assay
work
demonstr
ration
design
use
increas
bind
affin
multival
antivir
lectin
result
potent
activ
gideon
lapidoth
sarel
fleishman
abil
comput
design
effici
specif
enzym
rigor
test
understand
principl
catalysi
molecular
recognit
success
design
date
shown
sever
limit
target
simpl
reaction
involv
two
three
catalyt
residu
often
low
effici
select
impair
stabil
develop
new
algorithm
use
rosetta
combin
compat
backbon
fragment
natur
enzym
enzym
superfamili
gener
novel
conform
design
sequenc
optim
guid
sequenc
conserv
data
improv
stabil
express
use
algorithm
design
novel
tim
barrel
fold
enzym
belong
famili
capabl
hydrolyz
xylan
abund
plant
polysaccharid
kcatkm
valu
similar
natur
xylanas
design
enzym
conform
differ
one
anoth
known
natur
xylanas
conform
differ
substrat
specif
algorithm
complet
autom
appli
enzym
modular
fold
effici
broadli
explor
potenti
select
superfamili
selfassembl
supramolecular
nanostructur
complex
construct
protein
nanobuild
block
ryoichi
arai
naoya
kobayashi
naoya
kimura
shinshu
univers
japan
live
organ
maintain
variou
supramolecular
complex
selfassembl
biomolecul
includ
protein
nucleic
acid
sugar
lipid
chemic
reconstitut
live
matter
one
ultim
goal
chemistri
synthet
biolog
research
molecular
design
dynam
order
system
selfassembl
artifici
protein
complex
import
step
toward
achiev
goal
applic
recent
design
creat
protein
nanobuild
block
pnblock
fuse
intermolecularli
fold
dimer
de
novo
protein
trimer
foldon
domain
bacteriophag
fibritin
kobayashi
n
et
al
j
chem
soc
simpl
versatil
nanobuild
block
selfassembl
sever
oligomer
nanoarchitectur
multipl
also
design
creat
de
novo
extend
protein
nanobuild
block
epnblock
fuse
tandemli
two
variou
linker
construct
selfassembl
cycliz
extend
chainlik
nanostructur
complex
moreov
stabil
de
novo
protein
extens
applic
pnblock
nanotechnolog
design
develop
variant
call
suwa
super
sever
mutat
stabil
helic
hydrophob
core
thermal
denatur
experi
show
denatur
midpoint
temperatur
tm
suwa
extrem
high
degre
c
also
construct
pnblock
suwafoldon
nativ
page
sax
analys
suggest
suwafoldon
selfassembl
sever
homooligomer
complex
partial
thermal
denatur
reconstruct
experi
suggest
dynam
order
system
suwafoldon
supramolecular
complex
result
demonstr
pnblock
strategi
use
construct
selfassembl
protein
complex
nanoarchitectur
target
dynamicsbas
ration
design
kendra
hailey
giulia
palermo
patricia
jen
univers
california
san
diego
usa
crystal
nmr
cryoem
structur
provid
critic
start
point
understand
bimolecular
function
atom
level
howev
fulli
explain
mechanist
detail
within
system
vitro
ultim
vivo
expans
array
silico
md
amd
qmmm
solut
biophysicalbiochem
techniqu
employ
inform
us
function
import
phenomena
miss
inspect
structur
alon
dxm
medium
resolut
solut
method
nmr
dynam
dxm
sax
fret
measur
deuterium
incorpor
peptid
backbon
time
result
data
use
understand
nativ
state
dynam
protein
secondminut
time
scale
protein
fold
intermedi
ligandinduc
conform
chang
strength
dxm
includ
larg
sampl
size
rang
mda
eg
amen
divers
sampl
composit
ptm
membran
environ
amyloid
great
eas
use
data
collect
process
semiht
combin
quenchflow
dxm
also
use
track
nonn
state
conform
within
system
includ
intermedi
state
within
protein
fold
trajectori
well
dynam
potenti
alloster
pathway
within
molecul
pair
specif
fretlabel
scheme
aim
elucid
dynam
nativ
state
apo
sgrnabound
sgrnadnabound
well
follow
intermedi
via
stopflow
dxm
fret
aim
refin
data
analys
order
creat
higherthroughput
ration
design
workflow
figur
test
system
discov
select
new
target
function
introduct
high
temperatur
requir
serin
proteas
implic
intrins
nonclass
apoptot
pathway
proteolyt
activ
propos
tumor
abstract
suppressor
henc
potenti
therapeut
target
matur
compris
ntermin
region
serin
proteas
domain
spd
ctermin
pdz
domain
complex
mechan
activ
poorli
character
understand
biolog
function
limit
singl
natur
substrat
object
aim
perform
structur
function
analys
deciph
role
differ
domain
critic
residu
mediat
proteas
activ
specif
presenc
known
novel
bind
partner
might
aid
modul
activ
desir
characterist
method
clone
purif
variant
done
use
molecular
biolog
biochem
tool
conform
chang
stabil
function
enzymolog
interact
partner
studi
use
multidisciplinari
tool
result
enzym
kinet
demonstr
follow
alloster
model
activ
nspd
spd
spdpdz
variant
inact
mutat
ntermin
region
made
protein
monomer
inact
moreov
xlink
inhibitor
apoptosi
xiap
identifi
novel
bind
partner
conclus
domain
wise
dissect
import
ntermin
region
trimer
proteas
activ
demonstr
also
highlight
role
pdz
modul
protein
activ
might
also
promot
apoptosi
bind
deactiv
xiap
defin
detail
molecular
recognit
watersolubl
enzym
membran
fundament
understand
proteinlipid
interact
molecular
complementar
membran
function
pna
phospholipas
includ
cytosol
calciumindepend
lipoproteinassoci
provid
ideal
system
studi
proteinlipid
bind
interact
hydrogendeuterium
hd
exchang
mass
spectrometri
use
identifi
peptid
region
three
enzym
interact
phospholipid
vesicl
molecular
dynam
simul
guid
valid
experiment
hd
exchang
data
show
activ
site
enzym
alloster
regul
membran
membran
phospholipid
bind
alloster
site
locat
interfaci
surfac
shift
conform
close
open
state
process
facilit
extract
bind
phospholipid
molecul
activ
site
hydrolysi
occur
posit
phospholipid
constitut
first
detail
studi
describ
bind
interact
mechan
membran
bilay
well
bind
singl
phospholipid
molecul
catalyt
site
enzym
implic
chronic
inflammatori
diseas
understand
associ
membran
mechan
action
interact
membran
inhibitor
molecular
level
allow
us
identifi
potent
select
inhibitor
develop
novel
antiinflammatori
agent
j
numer
cellular
perturb
overwhelm
homeostat
capac
endoplasm
reticulum
er
caus
accumul
unfold
protein
activ
unfold
protein
respons
upr
upr
restor
er
homeostasi
adapt
prolong
stress
switch
prodeath
termin
output
protein
kinasernas
contain
dual
kinas
rnase
activ
shown
contribut
transit
adapt
termin
uproutput
er
stress
unfold
protein
result
lumen
domain
oligomer
lead
kinas
autophosphoryl
rnase
activ
case
prolong
stress
becom
hyperactiv
lead
endonucleolyt
decay
hundr
erloc
mrna
contribut
cell
death
present
mechanist
studi
probe
alloster
commun
kinas
rnase
domain
inhibitor
target
atpbind
site
kinas
diverg
alloster
effect
rnase
activ
inhibitor
alloster
activ
rnase
other
call
kira
alloster
inhibit
rnase
activ
perform
biochem
structur
studi
provid
insight
atpcompetit
inhibitor
affect
oligomer
state
directli
influenc
rnase
activ
comprehens
structur
model
differ
class
inhibitor
diverg
modul
oligomer
state
describ
furthermor
differ
class
inhibitor
affect
cell
fate
er
stress
present
recent
discov
tyrosinekinas
abl
alloster
activ
enzymat
activ
er
stress
abl
coloc
cytosol
face
er
membran
promot
autophosphoryl
stimul
rnase
activ
mechanist
studi
abl
scaffold
activ
molecular
detail
complex
present
kristyna
bousova
present
studi
protein
structur
vari
map
basic
function
studi
synergi
protein
elementari
unit
protein
domain
inform
mutual
interact
domain
use
decrypt
interintra
domain
commun
alloster
modul
function
team
studi
new
synthet
protein
chimera
compos
two
differ
function
protein
domain
domain
part
act
cytoskeleton
membran
protein
trpcage
artifici
protein
molecul
gener
silico
two
domain
flexibl
connect
two
differ
order
revers
use
variou
biochem
biophys
structur
method
describ
properti
de
novo
creat
protein
analyt
size
exclus
chromatographi
analyt
ultracentrifug
dynam
light
scatter
thermal
shift
assay
circular
dichroism
chevron
plot
kinet
studi
nmr
data
suggest
complet
differ
behaviour
studi
chimera
protein
character
singl
domain
protein
contrari
protein
show
two
domain
charact
lower
stabil
tendenc
aggreg
assum
order
protein
domain
cell
specif
multidomain
protein
key
factor
domain
alloster
modul
determin
specif
function
refer
aberr
proteinprotein
interact
ppi
network
node
identifi
highli
correl
prolifer
growth
acquisit
cancer
cell
render
ppi
becom
promis
anticanc
therapeut
target
use
interact
model
system
work
demonstr
peptidedirect
strategi
identif
alloster
fragment
rigidifi
protein
dynam
conform
nearli
half
cancer
anticanc
activ
protein
often
impair
overexpress
oncoprotein
homolog
mdmx
demand
effici
therapeut
disrupt
aberr
interact
restor
activ
consid
intrins
fluoresc
residu
transact
domain
play
import
role
determin
interact
construct
fusion
protein
make
use
intrins
fluoresc
signal
monitor
highthroughput
screen
compound
librari
aim
identifi
novel
scaffold
mdmx
inhibitor
fusion
protein
compos
follow
ntermin
domain
mdmx
nmdmx
flexibl
amino
acid
linker
whole
fusion
protein
contain
sole
intrins
fluoresc
probe
fusion
protein
evalu
use
fluoresc
spectroscopi
inhibitor
librari
identifi
alloster
fragment
enabl
rigidifi
dynam
conform
furthermor
alloster
fragment
util
design
mdmx
inhibitor
thu
work
provid
rational
optim
mdmx
inhibitor
fusion
protein
strategi
describ
work
also
applic
protein
target
drug
discoveri
quantifi
dynam
bleb
mammalian
cell
line
predict
migratori
behaviour
netra
unni
anam
qudrat
predict
cell
migrat
requir
care
analysi
chang
cell
morpholog
spatiotempor
scale
one
morpholog
chang
format
bleb
protrus
cell
plasma
membran
subsequ
fill
cytoplasm
fluid
recent
studi
shown
membran
bleb
may
use
mechan
predict
cell
migratori
pathway
analysi
mammalian
synthet
cell
line
characterist
bleb
format
quantifi
use
adapt
softwar
metric
bleb
size
growth
rate
direction
persist
quantifi
hypothes
dynam
persist
bleb
potenti
cell
migrat
defin
direct
distal
residu
may
modul
dynam
ornithin
transcarbamoylas
accord
small
angl
xray
solut
scatter
jenif
winter
lisa
ngu
dr
lee
makowski
dr
penni
j
beun
dr
mari
ondrechen
northeastern
univers
massachusett
usa
studi
enzym
catalyt
mechan
typic
focus
residu
direct
contact
react
substrat
molecul
howev
enzym
util
residu
obvious
import
catalysi
direct
contact
react
speci
partial
order
optimum
likelihood
pool
machin
learn
method
predict
catalyt
import
residu
base
protein
tertiari
structur
electrostat
properti
pool
predict
spatial
extend
activ
site
residu
direct
contact
substrat
import
catalysi
includ
ornithin
transcarbamoylas
otc
enzym
variant
creat
singlesit
direct
mutagenesi
subsequ
assay
kinet
activ
show
predict
residu
contribut
catalysi
nonpoolpredict
residu
smallangl
xray
solut
scatter
sax
use
determin
predict
distal
residu
play
role
dynam
structur
chang
thu
affect
catalysi
distanc
threedimension
reconstruct
solut
scatter
data
wildtyp
otc
variant
gener
use
reconstruct
program
atsa
suit
case
reconstruct
variant
mutat
distal
posit
suggest
structur
rearrang
revers
upon
addit
substrat
conclud
function
impact
poolpredict
electrostat
effect
realiz
least
partial
conform
rearrang
secondari
structur
element
support
nsf
leverag
reciproc
identifi
unknown
alloster
site
jame
lipchock
patrick
loria
danica
cui
patrick
ginther
washington
colleg
maryland
usa
yale
univers
connecticut
usa
protein
tyrosin
phosphatas
known
regul
insulin
leptin
signal
pathway
activ
target
treatment
type
ii
diabet
obes
given
import
therapeut
target
sought
identifi
unknown
site
alloster
regul
surfac
enzym
achiev
creat
seri
alanin
point
mutat
activ
site
monitor
composit
chemic
shift
perturb
across
protein
specif
mutat
span
acidloop
shown
previous
move
rate
enzym
catalysi
structur
map
chemic
shift
perturb
reveal
network
residu
connect
activ
site
opposit
side
enzym
includ
three
distal
cluster
residu
surfac
one
cluster
includ
benzbromaron
analog
bind
site
known
alloster
inhibitor
confirm
import
two
cluster
six
residu
site
mutat
analyz
kinet
assay
nmr
spectroscopi
result
mutant
exhibit
decreas
catalyt
effici
rang
yield
signific
chemic
shift
chang
along
alloster
network
activ
site
confirm
role
alloster
regul
believ
work
help
advanc
drug
discoveri
effort
proven
difficult
date
also
enzym
unknown
alloster
network
naoto
soya
gerg
lukac
ariel
roldan
haijin
xu
ryosuk
fukuda
tama
hegedu
mcgill
univers
montreal
canada
semmelwei
univers
hungari
cystic
fibrosi
cf
one
common
autosom
recess
diseas
caus
function
express
defect
cystic
fibrosi
transmembran
conduct
regul
cftr
anion
channel
delet
residu
nucleotid
bind
domain
preval
mutat
lead
misfold
er
degrad
cftr
residu
pivot
foldingst
cftr
coupl
domain
fold
stabil
hydrophob
pocket
cytosol
loop
interfac
hyperstabil
alon
combin
interfac
pursu
correct
fold
defect
despit
extens
effort
still
lack
pharmacolog
chaperon
robustli
rescu
mutant
cftr
stabil
defect
use
hydrogendeuterium
exchang
mass
spectrometri
hdxm
continu
label
techniqu
molecular
dynam
simul
monitor
spatiotempor
unfold
mutant
gain
insight
conform
defect
unfold
acceler
unfold
start
asubdomain
spread
atpbind
contrast
secondsit
suppressor
mutat
restor
subdomain
stabil
contain
cfcaus
mutat
result
concert
molecular
dynam
analysi
help
identifi
network
residu
render
subdomain
sensit
alloster
unfold
may
serv
ration
select
pharmacolog
chaperon
allevi
mutant
fold
defect
chitra
narayanan
david
n
bernard
khushboo
bafna
pratul
k
agarw
nicola
doucet
inr
univers
quebec
canada
univers
tennesse
knoxvil
usa
oak
ridg
nation
laboratori
tennesse
usa
correl
enzym
function
conform
motion
amino
acid
network
activ
site
well
establish
discret
enzym
system
howev
approach
character
dynam
properti
across
divers
sequenc
homolog
within
famili
correl
enzym
activ
remain
challeng
member
pancreatictyp
ribonucleas
ptrnase
superfamili
share
similar
structur
fold
display
larg
variat
conform
dynam
catalyt
effici
tissu
specif
biolog
activ
make
ideal
model
system
probe
relationship
conform
motion
function
step
toward
determin
relationship
dynam
catalyt
effici
variou
member
broad
vertebr
famili
perform
systemat
character
intrins
dynam
rnase
experiment
solv
structur
wide
rang
timescal
integr
molecular
dynam
simul
nmr
relax
dispers
experi
result
show
distinct
pattern
dynam
variat
canon
rnase
cluster
taxonom
group
henceforth
refer
subfamili
show
conform
motion
catalyt
relev
microto
millisecond
timescal
significantli
differ
rnase
share
common
fold
interestingli
sequenc
share
similar
conform
exchang
timescal
also
share
similar
biolog
function
quantit
character
pairwis
correl
dynam
properti
rnase
member
show
strong
correl
within
subfamili
share
similar
function
result
suggest
select
pressur
conserv
specif
atomicscal
dynam
behavior
among
factor
may
potenti
impact
distinct
biolog
function
enzym
share
fold
experi
requir
character
correl
conserv
dynam
properti
biolog
function
camkii
biophys
role
longterm
potenti
margaret
stratton
ana
torr
yasunori
hayashi
takeo
saneyoshi
emili
agnello
rori
oconnel
brendan
page
megan
west
umass
amherst
usa
kyoto
univers
japan
depend
protein
kinas
ii
camkii
assembl
oligomer
ring
kinas
domain
organ
around
central
hub
notabl
stimul
activ
camkii
persist
even
withdraw
calcium
stimulu
camkii
acquir
activ
threshold
frequenc
properti
implic
longterm
potenti
ltp
inde
transgen
mice
express
mutant
version
camkii
limit
ltp
defect
learn
memori
previous
shown
camkii
remark
properti
activ
camkii
trigger
exchang
subunit
holoenzym
includ
inact
one
enabl
activ
neighbor
subunit
result
implic
earlier
idea
subunit
exchang
camkii
may
relev
longterm
memori
format
hypothes
subunit
exchang
along
recent
find
specif
substrat
bind
may
also
potenti
activ
play
role
import
camkii
ltp
present
substrat
interact
camkii
may
play
role
neuron
signal
addit
present
find
subunit
exchang
occur
multipl
isoform
camkii
may
import
chang
gene
express
hallmark
ltp
recent
experiment
evid
suggest
conform
exchang
may
affect
catalyt
function
number
enzym
system
howev
underli
mechan
link
flexibl
biolog
function
remain
elus
instanc
unknown
whether
protein
sequenc
andor
structur
evolutionarili
conserv
promot
conform
exchang
among
function
enzym
homolog
herein
use
combin
function
assay
nmr
relax
experi
character
catalyt
relev
millisecond
time
frame
variou
member
pancreaticlik
ribonucleas
superfamili
provid
inform
evolutionari
conserv
dynam
biolog
function
character
mammalian
homolog
human
ribonucleas
also
known
eosinophil
cation
protein
ecp
specif
focus
monkey
ecp
homolog
macaca
fasciculari
pongo
pygmaeu
pongo
abelii
aotu
trivirgatu
find
show
conform
exchang
monkey
enzym
strongli
resembl
human
counterpart
subtl
chang
exchang
rate
andor
structur
local
thu
provid
insight
effect
sequenc
phylogenet
divers
protein
dynam
parallel
antibacteri
assay
e
coli
aureu
illustr
antimicrobi
activ
correl
evolutionari
distanc
common
ancestor
final
cytotox
assay
perform
hela
cell
highlight
stark
differ
potenc
human
ecp
monkey
enzym
prototyp
rnase
homolog
altogeth
experi
provid
detail
potenti
interdepend
protein
function
atomicscal
flexibl
dynam
interact
hepat
c
viru
hcv
helicas
nucleic
acid
subject
great
interest
given
key
role
enzym
viral
replic
better
character
dynam
step
preced
atpfuel
unwind
describ
singlemolecul
protein
induc
fluoresc
enhanc
smpife
assay
monitor
realtim
fluoresc
enhanc
induc
bind
purifi
recombin
individu
surfaceimmobil
dna
substrat
label
cyanin
dye
smpife
experi
reveal
three
enhanc
level
correspond
three
discret
bind
site
adjac
base
ssdna
overhang
model
substrat
prefer
singlestrandeddoublestrand
junction
wt
transit
bind
site
direct
without
dissoci
mutant
display
poor
atpdepend
unwind
activ
sever
compromis
switch
activ
presenc
nonhydrolyz
atp
analogu
wt
adopt
singl
bind
site
transit
reduc
affin
nucleic
acid
correspond
larg
decreas
rate
associ
littl
chang
rate
dissoci
togeth
data
consist
model
favor
atpindepend
slide
singlestrand
overhang
via
brownian
motor
model
atp
bind
hydrolysi
would
fuel
process
direct
propos
inchwormlik
activ
unwind
process
sequenc
ra
nearli
invari
vertebr
despit
gener
toler
protein
mutat
defin
function
constraint
sequenc
ra
develop
bacteri
twohybrid
select
system
ra
activ
screen
librari
contain
singlesit
mutant
human
ra
wildtyp
ra
regul
gtpase
activ
protein
guanin
nucleotid
exchang
factor
rel
toler
mutat
except
hydrophob
core
bind
element
nucleotid
effector
regul
remov
regul
reveal
hotspot
activ
mutat
wildtyp
ra
identifi
residu
appear
act
latch
ra
dynam
activ
effect
latch
mutat
mute
oncogen
variant
ra
indic
widelydistribut
epistasi
within
structur
evolutionari
analysi
combin
mutat
analysi
suggest
vertebr
ra
acquir
addit
alloster
control
distinguish
invertebr
ra
close
rel
rap
kallikrein
klk
famili
serin
proteas
import
develop
normal
physiolog
mani
similar
substrat
specif
activ
site
predominantli
involv
normal
prostat
physiolog
also
implic
develop
metastasi
cancer
determin
activ
regul
critic
develop
select
inhibitor
henc
potenti
cancer
therapeut
atom
resolut
xray
crystal
structur
determin
complex
cyclic
peptid
base
sunflow
trypsin
nickel
ni
addit
molecular
dynam
md
simul
complex
select
sfti
perform
identifi
differenti
motion
structur
structur
altern
conform
peptid
bond
oxyanion
hole
observ
suggest
inhibit
destabil
oxyanion
hole
unstructur
loop
region
adjac
inhibitori
metal
bind
site
also
seen
md
simul
show
differenti
motion
seen
upon
metal
bind
transmit
activ
site
result
provid
molecular
ration
potenc
select
select
inhibitor
well
insight
indirect
mechan
inhibit
applic
serin
proteas
superfamili
hisactophilin
myristoyl
histidinerich
phdepend
actinand
membranebind
protein
respons
cellular
chang
ph
hisactophilin
revers
interconvert
cytosol
abstract
membranebound
form
wherebi
coval
link
ntermin
myristoyl
group
escap
hydrophob
core
fold
insert
lipid
bilay
despit
preval
myristoyl
switch
detail
mechan
commun
site
proton
buri
myristoyl
moieti
remain
elus
mutat
studi
hisactophilin
thermodynam
hint
myristoyl
switch
enabl
strain
aris
overpack
hydrophob
core
pursuit
strain
sought
atomist
insight
temperatur
depend
amid
group
chemic
shift
nmr
tool
elucid
protein
fold
function
mechan
readili
measur
bounti
proxi
local
structur
stabil
conform
heterogen
hydrophob
residu
notabl
pack
myristoyl
group
exhibit
nonlinear
chemic
shift
temperatur
depend
may
indic
access
function
relev
lowenergi
altern
state
complementari
measur
local
stabil
analyz
linear
temperatur
depend
highlight
area
throughout
protein
includ
myristoyladjac
complicit
strain
switch
behavior
mutat
myristoylproxim
combin
ablat
switch
behavior
measur
temperatur
depend
support
import
local
stabil
strain
conform
heterogen
drive
hisactophilin
myristoyl
switch
probe
alloster
commun
longrang
rigid
propag
across
protein
network
adnan
sljoka
kwansei
gakuin
univers
japan
allosteri
view
effect
bind
one
site
protein
second
often
significantli
distant
function
site
enabl
regul
protein
function
molecular
mechan
network
mediat
distant
commun
give
rise
allosteri
poorli
understood
develop
rigiditytransmiss
allosteri
rta
algorithm
comput
method
base
mathemat
rigid
theori
start
xray
crystal
structur
ensembl
snapshot
model
protein
constraint
network
consist
vertic
atom
edg
ie
coval
bond
electrostat
bond
hydrogen
bond
hydrophob
contact
rta
algorithm
provid
mechan
interpret
alloster
signal
design
predict
perturb
rigid
mimick
ligand
bind
one
site
protein
transmit
propag
across
protein
network
turn
caus
transmiss
chang
conform
degre
freedom
second
distant
site
result
alloster
transmiss
presenc
rigiditybas
allosteri
mean
chang
shape
conform
one
site
ie
mechan
chang
shape
bind
might
would
lead
chang
shape
conform
second
site
describ
rta
method
illustr
predict
alloster
interact
sever
pdb
structur
includ
gpcr
enzym
other
show
predict
agreement
nmr
chemic
shift
chang
caus
alloster
propag
rta
algorithm
comput
effici
take
minut
comput
time
standard
pc
use
quantif
alloster
signal
map
alloster
pathway
identif
novel
alloster
site
fe
cluster
essenti
cofactor
requir
cellular
function
biogenesi
fe
cluster
escherichia
coli
oxid
stress
iron
deplet
carri
suf
system
protein
involv
suf
pathway
work
togeth
mobil
sulfid
iron
form
fe
cluster
regul
assembl
pathway
proteinprotein
interact
e
coli
cystein
desulfuras
suf
accessori
protein
sufe
work
togeth
mobil
persulfid
lcystein
transfer
scaffold
protein
sufb
part
complex
overal
suf
reaction
occur
two
half
reaction
transfer
sulfid
cystein
form
enzym
bound
persulfid
intermedi
along
releas
alanin
follow
transfer
persulfid
accessori
protein
sufe
better
understand
structur
chang
involv
promot
half
reaction
aposuf
treat
excess
cystein
creat
persulfid
intermedi
sufsper
amid
hydrogen
deuterium
exchang
mass
spectrometri
hdxm
use
investig
dynam
chang
occur
upon
persulfur
suf
hdxm
analysi
show
conform
chang
occur
suf
dimer
interfac
peptid
addit
chang
activ
site
predict
sufsper
crystal
structur
peptid
figur
b
superposit
structur
contain
plpbound
product
analog
also
indic
chang
interact
along
dimer
interfac
suf
correl
hdxm
result
figur
sitedirect
mutagenesi
residu
current
underway
better
elucid
role
structur
chang
regul
catalysi
sufssuf
system
dynam
key
player
psoriasi
nichola
tiee
patricia
jen
kendra
hailey
famili
cytokin
regul
innat
adapt
immun
respons
misregul
manifest
autoimmun
disord
death
recent
famili
addit
quintet
protein
agonist
antagonist
receptor
specif
gener
pustular
psoriasi
gpp
life
threaten
form
psoriasi
link
point
mutat
famili
appear
process
nterminu
drastic
affect
bind
affin
inflammatori
activ
oddli
report
inhibitori
activ
without
ntermin
process
howev
oppos
member
famili
ntermin
methionin
cleav
result
startl
show
singl
residu
cleavag
abl
turn
inhibitori
pathway
complet
use
nmr
structur
determin
suit
dynam
studi
array
timescal
well
receptor
bind
experi
aim
identifi
molecular
mechan
respons
differ
process
preprocess
studi
abl
observ
alloster
mechan
transfer
inform
process
nterminu
opposit
side
molecul
respons
receptor
interact
univers
iowa
usa
fast
global
protein
dynam
particip
catalysi
hydrid
transfer
alcohol
dehydrogenas
substitut
buri
conserv
amino
acid
residu
distal
activ
site
alter
stabil
dynam
protein
affect
catalysi
chang
fast
dynam
reflect
xray
crystallograph
temperatur
factor
enzym
kinet
five
differ
amino
acid
residu
substitut
partial
random
sitedirect
mutagenesi
structur
complex
determin
xray
crystallographi
high
resolut
l
f
enzym
almost
ident
structur
except
local
perturb
site
substitut
compar
wildtyp
enzym
enzym
similar
kinet
constant
oxid
benzyl
alcohol
reduct
benzaldehyd
rate
conform
chang
appar
alter
singl
substitut
amino
acid
residu
decreas
express
thu
appear
five
residu
critic
locat
affect
protein
stabil
dynam
conclud
alcohol
dehydrogenas
toler
conserv
distal
substitut
affect
scaffold
protein
fast
global
dynam
particip
significantli
catalysi
support
nih
grant
tandem
calponinhomolog
ch
domain
common
actin
bind
domain
protein
yet
structurefunct
relationship
less
understood
molecular
knowledg
might
help
understand
diseas
trigger
mechan
muscl
diseas
muscular
dystrophi
recent
studi
tandem
ch
domain
dystrophin
utrophin
alphaactinin
filamin
spectrin
shown
surpris
invers
relationship
thermodynam
stabil
actin
bind
function
mani
mutant
destabil
protein
structur
increas
actinbind
affin
probe
origin
neg
relationship
stabil
function
examin
properti
individu
ch
domain
utrophin
role
interchdomain
interact
isol
ntermin
domain
quit
unstabl
exist
molten
globul
compar
stabl
tandem
ch
domain
ctermin
domain
domain
bind
factin
higher
affin
compar
tandem
ch
domain
domain
result
suggest
invers
relationship
stabil
function
tandem
ch
domain
may
origin
natur
individu
ch
domain
isol
less
stabl
bind
factin
higher
affin
isol
stabl
bind
factin
lesser
affin
addit
tandem
ch
domain
mutant
favor
close
conform
stabil
interchdomain
interact
bind
factin
weaker
favor
open
conform
indic
interdomain
interact
hinder
tandem
ch
domain
bind
actin
helicobact
pylori
arginas
bimetal
enzym
crucial
pathogenesi
bacterium
human
stomach
despit
conserv
signatur
motif
arginas
helicobact
pylori
homologu
nonconserv
motif
whose
role
recent
shown
critic
stabil
function
sequenc
analysi
also
reveal
presenc
motif
critic
residu
homologu
helicobact
gastric
pathogen
howev
underli
mechan
signific
catalyt
function
properli
understood
use
h
pylori
arginas
show
interact
indispens
tertiari
structur
intact
optim
posit
motif
thu
catalyt
function
singl
doubl
mutant
enhanc
solvent
access
conform
flexibl
also
show
complet
loss
catalyt
activ
intact
bimetal
center
unalt
substrat
bind
indic
proper
posit
motif
aromaticaromat
contact
vital
gener
catalyt
activ
conform
addit
metal
ion
provid
higher
stabil
holo
protein
also
identifi
presenc
two
residu
exclus
arginas
helicobact
gastric
pathogen
may
similar
function
find
therefor
highlight
first
time
arginas
helicobact
gastric
pathogen
util
uniqu
noncatalyt
triad
catalysi
could
exploit
therapeut
deaminas
ec
catalyz
isomerizationdeamin
glucosamin
releas
fructos
ammonium
ion
e
coli
regulatori
metabol
step
posit
cooper
alloster
k
activ
nacetylglucosamin
studi
enzym
share
rossmannlik
fold
nevertheless
sugarisomeras
fold
si
fold
found
display
similar
regulatori
properti
base
entir
differ
mechan
work
structur
function
character
si
fold
deaminas
shewanella
oneidensi
shewanella
denitrifican
locat
protein
bind
site
identifi
molecular
dock
subsequ
verifi
sitedirect
mutagenesi
expect
bind
stoichiometri
confirm
direct
bind
experi
use
isotherm
titrat
calorimetri
itc
posit
cooper
alloster
activ
enzym
depend
differ
molecular
mechan
sinc
function
dissoci
sitedirect
mutagenesi
herein
present
studi
molecular
quaternari
transit
associ
alloster
activ
bind
commun
substrat
bind
site
xray
crystallographi
molecular
dynam
conclus
enzym
show
singl
alloster
site
per
dimer
locat
intersubunit
space
contrast
subunit
present
two
bind
site
substrat
conserv
catalyt
one
emerg
regulatori
one
modul
cooper
behavior
everincreas
presenc
emerg
pollut
environ
becom
seriou
environment
health
issu
one
major
class
danger
pollut
pharmaceut
person
care
product
ppcp
grow
famili
chemic
includ
antibiot
antiinflammatori
drug
oral
contracept
etc
found
high
concentr
water
suppli
eg
field
concentr
ibuprofen
high
ugl
amongst
new
novel
approach
degrad
ppcp
water
bodi
use
enzym
call
peroxidas
recent
shown
hold
promis
bioremedi
applic
howev
peroxidas
larg
famili
enzym
differ
type
peroxidas
may
behav
differ
toward
differ
ppcp
current
studi
focus
first
kind
compar
studi
examin
effici
three
differ
peroxidas
soybean
peroxidas
chloroperoxidas
lactoperoxidas
degrad
differ
class
ppcp
eg
antibiot
sulfamethoxazol
antiinflammatori
ibuprofen
result
show
peroxidas
show
remark
differ
degrad
abil
like
chloroperoxidas
seem
promiscu
could
degrad
ppcp
addit
show
use
redox
mediat
abl
dramat
increas
degrad
otherwis
recalcitr
ppcp
result
first
studi
three
differ
peroxidas
directli
compar
abil
degrad
differ
emerg
pollut
monika
dolinska
yuri
sergeev
ogvfb
neinih
usa
tyrosinas
relat
protein
transmembran
glycoenzym
involv
melanin
synthesi
pathway
exhibit
signific
homolog
tyrosinas
dopachrom
tautomeras
enzym
play
import
role
pigment
format
although
abund
among
melanosom
specif
role
human
melanogenesi
fulli
known
date
effort
deciph
function
mostli
limit
melanoma
cell
murin
model
studi
studi
vitro
recombin
intramelanosom
domain
human
tyrosinas
relat
protein
human
tyrosinas
htyrctr
express
baculoviru
produc
whole
tni
larva
purifi
milligram
quantiti
use
imac
size
exclus
chromatographi
sec
protein
contain
atom
shown
induct
coupl
plasmamass
spectroscopi
howev
htyrctr
demonstr
diphenol
oxidas
enzymat
activ
use
ldopa
substrat
show
activ
oxid
dhica
murin
use
sec
sediment
equilibrium
show
htyrctr
behav
monomer
protein
form
stabl
heterodim
heterooligom
among
contrast
vivo
studi
mous
cell
prove
heterodimer
complex
format
nonetheless
incub
excess
amount
htyrctr
increas
protect
tyrosinas
stabil
time
observ
suggest
although
import
tyrosinas
stabil
condit
mechan
base
format
stabl
heterooligom
two
protein
laboratori
recent
discov
new
biosynthet
pathway
bacillu
spp
gener
kanosamin
key
compon
mani
antibiot
studi
structur
function
enzym
pathway
make
kanosamin
glucos
kaba
pyridox
plp
depend
aminotransferas
catalyz
convers
lglutam
report
first
steadyst
kinet
studi
kaba
use
fluorescencebas
coupledenzym
assay
kinet
constant
pingpong
kinet
mechan
determin
highresolut
xray
crystal
structur
presenc
absenc
show
intern
extern
aldimin
establish
key
activ
site
residu
requir
schiffbas
ligat
plp
indic
import
interact
kaba
aminoglycosid
substrat
thioredoxin
system
thermophil
bacterium
thermosipho
africanu
structur
function
naheda
sahtout
david
r
sander
jijin
raj
ayanath
kuttiyatveetil
univers
saskatchewan
canada
thioredoxin
system
ubiquit
oxidoreductas
system
consist
enzym
thioredoxin
reductas
trxr
protein
thioredoxin
trx
cofactor
nadph
system
comprehens
studi
mani
organ
escherichia
coli
e
coli
howev
structur
function
analysi
system
thermophil
bacteria
extens
thermosipho
africanu
africanu
thermophil
bacterium
strain
isol
hightemperatur
oil
reservoir
north
sea
analysi
complet
genom
sequenc
africanu
strain
suggest
presenc
two
put
trx
trxr
tatrxr
compon
thioredoxin
system
studi
tatrxr
success
clone
overexpress
purifi
character
use
biophys
techniqu
biochem
assay
xray
crystallographi
studi
indic
surprisingli
tatrxr
far
stabl
thioredoxin
system
compon
e
coli
consist
result
kinet
assay
indic
tatrxr
higher
optim
temperatur
activ
compar
e
coli
trxr
ectrxr
furthermor
tatrxr
found
catalyt
effici
optim
temperatur
room
temperatur
x
x
trend
observ
ectrxr
understand
identifi
differ
may
contribut
result
xray
crystallographi
use
determin
structur
tatrxr
phase
problem
effect
solv
use
ssad
sahtout
et
al
crystal
structur
tatrxr
success
solv
use
molecular
replac
polyglycin
hydrolas
secret
fungal
endoproteas
cleav
peptid
bond
polyglycin
interdomain
linker
chita
chitinas
antifung
protein
domest
corn
polyglycin
hydrolas
novel
protein
term
activ
sequenc
object
studi
understand
recogn
substrat
cleav
featureless
polyglycin
sequenc
multipl
proteas
plant
chitinas
substrat
mutant
form
produc
recombinantli
sdspage
malditofm
base
vitro
proteas
assay
perform
identifi
catalyt
serin
within
sxxk
motif
indic
activ
site
relat
bacteri
betalactamas
analysi
reaction
product
assay
plant
chitinas
analog
peptid
show
activ
site
play
limit
role
substrat
specif
mutagenesi
studi
found
seven
invari
tryptophan
crucial
polyglycin
hydrolas
fold
stabil
also
found
proteas
mutat
chang
cleavag
site
prefer
summari
activ
novel
proteas
character
map
activ
amino
acid
sequenc
role
cystathionin
synthas
modul
trypanosoma
brucei
gmp
reductas
akira
imamura
takuya
otani
takuya
otani
manatsu
tamura
tomoka
kobayashi
asami
shibata
tetsuya
okada
shigenori
nishimura
takashi
inui
life
scienc
graduat
school
life
environment
scienc
osaka
prefectur
univers
japan
gmp
reductas
gmpr
involv
purin
salvag
pathway
catalyz
reduct
deamin
gmp
imp
recent
studi
reveal
tbgmpr
possess
cystathionin
synthas
cb
abstract
modul
absent
mammalian
gmpr
studi
evalu
effect
purin
nucleotid
tbgmpr
activ
bind
affin
cb
modul
tbgmpr
furthermor
prepar
cb
moduledelet
mutant
tbgmpr
tbgmprdcb
character
enzymat
properti
investig
contribut
cb
modul
tbgmpr
activ
fluoresc
quench
assay
perform
evalu
bind
affin
purin
nucleotid
tbgmpr
util
tryptophan
residu
uniqu
local
cb
modul
gtp
atp
amp
induc
fluoresc
quench
show
bound
vicin
cb
modul
absenc
nucleotid
hill
coeffici
nhill
tbgmpr
gmp
demonstr
gmp
induc
posit
cooper
effect
enzymat
activ
contrast
nhill
tbgmprdcb
gmp
absenc
purin
nucleotid
indic
delet
cb
modul
tbgmpr
caus
loss
posit
cooper
effect
addit
gtp
decreas
km
gmp
increas
kcat
addit
atp
amp
increas
km
gmp
without
alter
nhill
kcat
result
suggest
gtp
atp
amp
bind
vicin
cb
modul
tbgmpr
alter
affin
gmp
tbgmpr
regul
enzymat
activ
phosphoenolpyruv
carboxykinas
pepck
tradit
label
enzym
respons
first
commit
step
toward
gluconeogenesi
respons
revers
convers
oxaloacet
acid
oaa
phosphoenolpyruv
pep
recent
metabol
enzym
role
greatli
expand
implic
cancer
mycobacterium
tuberculosi
infect
glucos
stimul
insulin
secret
age
gener
tca
cycl
flux
regul
mani
biochem
character
complet
variou
isozym
pepck
one
kinet
phenomena
identifi
substrat
inhibit
studi
shown
substrat
inhibit
actual
manifest
kinet
assay
condit
bicarbon
sourc
use
high
concentr
bicarbon
seem
inhibit
enzym
upon
investig
shown
inhibit
gener
inhibit
anion
speci
inform
give
context
regard
prefer
direct
catalysi
vivo
toward
product
pep
use
macromolecular
crystallograph
techniqu
determin
inhibit
constant
anion
correspond
experiment
deriv
paramet
evolut
carbapenemas
increas
level
antibiot
resist
danger
gram
neg
bacteria
acinetobact
baumannii
carbapenemas
weak
hydrolyt
activ
substrat
thu
low
potenti
harm
presenc
singl
substitut
shown
increas
affin
carbapenem
substrat
doripenem
associ
increas
level
resist
potent
drug
use
xray
crystallographi
solv
structur
doripenem
bound
acylintermedi
case
substitut
result
rotat
key
activ
site
isoleucin
sidechain
normal
hinder
bind
doripenem
thu
provid
explan
gainoffunct
kinet
result
observ
molecular
dynam
simul
confirm
interact
suffici
affect
orient
manner
class
clinic
variant
acinetobact
baumannii
possess
unusu
high
turnov
rate
cephalosporin
jonika
forbesbenjamin
cynthia
june
joshua
mitchel
rachel
power
david
leonard
grand
valley
state
univers
michigan
usa
class
pose
seriou
threat
treatment
infect
caus
gram
neg
bacteria
investig
biochem
properti
class
clinic
variant
differ
baumannii
carbapenemas
singl
substitut
express
purifi
variant
use
steadyst
kinet
analysi
compar
kinet
properti
discov
substitut
differ
effect
turnov
rate
kcat
depend
substrat
use
increas
kcat
valu
observ
cephalosporin
centa
ceftriaxon
carbapenem
doripenem
carbapenem
imipenem
saw
decreas
kcat
kcat
aztreonam
unchang
km
valu
modestli
chang
compar
explor
potenti
mechan
differenti
effect
turnov
rate
use
xray
crystallographi
determin
structur
absenc
presenc
variou
substrat
result
show
normal
involv
stabil
unusu
ncarboxyl
lysin
act
gener
base
catalyt
mechan
thu
substitut
potenti
disrupt
carboxyl
state
import
catalyt
residu
direct
modul
stabil
carboxylysin
novel
mechan
clinic
substitut
increas
activ
thu
potenti
threat
enzym
refin
sequenc
signatur
bacteri
laccas
robert
collin
eastern
connecticut
state
univers
usa
laccas
copper
oxidas
directli
oxid
phenol
compound
indirectli
oxid
substrat
redox
mediat
laccas
use
industri
shown
promis
pilot
applic
includ
wastewat
treatment
enzymat
synthesi
enzymat
fuel
cell
fungal
laccas
highest
redox
potenti
broadest
rang
substrat
recombinantli
express
bacteria
tap
potenti
class
enzym
costeffect
manner
focu
turn
microbi
laccaselik
protein
microbi
copper
oxidas
includ
laccaselik
multi
copper
oxidas
lmco
also
includ
oxidas
lower
redox
potenti
limit
substrat
rang
eg
bilirubin
oxidas
catechol
oxidas
microbi
enzym
share
low
sequenc
ident
less
fungal
laccas
signatur
motif
distinguish
enzym
industri
potenti
less
desir
enzym
remain
elus
databas
includ
low
redox
nonlaccas
copper
oxidas
sequenc
align
erod
sequenc
signatur
laccas
remedi
align
curat
sequenc
character
bacteri
fungal
laccas
conserv
motif
use
search
archaeal
bacteri
genom
divers
put
laccas
select
gene
synthesi
express
e
coli
success
express
bacteri
enzym
laccaselik
activ
indic
sequenc
motif
identifi
discern
laccas
hit
help
refin
search
biochem
biophys
character
indic
stabl
enzym
broad
specif
model
substrat
isol
project
design
undergradu
biochemistri
lab
cours
role
residu
activ
site
human
inactiv
lipid
peroxidt
product
lui
francisco
calleja
jo
e
rodr
zavala
instituto
nacion
de
cardiolog
mexico
aldehyd
dehydrogenas
aldh
respons
detoxifi
aldehyd
gener
lipid
peroxid
oxid
correspond
carboxyl
acid
though
lipid
aldehyd
inactiv
enzym
time
resist
inactiv
lipid
aldehyd
compar
analysi
amino
acid
sequenc
aldehyd
bind
site
show
enzym
suscept
lipid
peroxid
product
cystein
residu
near
reactiv
cy
base
criteria
consid
aldehyd
react
preferenti
cystein
residu
gener
two
mutat
enzym
chang
cy
residu
adjac
reactiv
cy
first
one
residu
chang
second
one
residu
chang
mutant
enzym
resist
inactiv
effect
acrolein
catalyt
effici
lipid
aldehyd
chang
significantli
compar
wildtyp
enzym
howev
doubl
mutant
present
modif
ratelimit
step
reaction
final
evalu
effect
doubl
mutant
express
escherichia
coli
cell
expos
hydrogen
peroxid
cell
express
mutant
enzym
resist
express
wildtyp
enzym
indic
express
mutant
protect
cell
toxic
aldehyd
gener
lipid
peroxid
promot
exposur
oxid
agent
data
reveal
cy
residu
near
reactiv
cy
import
inactiv
process
induc
lipid
aldehyd
excess
gener
ro
ischemiareperfus
event
differ
cardiovascular
diseas
exacerb
peroxid
polyunsatur
fatti
acid
present
biolog
membran
lipid
hydroperoxid
subsequ
form
secondari
toxic
product
aldehyd
accumul
cell
cardiac
function
compromis
due
reaction
differ
biomolecul
progress
damag
mitochondri
function
thu
particip
aldehyd
dehydrogenas
aldh
detoxif
aldehyd
crucial
maintain
cell
function
therefor
diminut
aldehyd
content
gener
heart
ischemiareperfus
event
activ
stabil
may
contribut
preserv
cell
integr
date
tamoxifen
character
activ
aldh
howev
compound
may
potenti
toxic
effect
current
character
effect
piperlonguminin
pplg
compound
structur
similar
activ
studi
vitro
show
compound
increas
activ
protect
enzym
inactiv
toxic
aldehyd
base
result
evalu
protect
effect
compound
model
myocardi
infarct
regard
observ
damag
ischemiareperfus
period
prevent
administ
pplg
restor
blood
pressur
heart
rate
correl
lower
content
lipid
aldehyd
preserv
activ
aldh
tissu
therefor
suggest
activ
pplg
may
help
diminish
damag
gener
patholog
involv
high
level
oxid
stress
structur
abund
differ
cellsurfac
carbohydratesor
glycansheavili
influenc
cellular
signal
mechan
control
cell
behavior
growth
death
mani
cancer
modif
glycan
fucosylationth
addit
fucos
sugar
residueresult
upregul
fucosyltransferas
enzym
fucosyl
cellsurfac
glycan
mani
downstream
effect
cancer
develop
exampl
one
fucosyl
glycan
call
sialyllewi
x
promot
higher
metastat
potenti
malign
order
screen
potenti
inhibitor
fucosyltransferas
involv
assembl
sialyllewisx
develop
fluorescencebas
inhibit
assay
fucosyl
label
synthet
oligosaccharid
upon
treatment
specif
glycosidas
enzym
hydrolysi
oligosaccharid
releas
fluoresc
howev
fucosyl
label
oligosaccharid
prior
treatment
result
structur
recogn
glycosidas
prevent
hydrolysi
associ
fluoresc
signal
demonstr
assay
use
detect
inhibit
fucosyltransferas
sinc
block
fucosyl
allow
glycosidasecatalyz
hydrolysi
label
oligosaccharid
produc
fluoresc
signal
aim
har
inhibit
assay
microfluid
platform
combin
digit
droplet
microfluid
achiev
precis
autom
highthroughput
lowcost
drug
discoveri
ornithin
transcarbamoylas
otc
import
enzym
urea
cycl
convert
excess
ammonium
urea
import
arginin
biosynthesi
otc
catalyz
reaction
carbamoyl
phosphat
cp
ornithin
orn
produc
citrullin
inorgan
phosphat
appli
partial
order
optimum
likelihood
pool
machin
learn
comput
tool
develop
northeastern
univers
predict
catalyt
import
residu
unlik
pure
informaticsbas
approach
pool
use
structur
protein
comput
electrostat
properti
accur
predict
residu
import
enzym
activ
includ
remot
substrat
pool
predict
spatial
extend
activ
site
e
coli
otc
inducedfit
conform
chang
upon
bind
cp
believ
play
role
catalyt
mechan
conserv
mutat
poolpredict
residu
kinet
assay
variant
show
signific
loss
catalyt
effici
rel
wildtyp
otc
order
understand
residu
play
role
otc
catalysi
md
simul
wt
variant
perform
determin
mutat
posit
affect
conform
dynam
enzym
mutat
gene
parkin
gene
associ
autosom
recess
form
parkinson
diseas
protein
kinas
best
known
role
signal
mitochondri
damag
consequ
initi
mitochondri
repair
autophagi
mechan
upon
mitochondri
damag
accumul
outer
membran
omm
mitochondria
activ
kinas
recruit
ubiquitin
ligas
parkin
ubiquitin
multipl
omm
protein
signal
mitochondria
autophag
destruct
recent
year
mechan
parkin
recruit
activ
subject
extens
studi
context
kinas
activ
recent
evid
suggest
role
directli
phosphoryl
parkin
ubiquitinlik
domain
ubiquitin
complet
activ
parkin
make
first
known
ubiquitin
kinas
howev
underli
molecular
mechan
underli
parkin
activ
unknown
use
insect
speci
tribolium
castaneum
character
kinet
parkin
ubiquitin
phosphoryl
consequ
activ
parkin
recent
work
elucid
role
phosphoryl
ubiquitin
pub
enhanc
parkin
phosphoryl
henc
establish
role
pub
mitochondri
qualiti
control
pathway
nmr
studi
phosphoryl
assay
also
reveal
residu
parkin
critic
interact
recent
studi
show
phenol
compound
pc
potenti
natur
ptl
inhibitor
howev
molecular
mechan
support
effect
well
understood
work
evalu
abil
pc
mango
mangifera
indica
l
inhibit
ptl
activ
enzym
kinet
fluoresc
quench
molecular
dock
seven
pc
mango
assess
porcin
ptl
model
enzym
due
high
similar
human
ptl
result
show
tannic
acid
ta
pgg
effect
ptl
inhibitor
valu
mm
mm
respect
moreov
inhibit
kinet
assay
indic
compound
uncompetit
inhibitor
ptl
show
low
ki
valu
pgg
mm
ta
mm
suggest
high
affin
toward
enzym
furthermor
pgg
ta
quench
ptl
intrins
fluoresc
concentr
depend
manner
caus
red
shift
enzym
emiss
maxima
impli
tryptophan
residu
expos
polar
environ
final
molecular
dock
analysi
show
ta
pgg
may
bind
ptlcolipas
complex
openact
conform
interfac
form
ptl
ctermin
lid
domain
colipas
support
experiment
find
research
highlight
potenti
ta
pgg
found
mango
peel
use
nutraceut
ptl
inhibit
obes
treatment
bind
epigallocatechingal
porcin
trypsin
follow
isotherm
titrat
calorimetri
enzym
kinet
aldo
arvizuflor
manuel
carretasvaldez
elena
morenocordova
mar
morenov
asquez
abril
gracianoverdugo
departament
de
ciencia
qu
biol
ogica
universidad
de
sonora
mexico
departamento
de
investigaci
posgrado
en
alimento
unviersidad
de
sonora
mexico
trypsin
member
serineproteas
famili
wide
studi
enzym
structur
function
relationship
sinc
increas
interest
health
function
polyphenol
compound
like
epigallocatechingal
egcg
mani
research
look
molecular
target
compound
work
use
isotherm
titrat
calorimetri
itc
enzym
kinet
assess
bind
egcg
porcin
trypsin
model
enzym
itc
conduct
vpitc
microcalorimet
trypsin
titrat
sever
aliquot
egcg
bind
egcg
porcin
trypsin
enthalp
favor
wherea
entropi
chang
neglig
egcg
show
high
affin
trypsin
bind
kd
mm
inhibit
kinet
show
noncompetit
inhibit
mechan
use
nabenzoyllarg
ethyl
ester
baee
substrat
kinet
data
indic
egcg
bind
altern
site
block
enzym
catalysi
data
suggest
multipl
interact
form
porcin
trypsin
egcg
conform
chang
requir
catalysi
affect
itc
enzym
kinet
correl
give
insight
molecular
basi
egcg
inhibit
digest
enzym
extrapol
human
trypsin
ulvan
complex
sulfat
polysaccharid
biosynthes
marin
green
alga
constitut
one
two
major
polysaccharid
cell
wall
watersolubl
polysaccharid
compris
predominantli
rhamnos
glucuron
acid
glua
iduron
acid
idoa
xylos
physicochem
biolog
properti
ulvan
make
interest
numer
industri
applic
bacteria
cohabit
green
alga
contain
enzym
abl
degrad
ulvan
lytic
mechan
gene
code
lyas
discov
genom
sever
bacteria
pseudoalteromona
sp
strain
plsv
gene
encod
ulvan
lyas
cleav
glycosid
bond
rhamnos
glucuron
acid
glua
iduron
acid
idoa
anoth
ulvan
lyas
discov
alteromonadal
encod
gene
degrad
ulvan
endolyticali
cleav
bond
glucuron
acid
character
biochem
two
lyas
determin
threedimension
structur
repres
first
structur
lyas
capabl
degrad
ulvan
spite
sequenc
ident
two
enzym
share
propel
fold
put
activ
site
identifi
structur
conserv
confirm
mutagenesi
structur
enzym
bound
tetrasaccharid
substrat
catalyt
residu
histidin
tyrosin
substrat
acid
group
neutral
arginin
metal
ion
detect
lyas
play
structur
role
involv
directli
catalysi
sever
studi
recent
report
enhanc
diffus
enzym
exotherm
catalysi
explain
phenomenon
remain
controversi
heat
produc
activ
site
affect
enzym
surround
medium
enzym
structur
destabil
question
matter
debat
employ
programm
dna
switch
measur
structur
destabil
possibl
local
temperatur
rise
vicin
enzym
unfold
temperatur
dna
stemloop
readili
tune
vari
nucleobas
composit
attach
fluorophor
quencher
pair
extrem
stemloop
obtain
librari
fluoresc
switch
act
nanothermomet
select
dna
switch
optim
signal
sensit
around
anchor
onto
enzym
via
strong
biotinstreptavidin
interact
measur
effect
heat
releas
enzym
catalysi
monitor
fluoresc
variat
alkalin
phosphatas
chosen
convers
paranitrophenylphosph
paranitrophenol
highli
exotherm
enzym
undergo
enhanc
diffus
reaction
find
dna
switch
attach
enzym
destabil
enzym
catalysi
control
dna
switch
attach
enzym
ie
free
solut
undergo
destabil
along
distancedepend
destabil
result
suggest
enzym
activ
may
destabil
structur
locat
near
vicin
thermodynam
analysi
enzym
reaction
lactat
dehydrogenas
shogo
furuya
ai
higashiyama
noriko
nakagawa
seed
program
osaka
univers
japan
depart
biolog
scienc
graduat
school
scienc
osaka
univers
japan
thermodynam
paramet
enzym
reaction
determin
lactat
dehydrogenas
extrem
thermophil
thermu
thrmophilu
steadyst
kinet
paramet
kcat
km
determin
thermodynam
paramet
substrat
pyruv
bind
step
km
dg
kjmol
dh
kjmol
td
kjmol
ratelimit
step
kcat
dg
kjmol
dh
kjmol
td
kjmol
contribut
water
molecul
reflect
compens
dh
td
substratebind
step
small
td
valu
function
analysi
new
proteas
extrem
thermophil
organ
thermu
theromphilu
yumi
kimura
daisuk
sasaki
naoya
fujimura
tadashi
ono
chinami
sako
suzuka
yamasaki
ryoji
masui
noriko
nakagawa
seed
program
osaka
univers
japan
osaka
prefectur
kozu
senior
high
school
japan
depart
biolog
faculti
scienc
osaka
citi
universit
japan
depart
biolog
scienc
graduat
school
scienc
osaka
univers
japan
challeng
discov
new
function
protein
target
protein
zinc
proteas
b
differ
famili
extrem
thermophil
organ
thermu
thermophilu
substrat
protein
digest
proteas
b
result
peptid
separ
liquid
chromatographi
analyz
mass
spectromet
determin
sequenc
nand
ctermin
peptid
gave
us
inform
cleav
peptid
bond
except
substrat
protein
proteas
result
analyz
substrat
specif
subsit
proteas
b
proteas
show
broad
substrat
specif
laccas
multipurpos
biocatalyst
reduc
oxid
sever
hazard
chemic
compound
due
broad
substrat
specif
among
applic
laccas
employ
degrad
lignin
chemic
dye
phenol
compound
act
ecofriendli
altern
pollut
wast
manag
howev
lack
industri
interest
massiv
use
laccas
bioremedi
primarili
due
high
product
cost
object
research
identifi
character
laccas
activ
nativ
colombian
fungi
dictyopanu
pusillu
enzymat
extract
pusillu
show
laccas
activ
obtain
ferment
use
lignocellulos
substrat
purifi
liquid
chromatographi
isol
put
new
laccas
enzym
activ
assess
dye
degrad
delignif
lignocellulos
oil
palm
show
higher
stabil
high
temperatur
low
ph
rel
commerci
laccas
peptid
identifi
mass
spectrometri
use
design
degener
oligonucleotid
primer
isol
code
sequenc
cdna
synthes
identifi
laccas
isoenzym
experi
underway
improv
laccas
overexpress
pichia
pastori
heterolog
system
provid
mean
adapt
system
low
cost
industri
product
timolol
pentos
phosphat
pathway
enzym
n
nuray
ulusu
muslum
gok
belma
turan
faculti
medicin
turkey
depart
biochemistri
hacettep
univers
turkey
aim
investig
whether
timolol
treatment
benefici
effect
pentosephosph
pathway
enzym
activ
dehydrogenas
dehydrogenas
diabet
induc
streptozotocin
old
male
wistar
rat
confirm
measur
high
bloodglucos
level
diabet
rat
treat
timolol
mgkg
bodi
weight
week
control
group
receiv
salin
timololtreat
stzinduc
diabet
rat
noteworthi
effect
high
bloodglucos
level
howev
treatment
induc
activ
diabet
rat
sinc
camp
one
neg
regul
directli
associ
signal
measur
camp
level
pancreat
tissu
interestingli
timolol
treatment
significantli
increas
camp
level
diabet
pancreat
tissu
support
use
protein
data
bank
structur
perform
silico
calcul
show
timolol
bind
strong
enough
either
bind
affin
adenylyl
cyclas
ac
respons
camp
product
serv
regulatori
signal
via
specif
campbind
protein
rel
high
comparison
other
data
point
timolol
treatment
benefici
action
antioxid
defens
mechan
enzym
pancrea
stzinduc
diabet
rat
locat
rna
posttranscript
modif
give
clue
potenti
function
certain
modif
method
use
determin
sequenc
locat
modif
refer
posttranscript
modif
map
method
make
use
ribonucleas
cleav
long
rna
sequenc
fragment
detect
mass
spectromet
method
involv
use
multipl
enzym
differ
cleavag
specif
character
much
sequenc
coverag
possibl
current
rnase
basespecif
enzym
avail
market
goal
studi
explor
potenti
rnase
purin
specif
enzym
prefer
cleav
adenosin
end
tool
rna
modif
map
demonstr
use
rnase
nonspecif
variant
rnase
gener
random
long
sequenc
allow
rna
modif
map
discuss
advantag
setback
use
enzym
current
work
also
explor
enhanc
adenosin
specif
rnase
phage
display
mutagenesi
mycobacterium
tuberculosi
mt
caus
agent
tuberculosi
activ
alanin
racemas
alr
exist
dimer
two
activ
site
form
interfac
individu
monom
complet
understand
interact
two
monom
could
provid
insight
approach
inactiv
dimer
alr
investig
degre
associ
alr
mean
high
perform
size
exclus
liquid
chromatographi
hpsec
buffer
contain
phosphat
ph
rang
mt
alr
elut
retent
volum
consist
molar
mass
approxim
kda
ie
monomerdim
equilibrium
mixtur
howev
ph
borat
buffer
mt
alr
elut
retent
volum
consist
molar
mass
kda
ie
expect
dimer
phosphat
ad
borat
buffer
hpsec
retent
volum
mt
alr
decreas
result
consist
mt
alr
possess
phosphat
bindingsit
inhibit
dimer
necessari
activ
use
biophys
method
character
substrat
recognit
use
hydrogendeuterium
exchang
mass
spectrometri
find
chelix
canon
featur
activ
kinas
disord
catalyticallydead
state
chelix
preced
invari
serin
residu
exclus
target
autophosphoryl
tran
mutant
retain
catalyt
activ
fail
phosphoryl
ubiquitin
nmr
studi
show
activ
phosphoryl
bind
parkin
ubl
kd
mm
ubiquitin
kd
mm
final
use
target
proteom
method
show
phosphoryl
ubiquitin
chain
foremost
explain
substrat
specif
ligas
parkin
find
suggest
must
autophosphoryl
first
prior
engag
ubiquitin
chain
immedi
vicin
mitochondri
outer
membran
develop
highthroughput
assay
detect
fatti
acid
decarboxylas
activ
jama
hagiyusuf
david
kwan
centr
appli
synthet
biolog
concordia
univers
canada
biofuel
potenti
move
societi
depend
away
fossilfuel
system
toward
cleaner
renew
energi
sourc
technolog
move
focus
ethanoldepend
fuel
sourc
complex
energi
rich
hydrocarbon
similar
found
petroleum
recent
hemedepend
decarboxylas
enzym
oletj
discov
bacterium
jeotgalicoccu
sp
determin
via
vitro
vivo
studi
capabl
catalyz
decarboxyl
longchain
fatti
acid
produc
termin
alken
thu
make
oletj
ideal
candid
biofuel
product
develop
highthroughput
assay
import
engin
studi
protein
oletj
activ
determin
detect
byproduct
oletjecatalyz
convers
fatti
acid
termin
alken
develop
highthroughput
coupl
enzym
assay
detect
oletj
activ
assay
convert
bicarbon
consum
along
phosphoenol
pyruv
phosphoenolpyruv
carboxylasecatalyz
reaction
gener
oxaloacet
releas
phosphat
coupl
exist
phosphatedepend
assay
result
highli
sensit
highthroughput
fluorescencebas
assay
detect
oletj
activ
departamento
de
investigaci
porsgrado
en
alimento
universidad
de
sonora
mexico
departamento
de
ciencia
qu
biol
ogica
universidad
de
sonora
mexico
laboratorio
de
estructura
biomolecular
centro
de
investigaci
en
alimentaci
desarrollo
ac
mexico
trypsin
ec
wellknown
member
serin
proteas
famili
catalyz
hydrolysi
protein
peptid
specif
carboxyl
group
lysin
arginin
residu
trypsin
iii
studi
monterey
sardin
present
high
catalyt
effici
low
temperatur
describ
enzym
adapt
extrem
cold
work
kinet
constant
optimum
temperatur
mutant
trypsin
iii
monterey
sardin
determin
previou
work
first
establish
experiment
condit
perform
recombin
express
trypsin
iii
mutant
escherichia
coli
purif
obtain
solubl
activ
form
kinet
constant
mutant
trypsin
iii
determin
isotherm
titrat
calorimetri
use
baee
substrat
optimum
temperatur
determin
spectrophometr
assay
use
bapna
substrat
mutant
show
optimum
temperatur
wherea
kinet
paramet
mm
kcat
km
respect
molecular
model
predict
alter
structur
compar
wildtyp
trypsin
iii
could
explain
lower
optimum
temperatur
also
mutant
show
higher
specif
activ
wildtyp
trypsin
iii
mutant
trypsin
iii
monterey
sardin
could
potenti
applic
food
industri
trypsin
iii
monterey
sardin
feasibl
model
structurefunct
studi
insulindegrad
enzym
ide
highli
conserv
metalloproteas
major
proteas
degrad
insulin
howev
despit
previou
investig
mechan
degrad
insulin
still
well
understood
probe
steadyst
kinet
idecatalyz
degrad
insulin
circular
dichroism
spectroscopi
result
show
catalyt
effici
enzym
toward
insulin
measur
kcatkm
affect
high
concentr
salt
suggest
electrostat
interact
play
signific
role
specif
ide
toward
insulin
north
atlant
cod
gadu
morhua
cold
adapt
contain
numer
differ
enzym
digest
prey
extrem
condit
understand
biochem
properti
cod
enzym
give
insight
function
evolut
possibl
use
research
industri
therapeut
purpos
previous
two
cod
trypsin
isoenzym
trypsin
character
isol
benzamidin
purifi
cod
trypsin
isol
use
anion
exchang
chromatographi
studi
describ
character
novel
trypsin
zt
purifi
isol
uniqu
cleavag
properti
rel
trypsin
fraction
result
anion
exchang
chromatographi
contain
novel
trypsin
analyz
use
malditof
mass
spectrometri
four
close
relat
trypsin
amino
acid
sequenc
trypsin
trypsin
trypsin
trypsin
deduc
express
cod
sequenc
tag
est
gave
best
match
compar
substrat
specif
cod
trypsin
zt
isoenzym
cod
trypsin
multiplex
substrat
profil
mass
spectrometri
mspm
use
mspm
method
use
ms
character
proteas
cleavag
pattern
within
librari
peptid
defin
peptid
total
peptid
bond
also
provid
data
effect
differ
amino
acid
side
scissil
amid
bond
mspm
trypsin
zt
reveal
amino
acid
surround
arginin
lysin
substrat
differ
effect
cleavag
compar
trypsin
unexpectedli
cleavag
site
identifi
uniqu
trypsin
zt
compar
trypsin
continu
studi
explor
biochem
properti
cod
trypsin
zt
compar
cod
trypsin
certain
e
coli
strain
cglycosyltransferas
irob
glycosyl
enterobactin
prior
secret
glycosyl
enterobactin
aka
salmochelin
facilit
bacteri
iron
uptak
host
evad
mammalian
immun
system
character
enzymat
properti
recombin
hexahistidinetag
irob
express
purifi
nearhomogen
develop
coupl
enzym
assay
util
udpglucos
dehydrogenas
ugd
quantit
udpglucos
consumpt
thu
irob
activ
rapidli
effici
previous
report
hplcbase
assay
purifi
irob
recombin
e
coli
employ
coupl
assay
glycosyl
enterobactin
catalyz
irob
use
substrat
udpglucos
quench
appropri
time
point
upon
addit
use
convert
remain
udpglucos
udpglucuron
nadh
consumpt
udpglucos
irob
quantit
nadh
product
measur
spectrophotometr
initi
rate
obtain
michaelismenten
steadyst
kinet
paramet
determin
wild
type
irob
agre
previous
report
valu
kinet
paramet
mutant
variant
hypothes
impair
udpglucos
bind
determin
equilibriumbind
assay
employ
spin
column
use
determin
equilibriumbind
paramet
irob
cosubstr
expect
satur
variant
udpglucos
observ
confirm
role
udpglucos
bind
furthermor
bind
assay
demonstr
kd
udpglucos
bind
wildtyp
irob
absenc
enterobactin
higher
observ
km
valu
udpglucos
obtain
coupl
assay
catalyt
mechan
salmonella
typhimurium
effector
acetyltransferas
avra
jonathan
labriola
bhushan
nagar
bacteri
effector
protein
play
essenti
role
infect
prolifer
pathogen
bacteria
within
target
manipul
host
immun
respons
pathway
avra
bacteri
effector
acetyltransferas
salmonella
typhimurium
suppress
jnk
signal
intestin
epitheli
cell
occur
acetyl
jnk
pathway
specif
essenti
mitogen
activ
receptor
kinas
kinas
mkk
avra
belong
yopj
famili
acetyltransferas
close
relat
ce
peptidas
clan
suggest
acetyltransferas
activ
enzym
proceed
novel
mechan
biophys
kinet
analysi
determin
avra
acetyl
mkk
via
pingpong
mechan
also
identifi
residu
avra
may
play
role
substrat
bind
andor
recognit
target
develop
enzym
candida
antarctica
lipas
cala
improv
biocatalyst
food
industri
studi
suggest
milkfat
product
rich
diglycerid
compos
shortchain
satur
fatti
acid
might
health
benefit
cala
alreadi
intrins
select
hydrolysi
triglycerid
goal
evolv
enzym
make
abl
discrimin
hydrolysi
shortchain
vs
longchain
fatti
acid
ester
thu
develop
strategi
enrich
content
shortchain
lipid
combinatori
approach
base
synthet
biolog
golden
gate
clone
strategi
adopt
creation
smart
mutant
librari
cala
disassembl
three
constitut
domain
separ
mutat
flexibl
reassembl
later
stage
librari
variant
screen
agar
plate
contain
model
triglycerid
name
tributyrin
oliv
oil
mainli
use
highthroughput
screen
method
develop
promis
variant
show
abil
discrimin
short
longchain
substrat
quantit
character
standard
ester
assay
substrat
differ
chain
length
refer
mitochondria
origin
intern
alphaproteobacterium
develop
perman
endosymbiot
relat
host
eukaryot
evolut
nearli
endosymbiont
gene
lost
ribosom
particular
underw
drastic
chang
featur
novel
mitoribosom
protein
mtrprotein
shorten
mitoribosom
rna
mtrrna
exactli
evolutionari
remodel
took
place
remain
specul
due
small
number
studi
primit
eukaryot
get
insight
process
analyz
composit
mitoribosom
andalucia
godoyi
freeliv
heterotroph
flagel
jakobid
contain
largest
least
deriv
mitochondri
gene
set
current
known
silico
analysi
nucleusencod
portion
andalucia
mitoribosom
predict
gene
ad
togeth
mitochondrionencod
portion
total
mtrprotein
number
slightli
higher
bacteria
much
smaller
eg
human
present
data
show
far
andalucia
mtrprotein
resembl
bacteri
homolog
counterpart
deriv
eukaryot
human
yeast
order
valid
find
experiment
current
purifi
andalucia
mitoribosom
identifi
whether
predict
protein
inde
part
mitochondri
translat
machineri
provid
convinc
evid
andalucia
mitoribosom
repres
intermedi
frozen
timein
evolutionari
process
mtrprotein
recruit
acknowledg
thank
michael
w
gray
help
annot
nucleusencod
protein
univers
british
columbia
canada
australian
nation
univers
canberra
australia
genet
variat
across
ortholog
protein
gener
neutral
respect
nativ
physiolog
function
caus
cryptic
genet
variat
ie
phenotyp
variat
nonphysiolog
properti
cryptic
genet
variat
may
also
defin
adapt
evolutionari
potenti
ie
evolv
protein
word
ortholog
enzym
may
evolv
significantli
differ
evolutionari
outcom
enzym
subject
select
pressur
address
question
use
laboratori
evolut
enzym
combin
genet
molecular
catalyt
activ
protein
solubl
express
thermost
oligomer
state
crystal
structur
chang
evolutionari
trajectori
evolv
two
ortholog
metallobetalactamas
mbl
toward
promiscu
phosphon
hydrolas
pmh
activ
found
seemingli
neutral
genet
variat
ortholog
enzym
caus
signific
differ
evolutionari
outcom
level
pmh
activ
ie
differ
enzym
fit
increas
two
enzym
interestingli
mutat
analysi
reveal
two
trajectori
follow
complet
differ
mutat
pathway
increas
enzym
fit
moreov
two
enzym
increas
enzym
fit
substanti
differ
adapt
strategi
one
adapt
though
increas
catalyt
effici
though
combin
catalyt
effici
protein
express
oligomer
use
structur
analysi
md
simul
also
unveil
molecular
basi
underli
variat
evolv
ie
cryptic
subtl
structur
properti
orient
key
activ
site
residu
caus
larg
differ
mutat
respons
thu
genet
variat
among
ortholog
enzym
defin
evolutionari
outcom
propos
import
implic
evolut
natur
protein
engin
strategi
gener
new
function
laboratori
attempt
design
protein
specif
ligand
bind
properti
still
difficult
achiev
time
comput
design
ligand
bind
behav
expect
wet
lab
sinc
detail
need
succeed
ancestr
reconstruct
could
provid
inform
sequenc
chang
led
modifi
affin
specif
ligand
clue
understand
combinatori
event
led
divers
method
result
evolutionari
relationship
subfamili
well
resolv
protein
separ
accord
report
ligand
specif
posit
charg
ligand
neg
bind
noncharg
amin
conclus
result
could
lead
obtain
ancestr
sequenc
good
posterior
probabl
node
interest
current
abil
predict
pathway
bacteri
evolut
drug
resist
limit
entail
bridg
sever
constraint
variou
level
biolog
organizationfrom
molecular
properti
protein
organism
fit
microbi
popul
dynam
address
issu
develop
new
multiscal
framework
microbi
evolut
integr
protein
biophys
popul
genet
relat
biochem
effect
mutat
popul
demographi
structur
predict
pathway
drug
resist
addit
util
previous
publish
deep
mutat
scan
dm
data
determin
mutat
fit
landscap
experiment
data
integr
comput
model
evolut
replic
bacteri
popul
dynam
popul
dynam
simul
find
quantit
depend
time
emerg
resist
drug
concentr
microbi
popul
size
depend
surprisingli
nonlinear
due
complex
fit
landscap
measur
experiment
dm
broadli
abl
trace
evolut
minim
inhibitor
concentr
mic
framework
use
studi
emerg
antibiot
resist
complex
select
scenario
oscil
drug
concentr
dosag
explor
innov
potenti
primit
enzym
confer
antibiot
resist
lorea
alejaldr
joell
pelleti
universit
e
de
montr
eal
canada
rise
antibiot
resist
emerg
health
crisi
due
speed
develop
econom
clinic
repercuss
develop
novel
enzymat
activ
within
bacteri
cell
one
common
caus
antibiot
resist
therefor
assess
capac
enzym
evolv
toward
novel
activ
import
understand
counteract
issu
current
studi
explor
capac
primit
enzym
dihydrofol
reductas
dhfr
confer
resist
commonli
prescrib
antibiot
trimethoprim
develop
new
antibiot
resist
activ
whether
dhfr
could
evolv
render
bacteri
cell
multidrug
resist
preserv
trimethoprim
resist
evolv
enzymat
activ
confer
differ
antibiot
resist
sitedirect
satur
mutagenesi
librari
residu
involv
bind
catalysi
enzym
dhfr
screen
sever
type
antibiot
previou
studi
shown
activ
site
could
thoroughli
modifi
maintain
nativ
activ
antibiot
chosen
allow
us
screen
known
strategi
enzymat
inactiv
antibiot
hydrolysi
group
transfer
redox
reaction
differenti
surviv
clone
allow
identifi
variant
confer
mild
resist
antibiot
chemic
unrel
trimethoprim
tetracyclin
work
understand
resist
mechan
tetracyclin
ongo
result
obtain
help
understand
evolut
primit
enzym
potenti
multidrug
resist
sourc
tune
cours
viral
evolut
protein
fit
landscap
use
droplet
microfluid
adrian
serohijo
assaf
rotem
eugen
shakhnovich
david
weitz
christian
wobu
jame
pipa
andrew
feldman
univers
montreal
canada
harvard
univers
usa
univers
michigan
ann
arbor
usa
univers
pittsburg
usa
john
hopkin
univers
usa
evolut
unifi
theme
urgent
medic
public
health
problem
face
today
includ
cancer
rise
antibiot
resist
spread
pathogen
abil
predict
evolut
remain
major
challeng
requir
bridg
sever
scale
biolog
organ
potenti
evolutionari
pathway
determin
fit
landscap
genotypephenotyp
relationship
landscap
explor
depend
microbi
popul
dynam
describ
recent
work
show
fit
landscap
noroviru
escap
neutral
antibodi
project
onto
two
trait
capsid
fold
stabil
bind
affin
antibodi
develop
theori
base
protein
biophys
popul
genet
predict
fit
landscap
might
explor
use
dropletbas
microfluid
evolut
chip
propag
million
independ
viral
subpopul
show
tune
viral
popul
size
per
drop
could
control
direct
viral
evolut
addit
describ
combin
framework
biophys
evolutionari
biolog
also
appli
bacteri
evolut
due
horizont
gene
transfer
altogeth
stori
demonstr
broad
applic
techniqu
concept
protein
engin
fundament
problem
evolut
genet
mutat
robust
abil
cell
perform
normal
function
spite
genet
perturb
paralog
protein
deriv
gene
duplic
retain
redund
function
compens
face
deleteri
mutat
thu
contribut
mutat
robust
instanc
deleteri
mutat
paralog
gene
lead
less
sever
effect
mutat
singl
copi
gene
yeast
human
recent
shown
could
achiev
directli
level
proteinprotein
interact
due
abil
paralog
compens
loss
howev
human
genet
diseas
contrari
associ
paralog
mechan
underli
contradictori
observ
still
poorli
understood
recent
suggest
paralog
often
compens
loss
rather
depend
proteinprotein
interact
network
work
hypothesi
duplic
ancestr
gene
form
homodim
lead
format
heterodim
paralog
evolv
way
make
depend
studi
mechan
underli
emerg
constraint
reconstruct
evolutionari
step
lead
phenomenon
use
protein
complement
assay
pca
yeast
protein
interact
network
examin
evolut
homodim
heterodim
interact
gene
duplic
understand
duplic
homodim
lead
physic
depend
paralog
result
help
understand
protein
interact
network
increas
complex
without
necessarili
gain
mutat
robust
extent
nonaddit
interact
among
mutat
epistasi
reflect
rugged
fit
landscap
map
genotyp
reproduct
fit
protein
evolut
strong
support
import
preval
epistasi
whether
univers
mechan
behind
epistasi
remain
unclear
also
establish
biophys
properti
proteinsfold
stabil
activ
bind
affin
dynamicshav
strongest
contribut
epistasi
protein
determin
contribut
select
fold
stabil
epistasi
protein
evolut
combin
theoret
estim
rate
molecular
evolut
protein
fold
thermodynam
use
numer
integr
mont
carlo
sequenceexplicit
simul
show
stabil
account
epistasi
among
substitut
model
predict
substanti
epistasi
margin
stabil
therefor
link
epistasi
strength
select
sinc
strength
select
thermodynam
stabil
substanti
higher
gene
higher
express
level
epistasi
predict
stronger
highli
express
gene
line
theoret
predict
estim
extent
epistasi
gene
e
coli
found
stronger
epistasi
highli
express
gene
take
altogeth
result
show
select
protein
fold
stabil
minim
cost
unfold
aggreg
would
account
signific
fraction
epistasi
protein
evolut
estim
contribut
govern
factor
molecular
evolut
protein
fold
stabil
express
level
epistasi
would
provid
better
understand
epistasi
henc
insight
predict
molecular
evolut
despit
critic
role
epistasi
molecular
evolut
comput
method
protein
evolut
assum
addit
mutat
effect
independ
evolut
residu
thu
account
epistasi
remain
challeng
approach
one
reason
shortcom
lack
univers
mechan
evolut
molecular
level
among
prime
candid
mechan
behind
epistasi
molecular
level
select
protein
fold
stabil
addit
consist
observ
compar
genom
protein
highli
express
abund
cytoplasm
evolv
slowli
result
observ
genom
across
kingdom
lifein
bacteria
yeast
worm
mammal
link
express
level
strongest
predictor
evolutionari
rate
protein
epistasi
still
unclear
elucid
extent
epistasi
gene
differ
express
level
estim
extent
epistasi
gene
e
coli
use
sever
hundr
orthologu
gene
find
highli
express
protein
experi
stronger
epistasi
use
combin
numer
integr
forward
evolutionari
simul
protein
evolut
show
posit
correl
epistasi
express
level
explain
select
protein
fold
stabil
minim
cost
unfold
aggreg
biochem
structur
insight
evolut
ubiquitin
ligas
casita
blineag
lymphoma
cbl
highli
conserv
mechan
action
ubiquityl
tyrosin
kinas
target
jeanin
amach
john
kuriyan
helen
hobb
sarah
mulchand
deepti
karandur
aaron
cantor
uc
berkeley
california
usa
tyrosin
phosphoryl
hallmark
metazoan
signal
transduct
pathway
directli
regul
critic
cellular
process
cell
growth
recent
believ
tyrosin
kinas
signal
emerg
multicellular
howev
full
complement
necessari
protein
tyrosin
phosphoryl
dephosphoryl
exist
choanoflagel
closest
nonmetazoan
ancestor
presenc
signal
compon
distantli
relat
organ
intrigu
suggest
remain
lot
pathway
fulli
understand
focu
attent
import
mediat
tyrosin
kinas
signal
ubiquitin
ligas
casita
blineag
lymphoma
cbl
target
mani
extant
tyrosin
kinas
lysosom
degrad
biochem
structur
character
number
cbl
homologu
vari
degre
sequenc
ident
includ
protein
choanoflagel
speci
salpingoeca
rosetta
well
caenorhabd
elegan
drosophila
melanogast
reveal
highli
conserv
phosphoactiv
substrat
recognit
mechan
addit
solv
crystal
structur
choanoflagel
cbl
scbl
inact
state
reveal
remark
similar
human
cbl
perform
molecular
dynam
simul
scbl
human
cbl
confirm
substrat
interact
outsid
domain
tyrosin
kinas
bind
domain
work
provid
import
insight
evolut
cbl
reveal
addit
nuanc
mechan
action
ethan
mcspadden
john
kuriyan
uc
berkeley
california
usa
protein
kinas
ii
camkii
protein
kinas
import
learn
memori
camkii
function
homomer
holoenzym
ntermin
kinas
domain
tether
unstructur
linker
extend
central
ring
assembl
ctermin
associ
hub
domain
character
diverg
camkii
ortholog
help
us
begin
understand
surpris
structur
plastic
camkii
hub
domain
chose
studi
predict
camkii
hub
domain
singl
cell
green
alga
chlamydomona
reinhardtii
ortholog
ident
human
hub
appear
particularli
interest
camkii
kinas
domain
present
open
read
frame
gene
biochem
structur
character
purport
chlamydomona
camkii
hub
show
true
camkii
hub
domain
chlamydomona
hub
domain
form
ring
assembl
radial
symmetri
contrast
human
camkii
hub
domain
form
roughli
equal
propens
ring
assembl
subtl
compact
chlamydomona
hub
domain
fold
rel
human
may
allow
differ
stoichiometri
compact
fold
lack
stoichiometr
variabl
suggest
hub
domain
less
flexibl
rel
human
counterpart
mutat
core
residu
human
camkii
hub
present
chlamydomona
heavili
disfavor
format
assembl
suggest
domain
rigidifi
understand
hub
domain
plastic
help
us
understand
disassembl
reassembl
camkii
holoenzym
facilit
signal
kinas
current
three
nonhomolog
nad
p
alcohol
dehydrogenas
adh
famili
report
type
adh
compris
zndepend
adh
type
ii
adh
compris
shortchain
adh
describ
first
drosophila
type
iii
adh
compris
ironcontain
adh
feadh
three
famili
aros
independ
throughout
evolut
possess
differ
structur
mechan
reaction
type
ii
adh
extens
studi
type
iii
adh
scarc
analyz
therefor
work
evolutionari
analysi
feadh
perform
result
show
feadh
distribut
twenti
two
protein
subfamili
eight
exhibit
univers
distribut
protein
sequenc
bacteria
present
feadh
subfamili
protein
sequenc
archaea
eukarya
present
fourteen
thirteen
subfamili
respect
interestingli
none
protein
subfamili
possess
protein
sequenc
found
simultan
three
main
eukaryot
kingdom
anim
plant
fungi
anim
feadh
found
one
protein
subfamili
hydroxyacidoxoacid
transhydrogenas
hot
subfamili
includ
protein
sequenc
wide
distribut
fungi
plant
sever
taxa
lower
eukaryot
bacteria
archaea
fungi
feadh
found
mainli
two
subfamili
hot
maleylacet
reductas
mar
found
also
three
differ
protein
subfamili
plant
feadh
found
chlorophyta
higher
plant
distribut
three
differ
protein
subfamili
conclus
feadh
ancient
protein
famili
probabl
present
last
common
ancestor
compris
divers
subfamili
share
common
scaffold
result
patchi
distribut
eukaryot
coldadapt
adpdepend
sugar
kinas
biophys
evolutionari
studi
flexibl
victoria
guix
ricardo
zamora
cesar
ramirezsarmiento
victor
castrofernandez
pablo
villalobo
elizabeth
komiv
universidad
de
chile
santiago
chile
p
universidad
cat
olica
de
chile
santiago
chile
univers
california
san
diego
usa
gener
mechan
adopt
psychrophil
enzym
perform
catalysi
low
temperatur
reduc
free
energi
transit
state
rather
micha
constant
km
achiev
relax
structur
enzym
structur
modif
compris
absenc
stabil
ionic
interact
increas
structur
flexibl
decreas
affin
substrat
shown
compens
increas
catalyt
rate
kcat
psychrophil
enzym
report
optim
catalyt
effici
kcatkm
decreas
km
valu
use
psychrophil
phosphofructokinaseglucokinas
methanococcoid
burtonii
mbpfkgk
mesophil
phosphofructokinaseglucokinas
methanococcu
maripaludi
mmpfkgk
identifi
function
structur
featur
psychrophil
enzym
would
make
enzym
flexibl
thermost
homologu
enzym
character
spectroscop
biophys
comput
techniqu
hd
exchang
coupl
mass
spectrometri
show
psychrophil
enzym
present
increas
structur
flexibl
particularli
segment
flank
metalnucleotid
bind
motif
mainli
due
absenc
two
ion
pair
present
mmpfkgk
increas
structur
flexibl
reflect
exponenti
increas
km
valu
temperatur
reconstruct
phylogenet
tree
enzym
famili
infer
ancestr
sequenc
psychrophil
mesophil
enzym
allow
us
establish
absenc
ionic
interact
psychrophil
branch
ancestr
trait
insert
two
ionic
interact
psychrophil
enzym
show
silico
well
experiment
alter
activ
site
flexibl
enzym
dynam
fondecyt
helena
gome
do
santo
jessica
siltbergliberl
florida
intern
univers
usa
recent
found
cladespecif
variat
predict
intrins
disord
tyrosin
kinas
across
paralog
clade
speci
explicitli
character
protein
conform
dynam
free
energi
model
protein
flexibl
address
normal
mode
analysi
model
conform
ensembl
intrins
dynam
compar
across
sameprotein
conform
ortholog
paralog
molecular
dynam
simul
perform
two
repres
subset
subset
contain
human
paralog
clade
subset
contain
speci
close
relat
paralog
result
infer
differ
conform
access
protein
prefer
differ
clade
ii
extens
variat
amount
intrins
dynam
persist
within
differ
paralog
iii
cladespecif
shift
stabil
partli
due
shift
electrostat
contribut
free
energi
appar
consist
conform
iv
larg
shift
electrostat
potenti
surfac
differ
clade
regardless
conform
remark
one
paralog
clade
becom
significantli
dynam
diverg
multipl
measur
gene
duplic
clade
appear
evolv
perform
function
via
uniqu
mechan
bind
stabil
paralog
confirm
previou
experiment
studi
overal
diverg
protein
dynam
gene
duplic
support
result
impli
import
alter
dynam
function
diverg
gene
duplic
earli
anim
evolut
instrument
creat
divers
neurotransmitt
signal
found
throughout
anim
kingdom
today
recent
duplic
two
subunit
filari
parasit
nematod
acetylcholin
receptor
provid
uniqu
tractabl
model
mechan
involv
object
reconstruct
ancestr
subunit
present
duplic
occur
estim
select
pressur
act
duplic
subunit
determin
amino
acid
site
posit
select
subsequ
evolut
predict
subunit
identifi
nematod
speci
helminth
genom
initi
ancestr
gene
complement
loss
duplic
event
infer
dollo
parsimoni
ml
phylogeni
phyml
rel
substitut
rate
evalu
use
codeml
paml
posit
select
site
use
fel
hyphi
map
onto
predict
structur
yasara
three
site
class
identifi
highli
conserv
like
respons
conserv
core
structur
less
conserv
possibl
site
subunit
interfac
least
conserv
possibl
nonconserv
loop
last
rate
class
elev
duplic
subunit
consist
function
adapt
strongli
select
site
infer
adjac
characterist
cysloop
linker
differ
elev
substitut
rate
posit
select
site
suggest
duplic
subunit
two
gene
evolv
differ
function
constraint
provid
possibl
mechan
subunit
function
chang
charlott
miton
nobuhiko
tokuriki
much
debat
extent
mutat
epistasi
ie
depend
outcom
mutat
particular
genet
background
constrain
evolutionari
trajectori
degre
unpredict
introduc
epistasi
due
nonaddit
phenotyp
effect
strongli
hinder
strategi
develop
protein
engin
sever
studi
tackl
issu
systemat
character
evolutionari
trajectori
within
individu
model
enzym
field
lack
consensu
view
scope
address
need
perform
comprehens
survey
mutat
epistasi
base
nine
previou
studi
examin
evolut
novel
function
natur
laboratori
system
quantifi
epistasi
compar
effect
mutat
occur
two
genet
background
start
enzym
typic
wild
type
intermedi
variant
mutat
occur
trajectori
found
trajectori
exhibit
posit
epistasi
mutat
effect
benefici
occur
later
evolutionari
trajectori
approxim
half
function
mutat
neutral
neg
wild
type
background
becam
benefici
later
stage
trajectori
indic
function
mutat
predict
initi
start
point
case
strong
epistasi
associ
direct
interact
residu
mani
other
caus
longrang
indirect
interact
mutat
find
highlight
preval
epistasi
enzym
adapt
evolut
implic
engin
design
function
optim
catalyst
identif
understand
epistat
interact
pivot
chemic
biolog
prepar
polypeptid
chain
gener
need
fold
bioactiv
nativ
state
two
chemic
reaction
random
disulfid
ss
format
subsequ
shss
isomer
search
nativ
ss
pair
wherea
oxid
fold
greatli
promot
assist
protein
disulfid
isomeras
pdi
enzymat
system
applic
practic
oxid
fold
test
tube
expens
enzym
contrast
use
synthet
addit
imit
function
foldas
one
use
strategi
achiev
oxid
fold
effici
studi
therefor
attempt
synthes
organoselenium
compound
figur
foldas
mimic
deriv
inexpens
start
materi
demonstr
applic
fold
addit
dihydoroxi
selenolaneoxid
much
higher
redox
potenti
mv
cysteinecystin
mv
react
reduc
ribonucleas
rnase
eight
thiol
group
fulli
oxid
speci
nonn
ss
bond
produc
quickli
min
addit
obtain
speci
subsequ
react
gsh
mm
presenc
catalyt
amount
cyclic
diselenid
nativ
state
effici
recov
shss
isomer
catalyz
work
reduc
diselenid
ie
selenol
moieti
gener
reaction
solut
also
found
pka
valu
selenol
diselenidereduct
potenti
factor
affect
pdilik
catalyt
activ
control
chang
substitu
ring
size
compound
nearli
twothird
human
proteom
compris
multidomain
protein
intric
fold
unfold
behavior
multidomain
protein
highlight
presenc
nonn
structur
fold
intermedi
intermedi
engag
cellular
event
like
misfoldingaggreg
interact
protein
calnuc
multidomain
multifunct
calciumbind
protein
report
interact
numer
protein
pleiotrop
function
unfold
calciumfre
calnuc
proce
two
structur
intermedi
detect
circular
dichroism
despit
fluoresc
spectral
signatur
similar
two
intermedi
state
trap
guanidinium
chlorid
gdmcl
complet
unfold
gdmcl
unfold
calciumbound
calnuc
proce
singl
intermedi
state
gradual
loss
secondari
structur
calciumbind
confer
margin
increas
stabil
dg
unfold
ca
kcal
infer
thermodynam
analysi
faruv
nearuv
dsc
experi
demonstr
local
conform
chang
around
efhand
calciumbind
domain
fluoresc
studi
singl
tryptophan
mutant
report
stabl
natur
intermedi
differ
calciumfre
calciumbound
form
hypothes
calciumbind
might
alter
conform
stabil
calnuc
regul
proteinprotein
interact
incorpor
function
mutat
symmetr
scaffold
proxi
function
adapt
via
rearrang
fold
nucleu
conni
tenorio
florida
state
univers
usa
protein
conserv
herit
unit
fold
known
fold
nucleu
fn
describ
subset
amino
acid
posit
favor
local
contact
induc
nucleat
abstract
format
fold
structur
fn
previous
identifi
hyper
stabl
functionless
deriv
protein
adopt
fold
threefold
symmetri
use
known
locat
fold
nucleu
hypothes
concern
tradeoff
fold
function
well
tradeoff
stabil
function
probe
term
fn
perturb
use
pure
symmetr
scaffold
design
insert
function
cassett
symmetr
relat
domain
elucid
plastic
fn
upon
acquisit
function
function
cassett
util
amalgam
multipl
heparin
sulfat
bind
motif
within
fibroblast
growth
famili
studi
report
effect
function
mutat
upon
thermost
fold
map
rearrang
protein
uniqu
fn
within
proxi
function
adapt
invalu
futur
endeavor
de
novo
protein
design
effort
protein
evolut
studi
lipocalintyp
prostaglandin
synthas
lpgd
uniqu
multifunct
protein
act
synthas
extracellular
transport
small
lipophil
molecul
use
bind
capabl
variou
hydrophob
ligand
recent
propos
novel
drug
deliveri
system
lpgd
deliveri
vehicl
poorli
watersolubl
compound
lpgd
classic
lipocalin
fold
consist
eightstrand
antiparallel
intern
disulfid
ss
bond
ss
bond
link
cterminu
lpgd
c
strand
hairpin
highli
conserv
lipocalin
see
figur
purpos
studi
reveal
effect
ss
bond
stabil
lpgd
construct
disulfid
bond
mutant
sitedirect
mutagenesi
investig
conform
thermal
stabil
use
circular
dichroism
cd
spectroscopi
cd
measur
show
remov
ss
bond
slightli
chang
tertiari
structur
lpgd
decreas
tm
valu
pb
next
perform
two
dimension
heteronuclear
singl
quantum
coher
experi
molecular
dynam
md
simul
crosspeak
residu
disappear
without
ss
bond
mainli
locat
hairpin
lpgd
furthermor
hairpin
significantli
fluctuat
md
simul
ns
experiment
theoret
result
reveal
lack
ss
bond
affect
chemic
environ
dynam
hairpin
lpgd
taken
togeth
highli
conserv
ss
bond
lpgd
play
import
role
mainten
structur
physiolog
condit
human
tast
five
basic
tast
qualiti
sweet
umami
bitter
salti
sour
ikeda
discov
umami
tast
name
umai
recent
interest
food
cultur
rais
therebi
season
market
grow
season
contain
umami
tastant
msg
imp
gmp
etc
therefor
mani
effort
make
tast
detect
tool
develop
last
decad
howev
establish
detect
tool
low
sensit
select
also
need
amount
inform
detect
therebi
possibl
detect
unknown
compound
herein
group
develop
highperform
bioelectron
sensor
umami
tast
use
human
gprotein
coupl
receptor
gpcr
umami
tast
receptor
heterodimer
class
c
gpcr
accord
recent
research
extracellular
ntermin
domain
ligand
domain
umami
tastant
therefor
express
extracellular
ntermin
domain
escherichia
coli
purifi
function
reconstitut
graphen
fieldeffect
transistor
fet
function
reconstitut
protein
wellestablish
bioelectron
sensor
umami
tast
use
extracellular
nterminu
domain
abl
detect
msg
low
concentr
ca
nm
select
detect
target
ligand
also
bioelectron
sensor
detect
enhanc
effect
use
imp
human
sensori
system
bioelectron
tongu
use
tool
food
beverag
industri
studi
class
c
gpcr
fold
cooper
tandemrepeat
protein
follow
differ
paradigm
globular
protein
signific
repercuss
stabil
function
repeat
coupl
nearestneighbour
stabil
tandemrepeat
array
follow
ise
model
despit
structur
differ
repeat
protein
studi
date
follow
paradigm
includ
exampl
helic
ankyrin
repeat
tetratricopeptid
repeat
tpr
differ
greatli
interrepeat
loop
length
tpr
short
loop
littl
appar
impact
fold
structur
tpr
promis
build
block
biomateri
research
herein
explor
possibl
loop
extens
enabl
materi
diversif
purpos
design
seri
consensu
tpr
protein
differ
number
length
loop
extens
interestingli
found
loop
extens
conserv
respect
fold
structur
effect
stabil
follow
addit
rule
ise
model
tpr
array
destabil
due
entrop
penalti
also
due
decoupl
fold
repeat
furthermor
stabil
repeat
array
longer
increas
linearli
number
repeat
find
provid
insight
relationship
structur
fold
repeat
protein
import
predict
biophys
function
properti
natur
repeatprotein
sequenc
implic
exploit
design
proteinbas
biomateri
quantifi
number
microscop
rout
avail
protein
molecul
fold
challeng
ventur
challeng
address
experiment
singlemolecul
studi
constrain
number
observ
fold
event
atomist
simul
restrict
sampl
inabl
reproduc
thermodynam
observ
directli
work
around
constraint
provid
comprehens
pictur
intric
network
fold
rout
borrow
concept
statist
mechan
physic
kinet
graph
theori
studi
fold
behavior
five
singledomain
protein
fold
differ
timescal
possess
vari
secondari
structur
content
topolog
two
thermodynam
condit
analysi
fold
event
gener
statist
mechan
model
result
microst
energet
million
conform
state
predict
variou
ensembl
base
measur
includ
result
protein
engin
experi
thermodynam
stabil
secondarystructur
segment
endtoend
distanc
estim
singlemolecul
studi
graph
theoret
network
reveal
presenc
rich
ensembl
fold
mechan
gener
mask
reduc
represent
eg
onedimension
free
energi
profil
shown
rel
flux
order
numer
fold
rout
depend
stabil
condit
topolog
complex
resolut
fold
event
observ
predict
methodolog
thu
reconcil
contradictori
observ
experi
simul
provid
experiment
consist
avenu
quantifi
fold
heterogen
molecular
origin
temperatureinduc
collaps
intrins
disord
protein
idp
current
unclear
explor
phenomenon
perform
multiprob
spectroscop
studi
intrins
disord
cytidin
repressordna
bind
domain
cytrdbd
includ
dynam
light
scatter
circular
dichroism
fluoresc
nmr
scan
calorimetri
measur
find
cytr
lose
secondari
structur
increas
temperatur
signific
local
global
structur
rearrang
preced
actual
collaps
transit
remark
hydrophob
surfac
burial
happen
thermodynam
much
earlier
collaps
transit
collaps
transit
regim
span
k
character
continu
increas
enthalp
fluctuat
first
measur
idp
argu
specif
collaps
state
also
observ
littl
chang
bind
affin
cytr
cognat
dna
transit
regim
despit
disord
molecular
dimens
reduc
experiment
result
togeth
implicit
solvent
simul
suggest
cytr
collaps
transit
secondord
like
furthermor
seem
go
handinhand
increas
number
nonn
hydrogen
bond
minim
contribut
hydrophob
surfac
burial
abhishek
narayan
athi
n
naganathan
mesoscal
natur
protein
allow
effici
coupl
environment
cue
conform
chang
enabl
function
molecular
transduc
delin
precis
structur
origin
connect
expect
spectroscop
respons
howev
challeng
work
perform
combin
ureatemperatur
doubl
perturb
experi
theoret
model
probe
nativ
conform
landscap
cnu
natur
thermosensor
protein
belong
hhafamili
protein
hhafamili
conserv
among
enterobacteriacea
implic
dynam
regul
express
pathogen
gene
upon
temperatur
shift
cnu
display
probe
depend
unfold
grade
increas
structur
fluctuat
temperaturedepend
swell
nativ
ensembl
within
physiolog
rang
temperatur
addit
observ
uniqu
ensembl
signatur
point
continuum
conform
substat
nativ
ensembl
respond
intric
perturb
upon
monitor
secondari
tertiarystructur
distanc
intrins
fret
pair
hydrodynam
volum
bind
assay
reveal
weaken
cnu
function
complex
temperatur
highlight
molecular
origin
signal
transduct
critic
pathogen
respons
enterobacteriacea
conjug
ubiquitin
ub
protein
posttransl
modif
found
eukaryot
cell
respons
maintain
intracellular
protein
level
regul
protein
activ
ubiquitin
protein
catalyz
set
three
enzym
first
enzym
ubiquitin
activ
enzym
activ
transfer
ub
conjug
enzym
yeast
monomer
multidomain
protein
size
delet
gene
result
lethal
adenyl
ubiquitin
form
thioester
bond
crystal
structur
yeast
complex
alreadi
resolv
xray
crystallographi
howev
detail
mechan
fold
domain
unknown
second
catalyt
cystein
halfdomain
scch
one
six
domain
span
residu
catalyt
cystein
posit
form
thioester
bond
ctermin
glycin
residu
adenyl
ubiquitin
scch
core
motif
residu
around
catalyt
cystein
moreov
scch
link
neighbour
domain
linker
suggest
conform
chang
domain
necessari
function
understand
structur
featur
scch
clone
express
purifi
carri
structur
studi
use
circular
dichroism
cd
fluoresc
spectroscopi
gradual
unfold
scch
observ
guanidin
hydrochlorid
establish
peptid
intact
structur
cd
spectra
scch
peptid
show
mainli
consist
ahelic
similar
scch
domain
present
crystal
suggest
scch
domain
fold
nativ
like
structur
independ
rest
protein
tim
barrel
fold
form
repetit
basic
build
motif
follow
ahelic
eight
time
altern
sequenc
structur
architectur
impos
alphabeta
betaalpha
loop
connect
alphahelic
adjac
betastrand
betastrand
alphahelic
contribut
stabil
function
respect
barrel
architectur
provid
uniqu
opportun
address
properti
reduc
loop
flexibl
increas
inter
residu
interact
aris
within
loop
flank
distant
secondari
structur
element
domin
alphabeta
loop
molecular
dynam
simul
coupl
structur
analysi
alpha
subunit
tryptophan
synthas
at
reveal
clear
distinct
alphabeta
betaalpha
loop
flexibl
deriv
thermal
factor
root
mean
squar
fluctuat
clear
distinct
resist
thermal
chemic
unfold
also
observ
unfold
simul
first
four
beta
strand
along
coupl
alphahelic
show
stabil
four
strand
alphabeta
loop
rigid
stabl
unfold
betaalpha
counterpart
increas
number
inter
residu
noncoval
interact
includ
hydrogen
bond
ionic
hydrophob
contact
within
loop
flank
secondari
structur
element
observ
alphabeta
loop
therefor
noncoval
interact
domin
alphabeta
loop
could
contribut
overal
fold
stabil
at
intriguingli
featur
observ
prototyp
at
recapitul
entir
set
tim
barrel
larg
multidomain
protein
loos
dependentindepend
domain
fold
nativ
state
despit
slower
refold
rate
possibl
domain
interact
understand
seemingli
simpl
yet
complex
phenomena
studi
malat
synthas
g
enzym
perform
use
classic
equilibrium
kinet
techniqu
previous
gdmclmediat
denatur
establish
fold
mechan
nativ
like
onpathway
speci
aggreg
higher
concentr
explor
detail
unfold
mechan
ureaassist
denatur
equilibrium
studi
suggest
least
two
intermedi
nativ
like
helix
content
io
system
explor
use
kinet
method
singl
jump
refold
convers
entir
popul
io
observ
within
mix
dead
time
irrespect
initi
unfold
condit
subsequ
refold
obligatori
intermedi
biphas
phenomenon
exhibit
pathway
like
rollov
two
refold
arm
addit
viscos
depend
refold
experi
demonstr
diffus
control
natur
slower
phase
interrupt
refold
experi
confirm
accumul
fast
phase
produc
nativ
state
probabl
via
slow
domain
rearrang
step
tripl
phasic
unfold
reaction
reveal
although
intersect
linear
unfold
arm
chevron
exclud
addit
unfold
intermedi
thu
minim
model
protein
fold
essenti
compulsori
pathway
intermedi
fold
nativ
state
sequenti
manner
structur
qualiti
assess
qa
crucial
step
comput
protein
structur
predict
step
one
predict
qualiti
candid
structur
select
like
closest
nativ
one
current
qa
model
typic
reli
predefin
list
structur
featur
contact
distanc
secondari
structur
solvent
exposur
mani
featur
use
defin
qualiti
structur
expect
approach
base
deep
learn
featur
learn
data
would
perform
better
deep
convolut
network
recent
achiev
outstand
perform
comput
vision
work
explor
applic
deep
convolut
network
qualiti
assess
individu
structur
figur
show
architectur
network
input
model
atom
densiti
broken
atom
type
output
real
number
rank
structur
model
train
rank
set
decoy
structur
accord
proxim
correspond
nativ
structur
train
model
dataset
assess
qualiti
predict
dataset
dataset
preprocess
scwrl
tabl
show
approach
achiev
result
compar
stateoftheart
qa
method
without
need
featur
engin
applic
deep
learn
algorithm
protein
model
qa
still
spars
explor
believ
work
facilit
use
similar
techniqu
protein
fold
problem
histidin
amino
acid
call
diphthamid
diphthamid
found
bacteri
homolog
elong
factor
g
lack
modif
previou
work
suggest
diphthamid
import
translat
fidel
precis
function
remain
elus
diphthamid
synthesi
pathway
also
complex
mechan
divid
three
stage
requir
seven
differ
protein
yeast
dph
synthesi
diphthamid
yet
reconstitut
vitro
order
studi
function
diphthamid
synthesi
develop
protocol
purifi
human
without
diphthamid
modif
chose
express
e
coli
due
lack
diphthamid
synthesi
bacteria
overexpress
partit
insolubl
fraction
e
coli
lysat
subsequ
purifi
evalu
refold
condit
increas
solubl
result
suggest
strategi
prepar
lack
diphthamid
futur
direct
includ
use
mass
spectrometri
confirm
absenc
diphthamid
modif
refold
condit
maxim
solubl
compar
fold
dynam
prion
protein
speci
differ
diseas
suscept
singlemolecul
level
michael
woodsid
uttam
anand
craig
garen
misfold
prion
protein
prp
caus
prion
diseas
includ
bse
cattl
scrapi
sheep
chronic
wast
diseas
cervid
cjd
human
prp
highli
conserv
across
speci
yet
diseas
suscept
vari
wide
deer
bank
vole
suscept
exampl
wherea
rabbit
hors
resist
differ
result
aminoacid
chang
chang
alter
misfold
remain
unclear
explor
effect
speciesrel
sequenc
differ
use
forc
spectroscopi
observ
fold
dynam
singl
prp
molecul
held
optic
tweezer
compar
behavior
hamster
prp
haprp
rabbit
prp
rbprp
bank
vole
prp
bvprp
hamster
diseasesuscept
rabbit
resist
bank
vole
extrem
suscept
unfold
refold
trajectori
measur
ramp
appli
forc
updown
result
forceextens
curv
fec
reveal
exist
onpathway
intermedi
misfold
offpathway
state
reflect
also
energet
kinet
properti
contrast
haprp
exhibit
twostat
fold
rbprp
fold
via
multipl
onpathway
intermedi
case
nativ
fold
rapid
misfold
state
detect
fec
fec
bvprp
show
onpathway
intermedi
much
slower
kinet
notabl
misfold
state
secondscal
lifetim
also
observ
relat
observ
contourlength
chang
structur
featur
prp
propos
possibl
intermedi
nativ
fold
pathway
rbprp
bvprp
result
show
subtl
sequenc
differ
prp
differ
speci
produc
import
differ
fold
dynam
may
relev
diseas
suscept
protein
commonli
fold
singl
nativ
state
basin
energi
landscap
low
enough
stabl
solut
broad
enough
allow
motion
associ
protein
function
howev
group
socal
metamorph
protein
challeng
paradigm
fold
least
two
structur
differ
yet
function
relev
configur
bacteri
transcript
regul
rfah
constitut
dramat
exampl
behavior
ctermin
domain
ctd
refold
stabl
ahel
hairpin
bound
occlud
rna
polymeras
bind
site
ntermin
domain
ntd
small
explor
detail
metamorph
process
rfah
use
combin
multiscal
molecular
dynam
biophys
experi
dualfunnel
coarsegrain
simul
highlight
role
specif
ntdctd
interact
stabil
astat
ctd
residu
dual
role
stabil
fold
impact
rna
polymeras
facilit
metamorph
process
moreov
perresidu
freeenergi
decomposit
allatom
simul
use
confineconvertreleas
method
ccr
unveil
local
structur
prefer
toward
either
nativ
state
within
ctd
residu
contribut
stabil
astat
local
upper
part
ahel
hairpin
residu
strong
consist
previou
nmr
evid
effect
mutat
region
comparison
comput
simul
hydrogen
deuterium
exchang
mass
spectrometri
experi
rfah
exhibit
remark
high
correl
demonstr
combin
strategi
unveil
determin
structur
transform
rfah
revers
inform
back
primari
sequenc
fund
fondecyt
superoxid
dismutas
ubiquit
express
metalloenzym
reduc
oxid
stress
cell
catalyz
dismut
superoxid
radic
mutat
gene
encod
link
fatal
neurodegen
diseas
amyotroph
later
sclerosi
al
preval
hypothesi
mutant
caus
diseas
format
toxic
intracellular
protein
aggreg
undergo
posttransl
modif
vivo
includ
metal
bind
disulphid
bond
format
dimer
reach
final
matur
state
stabl
homodim
recent
studi
support
theori
immatur
state
may
play
key
role
diseas
patholog
monomer
speci
may
link
toxic
zincbound
form
reduc
disulphid
bond
e
zn
sh
centr
debat
contradictori
literatur
publish
regard
whether
exist
monom
dimer
although
key
state
wide
discuss
rel
littl
character
compar
form
protein
investig
e
zn
sh
use
combin
isotherm
titrat
calorimetri
itc
measur
dimer
dissoci
differenti
scan
calorimetri
dsc
measur
global
unfold
protein
order
dissect
contribut
mutat
protein
stabil
result
compar
effect
mutat
form
better
understand
protein
matur
differ
role
speci
misfold
diseas
speci
function
relev
mechan
describ
wide
studi
protein
diphtheria
toxin
thermodynam
kinet
behavior
mechan
shown
unfold
state
requir
obtain
dimer
oligomer
conform
crystallograph
solut
experi
show
dnabind
domain
human
foxp
protein
reach
dimer
structur
via
domain
swap
specif
obtain
relev
biophys
detail
relat
process
use
model
present
dissoci
constant
two
three
order
magnitud
lower
domainswap
protein
obtain
detail
structur
inform
domainswap
dimer
fluorophor
attach
cystein
introduc
specif
region
protein
studi
dynam
possibl
subensembl
conform
via
singlemolecul
fret
use
multiparamet
fluoresc
detect
mfd
approach
data
show
timescal
event
regiondepend
accord
differ
flexibl
observ
wildtyp
protein
hand
two
conform
dimer
protein
observ
close
subensembl
consist
domainswap
open
subensembl
whose
distanc
dynam
possibl
correspond
unstructur
flexibl
protein
find
relev
understand
kinet
thermodynam
properti
protein
studi
multiplo
fund
fondecyt
doctor
fellowship
work
describ
investig
differ
structur
function
properti
report
pdb
triosephosph
isomeras
monomer
mutant
monotim
particular
regard
monotctim
monomer
mutant
deriv
trypanosom
cruzi
tim
tctim
design
synthet
purifi
character
team
z
aratep
erez
et
al
biochem
biophi
re
comm
structur
function
thermodynam
properti
monotctim
compar
avail
monomer
tim
mutant
comparison
shown
like
properti
mutant
like
main
structur
characterist
tim
barrel
fold
well
differ
three
dimension
structur
mani
deriv
differ
found
origin
mutat
perform
amino
acid
sequenc
case
thermodynam
analysi
avail
howev
differ
stabil
mutant
found
final
discuss
origin
low
catalyt
activ
tim
monomer
mutant
comprehens
understand
protein
fold
process
modul
evolut
critic
understand
engin
protein
biophys
properti
studi
character
fold
trajectori
ancestr
protein
ribonucleas
h
rnase
h
famili
use
ancestr
sequenc
reconstruct
access
evolutionari
histori
rnase
h
mesophil
thermophil
bacteria
find
overal
fold
pathway
rnase
h
preserv
billion
year
evolut
although
thermodynam
stabil
diverg
mesophil
thermophil
lineag
kinet
stabil
increas
along
last
common
ancestor
fold
unfold
faster
modern
descend
conserv
fold
intermedi
permit
paradox
uncoupl
thermodynam
kinet
allow
fold
landscap
independ
respond
differ
select
pressur
global
stabil
kinet
barrier
addit
character
rnase
h
fold
pathway
fragment
model
hydrogenexchang
mass
spectrometri
hxm
reveal
distinctli
chang
fold
pathway
rnase
h
famili
highlight
subtl
sequenc
chang
alter
structur
partial
fold
intermedi
cours
evolut
examin
effect
ubiquitin
energet
substrat
protein
emma
carrol
susan
marquse
susan
marquse
ubiquitin
common
protein
posttransl
modif
protein
ubiquitin
attach
primari
amin
lysin
k
residu
target
protein
ubiquitin
canon
associ
target
protein
proteasom
degrad
howev
ubiquitin
also
involv
mani
cellular
process
cell
must
care
regul
ubiquitin
protein
degrad
proteasom
degrad
depend
ubiquitin
chain
length
topolog
also
shown
conform
featur
tag
protein
play
role
proteasom
engag
howev
biophys
factor
drive
vivo
proteasom
degrad
code
remain
larg
unexplor
type
studi
hamper
difficulti
character
energet
dynam
associ
probe
macromolecular
complex
ubiquitin
protein
present
approach
result
model
system
character
stabil
dynam
protein
without
defin
ubiquitin
modif
john
strahan
sheila
jaswal
paul
cohen
amherst
colleg
depart
chemistri
massachusett
usa
brown
univers
depart
emerg
medicin
massachusett
usa
understand
energet
landscap
protein
conform
space
key
understand
mechan
underli
protein
fold
denatur
one
common
way
probe
free
energi
landscap
destabil
protein
use
high
concentr
denatur
urea
guanidin
hydrochlorid
fold
kinet
thermodynam
measur
extrapol
back
zero
denatur
concentr
sever
model
propos
carri
extrapol
common
simpl
linear
fit
method
work
well
mani
protein
sever
case
curvatur
observ
unfold
rate
function
denatur
lead
error
extrapol
rate
constant
work
develop
sever
model
understand
unfold
kinet
kinet
stabl
proteas
denatur
depend
unfold
rate
measur
larg
rang
denatur
concentr
temperatur
order
develop
model
make
use
denatur
depend
transfer
free
energi
data
sever
polar
amino
acid
model
hydrophob
amino
acid
analogu
nacetyltryptophanamid
found
curvatur
activ
free
energi
plot
well
model
scale
contribut
solvat
model
nonpolar
polar
amino
acid
result
suggest
solvat
polar
surfac
area
make
larg
contribut
denatur
stabil
effect
transit
state
amino
acid
sequenc
spontan
fold
protein
must
balanc
requir
fold
function
singl
landscap
protein
fold
assist
chaperon
pro
region
freed
limit
one
hypothesi
hold
function
featur
sequenc
becom
extrem
requir
spontan
fold
remov
exampl
bacteri
alyt
proteas
alp
fold
precursor
demonstr
extrem
function
longev
proregion
remov
extend
lifetim
propos
result
extrem
tune
structur
dynam
minim
unfold
scale
probe
hypothesi
compar
alp
dynam
mammalian
homologu
trypsin
also
fold
precursor
function
hexapeptid
remov
hydrogen
exchang
mass
spectrometri
fluoresc
loss
enzymat
activ
use
monitor
structur
dynam
rang
local
nativest
fluctuat
global
unfold
alp
trypsin
display
high
barrier
activ
loss
alp
preserv
barrier
higher
temperatur
case
trypsin
smallscal
nativ
state
dynam
appear
render
trypsin
sensit
proteolyt
cleavag
actual
inactiv
enzym
alp
howev
becom
sensit
proteolysi
global
unfold
initi
experi
trypsin
precursor
demonstr
even
enhanc
nativ
state
dynam
may
correl
trypsinogen
signific
thermodynam
stabil
addit
experi
compar
distinct
fold
function
landscap
alp
trypsin
trypsinogen
illumin
interplay
nativest
dynam
stabil
function
protein
function
depend
proper
calibr
stabil
dynam
structur
nativ
state
defin
protein
landscap
term
conform
sampl
differ
thermodynam
stabil
rate
transit
essenti
approach
investig
link
function
energet
tradit
landscap
paramet
measur
use
equilibrium
denatur
kinet
chevron
analysi
monitor
spectroscop
method
addit
requir
larg
number
measur
function
denatur
andor
temperatur
induc
bulk
unfold
condit
far
nativ
studi
limit
protein
unfold
refold
revers
short
timescal
without
misfold
aggreg
develop
approach
use
nativest
hydrogen
exchang
coupl
mass
spectrometri
nhxm
address
challeng
fit
mass
chang
nhxm
time
cours
data
intact
protein
method
extract
landscap
paramet
limit
measur
nondenatur
condit
valid
approach
verifi
landscap
paramet
measur
nhxm
across
hx
regim
determin
tradit
denatur
experi
model
twostat
protein
protein
l
addit
explor
potenti
nhxm
certain
condit
allow
simultan
determin
unfold
fold
rate
constant
small
number
hxm
time
cours
work
help
establish
nhxm
possibl
altern
chevron
analysi
equilibrium
denatur
requir
less
time
materi
twostat
protein
milder
method
probe
landscap
protein
gener
secret
serpin
regul
serin
proteas
associ
inflamm
fold
endoplasm
reticulum
er
well
understood
misfold
result
defici
lung
diseas
topolog
complex
serpin
fold
consist
two
domain
mainli
domain
contain
region
near
nand
ctermini
complic
fold
along
serpin
misfold
diseas
rais
question
larg
protein
like
amino
acid
nonsequenti
domain
fold
cell
one
hypothes
rel
long
protein
like
may
fold
cotransl
mimic
cotransl
fold
vitro
ntermin
fragment
predict
fold
autonom
purifi
character
analyt
ultracentrifug
experi
show
fragment
consist
ntermin
piec
domain
monomer
fragment
protein
denatur
monitor
far
uv
circular
dichroism
reveal
ntermin
fragment
also
display
signific
amount
secondari
like
tertiari
structur
suggest
fragment
could
fold
cotransit
longer
fragment
adopt
multipl
oligomer
state
oligomer
fragment
contain
incomplet
rich
domain
may
induc
aggreg
cell
region
like
need
interact
chaperon
andor
form
stabl
hydrogen
bond
fold
quickli
order
avoid
aggreg
diseaseassoci
polymer
liquidliquid
phase
separ
underli
spontan
format
proteinrich
droplet
proteinpoor
solut
phase
concomit
sharp
increas
solut
turbid
phase
separ
typic
trigger
respons
stimulu
chang
protein
concentr
ionic
strength
temperatur
may
revers
preced
gelat
fibr
format
aggreg
phase
separ
wellknown
properti
synthet
polym
exploit
materi
design
exampl
capsul
drug
deliveri
fastset
hydrogel
well
understood
protein
exampl
phasesepar
protein
system
includ
len
gamma
crystallin
implic
cataract
format
membraneless
organel
transient
form
intracellular
compart
regul
molecular
interact
selfassembl
elast
protein
includ
spider
silk
insect
resilin
vertebr
elastin
phase
separ
onpathway
format
elast
materi
studi
phase
separ
model
polypeptid
base
protein
elastin
polypeptid
contain
region
welldefin
secondari
structur
intrins
disord
droplet
growth
biophys
properti
monitor
use
varieti
microscopi
optic
spectroscopi
techniqu
amino
acid
sequenc
mutat
particularli
affect
fraction
secondari
structur
modul
size
stabil
revers
interact
phasesepar
droplet
data
indic
strategi
function
tunabl
droplet
applic
ration
load
small
molecul
promiscu
select
intrins
disord
protein
regul
apoptosi
bind
like
protein
liza
dahal
jane
clark
famili
protein
play
central
role
regul
cell
surviv
apoptosi
date
six
prosurviv
least
two
proapoptot
protein
identifi
third
group
ten
proapoptot
protein
term
intrins
disord
form
contigu
helic
segment
upon
bind
partner
protein
disord
natur
protein
might
sourc
promiscu
select
bind
thu
increas
divers
flexibl
intric
network
use
kinet
thermodynam
analys
understand
biophys
natur
interact
provid
insight
underli
molecular
mechan
regul
apoptosi
carboxyltermin
domain
ctd
essenti
domain
largest
subunit
rna
polymeras
ii
compos
tandem
repeat
sevenamino
acid
sequenc
ysptsp
least
repeat
requir
surviv
recent
shown
yeast
suboptim
ctd
length
promot
spontan
expans
contract
code
region
improv
fit
morril
et
al
work
make
use
tetoff
report
system
monitor
expans
contract
repetit
ctd
effect
variou
environment
stress
rate
ctd
expans
contract
includ
temperatur
salt
osmot
stress
investig
use
report
system
fluctuat
assay
result
suggest
sever
stress
especi
hyperosmot
stress
nacl
kcl
increas
rate
mutat
ctd
stressinduc
instabl
repetit
protein
domain
may
therefor
lead
phenotyp
divers
enabl
popul
better
cope
environment
stress
polyglutamin
polyq
tract
expans
link
varieti
neurodegen
diseas
conserv
sequenc
despit
evolutionari
pressur
point
relev
role
suggest
involv
organ
secondari
structur
element
particular
case
androgen
receptor
ar
recent
report
leurich
segment
ntermin
polyq
tract
act
helic
ncap
sequenc
propag
helic
tract
base
acquir
vitro
cd
nmr
well
silico
md
data
batteri
peptid
show
helic
sequenc
posit
correl
number
glutamin
tract
valu
found
averag
popul
residu
depend
ethnic
helix
stabil
depend
glutamin
sidechainmedi
hydrogen
bond
support
ccap
role
polyq
tract
minimum
number
glutamin
residu
requir
stabil
helic
growth
tract
detriment
increas
aggreg
rate
proteom
analysi
show
region
predict
fold
coiledcoil
highli
enrich
adjac
sequenc
ntermin
polyq
tract
thu
provid
ground
gener
role
tract
ccap
helic
element
intrins
disord
protein
intrins
disord
region
especi
common
eukaryot
proteom
mani
signific
biolog
function
like
cellular
signal
transduct
transcript
translat
associ
protein
disord
underli
import
phenomenon
recent
intrins
disord
propos
play
key
role
liquidliquid
phase
separ
llp
llp
cell
nuclei
allow
organ
organel
gener
membraneless
organel
nucleoli
splice
speckl
cajal
bodi
gem
pml
bodi
androgen
receptor
ar
transcript
factor
regul
express
specif
subset
gene
associ
androgen
respons
element
dysfunct
associ
prostat
cancer
rare
neuromuscular
diseas
spinal
bulbar
muscular
atrophi
intrins
disord
ntermin
domain
ar
largest
famili
nuclear
receptor
constitut
protein
show
ar
undergo
llp
present
preliminari
character
phenomenon
elastin
endow
tissu
skin
arteri
wall
lung
alveoli
uteru
extens
elast
elastin
elastinlik
peptid
structur
disord
selfaggreg
via
liquidliquid
phase
separ
process
although
elastin
object
biophys
investig
eighti
year
structur
basi
selfassembl
mechan
properti
elastin
remain
controversi
essenti
step
toward
elucid
structur
ensembl
elastin
combin
molecular
dynam
simul
nmr
spectroscopi
studi
elastinlik
peptid
model
sequenc
altern
hydrophob
crosslink
domain
elastin
perform
extens
allatom
molecular
dynam
simul
total
hundr
microsecond
obtain
detail
structur
dynam
data
nmr
peptid
sequenc
simul
spectroscop
result
excel
agreement
show
although
peptid
highli
disord
possess
signific
propens
local
secondari
structur
crosslink
domain
character
fluctuat
helic
structur
wherea
hydrophob
domain
adopt
spars
local
hydrogenbond
turn
result
individu
domain
form
extens
interact
collaps
compact
remain
disord
hydrat
despit
predominantli
hydrophob
charact
find
resolv
longstand
discrep
previou
model
structur
function
elastin
afford
unpreced
insight
physic
structur
basi
liquidliquid
phase
separ
disord
protein
blood
plasma
protein
target
reactiv
oxygen
speci
ro
serv
biomark
oxid
stress
despit
signific
amount
issu
oxid
modif
protein
still
gener
lack
studi
aim
identif
oxid
site
molecul
number
amino
acid
residu
suscept
oxid
differ
structur
element
two
key
blood
clot
factor
fibrinogen
plasma
fibrinstabil
factor
identifi
studi
mass
spectrometri
method
among
modifi
amino
acid
detect
catalyt
subunit
pfxiii
calcium
bind
site
molecul
possibl
bring
enzymat
activ
loss
respect
fibrinogen
locat
oxid
residu
nearbi
coval
crosslink
may
impact
resist
fibrin
clot
plasmin
hydrolysi
oxid
alter
residu
site
reveal
acdomain
inhibit
later
aggreg
protofibril
oxid
residu
along
residu
within
structur
affect
conform
fragment
respons
later
aggreg
protofibril
react
two
inform
gain
play
crucial
role
gener
accur
protein
profil
quick
analysi
modif
brand
new
test
system
studi
support
rfbr
research
project
na
na
moladk
part
research
relat
peptid
ptm
identif
high
resolut
mass
spectrometri
measur
support
russian
scienc
foundat
na
princip
receptor
hedgehog
hh
pathway
signal
cascad
crucial
direct
morphogenesi
base
closelyrel
primari
structur
integr
membran
protein
neimannpick
diseas
type
whose
structur
recent
solv
cryoem
predict
distinct
modular
region
interact
regul
activ
cytoplasm
domain
contain
highlyconserv
proteinbind
motif
predict
form
intrins
disord
protein
region
idpr
motif
bind
specif
factor
includ
csrc
mediat
hhsignal
distinct
cascad
subsequ
demonstr
idrp
mediat
oligomer
activ
requir
princip
function
repress
smoothen
smo
activ
howev
idpr
act
complex
manner
control
repress
smo
specif
delet
middl
loop
gener
domin
form
despit
bind
hhligand
constitutivelyrepress
smo
constitut
activ
revers
introduc
discret
mutat
ctermin
domain
investig
activ
extracellular
transmembran
modul
use
seri
delet
mutat
well
chimer
protein
transpos
analog
region
analys
reveal
complex
interact
coreceptor
brother
cdon
boc
interact
multipl
region
also
shown
like
activ
region
exquisit
sensit
chang
primari
sequenc
data
begun
defin
complex
interact
structur
modul
regul
mani
signal
cellspecif
activ
protein
phase
separ
liquidliquid
demix
import
mechan
compartment
cell
creat
special
reaction
signal
environ
assembl
separ
proteinrich
phase
cluster
shown
biolog
relev
eukaryot
cell
wide
varieti
process
rna
process
stress
respons
tcell
receptor
signal
despit
fact
liquidliquid
demix
report
eukaryot
regulatori
domain
virul
abc
transport
mycobacterium
tuberculosi
mtb
possess
two
main
characterist
associ
protein
phase
separ
weak
interact
multival
consist
two
phosphointeract
forkhead
associ
fha
domain
connect
disord
linker
contain
phosphoacceptor
site
shown
associ
weakli
fha
domain
tandemfha
regulatori
domain
activ
phosporyl
also
critic
function
transport
virul
pathogen
show
upon
phosphoryl
sever
serin
threonin
kinas
mtb
tandem
fha
domain
undergo
phase
separ
liquid
droplet
commonli
report
dynam
characterist
process
revers
mtb
serin
threonin
phosphatas
pstp
furthermor
show
linker
connect
fha
domain
possess
abil
phase
separ
higher
concentr
point
synergi
classic
modular
interact
weak
selfassoci
disord
region
result
suggest
protein
phase
separ
play
role
mechan
phosphodepend
cluster
abc
transport
mtb
import
virul
first
bacteri
system
shown
phase
separ
disord
region
dr
protein
defin
region
lack
stabl
welldefin
structur
dr
ubiquit
protein
highli
relat
human
diseas
studi
perform
systemlevel
comput
investig
protein
disorderord
transit
induc
point
mutat
extract
human
proteom
use
bioinformat
analysi
predict
disord
region
analys
largescal
uptod
human
diseas
mutat
dataset
contain
protein
diseas
mutat
defin
disord
state
chang
region
mutat
divid
four
categori
ordertodisord
ordertoord
disordertoord
disordertodisord
addit
given
variabl
predict
among
predictor
test
crossreferenc
human
diseas
mutat
polymorph
current
avail
databas
experiment
valid
disord
region
protein
two
result
dataset
base
pure
comput
predict
verifi
disord
region
expect
provid
experiment
testabl
candid
protein
disorderord
transit
investig
microstructur
format
induc
point
mutat
famili
protein
arbitr
cellular
life
death
via
intrins
pathway
apoptosi
compos
twenti
protein
interact
network
allow
regul
cellular
fate
dissimilar
function
prosurviv
vs
proapoptot
structur
properti
fold
vs
disord
share
common
sequenc
homolog
motif
term
segment
involv
binari
interact
depend
member
either
found
disord
region
embed
protein
core
use
model
tripartit
system
interrog
role
consequ
structur
plastic
investig
whether
unfold
prerequisit
bind
use
thermodynam
kinet
character
biophys
signatur
coupl
un
fold
bind
reaction
provid
insight
mechan
underli
molecular
decisionmak
protein
skidmor
colleg
new
york
usa
eastern
new
mexico
univers
new
mexico
usa
domain
common
protein
interact
domain
howev
littl
known
intrins
disord
protein
idp
bind
domain
one
domain
found
yeast
bind
site
arka
idp
use
molecular
dynam
md
simul
model
domain
complex
sinc
idp
difficult
model
experiment
simul
allow
us
better
understand
residu
involv
arka
bind
bind
contribut
conform
allosteri
flexibl
domain
believ
twostep
bind
process
part
peptid
bind
surfac
remain
part
bind
surfac
ii
sii
sii
peptid
bind
domain
via
specif
interact
therefor
necessari
residu
locat
region
fluctuat
form
favor
bond
md
simul
unbound
structur
show
five
ten
residu
greatest
atom
fluctuat
sii
also
larg
atom
fluctuat
far
arka
bind
site
previous
larg
chemic
shift
measur
upon
bind
stollar
et
al
ten
flexibl
residu
altern
phi
dihedr
angl
frequent
popul
suggest
residu
flexibl
could
enabl
alloster
conform
chang
upon
bind
jaehyun
cho
qingliang
shen
danyun
zeng
jie
shi
baoyu
zhao
wonmuk
hwang
pingwei
li
depart
biochemistri
biophys
texa
univers
usa
depart
biomed
engin
texa
univers
usa
spanish
influenza
viru
iav
caus
one
seriou
pandem
human
histori
unlik
common
season
flu
strain
nonstructur
protein
iav
hijack
interact
human
crkii
cabl
kinas
cjunntermin
kinas
inhibit
host
antivir
immun
respons
singl
amino
acid
mutat
disord
prolinerich
motif
iav
enabl
uniqu
interact
ntermin
domain
crkii
littl
howev
known
molecular
mechan
recent
discov
bind
crkii
strikingli
rapid
kinet
high
affin
knowledg
strongest
bind
observ
known
mediat
protein
interact
perform
xray
crystallographi
nmr
relax
dispers
experi
fluoresc
spectroscopi
determin
structur
kinet
thermodynam
mechan
underli
hijack
crkii
iav
addit
molecular
dynam
simul
elucid
interplay
longrang
electrostat
structur
disord
play
import
role
enhanc
bind
affin
kinet
crkii
result
provid
unpreced
insight
mechan
iav
hijack
crkii
disrupt
interact
critic
cellular
signal
protein
moreov
show
peptid
deriv
great
potenti
proteinprotein
interact
inhibitor
crkii
cabl
kinas
play
import
role
mani
cancer
bacteri
infect
neuron
commun
primarili
via
releas
chemic
neurotransmitt
presynapt
nerv
termin
detect
postsynapt
thu
process
synapt
vesicl
exocytosi
heart
neuron
function
cognit
intriguingli
protein
play
key
role
fusion
vesicl
membran
snare
protein
idp
number
addit
factor
regul
neuron
snare
function
also
intrins
disord
includ
protein
complexin
complexin
function
inhibit
synapt
vesicl
fusion
manner
requir
central
region
protein
bind
snare
bundl
helix
disord
region
either
side
central
helix
requir
effici
inhibit
vesicl
releas
work
help
establish
mechan
disordertoord
transit
ctermin
domain
accessori
helix
complexin
contribut
function
novel
membranecurvatur
depend
structur
transit
help
local
complexin
gate
activ
surfac
synapt
vesicl
independ
stabl
accessori
helix
act
nucleat
propag
helic
structur
central
helix
region
order
facilit
snare
bind
olink
oglcnac
dynam
posttransl
modif
found
higher
eukaryot
remark
singl
enzym
oglcnac
transferas
ogt
catalyz
transfer
udpglcnac
serin
threonin
residu
numer
cytoplasm
nuclear
protein
singl
enzym
oglcnac
hydrolyas
oga
catalyz
remov
although
dysregul
oglcnacyl
link
mani
diseas
span
cancer
neurodegener
clear
mechanist
understand
widespread
posttransl
modif
regul
protein
function
help
address
question
prepar
sampl
ctermin
tail
casein
kinas
ckiia
residu
polypeptid
oglcnac
modifi
coexpress
ogt
e
coli
base
nmr
chemic
shift
relax
measur
ckiia
tail
intrins
disord
presenc
oglcnac
minim
perturb
local
structur
dynam
properti
addit
minor
site
oglcnacyl
also
identifi
data
indic
report
effect
oglcnac
activ
ckiia
aris
directli
alter
conform
properti
ctermin
tail
attempt
ligat
polypeptid
onto
catalyt
domain
kinas
use
sortas
transpeptidas
order
investig
oglcnacyl
modul
potenti
interact
two
segment
nativ
ckiia
intrins
disord
protein
idp
thought
influenc
conform
fold
protein
inher
idp
lack
fix
secondari
structur
howev
case
viral
infect
factor
vif
idp
gain
structur
complex
protein
enact
specif
function
idp
vif
bind
human
protein
elongin
c
eloc
elongin
b
elob
cbfb
also
refer
complex
vif
util
complex
hijack
ubiquitin
mechan
ubiquitin
antivir
apobec
enzym
structur
complex
solv
xray
crystallographi
guo
et
al
howev
crystal
structur
reveal
one
conform
complex
investig
dynam
altern
conform
hiv
vif
complex
molecular
dynam
md
simul
perform
simul
complex
without
investig
effect
complex
motion
flexibl
md
simul
analyz
use
principl
compon
analysi
pca
identifi
correl
motion
complex
result
indic
vcbc
exhibit
movement
absenc
rigid
structur
compar
vcbc
indic
complex
may
structur
defin
state
complex
infect
cell
howev
better
structur
character
vcbc
complex
without
allow
us
studi
role
potenti
function
altern
conform
bind
gonzalo
de
prat
gay
silvina
borkoski
leonardo
alonso
ignacio
sanchez
fundacion
instituto
leloirconicet
argentina
departamento
de
qu
biol
ogica
facultad
de
ciencia
exacta
natural
universidad
de
bueno
air
protein
intrins
disord
major
structur
categori
biolog
yet
definit
often
limit
absenc
fold
explos
inform
genom
era
show
may
account
code
region
across
life
domain
particularli
overrepres
virus
papillomavirus
unparallel
case
sequenc
structur
correl
analysi
exist
hundr
ancient
evolv
stabl
viru
type
diverg
enough
sequenc
conserv
function
protein
main
transform
oncoprotein
human
papillomavirus
paradigmat
exampl
intrins
disord
protein
patholog
moonlight
activ
evolv
hijack
cell
cycl
control
despit
intrins
disord
ntermin
domain
show
conserv
residu
globular
ctermin
domain
mutat
five
hyper
conserv
residu
precis
distribut
along
sequenc
lead
mark
increas
ahelix
structur
content
reflect
drastic
effect
equilibrium
propens
oligomer
kinet
result
strongli
suggest
exist
local
nuclei
yet
defin
structur
term
oppos
canon
fold
expect
globular
protein
antifold
nuclei
act
fold
relay
repres
novel
concept
must
involv
hidden
structur
code
intrins
disord
clearli
distant
random
coil
ensembl
signific
fraction
eukaryot
proteom
consist
protein
either
partial
complet
disord
nativelik
condit
intrins
disord
protein
idp
common
proteinprotein
interact
involv
numer
cellular
process
although
mani
protein
identifi
disord
much
less
known
bind
mechan
coupl
bind
fold
reaction
involv
idp
analyz
ratelimit
transit
state
bind
domain
creb
bind
protein
intrins
disord
transactiv
domain
sitedirect
mutagenesi
kinet
experi
uvalu
analysi
found
nativ
proteinprotein
bind
interfac
form
transit
state
bind
instead
nativ
hydrophob
bind
interact
form
late
cross
ratelimit
barrier
furthermor
ionic
strength
depend
bind
kinet
suggest
disord
natur
result
increas
number
possibl
collis
lead
product
onpathway
encount
complex
compar
fold
protein
initi
complex
thu
nonspecif
obligatori
contact
present
consist
avalu
analysi
also
linear
free
energi
relationship
clearli
demonstr
nativ
interact
cooper
form
scenario
usual
observ
protein
fold
accord
socal
nucleationcondens
mechan
thu
nativ
bind
interact
ratelimit
transit
state
associ
requir
could
common
mechan
idp
aggreg
misfold
protein
patholog
hallmark
neurodegen
diseas
amyotroph
later
sclerosi
al
devast
untreat
neurodegen
diseas
caus
fatal
paralysi
recent
year
tar
dna
bind
protein
kd
emerg
focal
point
al
research
pathognomon
neuron
inclus
found
contain
al
case
mutat
also
known
caus
al
suggest
central
role
pathogenesi
howev
littl
known
mechan
posit
inclus
produc
one
emerg
theori
suggest
aggreg
aris
improperli
form
persist
stress
granul
sg
caus
environment
factor
chronic
stress
would
explain
larg
sporad
natur
al
sg
membraneless
organel
form
liquidliquid
phase
separ
llp
partak
intrins
disord
ctermin
domain
ctd
character
convers
revers
droplet
state
irrevers
aggreg
therefor
import
understand
underli
caus
al
identifi
modul
process
may
provid
basi
treatment
diseas
develop
vitro
system
assess
dynam
droplet
state
diffus
rate
full
length
protein
ctd
fragment
diseasecaus
mutant
measur
use
fluoresc
recoveri
photobleach
frap
effect
compound
singlestrand
oligonucleotid
droplet
dynam
assess
carbohydr
esteras
ce
enzym
deesterifi
carbohydr
mani
potenti
applic
process
involv
biomass
convers
new
gener
biofuel
ce
group
famili
accord
cazi
carbohydr
activ
enzym
databas
encompass
protein
found
organ
rang
virus
multicellular
eukaryot
sequenc
predict
fungal
famili
enzym
unexpectedli
found
includ
two
distinct
predict
region
long
disord
segment
ld
well
domain
protein
show
esteras
activ
toward
model
paranitrophenylest
acetyl
carbohydr
two
document
activ
interestingli
domain
show
high
sequenc
similar
crystal
includ
catalyt
triad
residu
therefor
order
determin
protein
inact
relat
grade
disord
predict
ld
biophys
experi
conduct
chemicallydenatur
protein
show
phdepend
refold
sign
disord
contrari
expect
order
understand
signific
observ
well
role
two
domain
express
full
polypeptid
independ
domain
e
coli
attempt
progress
studi
report
base
sequenc
ld
determin
frequent
ldss
encount
famili
type
exist
construct
disorderord
landscap
addit
famili
superfamili
analyz
found
sequenc
exhibit
disord
valu
famili
lure
pollen
specif
receptor
kinas
regul
growth
develop
pollen
tube
remain
elus
resolv
signal
mechan
lure
cognat
receptor
kinas
growth
pollen
tube
express
lure
extracellular
domain
baculovirusinsect
system
solubl
protein
purifi
nickelaffin
gel
filtrat
chromatographi
suffici
quantiti
biochem
crystallograph
studi
therefor
structur
elucid
pollen
specif
receptor
kinas
alon
complex
cystein
rich
peptid
lure
provid
insight
role
pollen
tube
growth
ligand
percept
specif
interact
lure
cognat
receptor
ligandinduc
receptor
activ
research
broaden
overal
understand
reproduct
system
flower
plant
yunghua
li
xiaolin
tian
dalhousi
univers
canada
quorum
sens
activ
signal
peptid
pheromon
csp
streptococcu
mutan
depend
membraneassoci
histidin
kinas
receptor
comd
sens
signal
trigger
signal
cascad
bacteriocin
product
cell
densitydepend
activ
howev
mechan
signal
recognit
via
comd
receptor
speci
remain
elus
report
result
structur
function
analys
comd
receptor
use
dual
phoalacz
report
system
determin
role
membran
domain
comd
csp
recognit
quorum
sens
activ
result
show
membran
domain
comd
receptor
protein
form
six
transmembran
segment
three
extracellular
loop
loopa
loopb
loopc
mutat
analysi
extracellular
loop
combin
luciferas
report
assay
reveal
loopc
loopb
requir
csp
recognit
quorum
sens
activ
loopa
play
littl
role
csp
detect
delet
substitut
mutat
four
residu
nvip
loopc
abolish
csp
recognit
quorum
sens
activ
western
blot
confirm
mutant
protein
exist
membran
fraction
mutant
strain
suggest
delet
mutat
extracellular
loop
affect
insert
mutant
protein
membran
consist
find
loopc
loopb
mutant
complet
partial
defect
bacteriocin
product
conclud
loopc
loopb
involv
csp
recognit
residu
nvip
loopc
essenti
csp
percept
quorum
sens
activ
find
may
import
implic
ligandreceptor
interact
bacteria
tejashre
redij
zhijun
li
glucagonlik
peptid
receptor
belong
pharmaceut
import
class
b
famili
gprotein
coupl
receptor
incretin
peptid
ligand
analog
use
treatment
diabet
despit
remark
antidiabet
effect
peptidebas
agonist
sever
shortcom
hand
although
consider
progress
made
develop
nonpeptid
small
molecul
target
success
strategi
remain
elus
like
reason
orthoster
bind
site
larg
rel
flat
thu
challeng
target
small
molecul
recent
year
novel
venu
report
exploit
alloster
site
gpcr
develop
small
molecul
drug
treat
variou
diseas
lack
highqual
structur
tm
domain
hinder
progress
promis
approach
present
work
carri
computerbas
molecul
design
studi
first
construct
structur
model
activ
conform
use
model
techniqu
develop
lab
other
silico
screen
druglik
compound
predict
alloster
site
structur
model
identifi
compound
potenti
agonist
agonist
modul
activ
subsequ
confirm
use
camp
respons
element
cre
base
report
system
result
demonstr
alloster
regul
exist
exploit
develop
small
molecul
agonist
augment
activ
endogen
analog
success
work
help
pave
way
small
molecul
drug
discoveri
target
class
b
gpcr
anam
qudrat
anam
qudrat
versatil
signal
allow
regul
divers
cellular
process
migrat
apoptosi
motil
exocytosi
receptor
eg
signal
gener
upon
bind
ligand
eg
vegfa
employ
design
strategi
engin
protein
gener
signal
upon
bind
variou
extracellular
stimuli
creat
fusion
protein
domain
oligomer
transmembran
domain
cytoplasm
tail
test
strategi
creat
chimer
protein
gener
signal
upon
stimul
variou
extracellular
stimuli
eg
rapamycin
edta
extracellular
free
coupl
chimer
protein
gener
signal
protein
respond
rewir
exampl
dynam
cellular
bleb
increas
extracellular
free
thu
use
design
strategi
possibl
engin
protein
gener
signal
rewir
wide
rang
extracellular
stimuli
wide
rang
process
anam
qudrat
inflammatori
lesion
often
seen
diseas
rheumatoid
arthriti
atherosclerosi
cancer
featur
acid
ie
low
ph
microenviron
rampant
proinflammatori
cytokin
target
therapeut
intervent
site
engin
cell
must
abl
seek
sourc
assembl
system
four
protein
cell
accomplish
feat
introduc
chimera
receptor
name
previous
engin
carq
rhoabas
sensor
vsvg
thymidin
kinas
tk
cell
natur
abil
seek
sourc
bind
initi
signal
signal
use
carq
form
nonapoptot
bleb
migrat
toward
sourc
next
vsvg
protein
allow
engin
cell
fuse
sourc
cell
upon
low
ph
induct
final
cell
undergo
death
postganciclovir
treatment
via
tk
suicid
mechan
henc
assembl
group
protein
establish
basi
engin
cell
target
inflammatori
lesion
diseas
featur
microenviron
high
level
low
ph
develop
addit
extract
surfact
membran
protein
necessari
membran
protein
research
sinc
optim
combin
success
extract
target
membran
protein
biolog
membran
minim
protein
denatur
hard
predict
particular
uniqu
basal
molecular
framework
quit
attract
highli
desir
research
field
studi
success
construct
new
extract
surfact
membran
protein
peptidegeminisurfact
pgsurfact
molecular
framework
pgsurfact
ushap
lipopeptid
scaffold
consist
short
linker
peptid
x
two
long
alkylchainmodifi
cy
residu
peripher
peptid
ntermin
side
long
alkylchainmodifi
cy
residu
figur
use
photosystem
psi
photosystem
ii
psii
deriv
thermosynecoccu
vulcanu
repres
membran
protein
evalu
whether
could
solubil
membran
protein
maintain
structur
function
neither
membran
integr
domain
cytoplasm
domain
psi
psii
suffer
damag
upon
use
base
detail
photophys
measur
use
thylakoid
membran
vulcanu
repres
biolog
membran
sampl
perform
experi
extract
membran
protein
psi
psii
base
extract
effici
mainten
protein
supramolecular
structur
establish
use
clear
nativepag
analys
prove
function
novel
class
peptidecontain
extract
surfact
membran
protein
artifici
singlepass
transmembran
tm
protein
model
bovin
papillomaviru
protein
act
aptam
modul
express
activ
natur
occur
transmembran
protein
previous
isol
uniqu
chemic
simpl
tm
protein
consist
sole
leucin
isoleucin
specif
activ
platelet
deriv
growth
factor
receptor
beta
human
erythropoietin
receptor
hepor
analysi
reveal
surprisingli
singl
isoleucin
posit
acid
tm
domain
leucin
remain
posit
polyleu
abl
activ
determin
amino
acid
posit
within
polyleu
context
display
biolog
activ
construct
full
set
acid
long
polyleu
tm
protein
standard
amino
acid
present
posit
found
six
mutant
activ
differ
subset
activ
hepor
yet
anoth
larger
subset
activ
mous
epor
differ
hepor
three
posit
within
tm
domain
map
experi
show
crucial
differ
hepor
mous
epor
mepor
map
singl
tm
amino
acid
addit
simpl
activ
mepor
hepor
tune
specif
activ
mepor
substitut
leucin
isoleucin
certain
posit
flank
posit
result
challeng
understand
tm
proteinprotein
interact
suggest
ultrasimpl
protein
may
serv
power
new
tool
better
understand
protein
function
interact
within
hydrophob
environ
sulfonylurea
receptor
sur
protein
form
regulatori
subunit
atp
sensit
potassium
katp
channel
found
pancrea
tissu
sur
protein
member
atp
bind
cassett
famili
transport
thu
characterist
membran
span
domain
two
nucleotid
bind
domain
nbd
msd
direct
contact
mean
helic
extend
msd
cytoplasm
call
coupl
helic
bind
hydrolysi
mgatp
sur
nbd
result
open
katp
channel
pore
diseasecaus
mutat
locat
nbd
coupl
helic
impair
abil
sur
protein
regul
gate
katp
channel
mutat
reduc
katp
channel
open
caus
hypersinsulin
wherea
mutat
increas
channel
open
caus
diabet
use
nmr
fluoresc
spectroscopi
biolay
interferometri
determin
structur
function
consequ
hyperinsulinismand
diabetescaus
mutat
sur
protein
nmr
assign
provid
residu
level
inform
enabl
residuelevel
resolut
structur
chang
variou
mutat
result
show
hyperinsulinismcaus
mutat
alter
structur
impair
atp
bind
activ
thermal
stabil
interdomain
interact
diabetescaus
mutat
fewer
effect
structur
stabil
affect
atpbind
affin
interact
coupl
helic
result
combin
provid
structur
function
background
elucid
mechan
mutat
caus
diseas
studi
essenti
improv
design
drug
target
diabet
hyperinsulinsm
cadaverin
cv
deathassoci
odor
compound
gener
bacteri
decarboxyl
report
select
detect
cv
appli
variou
field
scientif
investig
variou
industri
trace
amineassoci
receptor
belong
g
proteincoupl
receptor
gpcr
could
gener
diamin
sens
element
select
bind
cadaverin
appli
bioelectron
sensor
moreov
platform
contain
stabl
gpcr
power
tool
develop
practic
biosensor
howev
develop
stabl
devic
highqual
receptor
remain
challeng
studi
firstli
purifi
reconstitut
nanodisc
lead
develop
bioelectron
sensor
selectivedetect
cadaverin
biolog
characterist
confirm
tryptophan
fluoresc
assay
dualglo
luciferas
assay
moreov
nanodisc
success
produc
appli
biosensor
selectivedetect
cadaverin
biosensor
show
highperform
select
sensit
realsampl
detect
result
util
gpcr
character
taarligand
interact
furthermor
biosensor
repres
novel
method
receptorbas
detect
deathassoci
odor
cadaverin
membran
bind
annexin
protein
involv
cell
membran
repair
xiaolin
yan
elodi
boisseli
object
protein
complex
allow
recruit
protein
ahnak
membran
presenc
calcium
form
platform
initi
membran
repair
howev
molecular
data
current
avail
membran
bind
differ
protein
involv
complex
aim
studi
membran
bind
annexin
complex
better
understand
role
cell
membran
repair
process
method
firstli
annexin
overexpress
purifi
langmuir
monolay
membran
model
use
character
interact
protein
differ
phospholipid
found
membran
secondari
structur
orient
membran
organ
protein
studi
polar
modul
infrar
reflectionabsorpt
spectrometri
later
local
determin
influenc
protein
physic
state
lipid
fluoresc
microscopi
result
overexpress
purifi
affin
chromatographi
cleavag
gst
tag
complet
optim
purif
procedur
obtain
pure
current
ongo
pure
avail
langmuir
monolay
model
set
investig
membran
bind
differ
condit
conclus
research
complet
current
knowledg
membran
bind
annexin
could
also
identifi
condit
lead
modif
membran
bind
possibl
loss
function
protein
thu
project
help
better
determin
role
membran
repair
well
physiolog
mechan
protein
contribut
class
fusion
protein
envelop
protein
env
drive
membran
fusion
form
sixhelix
bundl
structur
format
close
link
gener
enlarg
fusion
pore
studi
perform
alanin
insert
mutagenesi
ntermin
ctermin
heptad
repeat
nhr
chr
respect
includ
connect
loop
strain
kinet
extent
membran
fusion
mutant
evalu
split
luciferasebas
dual
split
protein
dsp
assay
syncytia
format
assay
dsp
assay
measur
rate
fusion
pore
format
syncytia
assay
provid
estim
pore
enlarg
membran
merg
found
insert
nhr
loop
proxim
region
chr
amino
acid
posit
number
base
env
made
neg
affect
process
env
insert
posit
chr
affect
process
insert
posit
reduc
fusion
pore
format
result
correspond
reduc
syncytia
format
interestingli
mutant
insert
posit
show
similar
sometim
augment
fusion
pore
format
yet
decreas
rate
syncytia
format
data
suggest
initi
fusion
pore
gener
partial
zip
chr
complet
zip
beyond
posit
may
requir
success
pore
enlarg
cell
divis
prokaryot
mediat
protein
complex
call
divisom
respons
direct
constrict
forc
divis
site
restructur
cell
wall
e
coli
format
divisom
variou
compon
occur
order
fashion
essenti
event
assembl
pathway
interact
ftsb
ftsl
form
subcomplex
bitop
membran
protein
known
interact
divisom
protein
well
interact
requir
complet
assembl
divisom
divis
site
larg
due
difficulti
obtain
structur
inform
integr
membran
protein
rel
littl
known
overal
organ
ftsbl
subcomplex
specif
interact
divisom
protein
obtain
better
understand
role
ftsbl
play
cell
divis
employ
crossdisciplinari
techniqu
develop
valid
structur
model
subcomplex
model
direct
experi
design
probe
function
ftsbl
turn
provid
feedback
refin
model
specif
fret
singl
molecul
photobleach
experi
support
tetramer
model
ftsb
ftsl
coevolutionari
analys
comput
model
provid
lowenergi
structur
model
vivo
vitro
assay
mutant
protein
help
valid
model
conclus
combin
varieti
divers
techniqu
develop
ration
model
essenti
divisom
ftsbl
subcomplex
lieu
hard
structur
data
like
xray
crystallographi
nmr
julia
koehler
leman
evan
baugh
richard
bonneau
simon
foundationnyu
new
york
usa
recent
effort
highthroughput
sequenc
number
sequenc
genom
increas
dramat
base
wealth
data
genomewid
associ
studi
aim
identifi
genet
variat
protein
mutant
caus
diseas
needleinahaystack
problem
approach
sever
method
current
mainli
reli
sequencebas
inform
disadvantag
tool
lack
interpret
effect
mutat
onto
protein
structur
function
recent
train
logist
regress
classifi
vipur
variant
predict
interpret
use
rosetta
predict
deleteri
mutat
solubl
protein
combin
sequenc
structurebas
inform
abil
identifi
underli
caus
deleteri
mutat
question
use
sequenc
featur
multiplesequ
align
structur
featur
exist
protein
structur
homolog
model
refin
score
rosetta
energi
function
parallel
implement
gener
framework
membran
protein
model
rosetta
creat
new
implement
highresolut
refin
protocol
work
larg
larg
protein
membran
protein
use
rosetta
protocol
adapt
membran
protein
train
classifi
predict
interpret
sequenc
variat
membran
protein
new
classifi
train
membran
protein
variat
use
transfer
learn
approach
setup
allow
highthroughput
predict
autom
interpret
caus
deleteri
structur
point
view
use
adapt
therapi
clinic
chemotaxi
receptor
great
system
studi
mechan
transmembran
signal
receptor
form
remark
nm
hexagon
array
membran
two
addit
protein
adaptor
chew
kinas
chea
outstand
question
signal
propag
membran
cytoplasm
tip
receptor
away
control
kinas
activ
chea
current
propos
suggest
signal
propag
receptor
cytoplasm
domain
via
invers
chang
dynam
differ
receptor
subdomain
one
challeng
test
hypothes
need
form
activ
complex
address
challeng
use
vesicl
templat
assembl
prepar
complex
receptor
cytoplasm
fragment
chea
chew
nativ
structur
function
properti
previous
use
hydrogen
deuterium
exchang
mass
spectrometri
complex
measur
differ
hydrogen
exchang
asp
receptor
kinaseon
kinaseoff
signal
state
result
show
greater
protect
exchang
kinaseon
state
protein
interact
domain
near
cytoplasm
tip
receptor
greater
peptid
coverag
observ
similar
chang
two
construct
kinaseon
kinaseoff
properti
result
compar
structur
model
receptorreceptor
receptorchea
receptorchew
interfac
research
support
nih
grant
parker
de
waal
x
edward
zhou
yuanzheng
xiang
gao
yanyong
kang
kang
ned
van
ep
yant
yin
kuntal
pal
devrishi
goswami
goswami
van
andel
research
institut
michigan
usa
univers
toronto
canada
scripp
research
institut
florida
usa
g
proteincoupl
receptor
gpcr
mediat
divers
signal
part
interact
arrestin
whose
bind
promot
receptor
intern
signal
g
proteinindepend
pathway
highaffin
bind
arrestin
gpcr
requir
receptor
phosphoryl
often
receptor
ctermin
tail
report
xray
free
electron
laser
xfel
crystal
structur
rhodopsinarrestin
complex
phosphoryl
ctermin
tail
rhodopsin
form
extend
intermolecular
ntermin
arrestin
phosphoryl
detect
rhodopsin
ctermin
tail
residu
two
phosphoresidu
togeth
form
extens
network
electrostat
interact
three
posit
charg
pocket
arrestin
mode
resembl
bind
phosphoryl
receptor
tail
base
observ
deriv
valid
set
phosphoryl
code
serv
common
mechan
phosphorylationdepend
recruit
arrestin
gpcr
technolog
breakthrough
cryoelectron
microscopi
cryoem
facilit
rapid
structur
determin
atom
resolut
mani
difficult
protein
target
howev
remain
number
challeng
broader
use
instanc
size
conform
heterogen
issu
mani
protein
limit
obtain
resolut
imag
synthet
antibodi
sab
base
fab
framework
kda
gener
use
phage
display
mutagenesi
bind
target
protein
increas
size
act
fiduci
orient
reduc
sampl
heterogen
select
condit
design
produc
regionand
conformationspecif
binder
differ
function
state
membran
protein
work
demonstr
sab
effect
trap
activ
state
cora
pentamer
archaeal
magnesium
channel
preliminari
negativestain
em
imag
function
studi
show
cora
trap
use
conform
specif
sab
open
state
stabil
open
conform
sab
recogn
adjac
epitop
avail
subunit
cora
state
obtain
seri
gener
fab
fiduci
develop
increas
size
symmetri
particl
combin
coraspecif
sab
fabspecif
reagent
provid
tool
necessari
structur
determin
activ
conduct
state
cora
high
resolut
cryoem
plugandplay
natur
fabspecif
reagent
divers
phage
display
librari
nanodisc
platform
biopan
technolog
applic
virtual
membran
protein
greatli
extend
capabl
singleparticl
cryoem
weill
cornel
medicin
new
york
usa
g
proteincoupl
receptor
gpcr
provid
bridg
extracellular
intracellular
space
sens
stimuli
light
hormon
neurotransmitt
convert
intracellular
signal
extraordinarili
divers
gpcr
famili
play
role
nearli
everi
diseas
account
current
drug
target
class
c
gpcr
includ
metabotrop
glutam
receptor
mglur
gabab
receptor
particularli
interest
alloster
signal
machin
propens
dimer
larg
extracellular
ligand
bind
domain
lbd
coupl
via
poorli
understood
mechan
transmembran
domain
tmd
work
aim
use
optic
method
develop
complet
biophys
mechan
class
c
gpcr
assembl
activ
signal
use
insight
ultim
determin
receptor
modul
neural
activ
physiolog
diseas
use
varieti
singl
molecul
photobleach
assay
show
mglur
strictli
specif
homoand
heterodimer
via
complex
combin
extracellular
transmembran
interfac
next
use
combin
ensembl
singl
molecul
fret
assay
deciph
character
intersubunit
conform
dynam
lbd
respons
ligand
variou
efficaci
final
complement
fluoresc
imag
assay
also
develop
famili
optopharmacolog
tool
manipul
specif
mglur
subunit
use
tool
conjunct
timeresolv
function
assay
comput
method
show
mglur
display
larg
ligandoccup
depend
cooper
mediat
part
tuneabl
interlbd
interact
senmiao
sun
nichola
last
christoph
miller
brandei
univers
massachusett
usa
fion
channel
fluc
famili
built
dualtopolog
antiparallel
dimer
provid
efflux
pathway
microorgan
counteract
toxic
environment
f
recent
crystal
structur
bacteri
homologu
reveal
two
conserv
phenylalanin
contribut
bind
site
poreresid
fion
electroposit
edgeon
aromatichalid
coordin
motif
never
seen
protein
unpreced
aromaticanion
coordin
geometri
conjectur
may
underli
channel
unusu
high
select
fover
cl
test
idea
mutat
phenylalanin
residu
examin
almost
substitut
though
wellfold
homodimer
caus
complet
loss
channel
function
even
tyrosin
surprisingli
howev
methionin
posit
retain
wildtyp
channel
activ
wherea
inact
crystal
structur
reveal
electroposit
acarbon
methionin
adopt
fcoordin
posit
similar
locat
aromat
edg
wildtyp
result
provid
initi
suggest
delic
chemic
requir
highli
select
fbind
site
larg
anhydr
protein
pore
transmembran
protein
otoferlin
calcium
sensit
scaffold
link
snare
calcium
channel
colin
johnson
nicol
ham
oregon
state
univers
usa
prelingu
hear
loss
common
hereditari
disord
approxim
everi
children
suffer
profound
deaf
mutat
tailanchor
transmembran
protein
otoferlin
identifi
respons
deaf
mani
case
hypothes
otoferlin
function
replac
synaptotagmin
synapt
calcium
sensor
neurotransmitt
releas
sensori
hair
cell
inner
ear
reason
replac
unknown
current
approach
studi
otoferlin
proven
inadequ
elucid
exact
function
otoferlin
report
use
twoprong
approach
coupl
biophys
assay
zebrafish
knockdown
rescu
studi
allow
us
probe
function
molecular
organism
level
use
zebrafish
model
find
otoferlin
mediat
exocytosi
neurotransmitt
sensori
hair
cell
synaps
involv
hear
balanc
report
first
rescu
studi
use
fulllength
truncat
form
otoferlin
restor
hear
deaf
zebrafish
use
total
intern
reflect
fluoresc
microscopi
find
otoferlin
synaptotagmin
bind
membran
fusion
snare
protein
otoferlin
interact
ltype
calcium
channel
demonstr
signific
differ
otoferlin
synaptotagmin
otoferlin
also
found
capabl
interact
multipl
snare
protein
simultan
form
heterooligom
complex
result
support
model
otoferlin
act
calcium
sensit
scaffold
protein
local
snare
protein
proxim
calcium
channel
synchron
calcium
influx
membran
fusion
encod
sound
membran
insert
polytop
membran
protein
gprotein
coupl
receptor
gpcr
involv
thermodynam
driven
partit
emerg
polypeptid
lipid
bilay
format
nativ
contact
transmembran
helic
tmh
part
higher
order
fold
oligomer
sequenti
insert
model
tmh
face
sever
challeng
hydrophil
domain
process
b
contact
requir
facilit
transit
assembl
c
energet
costli
residu
abundantli
toler
across
gpcr
appli
interdisciplinari
comput
approach
investig
structur
biophys
genom
signatur
associ
gpcr
fold
function
misfold
systemat
analysi
tmh
insert
probabl
singleresidu
energi
contribut
reveal
exist
thermodynam
insert
profil
tip
profil
larg
reflect
univers
fold
restraint
surprisingli
show
high
variabl
across
receptor
presum
due
need
evolv
highli
specif
intraand
intermolecular
interact
familyreceptor
specif
optim
fold
versu
function
give
rise
distinct
tip
also
demonstr
pattern
reflect
conserv
panreceptor
constraint
mechan
function
annot
highcost
segment
integr
genom
inform
analysi
establish
global
roadmap
investig
gpcr
stabil
misfold
result
shed
light
experiment
proven
contextdepend
tmh
insert
conform
prefer
receptor
fragment
conclus
suggest
receptor
region
vulner
mutat
caus
diseas
affect
protein
fold
traffick
insight
guid
develop
pharmacolog
chaperon
rescu
mutant
receptor
assist
fold
stabil
energet
favor
function
conform
inhibit
proton
channel
influenza
viru
prevent
viral
replic
occur
two
four
fdaapprov
drug
treatment
influenza
infect
amantadin
rimantadin
target
channel
howev
membran
protein
structur
studi
drug
bind
channel
limit
due
challeng
natur
target
obtain
multipl
crystal
structur
presenc
drug
inhibit
compound
use
lipid
cubic
phase
lcp
crystal
techniqu
present
first
crystal
structur
rimantadin
bound
cclose
copen
conform
channel
well
amantadin
bound
cclose
conform
resolut
rang
orient
bound
drug
unambigu
ammonium
group
adamantan
drug
seen
interact
order
water
molecul
present
within
channel
addit
report
bind
dualinhibit
compound
wild
type
channel
drugresist
mutant
posit
bound
inhibitor
within
channel
shift
presenc
mutat
structur
understand
drug
bind
inhibit
within
proton
channel
help
guid
design
compound
inhibit
drugresist
mutant
peripher
myelin
protein
tetraspan
membran
protein
vital
compon
compact
myelin
believ
regul
schwann
cell
prolifer
myelin
product
gene
duplic
mutat
causal
link
hereditari
neuropathi
peripher
nervou
system
known
charcotmarietooth
diseas
cmtd
treatment
avail
yet
detail
structur
character
aid
develop
therapeut
agent
cmtd
date
experiment
determin
structur
except
homologybas
model
base
crystal
structur
aim
determin
structur
model
membran
use
nuclear
magnet
reson
nmr
spectroscopi
obtain
nmr
spectra
differ
deterg
micel
bicel
screen
best
condit
structur
determin
previou
nmr
data
shown
first
transmembran
helix
higher
propens
dissoci
rest
transmembran
helix
bundl
sakakuram
sanderscr
structur
result
find
serv
groundwork
structur
character
import
integr
membran
protein
cmtd
mutant
form
fluoresc
correl
spectroscopi
fc
singl
molecul
base
techniqu
tempor
resolv
ratedepend
process
correl
fluoresc
fluctuat
individu
molecul
travers
confoc
volum
addit
chemic
process
like
proton
intersystem
cross
monitor
submicrosecond
rang
fc
therebi
provid
excel
tool
investig
proton
dynam
proton
pump
like
cytochrom
c
oxidas
cco
achiev
phdepend
fluoresc
dye
fluorescein
attach
proton
probe
cco
surfac
via
sitespecif
label
singl
reactiv
cystein
locat
close
entri
point
proton
input
channel
kpathway
analysi
proton
dynam
complic
overlap
triplet
proton
rate
fluorophor
mont
carlo
simul
base
algorithm
develop
facilit
discrimin
tempor
overlap
process
thu
allow
improv
proton
reaction
rate
determin
use
simulationguid
approach
determin
precis
local
proton
associ
dissoci
rate
provid
inform
protein
surfac
effect
proton
collect
antenna
transport
properti
proton
transfer
channel
binder
sperm
bsp
protein
repres
superfamili
exclus
express
male
reproduct
tract
play
role
fertil
recent
human
bsp
homolog
two
mous
bsp
homolog
identifi
sinc
protein
produc
minut
quantiti
organ
express
histag
recombin
protein
ecoli
purifi
use
hisbind
column
howev
recombin
protein
purifi
hisbind
column
still
impur
suitabl
function
analysi
previou
studi
shown
bsp
protein
interact
pseudocholin
group
diethylaminoethyl
deae
affin
interact
rather
ionic
interact
aim
current
studi
develop
method
purifi
recombin
bsp
protein
use
deaesephadex
mous
human
recombin
bsp
protein
express
origami
b
plyss
recombin
protein
extract
cell
bper
bacteri
protein
extract
reagent
contain
urea
pass
deaesephadex
column
column
wash
nacl
trisbuff
bound
bsp
protein
elut
urea
fraction
elut
urea
pool
desalt
lyophil
conclus
simpl
effici
novel
method
would
use
character
clarifi
role
bsp
protein
fertil
fund
cihr
engin
version
protein
program
yield
userspecifi
input
output
relationship
receptor
use
reprogram
cell
detect
cancer
antigen
induc
cellkil
transcript
program
natur
notch
signal
variou
mechan
use
finetun
activ
receptor
order
achiev
divers
contextdepend
signal
outcom
exampl
notch
glycosyl
endoplasm
reticulum
er
adjust
abil
recogn
specif
ligand
thu
control
percept
certain
cell
contrast
ligand
sens
control
mechan
synnotch
receptor
mostli
substitut
receptor
ligandbind
region
intracellular
transcript
effector
domain
describ
method
control
synnotch
receptor
analog
posttransl
mechan
use
chimera
contain
biotin
accept
peptid
enzymat
biotinyl
er
e
colideriv
biotin
ligas
show
regul
biotinyl
synnotch
receptor
use
enabl
disabl
signal
capac
respons
cell
bear
biotinbind
protein
streptavidin
antibiotin
antibodi
method
offer
new
level
control
mammalian
cell
enabl
precis
control
synthet
function
engin
therapeut
cell
escherichia
coli
versatil
bacterium
host
choic
produc
small
molecul
iptg
current
commonli
use
molecular
induc
heterolog
gene
express
achiev
high
level
product
isopren
escherichia
coli
use
iptginduc
ptrc
promot
overexpress
six
heterolog
mevalon
pathway
enzym
isopren
synthas
howev
iptg
feasibl
induc
largescal
manufactur
due
cost
toxic
poster
describ
develop
pseudomona
putidaderiv
posit
regul
xylspm
express
system
control
mevalon
pathway
gene
isopren
synthas
enzym
escherichia
coli
benzoic
acidderiv
induc
mtoluat
achiev
robust
timeand
dosedepend
isopren
product
howev
compar
ptrcexpress
pathway
growth
inhibit
product
reduc
use
wild
type
pm
promot
increas
pathway
intermedi
strain
pm
promot
suggest
growth
inhibit
due
metabolit
imbal
pm
promot
tightli
regul
compar
ptrc
promot
therefor
hypothes
isopren
synthas
express
pm
promot
accumul
fast
enough
prevent
accumul
toxic
intermedi
promot
stronger
less
tightli
regul
wild
type
pm
promot
combin
promot
control
isopren
synthas
wildtyp
pm
promot
drive
pathway
enzym
express
reliev
growth
inhibit
maxim
product
preprotein
translocas
essenti
bacteri
protein
secret
system
central
compon
seca
secyeg
seca
atpas
catalyz
transloc
unfold
preprotein
membraneintegr
secyeg
pore
preprotein
substrat
must
transloc
unfold
state
therefor
function
secret
system
involv
antifold
activ
atpasedepend
movement
preprotein
secyeg
pore
mediat
seca
gain
insight
molecular
mechan
process
use
truncat
construct
lack
ctermin
helic
domain
retain
atpas
peptid
bind
properti
seca
size
exclus
chromatographi
analyt
ultracentrifug
use
demonstr
form
monom
dimer
tetram
solut
contrast
unstructur
termini
trim
complet
monomer
therefor
unstructur
termini
sole
respons
oligom
format
diffract
crystal
obtain
introduc
surfac
entropi
reduct
mutat
two
locat
combin
crystal
structur
smallangl
xray
scatter
sax
data
molecular
model
tetram
construct
unstructur
ntermin
residu
also
import
dimer
fulllength
seca
new
model
seca
solut
dimer
propos
base
sax
data
tetram
surfac
plasmon
reson
spr
base
peptid
bind
assay
develop
sprbase
assay
use
demonstr
unstructur
ntermin
residu
seca
essenti
peptid
bind
therefor
extrem
nterminu
seca
import
oligomer
preprotein
bind
last
decad
multitud
biophys
experi
conduct
character
rotatori
catalysi
nevertheless
carri
almost
entir
bacteri
enzym
recent
studi
mitochondri
shown
differ
chemomechan
coupl
enzym
deriv
bacteri
eukaryot
sourc
p
denitrifican
pd
free
live
bacterium
phylogenet
relat
protomitochondria
harbor
respiratori
chain
extrem
similar
mitochondria
thu
character
rotatori
catalysi
provid
insight
adapt
atpas
machineri
upon
endosymbiosi
tightli
regul
hydrolyt
activ
control
uniqu
alphaproteobacteria
inhibitor
f
subunit
f
subunit
structur
differ
bacteri
e
mitochondri
regul
appear
function
resembl
structur
biochemistri
studi
propos
subunit
block
rotat
howev
direct
evid
inhibitori
mechan
establish
e
coli
express
system
use
molecular
chaperon
studi
rotatori
dynam
observ
counterclockwis
rotat
typic
atp
hydrolysi
fit
michealismenten
kinet
vmax
revolutionss
use
gold
nanoparticl
addit
observ
threestep
rotat
obtain
preliminari
result
effect
subunit
rotatori
behaviour
found
similar
assembl
machineri
regulatori
mechan
bacteri
mitochondri
mani
dsdna
virus
use
multicompon
atpas
motor
packag
genom
procapsid
viral
matur
motor
among
power
known
molecular
machin
coupl
atp
hydrolysi
dna
transloc
still
poorli
understood
use
multifacet
approach
combin
xray
crystallographi
small
angl
xray
scatter
protein
dock
biochem
assay
elucid
mechan
atp
hydrolysismedi
dna
transloc
present
novel
genom
packag
system
thermophil
viru
provid
new
insight
motor
structur
mechan
show
interfaci
contact
mediat
atp
hydrolysi
identifi
essenti
dna
bind
cleavag
motif
reveal
atpdepend
conform
chang
packag
motor
addit
show
motor
atpas
domain
necessari
suffici
dna
bind
attribut
previous
ascrib
nucleas
domain
find
lead
mechan
transloc
long
leverarm
gener
high
forc
steric
block
mechan
nucleas
regul
cockroach
household
insect
establish
model
organ
research
periplanetasin
deriv
american
cockroach
periplaneta
americana
exert
potent
antifung
effect
pathogen
fungi
without
caus
hemolysi
periplanetasin
induc
oxid
stress
gener
reactiv
oxygen
speci
ro
lipid
peroxid
periplanetasin
also
caus
apoptosi
exposur
phosphatidylserin
fragment
dna
exert
concentrationdepend
manner
henc
investig
mitochondri
apoptot
mechan
periplanetasin
candida
albican
treatment
periplanetasin
observ
mitochondri
depolar
calcium
accumul
moreov
observ
decreas
cytosol
glutathion
increas
mitochondri
glutathion
indic
periplanetasin
induc
oxid
stress
high
ro
product
mitochondria
mitochondri
dysfunct
cytochrom
c
releas
mitochondria
cytosol
caspas
activ
timedepend
manner
summari
antifung
peptid
periplanetasin
activ
apoptot
signal
mitochondria
induct
oxid
stress
cell
penetr
peptid
cpp
protein
transduct
domain
ptd
short
oligomer
peptid
capabl
transloc
across
cell
membran
simultan
employ
multipl
mechan
entri
mani
cpp
disord
structur
solut
adopt
alphahel
conform
cell
surfac
indic
structur
reorder
helix
vital
penetr
capabl
herein
describ
seri
helic
peptid
chap
structur
optim
electrostat
potenti
distribut
surfac
impart
cell
penetr
peptid
test
cancer
noncancer
cell
line
cell
penetr
exhibit
preferenti
uptak
cancer
cell
uptak
noncancer
cell
minim
chap
could
also
deliv
small
molecul
methotrex
insid
cell
therapeut
function
intact
moreov
deliveri
drug
peptidedrug
conjug
also
reduc
inhibitori
concentr
cell
compar
nativ
drug
suggest
dual
capabl
chap
select
deliv
drug
cancer
cell
also
increas
therapeut
valu
develop
novel
anticanc
therapi
secretin
peptid
hormon
exert
pleiotrop
physiolog
function
specif
bind
cognat
membranebound
receptor
membran
catalysi
model
peptidereceptor
interact
state
solubl
peptid
ligand
initi
interact
plasma
membran
interact
increas
local
concentr
structur
peptid
enhanc
rate
receptor
bind
howev
model
consid
dens
network
glycosaminoglycan
gag
surfac
eukaryot
cell
sulfat
polysaccharid
chain
known
sequest
numer
proteic
signal
mol
ecul
studi
evalu
interact
peptid
hormon
secretin
sulfat
gag
contribut
cell
surfac
bind
use
gagdefici
cell
competit
experi
solubl
gag
observ
confoc
microscopi
flow
cytometri
gag
mediat
sequestr
secretin
cell
surfac
isotherm
titrat
calorimetri
surfac
plasmon
reson
reveal
secretin
bind
heparin
dissoci
constant
rang
mm
design
secretin
deriv
restrict
conform
ensembl
observ
interact
mediat
presenc
specif
conform
gagrecognit
motif
decor
surfac
peptid
upon
helic
fold
studi
identifi
secretin
novel
gagbind
polypeptid
open
new
research
direct
function
role
gag
biolog
secretin
ion
channel
transmembran
protein
regul
flow
ion
cell
membran
requir
proper
function
cell
howev
ion
channel
nongat
nanopor
may
act
toxin
enabl
uncontrol
passag
ion
destroy
usual
electrochem
gradient
cell
lead
death
target
nongat
nanopor
toward
cancer
cell
would
promis
develop
new
nanochemotherapeut
agent
treat
resist
cancer
cell
intent
new
famili
synthet
ion
channel
develop
laboratori
use
transmembran
helic
peptid
framework
bear
six
crown
ether
creat
transmembran
channel
ion
even
though
biophys
studi
shed
light
sever
aspect
channel
mechan
action
incorpor
membran
remain
unclear
therefor
attempt
assess
drive
incorpor
crown
ethermodifi
peptid
bilay
membran
use
orient
circular
dichroism
ocd
spectroscopi
twoelectrod
voltag
clamp
method
tevc
studi
ocd
show
transmembran
orient
low
peptidelipid
ratio
lipid
bilay
aggreg
higher
ratio
tevc
show
ionic
current
genuin
xenopu
laevi
oocyt
cell
furthermor
oocyt
tend
die
probabl
deplet
energi
short
period
incub
peptid
thu
reveal
potenti
cytotox
agent
preeclampsia
pe
biomark
search
perform
mani
modern
techniqu
includ
proteom
repres
comprehens
analysi
thousand
protein
peptid
previous
qualit
result
show
peptid
specif
pe
mainli
fragment
achain
collagen
type
iii
uromodulin
serum
albumin
albu
tri
verifi
presenc
specif
peptid
western
blot
urin
sampl
three
group
patient
mild
sever
pe
obtain
v
kulakov
research
center
obstetr
gynecolog
perinatolog
patient
includ
studi
provid
written
inform
consent
approv
commiss
biomed
ethic
peptid
extract
ultrafiltr
sizeexclus
chromatographi
sec
hplcmsm
analysi
perform
urinari
peptid
sampl
sever
techniqu
page
compar
gradient
tristricinepag
select
peptid
transfer
onto
nitrocellulos
membran
probe
antibodi
oligom
albu
two
polyclon
antibodi
epitop
chemiluminesc
observ
band
indic
presenc
albu
misfold
structur
pe
sampl
low
peptid
concentr
everi
pe
sampl
show
detect
fragment
protein
interest
nevertheless
manag
verifi
previou
ms
result
acknowledg
work
support
rfbr
grant
pe
sampl
prepar
russian
scienc
foundat
grant
fticr
ms
measur
refer
altern
therapeut
approach
combat
ill
accomplish
focu
inhibit
protein
toxin
one
mani
virul
factor
pathogen
bacteria
produc
mani
toxin
includ
repeatsintoxin
rtx
protein
leukotoxin
ltxa
secret
aggregatibact
actinomycetemcomitan
recogn
bind
cholesterol
chol
host
cell
membran
initi
step
mechan
howev
viabl
method
inhibit
interact
yet
uncov
ltxa
recogn
chol
target
cell
membran
via
chol
recognit
amino
acid
consensu
crac
motif
within
primari
structur
previous
identifi
character
design
peptid
base
crac
motif
ltxa
use
biophys
method
demonstr
peptid
retain
affin
chol
fulllength
toxin
result
peptid
prevent
ltxa
bind
chol
therebi
inhibit
ltxa
cytotox
current
character
bind
chol
panel
relat
crac
peptid
better
understand
mechan
design
improv
peptid
therapeut
anticip
approach
inhibit
chol
bind
bacteri
toxin
could
broad
applic
treat
bacteri
diseas
deepti
mahapatra
research
part
wider
research
programm
contribut
focus
util
lower
valu
red
meat
compon
creat
new
meatderiv
food
ingredi
abund
protein
anim
meat
muscl
collagen
focu
specif
collagen
model
peptid
apart
bridg
gap
studi
oxid
modif
red
meat
process
food
industri
studi
self
assembl
collagen
model
peptid
also
prove
benefici
medic
applic
like
drug
deliveri
tissu
engin
biomed
applic
relat
collagen
etc
effect
chain
length
glycineprolinehydroxyprolin
n
peptid
sequenc
tripl
helic
first
order
selfassembl
format
supramolecular
assembl
format
studi
number
residu
indepth
investig
impact
temperatur
cycl
assembl
properti
collagen
peptid
perform
analyt
character
techniqu
use
studi
protein
chemistri
cd
dsc
dl
tem
afm
infrar
spectroscopi
mass
spectrometri
esi
maldi
sax
use
structur
determin
glycineprolinehydroxyprolin
collagen
tripl
helic
peptid
achiev
xray
crystallographi
hydrotherm
insult
cook
target
primari
structur
level
peptid
sequenc
found
instrument
impact
supramolecular
assembl
properti
redox
proteom
profil
approach
observ
middl
portion
peptid
strand
act
target
site
specif
residu
modif
instead
either
side
peptid
chain
trend
impact
textur
meat
deriv
food
product
identif
hydroxyprolinecontain
hairpinlik
peptid
barnyard
grass
echinochloa
crusgal
l
seed
structur
determin
compar
function
analysi
eugen
rogozhin
shemyakinovchinnikov
institut
bioorgan
chemistri
russian
academi
scienc
russia
plant
known
contain
rich
varieti
defens
protein
peptid
provid
first
defens
posit
variou
phytopathogen
microorgan
wild
plant
especi
weed
usual
widespread
worldwid
cereal
speci
phylogenet
close
cultiv
plant
demonstr
higher
resist
level
environment
biotic
stress
factor
wherea
crop
mainli
lost
key
role
breed
process
progress
barnyard
grass
echinochloa
crusgal
l
beauv
weed
plant
larg
pool
differ
defens
polypeptid
antimicrobi
insect
proteas
inhibit
properti
previous
number
novel
antimicrobi
peptid
hairpinlik
alphahairpinin
famili
ecamp
isol
seed
character
detail
display
novel
biolog
effect
plant
pathogen
anim
pathogen
fungi
bacteria
yeast
micromolar
activ
concentr
vitro
peptidom
analysi
seed
peptid
extract
combin
malditof
mass
spectrometri
autom
edman
degrad
disclos
two
similar
isoform
peptid
singl
differ
prolin
hydroxyprolin
substitut
posit
amino
acid
chain
follow
compar
antimicrobi
assay
detect
contribut
modifi
prolin
residu
peptid
function
realiz
first
report
display
presenc
hydroxyprolin
composit
natur
biolog
activ
peptid
cereal
work
support
russian
scienc
foundat
project
yunghua
li
genu
streptococcu
altern
sigma
factor
sigx
sx
key
regul
transcript
activ
compet
gene
essenti
take
exogen
dna
howev
recent
regul
proteolysi
sigx
involv
escap
compet
bacteria
provid
evid
adaptor
protein
meca
proteas
clpcclpp
requir
escap
compet
mechan
involv
mecamedi
proteolysi
sigx
streptococcu
mutan
analyz
cellular
level
sigx
demonstr
synthesi
sigx
transient
induc
competencestimul
peptid
csp
sigx
rapidli
degrad
follow
compet
induct
delet
either
meca
clpc
clpp
result
cellular
accumul
sigx
prolong
compet
state
overexpress
meca
enhanc
proteolysi
sigx
acceler
escap
compet
vitro
proteinprotein
interact
assay
confirm
meca
interact
sigx
via
ntermin
domain
clpc
via
ctermin
domain
interact
mediat
format
ternari
sigxmecaclpc
complex
trigger
atpdepend
degrad
sigx
presenc
clpp
delet
ntermin
ctermin
domain
meca
abolish
bind
sigx
clpc
also
found
mecamedi
proteolysi
sigx
ineffect
mutan
grown
chemic
defin
medium
suggest
possibl
unknown
mechan
may
involv
neg
regul
mecamedi
proteolysi
sigx
condit
conclud
adaptor
protein
meca
play
crucial
role
recogn
target
sigx
degrad
proteas
clpcclpp
chines
univers
hong
kong
china
telomeras
activ
telomer
mainten
critic
cancer
progress
transform
telomeras
regul
aberr
express
caus
telomer
shorten
identifi
interact
protein
import
understand
telomer
mainten
particular
identifi
direct
interact
ctermin
tail
nucleophosmin
npm
posit
telomeras
regul
interact
interfac
npm
map
show
act
linker
bridg
associ
npm
htert
catalyt
subunit
telomeras
also
recruit
npm
complex
could
partial
attenu
inhibit
telomeras
activ
result
report
novel
mechan
regul
telomeras
activ
interact
npm
telomeras
complex
furthermor
investig
bind
local
pattern
interact
htert
complex
format
differ
stage
cell
cycl
regul
epigenet
mark
demonstr
rnase
threelik
rtl
protein
cleav
dsrna
express
byl
activ
impair
investig
interact
thu
reveal
complex
drb
protein
antagon
rather
promot
rnase
iii
activ
product
sirna
plant
yongqi
huang
zhengd
su
mani
protein
function
context
proteinprotein
complex
threedimension
domain
swap
mechan
form
protein
homooligom
propos
sever
factor
includ
prolin
residu
hing
region
may
affect
occurr
domain
swap
although
introduc
prolin
hing
region
found
promot
domain
swap
protein
opposit
effect
also
observ
sever
studi
far
prolin
affect
domain
swap
remain
elus
work
base
larg
set
domainswap
structur
perform
systemat
analysi
explor
correl
presenc
prolin
hing
region
occurr
domain
swap
analyz
conform
prolin
preprolin
residu
investig
role
prolin
domain
swap
found
domainswap
structur
contain
prolin
residu
hing
region
unexpectedli
conform
transit
ci
tran
isom
prolin
residu
rare
observ
domain
swap
analysi
conform
prolin
preprolin
residu
show
strain
reliev
protein
upon
swap
strain
also
introduc
sever
protein
analys
suggest
critic
role
conform
constraint
backbon
strain
cistran
isomer
domain
swap
propos
prolin
question
propos
role
prolin
domain
swap
may
slow
fold
process
promot
intermolecular
interact
unfold
monom
chloroplast
biogenesi
reli
import
thousand
nuclearencod
preprotein
cytosol
preprotein
import
support
larg
protein
complex
call
toc
tic
translocon
outer
inner
envelop
membran
chloroplast
complex
work
cooper
transloc
preprotein
across
doublemembran
envelop
surround
chloroplast
one
preprotein
receptor
toc
complex
compris
distinct
domain
ntermin
acid
domain
intrins
disord
central
gtpase
g
domain
ctermin
membran
domain
anchor
protein
outer
membran
use
unknown
mechan
mdomain
known
homologu
contain
predict
transmembran
domain
contain
intrins
chloroplast
target
inform
extrem
cterminu
three
subdomain
mdomain
identifi
one
contain
predict
betahelix
motif
may
import
anchor
protein
chloroplast
outer
membran
interest
character
structur
mdomain
determin
mechan
target
natur
membran
associ
part
larger
goal
understand
role
play
protein
import
chloroplast
present
recent
data
structur
function
predict
betahelix
subdomain
mdomain
mechan
count
handoff
human
dna
primas
role
cluster
walter
chazin
jacquelin
barton
matthew
thompson
elizabeth
obrien
marilyn
holt
lauren
salay
aaron
ehling
vanderbilt
univers
tennesse
usa
california
institut
technolog
usa
gener
complementari
lead
lag
strand
dna
replic
requir
action
seri
polymeras
prime
templat
requir
action
dnadepend
rna
polymeras
dna
primas
synthes
first
nt
de
novo
ssdna
templat
despit
intens
studi
mani
year
mysteri
primas
count
hand
prime
substrat
polymeras
remain
unsolv
integr
crystallographi
sax
em
specif
design
substrat
character
activ
configur
primas
initi
elong
primer
test
model
mechan
primas
count
howev
handoff
prime
templat
fulli
explain
structur
alon
question
led
us
wonder
role
cluster
uniqu
ctermin
domain
regulatori
subunit
human
primas
although
discov
year
ago
function
cluster
prime
remain
enigmat
intriguingli
long
recogn
charg
transport
long
rang
fulli
basepair
duplex
dna
use
nanoscal
electrochem
devic
shown
abl
transport
charg
dna
remark
dna
charg
transport
ct
depend
redox
state
cluster
specif
tyrosinemedi
path
link
cluster
dna
bind
surfac
result
suggest
redox
switch
primas
cluster
mediat
dna
ct
provid
miss
factor
drive
handoff
initi
rna
prime
templat
dna
polymeras
cell
respond
extracellular
stimuli
via
membranebound
protein
tyrosin
kinas
receptor
rtk
order
surviv
adapt
environ
activ
rtk
bear
phosphotyrosin
ptyr
dock
site
adaptor
protein
function
coupl
ptyr
activ
receptor
via
singl
domain
cytoplasm
effector
contain
proargrich
motif
via
three
domain
regul
mechan
poorli
understood
sought
determin
whether
protein
regul
tyrosin
phosphoryl
use
mass
spectrometri
map
ptyr
residu
analys
effect
modif
signal
network
vivo
identifi
distinct
ptyr
includ
one
lay
bind
pocket
everi
domain
conserv
murin
domain
identifi
rtk
direct
binder
kinas
phosphoryl
residu
vitro
vivo
demonstr
phosphoryl
tyr
abrog
domain
interact
substrat
show
phosphomim
tripl
mutant
ye
conserv
tyr
dock
drosophila
ortholog
inhibit
function
develop
fli
eye
data
suggest
rtk
abl
termin
signal
directli
phosphoryl
substrat
includ
adaptor
protein
protein
modifc
diabet
mellitu
may
lead
earli
glycat
product
advanc
glycat
end
product
age
wherea
extens
studi
carri
assess
role
earli
glycat
product
chronic
kidney
diseas
ckd
numer
research
articl
demonstr
role
age
bioethic
committe
jn
medic
colleg
aligarh
muslim
univers
aligarh
find
object
human
sampl
collect
award
ethic
clearanc
studi
object
studi
design
compar
structur
function
chang
hsa
glycat
glucos
hsa
purifi
diabet
patient
without
ckd
method
structur
chang
nativ
glycatedhsa
observ
uv
fluoresc
circular
dichroism
spectroscopi
fourier
transform
infrar
spectroscopi
tryptophan
fluoresc
free
thiol
group
along
carbonyl
estim
result
enhanc
chang
structur
confirm
observ
glycatedhsa
signific
impair
structur
observ
ckdhsa
compar
normal
hsa
consequ
chang
associ
glycat
provok
reduct
free
thiol
group
strong
increment
protein
carbonyl
content
amadorihsa
diabetichsa
compar
normal
hsa
conclus
find
reveal
structur
comform
glycat
hsa
isol
diabet
patient
without
ckd
significantli
differ
nativ
hsa
addit
hsa
may
avail
extens
glycat
lead
impair
import
function
also
suggest
glycat
hsa
may
involv
pathogenesi
diabet
complic
ckd
might
import
biomark
monitor
diabet
pathophysiolog
especi
diabet
kidney
diseas
patient
factor
xiiia
fxiiia
transglutaminas
crosslink
intraand
extracellular
protein
substrat
calciumdepend
manner
fxiiia
member
transglutaminas
famili
found
homodim
zymogen
form
activ
thrombinmedi
cleavag
activ
peptid
ap
nonproteolyt
presenc
high
mm
activ
fxiiia
long
consid
homodim
like
zymogen
accumul
inconclus
evid
howev
suggest
monomer
state
activ
fxiiia
current
project
size
exclus
chromatographi
analyt
ultracentrifug
employ
assess
oligomer
state
hydrodynam
properti
fxiiia
intersubunit
interact
dimer
zymogen
form
tight
kd
nm
nonproteolyt
thrombinmedi
fxiiia
activ
result
monomer
speci
kd
mm
respect
thrombin
cleavag
singl
ap
fxiii
initi
transit
monom
remark
catalyt
activ
mm
caactiv
fxiiia
lower
proteolyt
activ
enzym
thu
first
time
quantit
assess
fxiiia
intersubunit
interact
perform
direct
experiment
evid
obtain
monomer
state
activ
fxiiia
solut
dimer
state
zymogen
propos
stabil
fxiiia
physiolog
set
prevent
prematur
protein
crosslink
contrast
cleavag
ap
dissoci
homodim
crucial
full
express
fxiiia
function
yazan
abba
bhushan
nagar
iren
xie
zixian
li
interferon
induc
protein
tetratricopeptid
repeat
ifit
famili
innateimmun
antivir
effector
human
compris
wellcharacter
member
ifit
shown
interact
rna
limit
viral
replic
addit
form
complex
made
host
factor
refer
ifit
interactom
may
role
antivir
immun
recent
crystal
structur
rnafre
reveal
ntermin
domainswap
wherebi
central
helic
exchang
two
protom
form
intertwin
dimer
thu
form
positivelycharg
rnabind
channel
origin
mechan
domainswap
role
ifit
complex
format
impact
rna
bind
unknown
use
xray
crystallographi
show
ntermin
domain
also
form
domainswap
dimer
mediat
two
hingeloop
similar
sequenc
structur
comparison
hingeloop
show
harbor
delet
site
comparison
nondomainswap
insert
mutagenesi
first
hingeloop
disrupt
homodimer
bacteri
coexpress
assay
suggest
form
heterodomain
swap
dimer
work
therefor
suggest
domainswap
ifit
protein
aros
ifit
precursor
follow
gene
duplic
delet
structur
hingeloop
allow
homoand
hetero
domainswap
may
import
ifit
interactom
assembl
current
work
focus
biophys
structur
character
monomer
mutant
heterodim
investig
rna
bind
properti
monom
dimer
flavivirus
dengu
denv
westnil
wnv
zika
zikv
virus
transmit
human
mainli
bite
mosquito
constitut
seriou
public
health
treat
despit
global
spread
diseas
sever
specif
effect
treatment
flavivirus
infect
part
due
poor
understand
viral
life
cycl
capsid
protein
c
major
drug
target
sinc
mediat
key
viral
life
cycl
step
includ
viral
assembl
encapsid
investig
wnv
zikvc
abil
bind
host
lipid
system
zeta
potenti
show
wnvc
interact
ld
surfac
protein
potassium
depend
manner
previous
shown
denvc
us
zikvc
also
interact
ld
similar
manner
although
contrast
potassium
ion
replac
sodium
dynam
light
scatter
measur
show
wnvc
interact
lowdens
lipoprotein
vldl
lowdens
lipoprotein
ldl
zikv
c
also
interact
vldl
observ
denv
c
moreov
wnvc
un
bind
forc
upon
interact
ld
vldl
quantit
determin
atom
forc
microscopi
afm
base
forc
spectroscopi
afm
confirm
wnvc
specif
bind
ld
vldl
ldl
process
requir
ion
furthermor
zikv
wnv
denv
c
protein
sequenc
reveal
similar
predict
hydrophob
ahel
propens
tertiari
structur
thu
target
via
similar
approach
combin
background
denvc
protein
inhibitor
denvc
interact
lipid
system
design
us
thu
pave
way
flaviviru
drug
develop
strategi
cysteinedepend
aspartatespecif
intracellular
proteas
multipl
role
dna
damag
respons
cell
cycl
regul
tumor
suppress
function
central
coordin
cell
metabol
apoptosi
function
regul
phosphoryl
sever
ser
residu
phosphoryl
bind
protein
interact
block
activ
unknown
mechan
elucid
regulatori
mechan
identifi
site
respons
protein
bind
perform
biophys
character
complex
use
analyt
ultracentrifug
map
bind
interfac
complex
use
hydrogendeuterium
exchang
kinet
coupl
mass
spectrometri
result
provid
first
structur
insight
regul
work
support
czech
scienc
foundat
project
toma
obsil
veronika
obsilova
olivia
petrvalska
katarina
psenakova
salom
kylarova
dana
kalabova
faculti
scienc
charl
univers
pragu
czech
republ
institut
physiolog
czech
academi
scienc
pragu
czech
republ
mani
protein
kinas
shown
regul
proteindepend
manner
howev
underli
molecular
mechan
partial
identifi
mainli
due
lack
structur
data
work
role
regul
two
protein
kinas
investig
apoptosi
signalregul
kinas
member
mitogenactiv
protein
kinas
kinas
kinas
famili
play
crucial
role
immun
stress
respons
protein
kinas
kinas
member
camk
signal
cascad
detect
chang
intracellular
concentr
calcium
ion
transduc
signal
activ
correspond
transcript
factor
investig
role
regul
kinas
perform
biophys
structur
character
complex
use
kinas
activ
measur
analyt
ultracentrifug
small
angl
xray
scatter
nmr
fluoresc
spectroscopi
result
indic
complex
dynam
conform
heterogen
structur
analysi
also
indic
interact
kinas
domain
close
proxim
activ
site
thu
indic
interact
might
block
access
andor
affect
conform
work
support
czech
scienc
foundat
project
chaperoneproteas
clpxp
lon
target
mind
proteolysi
e
coli
chri
labreck
jodi
camberg
univers
rhode
island
usa
min
system
e
coli
includ
minc
mind
mine
promot
placement
ftszring
midcel
prevent
ftsz
assembl
cell
pole
mind
atpas
associ
membran
atpbound
conform
dissoci
membran
follow
atp
hydrolysi
stimul
mine
bind
min
system
exhibit
poletopol
oscil
driven
bind
releas
mind
membran
minc
oscil
mind
direct
interact
inhibit
ftsz
polymer
clpxp
lon
major
prokaryot
chaperoneproteas
clpx
atpas
associ
clpp
proteas
unfold
degrad
substrat
lon
contain
proteas
modul
singl
polypeptid
clpxp
degrad
sever
cell
divis
protein
vivo
includ
ftsz
zapc
report
mind
degrad
clpxp
lon
vitro
character
mechan
govern
mind
recognit
proteolysi
monitor
degrad
purifi
mind
observ
slower
degrad
presenc
small
unilamellar
phospholipid
vesicl
deriv
e
coli
mind
ntermin
region
contain
put
clpx
recognit
motif
purifi
mind
mutant
protein
mind
contain
substitut
region
observ
impair
degrad
final
vivo
observ
alter
minc
oscil
rate
cell
overexpress
clpxp
suggest
clpxp
degrad
modifi
min
oscil
cycl
togeth
result
show
mind
clpxp
substrat
suggest
recognit
depend
mind
ntermin
region
furthermor
membran
associ
protect
mind
degrad
suggest
clpxp
may
target
cytoplasm
mind
bibek
parajuli
kriti
acharya
harri
bach
cameron
abram
irwin
chaiken
drexel
univers
colleg
medicin
pennsylvania
usa
drexel
univers
pennsylvania
usa
drexel
univers
colleg
engin
pennsylvania
usa
drexel
univers
colleg
medicin
aj
drexel
institut
basic
appli
protein
scienc
pennsylvania
usa
first
gener
recombin
cvndavei
construct
compos
cyanovirinn
cvn
fuse
membran
proxim
extern
region
mper
exhibit
potent
irrevers
inactiv
pseudotyp
fulli
infecti
virus
addit
engin
chimer
protein
identifi
molecular
determin
import
virolyt
activ
cvndavei
made
cvn
domain
bind
provid
suffici
bind
affin
steer
mper
engag
elicit
virolysi
howev
promiscu
cvn
associ
multipl
glycosyl
site
multival
limit
understand
molecular
arrang
davei
molecul
trimer
spike
need
virolysi
studi
construct
investig
virolyt
function
second
gener
davei
molecul
use
simpler
lectin
domain
deriv
microvirin
mvn
unlik
cyanovirin
microvirin
singl
glycan
bind
site
exhibit
toxic
mitogen
activ
bind
small
repertoir
glycan
outer
domain
found
like
exploit
similar
mechan
action
induc
virolysi
select
glycan
engag
sequenc
redesign
potenc
protein
significantli
increas
reengin
protein
bind
compet
specif
mab
bind
virolyt
assay
lectin
domain
davei
util
mvn
without
loss
virolyt
function
argu
simpl
monoval
restrict
env
glycan
engag
suffici
induc
virolysi
sinc
improvis
construct
defin
bind
site
provid
improv
tool
elucid
product
molecular
arrang
envdavei
enabl
virolysi
marjan
seirafi
zlata
plotnikova
guennadi
kozlov
jeanfrancoi
tremp
kall
gehr
mutat
parkin
gene
respons
common
inherit
form
parkinson
diseas
pd
earli
onset
gene
product
ubiquitin
ligas
parkin
kinas
involv
autophagi
damag
mitochondria
term
mitophagi
pathway
phosphoryl
parkin
ubiquitin
thu
activ
parkin
ligas
activ
parkin
contain
ubiquitinlik
ubl
domain
nterminu
inhibit
activ
autoinhibit
parkin
activ
phosphoryl
ubl
domain
bind
phosphoubiquitin
releas
ubl
domain
bind
site
parkin
parkin
ubl
domain
also
bind
domain
endophilin
brain
specif
protein
affin
compar
prolinerich
domain
prd
wellestablish
partner
parkin
structur
reveal
ubl
use
similar
surfac
bind
domain
parkin
domain
endophilin
could
explain
bind
fulllength
parkin
low
affin
condit
promot
phosphoryl
enhanc
interact
fulllength
protein
nerv
termin
report
phosphoryl
ubl
also
bind
domain
similar
affin
vitro
moreov
phosphoryl
parkin
bind
phosphoubiquitin
parkin
mutant
releas
ubl
domain
increas
bind
fulllength
parkin
domain
endophilin
current
work
direct
toward
studi
effect
interact
parkin
activ
vitro
cell
find
may
identifi
link
synapt
vesicl
endocytosi
mitophagi
jeanchristoph
duboi
alexandr
mar
echal
yate
cl
ement
laurent
cappadocia
luc
gaudreau
lee
zou
universit
e
de
sherbrook
quebec
canada
memori
sloan
ketter
cancer
center
new
york
usa
massachusett
gener
hospit
cancer
center
massachusett
usa
impedi
replic
fork
progress
induc
rpacoat
singlestrand
dna
rpassdna
accumul
rpassdna
orchestr
recruit
activ
mani
genom
mainten
factor
signal
repair
dna
damag
rpa
complex
heavili
phosphoryl
atr
atm
dnapk
kinas
replic
stress
redirect
function
dna
replic
damag
signal
repair
rpa
also
ubiquityl
ubiquitin
ligas
respons
damag
ligas
also
promot
replic
fork
repair
homolog
recombin
hr
howev
dna
damag
stimul
rpa
ubiquityl
still
unclear
whether
ubiquitin
ligas
activ
rpassdna
import
hr
remain
unexplor
find
wherea
constitut
interact
rpa
complex
assembl
rpassdna
upon
fork
damag
ubiquityl
rpa
interact
correl
phosphoryl
interestingli
nonphosphorylat
mutant
still
interact
bind
poorli
ubiquityl
upon
damag
posit
charg
pocket
domain
interact
rpa
suggest
recogn
phosphoryl
rpa
surfac
final
ubiquitin
ligas
activ
rpainteract
surfac
requir
optim
hr
atr
activ
propos
rpa
phosphoryl
promot
accumul
rpassdna
togeth
stimul
rpa
ubiquityl
similarli
phosphorylationubiquityl
cascad
underli
chromatinbas
dna
damag
respons
would
allow
spread
rpa
phosphoryl
ubiquityl
larg
segment
rpassdna
found
impair
fork
promot
robust
atr
activ
hrmediat
dna
repair
abraham
cheloff
daniel
turman
christoph
miller
fluc
ion
channel
famili
compris
dimer
membran
protein
whose
function
expel
excess
ffrom
cytoplasm
microorgan
resist
inhibitori
effect
environment
xenobiot
anion
recent
structur
e
coli
fluc
homolog
bound
engin
monobodi
protein
select
phage
display
librari
reveal
multipl
sidechain
contact
channelmonobodi
interfac
two
monobodi
share
similar
interfac
structur
nanomolarrang
bind
affin
differ
fold
focu
perresidu
energet
contribut
bind
affin
fluc
introduc
point
mutat
polar
contact
either
size
interfac
assess
chang
bind
affin
use
fluoresc
anisotropi
found
residu
diversifi
loop
contribut
significantli
bind
energi
futur
studi
mutagen
monobodychannel
interfac
deriv
inform
differ
monobodi
interact
fluc
channel
joy
yang
david
c
goldston
jeremi
r
keown
antiretrovir
restrict
factor
prevent
infect
divers
retrovirus
includ
disrupt
earli
postentri
stage
retrovir
lifecycl
member
trim
protein
famili
conserv
ntermin
domain
architectur
consist
ntermin
ring
domain
ubiquitin
ligas
activ
bbox
domain
antiparallel
coiledcoil
involv
selfassembl
restrict
particular
retroviru
must
recognis
capsid
incom
retroviru
recognit
result
ringmedi
ubiquityl
lead
activ
downstream
signal
event
induc
cellular
antivir
state
better
understand
capsid
recognit
translat
antiretrovir
activ
studi
selfassoci
ubiquityl
activ
ring
bbox
domain
oligomer
state
determin
sizeexclus
chromatographi
multiangl
light
scatter
sediment
veloc
analyt
ultracentrifug
ubiquityl
activ
test
vitro
ubiquityl
assay
involv
enzym
partner
establish
literatur
previou
work
establish
monomer
ring
domain
activ
ringbbox
construct
exhibit
higher
order
selfassembl
ubiquityl
activ
mutat
made
disrupt
selfassembl
also
result
decreas
ubiquityl
activ
result
demonstr
ubiquityl
activ
close
depend
upon
higherord
assembl
link
recognit
retrovir
capsid
ubiquityl
activ
restrict
diverg
eukaryot
prokaryot
express
system
phosphatas
catalyt
subunit
priyanka
sandal
shweta
shah
gururaj
rao
iowa
state
univers
iowa
usa
protein
phosphatas
serinethreonin
phosphatas
exist
heterotrimer
complex
compos
scaffold
subunit
catalyt
c
subunit
substrat
specif
variabl
b
subunit
two
isoform
c
subunit
arabidopsi
previous
demonstr
one
key
step
regul
form
cell
divis
root
interact
c
subunit
kinas
domain
receptor
like
kinas
arabidopsi
importantli
phosphoryl
becam
first
describ
novel
substrat
receptor
kinas
yue
sandal
et
al
pna
comprehens
biochemicalbiophys
character
interact
two
protein
invitro
significantli
inform
drive
planta
investig
howev
studi
requir
substanti
quantiti
protein
express
eukaryot
system
insect
cell
mammalian
cell
cultur
prefer
method
obtain
catalyt
activ
human
owe
intrins
avail
necessari
regulatori
protein
necessari
differenti
regul
activ
howev
pauciti
pure
protein
ratelimit
step
overcom
limit
express
arabidopsi
tradit
e
coli
system
although
protein
initi
express
inact
form
distinct
measur
activ
detect
time
room
temperatur
suggest
slow
conform
chang
activ
state
herein
character
biochem
properti
ecoli
express
demonstr
abil
recov
phosphatas
activ
vitro
presenc
absenc
phosphatas
activatorptpa
protein
engin
increas
stabil
improv
function
potenti
develop
new
bind
partner
increas
affin
specif
knowledg
librari
extend
protein
variant
explor
develop
extens
protein
engin
epe
method
explor
extens
natur
protein
sequenc
improv
stabil
studi
domain
domainpeptid
hybrid
subject
epe
discov
stabil
domain
highli
specif
peptid
screen
process
involv
recent
develop
high
throughput
protein
fold
equilibrium
kinet
assay
custom
data
analysi
program
screen
result
show
variant
rang
equilibrium
kinet
stabil
compar
wild
type
tyrosin
appear
key
residu
increas
bind
affin
multipl
prolin
decreas
bind
affin
top
variant
subject
second
round
epe
enhanc
properti
studi
begin
could
becom
highli
select
way
develop
high
affin
peptid
could
assist
develop
novel
therapeut
protein
relat
diseas
domain
famili
group
protein
typic
amino
acid
residu
long
domain
play
key
part
proteinprotein
interact
domain
yeast
domain
famili
good
model
approxim
human
domain
probe
structur
stabil
domain
insight
bind
properti
obtain
use
cd
measur
secondari
structur
domain
compar
variou
member
experiment
data
compar
known
predict
structur
model
simultan
melt
temperatur
measur
determin
thermal
stabil
use
differ
salt
concentr
overal
purifi
domain
preliminari
result
show
varieti
melt
temperatur
secondari
structur
content
rang
melt
temperatur
expect
previou
studi
indic
vari
stabil
across
domain
famili
howev
expect
secondari
structur
chang
drastic
famili
common
fold
combin
structur
stabil
data
help
determin
ideal
condit
studi
domain
member
bethun
cookman
univers
florida
usa
univers
arkansasfayettevil
arkansa
usa
anabaena
sensori
rhodopsin
transduc
asrt
tetramer
solubl
protein
indic
function
downstream
signal
partner
sensori
rhodopsin
solut
crystal
structur
revel
primarili
beta
strand
protein
exhibit
helic
face
carboxyl
terminu
besid
receptor
bind
asrt
shown
serv
novel
eukaryoticlik
interact
dna
demonstr
carboxyl
helic
face
tetram
involv
unusu
tetramer
stabil
bioinformat
analysi
reveal
phosphor
transfer
along
uniqu
structur
fold
may
transform
uniqu
carbohydr
bind
modul
howev
signal
statemechan
asrt
obscur
initi
data
effici
donor
acetyl
phosphat
acp
use
fluoresc
quench
lone
suggest
asrt
involv
phosphoryl
notic
two
notabl
consensu
phosphor
transfer
residu
motif
asrt
sdke
trld
acetyl
phosphat
use
phosphoryl
donor
vitro
numer
respons
regul
cheyphobompr
extent
quench
presenc
increas
concentr
acp
yield
lower
km
compar
phob
like
proxim
phosphor
accept
residu
lone
trp
compar
other
interestingli
asrt
mutant
indic
loss
phosphor
transfer
hypothes
put
posit
shown
red
figur
involv
asrt
phosphoryl
motif
close
proxim
receptor
bind
deduc
cab
dock
phosphor
transfer
data
along
plausibl
impact
tetramer
stabil
discuss
studi
support
nihnigm
score
award
vt
heme
essenti
protein
prosthet
group
biolog
process
antioxid
defens
respir
heme
synthesi
final
insert
ferrou
iron
protoporhyrin
ring
catalyz
ferrochelatas
fech
matrix
side
inner
mitochondri
membran
howev
acceptor
heme
fech
identifi
cytochrom
c
peroxidas
heme
protein
produc
ferment
condit
might
earli
acceptor
heme
yeast
cell
sinc
local
intermembran
space
hypothes
adpatp
put
heme
transport
intermedi
heme
traffick
fech
start
point
use
highperform
lcmsm
profil
protein
mitochondrialenrich
fraction
ferment
yeast
cell
mm
noctylglucosid
deterg
fech
among
protein
detect
pull
interactor
gst
neg
control
fraction
twelv
mitochondri
protein
identifi
includ
matrix
protein
aconitas
succin
malat
dehydrogenas
fech
detect
vitro
vivo
screen
underway
probe
fech
interactor
yeast
mitochondria
use
gstpulldown
proximitydepend
bioid
assay
domain
yeast
protein
essenti
role
actin
cytoskeleton
rearrang
highli
acid
residu
domain
net
charg
bind
extend
prolinerich
peptid
involv
electrostat
interact
studi
electrostat
interact
domain
domainpeptid
hybrid
varieti
salt
concentr
use
highthroughput
stabil
assay
denatur
urea
neutral
guanidin
charg
optimum
condit
found
use
crystal
trial
select
protein
led
determin
structur
hyperstabil
tripl
mutant
high
salt
condit
also
found
stabil
differ
salt
concentr
affect
differ
denatur
domain
stabl
higher
salt
concentr
regardless
denatur
domainpeptid
hybrid
found
stabl
high
salt
guanidin
salt
gave
highest
stabil
urea
believ
high
ionic
strength
guanidin
alreadi
disrupt
favor
peptidedomain
electrostat
interact
hybrid
allow
salt
show
net
posit
effect
due
stabil
domain
neutral
denatur
urea
high
salt
decreas
domainpeptid
hybrid
stabil
due
screen
strong
electrostat
still
present
peptid
domain
highthroughput
method
determin
optim
condit
domain
domainpeptid
hybrid
futur
structur
function
studi
character
novel
bind
peptid
improv
method
purifi
activ
wildtyp
chimer
botulinum
neurotoxin
bont
sulyman
barkho
min
dong
boston
children
hospit
massachusett
usa
botulinum
neurotoxin
bont
highli
potent
protein
toxin
produc
sporebear
clostridium
botulinum
last
decad
deadli
agent
found
use
treat
numer
neuromuscular
disord
aesthet
applic
block
neurotransmitt
releas
inject
muscl
establish
therapeut
agent
bont
wide
produc
larg
scale
sever
manufactur
around
world
avail
data
suggest
manufactur
procedur
reli
decadesold
methodolog
util
sporul
strain
toxin
isol
achiev
mani
labori
ineffici
bulk
purif
step
util
recent
structur
biochem
knowledg
specif
interact
bont
nontox
partner
formul
improv
method
direct
purif
activ
therapeut
bont
ureas
nickel
contain
metalloenzym
catalyz
hydrolysi
urea
produc
acid
neutral
ammonia
essenti
surviv
helicobact
pylori
peptic
ulcer
caus
pathogen
human
stomach
matur
ureas
involv
carbamyl
activ
lysin
residu
insert
two
nickel
ion
activ
site
process
facilit
four
ureas
accessori
protein
ure
uref
ureg
ureh
understand
ureas
accessori
protein
interact
facilit
ureas
matur
determin
crystal
structur
complex
contain
flexibl
ctermin
tail
form
extra
helix
ftail
loop
stabil
newli
form
structur
facilit
recruit
ureg
form
complex
structur
complex
illustr
dimer
ureg
assembl
nickel
bind
site
bring
two
conserv
cph
motif
dimer
interfac
addit
nickel
gtp
complex
releas
gtpnickel
bound
ureg
dimer
activ
ureas
invitro
presenc
complex
recent
determin
crystal
structur
gtpnickel
bound
ureg
dimer
show
conform
differ
ureg
differ
nucleotidebound
state
reveal
gtp
hydrolysi
induc
conform
chang
dissoci
ureg
dimer
releas
bound
nickel
use
mutagenesi
studi
along
activ
assay
interact
studi
static
light
scatter
provid
insight
role
ureg
deliveri
nickel
ureas
matur
juan
carlo
barragangalvez
vianney
ortiznavarret
crtam
transmembran
protein
belong
immunoglobulin
superfamili
express
activ
lymphocyt
constitut
epitheli
cell
compos
variabl
v
constant
c
immunoglobulinlik
domain
extracellular
region
interact
vdomain
nectinlik
ligand
express
constitut
dendrit
cell
surfac
dc
epitheli
cell
howev
role
constant
iglik
domain
interact
studi
extracellular
region
crtam
clone
express
bacteri
system
recombin
protein
purifi
affin
chromatographi
subject
gel
filtrat
kinet
paramet
interact
measur
surfac
plasmon
reson
result
show
cdomain
crtam
present
oligomer
form
solut
affin
interact
kd
suggest
cdomain
molecul
could
improv
affin
interact
compar
affin
variabl
domain
kd
x
alreadi
report
design
biolog
oscil
intrigu
topic
synthet
biolog
although
mani
artifici
design
biolog
oscil
none
period
around
hour
like
circadian
clock
oscil
especi
sole
base
protein
core
circadian
oscil
cyanobacteria
consist
three
protein
kaia
kaib
kaic
circadian
oscil
could
function
reconstitut
vitro
three
protein
therefor
import
model
circadian
rhythm
research
kaia
bind
kaic
stimul
phosphoryl
wherea
kaib
antagon
kaia
function
lead
dephosphoryl
kaic
use
proteinbas
circadian
clock
oscil
model
aim
find
control
point
redesign
oscil
end
combin
tool
bioinformat
evolutionari
biolog
protein
design
molecular
biolog
mathemat
model
studi
interact
kaia
kaic
found
exist
complic
critic
structur
movement
bind
kaia
kaic
movement
determin
oscil
kaiabc
system
reveal
kaia
asymmetr
structur
flexibl
regul
autoinhibit
interact
kaic
base
find
could
possibl
redesign
oscil
interest
function
would
provid
use
insight
design
proteinbas
oscil
c
difficil
infect
cdi
identifi
lead
caus
hospitalacquir
diarrhea
diseas
primarili
mediat
two
exotoxin
b
damag
line
intestin
toxin
multifunct
protein
similar
domain
architectur
monoclon
antibodi
neutral
two
toxin
isol
identifi
varieti
method
employ
analyz
antibodiestoxin
interact
use
fort
ebio
octet
biolay
interferometri
bli
system
abl
map
domain
mab
bind
use
sechplc
found
antibodi
one
bind
site
other
multipl
site
interact
two
mab
ntermin
domain
toxin
b
analyz
hydrogendeuterium
exchang
mass
spectrometri
hdxm
although
two
antibodi
bind
differ
site
ntermin
domain
bind
result
similar
conform
chang
instanc
one
neutral
antibodi
found
bind
region
distant
substrat
bind
subdomain
bind
led
flexibl
chang
substrat
bind
subdomain
suggest
possibl
mechan
neutral
involv
induc
alloster
conform
chang
specif
antibodi
molecul
cognat
antigen
exploit
develop
varieti
immunoassay
vaccin
therapeut
almost
highresolut
structur
current
avail
antibodi
determin
xray
crystallographi
although
inform
structur
limit
insight
function
conform
dynam
appli
studi
proteinprotein
interact
dynam
well
fragmentbas
drug
discoveri
nexom
bioscienc
leverag
advanc
nmr
technolog
includ
studi
antibodyantigen
interact
enabl
drug
discoveri
three
human
fab
select
success
express
e
coli
uniform
label
trosyhsqc
nmr
spectra
demonstr
isotopespecif
label
fab
sampl
well
suit
antibodyantigen
interact
studi
nmr
signific
chemic
shift
perturb
due
antigen
bind
observ
trosyhsqc
nmr
spectra
three
differ
fab
studi
demonstr
strategi
specif
isotop
label
fab
suitabl
prepar
sampl
fab
nmr
studi
character
interact
fab
antigen
platform
becom
extrem
use
tool
pharmaceut
biotech
commun
drug
discoveri
especi
field
antibodi
engin
yun
zhu
alan
davidson
depart
molecular
genet
univers
toronto
usa
domain
among
common
peptid
recognit
modul
eukaryot
difficult
understand
interact
network
vivo
studi
develop
compensatori
mutat
approach
identifi
biolog
relev
bind
target
domain
cerevisia
compensatori
mutat
pair
mutat
domain
bind
motif
interact
wildtyp
bind
partner
recogn
engin
mutat
wildtyp
domain
bind
motif
abl
isol
interact
interest
determin
biolog
import
vivo
use
approach
examin
interact
network
cerevisia
adaptor
protein
contain
domain
domain
shown
interact
prolinerich
motif
vitro
confirm
biolog
relev
bind
target
domain
high
temperatur
condit
also
identifi
biolog
relev
target
mate
pathway
regul
interact
import
adapt
yeast
cell
mate
pheromon
interestingli
also
import
activ
mate
pathway
function
relat
interact
summari
establish
compensatori
mutat
approach
demonstr
effect
identifi
biolog
relev
bind
target
concept
potenti
appli
understand
proteinprotein
interact
network
bacteria
remodel
peptidoglycan
network
crucial
cell
growth
divis
amia
amib
two
three
amidas
cleav
peptidoglycan
network
cell
divis
e
coli
activ
two
enzym
tightli
regul
complex
network
protein
includ
envc
ftsx
ftse
amia
amib
adopt
inact
conform
catalyt
site
occlud
autoinhibitori
helix
howev
upon
bind
lytm
domain
envc
amia
amib
postul
undergo
conform
chang
releas
autoinhibitori
helix
catalyt
site
thu
lead
enzym
activ
sought
gain
structur
inform
lytm
domain
envc
modul
amia
amib
activ
type
inform
essenti
design
small
molecul
would
activ
two
amidas
interfer
bacteri
prolifer
could
potenti
develop
potent
antibiot
use
nuclear
magnet
reson
nmr
character
interact
amib
activ
lytm
domain
envc
map
studi
nmr
reveal
bind
interfac
amiblytm
complex
also
show
contrari
current
hypothesi
interact
amib
lytm
domain
envc
appear
mediat
autoinhibitori
helix
amib
differ
region
within
amib
surfac
rna
transcript
mononegaviral
decreas
gradual
leader
singl
promot
toward
end
genom
due
decay
transcript
process
syncyti
respiratori
rsv
metapneumovirus
mpnv
protein
uniqu
virus
respons
transcript
antitermin
despit
homotetram
rsv
bind
two
molecul
rna
nt
longer
per
tetram
four
molecul
shorter
rna
bind
per
tetram
rna
oligom
show
temperatur
sensit
secondari
structur
unfold
stoichiometr
interact
fine
quantit
spectroscop
analysi
bind
data
show
posit
cooper
indic
conform
asymmetri
tetram
bind
shorter
rna
respond
model
four
independ
ident
bind
site
lower
affin
rna
bind
fast
bimolecular
associ
follow
two
slow
rearrang
correspond
inducedfit
mechan
protein
side
data
provid
sequenti
descript
time
event
cooper
first
bind
event
half
rna
molecul
one
site
increas
affin
second
bind
event
product
increas
effect
concentr
entrop
link
mechan
allow
high
affin
bind
otherwis
loos
sequenc
specif
suggest
structur
recognit
signatur
rna
modul
gene
transcript
work
provid
basi
understand
mechan
transcript
antitermin
essenti
event
ensur
transcript
polar
pneumovirus
constitut
one
kind
exampl
among
rna
virus
ra
gene
encod
small
gtpase
function
molecular
switch
regul
cellular
growth
approxim
onethird
human
cancer
contain
activ
mutat
ra
gene
codon
hotspot
posit
point
mutat
render
ra
protein
insensit
regul
result
chronic
ra
activ
constitut
oncogen
signal
histor
consid
oncogen
equival
howev
recent
observ
suggest
codonspecif
ra
mutat
show
differ
rel
abil
function
molecular
switch
engag
regul
effector
signal
tumorigen
properti
also
differ
differ
also
observ
respons
resist
specif
anticanc
therapi
thu
understand
differ
like
import
clinic
biolog
implic
better
understand
cancerspecif
ra
mutat
differ
conduct
structur
biochem
character
studi
oncogen
kra
mutat
find
distinct
oncogen
kra
mutant
differenti
alter
bind
raf
kinas
employ
nmr
elucid
differ
bind
determin
ra
band
craf
ra
bind
domain
rbd
identifi
point
mutat
craf
rbd
revert
isoform
depend
bind
bret
signal
assay
process
interrog
isoform
depend
bind
alter
signal
properti
cell
anam
qudrat
anam
qudrat
certain
diseas
eg
atherosclerosi
cancer
local
format
cell
mass
eg
plaqu
tumour
low
ph
extracellular
microenviron
secret
variou
proinflammatori
cytokin
tnfa
abil
engin
cell
seek
tnfa
sourc
allow
target
local
deliveri
therapeut
intervent
diseas
site
impart
abil
cell
natur
target
tnfa
sourc
introduc
system
protein
engin
tnfa
chimer
receptor
name
previous
engin
rhoa
name
carq
vsvg
thymidin
kinas
upon
bind
tnfa
gener
signal
signal
turn
activ
carqmedi
nonapoptot
bleb
allow
migrat
toward
tnfa
sourc
next
addit
vsvg
upon
low
ph
induct
engin
cell
fuse
tnfa
sourc
cell
final
postganciclovir
treatment
cell
undergo
death
via
suicid
mechan
assist
thymidin
kinas
henc
assembl
system
protein
form
basi
engin
cell
target
inflammatori
diseas
site
character
secret
tnfa
microenviron
low
ph
mechan
singl
antisigma
factor
like
fpvr
complex
two
differ
sigma
factor
protocol
develop
coexpress
purif
spvd
sfpvi
complex
truncat
form
fpvr
confirm
interact
protein
analyt
ultracentrifug
auc
show
express
stoichiometr
complex
furthermor
characteris
biophys
properti
complex
auc
indic
similar
bind
affin
sigma
factor
spvd
sfpvi
find
reveal
model
iron
acquisit
control
p
aeruginosa
alex
guseman
gerardo
perez
goncalv
gari
pielak
depart
chemistri
unc
chapel
hill
usa
protein
crowd
cellular
interior
influenc
interact
found
simpl
buffer
solut
hardcor
repuls
transient
chemic
interact
crowd
molecul
protein
scaledparticl
theori
predict
hardcor
repuls
littl
effect
stabil
dumbbellshap
dimer
stabil
effect
ellipsoidalspher
dimer
test
idea
use
variant
form
sidebysid
dimer
variant
form
domainswap
dimer
dimer
use
test
idea
scaledparticl
theori
sidebysid
dimer
dumbbel
shape
domainswap
dimer
ellipsoid
importantli
dimer
similar
surfac
mean
similar
chemic
interact
crowder
use
nmr
quantifi
free
energi
dissoci
ddm
dimer
predict
scaledparticl
theori
hardcor
repuls
small
effect
ddm
ddm
ddm
buffer
gl
gl
kda
peg
kcalmol
kcalmol
respect
predict
ddm
domainswap
dimer
larger
kcalmol
kcalmol
respect
support
idea
dimer
shape
modul
hardcor
repuls
support
conclus
test
effect
protein
cosolut
bovin
serum
albumin
kda
gl
lysozym
kda
gl
protein
cosolut
predict
scale
particl
theori
minim
contribut
hardcor
repuls
furthermor
ddm
valu
within
error
dimer
system
support
hypothesi
protein
crowder
interact
chemic
interact
investig
dimer
cell
use
nmr
gerardo
perez
goncalv
alex
guseman
gari
pielak
cellular
interior
complex
environ
concentr
macromolecul
exce
gl
crowd
condit
protein
experi
hardcor
repuls
chemic
interact
cytoplasm
compon
absent
buffer
alon
hardcor
repuls
stabil
globular
protein
chemic
interact
stabil
repuls
destabil
attract
studi
interact
broaden
understand
protein
biophys
cell
simplic
sake
focus
fold
howev
protein
rare
work
alon
proteinprotein
interact
give
rise
complex
architectur
variant
domain
protein
g
form
domainswap
homodim
label
sole
tryptophan
fluorin
use
nuclear
magnet
reson
spectroscopi
quantifi
effect
small
larg
cosolut
equilibrium
thermodynam
dimer
k
synthet
polym
ficol
kda
polyethylen
glycol
kda
stabil
dimer
kcalmol
kcalmol
respect
addit
observ
macromolecular
effect
monom
ficol
sucros
stabil
dimer
kcalmol
ethylen
glycol
destabil
dimer
kcalmol
also
investig
biologicallyrelev
macromolecular
cosolut
find
act
primarili
via
chemic
interact
preliminari
data
show
bovin
serum
albumin
net
charg
sign
stabil
dimer
kcalmol
lysozym
charg
opposit
sign
destabil
dimer
kcalmol
data
provid
new
insight
biophys
proteinprotein
interact
physiolog
relev
condit
crude
fiber
ash
cellulos
content
rna
content
profil
amino
acid
final
fbp
exhibit
essenti
amino
acid
present
great
quantiti
fbp
produc
fungu
shown
good
nutrit
valu
supplement
poultri
result
present
studi
practic
implic
fungu
harzianum
could
use
success
produc
fungal
biomass
protein
use
rice
polish
introduct
aim
lab
pioneer
show
famili
antioxid
call
peroxiredoxin
prdx
major
role
protect
oxid
stress
spermatozoa
howev
spermatozoa
maintain
prdx
activ
remain
unknown
aim
determin
impact
differ
reactiv
oxygen
speci
ro
level
produc
inhibit
specif
player
prdx
system
sperm
viabil
dna
oxid
experiment
approach
highli
motil
spermatozoa
healthi
donor
incub
differ
inhibitor
prdx
system
viabil
ro
level
dna
oxid
ass
flow
cytometri
result
observ
signific
decreas
viabl
cell
dose
depend
manner
incub
inhibitor
prdx
calcium
independ
phospholipas
activ
prdx
reactiv
system
compar
control
p
inhibit
strongest
detriment
effect
viabil
promot
signific
increas
ocl
onoo
dna
oxid
label
compar
control
p
inhibit
nadph
donor
reactiv
system
effect
sperm
viabil
level
howev
found
signific
increas
level
other
ro
onoo
conclus
prdx
especi
activ
essenti
maintain
sperm
viabil
dna
integr
contribut
chromosom
ccdab
operon
bacteri
drug
toler
kritika
gupta
raghavan
varadarajan
arti
tripathi
indian
institut
scienc
india
center
cancer
research
nation
cancer
institut
bethesda
maryland
usa
larg
number
freeliv
pathogen
bacteria
known
harbor
multipl
toxinantitoxin
system
plasmid
well
chromosom
fplasmid
ccdab
system
extens
studi
known
involv
plasmid
mainten
contrast
littl
known
function
chromosom
counterpart
found
sever
pathogen
ecoli
strain
show
nativ
ccd
operon
ecoli
strain
well
ccd
operon
fplasmid
insert
ecoli
chromosom
lead
protect
cell
death
multipl
antibiot
stress
condit
operon
show
higher
protect
toxin
encod
plasmid
ccd
operon
potent
gyras
inhibitor
lead
bacteri
cell
death
chromosom
encod
toxin
lead
growth
inhibit
vitro
gyras
bind
purifi
ccdbf
use
spr
show
five
fold
lower
affin
target
gyra
ccdbf
analysi
ccdbfgyras
bound
structur
indic
substitut
observ
like
disrupt
gyras
bind
confirm
studi
involv
satur
mutagenesi
ccdbf
protein
studi
demonstr
import
role
chromosom
ccd
system
bacteri
persist
implic
gener
potenti
therapeut
target
ta
system
pathogen
unravel
new
role
bacterioferritin
bfrb
pseudomona
aeruginosa
step
toward
ration
target
bacteri
iron
homeostasi
huili
yao
mario
rivera
achala
hewag
univers
kansa
usa
urgent
need
discov
novel
antibiot
due
sever
multidrug
resist
develop
mani
pathogen
among
pseudomona
aeruginosa
pa
major
pathogen
respons
lethal
infect
among
cf
cystic
fibrosi
patient
immunecompromis
patient
bacteri
iron
homeostasi
play
crucial
role
cell
growth
cell
fit
among
protein
involv
regul
bacteri
iron
concentr
iron
storag
proteinbacterioferritin
bfrb
probabl
uniqu
target
new
antibiot
develop
due
follow
reason
exist
bacteria
mobil
iron
store
bfrb
bacteri
cytosol
physiolog
partner
bfd
need
previou
studi
identifi
key
residu
stabil
bfrbbfd
interact
new
result
inhibit
bfrbbfd
interact
pa
cell
demonstr
target
bfrbbfd
interfac
expos
bacteri
vulner
perturb
bfrbbfd
interact
caus
irrevers
iron
accumul
bfrb
caus
low
free
iron
level
cytosol
irrevers
iron
accumul
bfrb
also
caus
secret
high
level
iron
chelat
whose
function
help
bacteri
cell
acquir
iron
environ
signal
acut
bacteri
iron
starvat
final
studi
also
show
iron
store
bfrb
main
sourc
iron
incorpor
ironutil
protein
henc
iron
irrevers
trap
bfrb
due
inhibit
bfrbbfd
interact
bacteri
cell
growth
inhibit
find
take
us
step
closer
longterm
goal
develop
novel
antibacteri
strategi
target
bacteri
iron
homeostasi
univers
kansa
usa
pseudomona
aeruginosa
gramneg
opportunist
pathogen
form
divers
bacteri
commun
enclos
within
extracellular
matrix
biofilm
aid
surviv
varieti
environ
grow
static
cultur
form
biofilm
airsurfac
interfac
also
known
pellicl
appear
impart
growth
advantag
sever
studi
suggest
iron
avail
import
support
variou
stage
biofilm
develop
previou
work
demonstr
main
iron
storag
protein
p
aeruginosa
bacterioferritin
bfrb
iron
mobil
bfrb
requir
specif
interact
ferredoxin
bfd
establish
dynam
equilibrium
buffer
concentr
free
iron
cytosol
present
studi
investig
implic
perturb
bfrb
bfd
interact
format
integr
p
aeruginosa
biofilm
compar
establish
stabil
pellicl
form
wild
type
strain
mutant
strain
bfrb
bfd
interact
block
frame
delet
bfrb
bfd
gene
variant
bfrb
allel
encod
bfrb
effect
mutat
evalu
timedepend
microscop
inspect
pellicl
quantit
determin
total
biofilm
mass
ii
concentr
iron
pyoverdin
pyocyanin
spent
cultur
media
result
reveal
perturb
iron
homeostasi
disrupt
bfrb
bfd
interact
caus
earli
cell
detach
concomit
biofilm
dissolut
consequ
find
suggest
inhibit
bfrb
bfd
proteinprotein
interact
advers
affect
integr
p
aeruginosa
biofilm
nucleotidebind
domain
leucinerich
repeat
pyrin
domaincontain
nlrp
protein
innat
immun
sensor
regul
inflammatori
signal
respons
wide
rang
microbi
endogen
danger
signal
prototyp
member
initi
assembl
multiprotein
inflammasom
complex
result
autoproteolyt
cleavag
activ
cystein
proteas
regul
multipl
host
defens
pathway
includ
inflammatori
cytokin
nlrp
famili
member
character
conserv
atpbind
domain
control
inflammasom
assembl
nlrp
inflammasom
underrepres
biomark
mechanist
studi
diseas
due
factor
preclud
facil
examin
low
express
lack
specif
antibodi
peculiar
biophys
characterist
link
atp
sepharos
linker
provid
effect
nlrp
captur
effici
observ
bind
particularli
sensit
atp
linkag
nlink
atp
sepharos
bind
effici
low
gammalink
atp
sepharos
appli
target
proteom
studi
fluorescencelink
enzym
chemoproteom
strategi
flec
use
screen
small
molecul
librari
sever
molecul
could
competit
elut
atpsepharos
lead
compound
benzo
inhibit
inflammasometrigg
activ
interleukin
il
atpstimul
monocyt
next
atpsepharos
enrich
success
appli
antibodyindepend
identif
selectedreact
monitor
mass
spectrometri
srmm
method
summari
atp
captur
technolog
offer
opportun
identifi
diseaseassoci
nlrp
protein
biomark
profil
drug
discoveri
initi
specif
target
atpbind
properti
nlrp
acetaminophen
apap
one
commonli
counter
medicin
also
main
caus
acut
liver
failur
north
america
hepatotox
relat
coval
bind
apap
reactiv
metabolit
nacetylpbenzoquinoneimin
napqi
protein
aim
studi
identifi
vivo
protein
target
apap
rat
mous
model
compar
result
speci
use
bottomup
proteom
approach
sampl
prepar
involv
protein
extract
digest
rat
mous
liver
sampl
liver
extract
digest
trypsin
pepsin
subject
strong
cation
exchang
scx
prior
reversedphas
uhplmsm
data
process
involv
use
proteinpilot
softwar
find
potenti
modifi
peptid
follow
verif
peak
integr
compar
apaptr
sampl
control
remov
potenti
fals
posit
current
sever
protein
identifi
modifi
napqi
includ
ubiquitinconjug
enzym
hydrolas
carboxylesteras
domaincontain
ring
finger
protein
mous
two
modifi
protein
found
mous
rat
includ
carbon
anhydras
triosephosph
isomeris
protein
known
involv
sever
import
biolog
pathway
involv
cell
surviv
oxid
stress
could
potenti
link
hepatotox
apap
modifi
protein
compar
rat
mous
strengthen
understand
acetaminophen
toxic
speci
differ
futur
verif
modifi
peptid
potenti
biomark
hepatotox
use
peptid
standard
msm
retent
time
match
follow
immunoglobulin
g
igg
kda
molecul
abund
serum
protein
describ
sensit
glycat
nitrat
oxid
modif
amongst
post
translat
modif
glycat
oxid
common
deserv
special
attent
increas
evid
suggest
role
glycoxid
onset
progress
rheumatoid
arthriti
ra
studi
design
elabor
cumul
effect
glycat
use
methylglyox
oxid
use
hydroxyl
radic
igg
refer
ra
found
appreci
bind
ra
autoantibodi
toward
epitop
hydroxyl
radic
modifi
methylglyox
glycat
igg
furthermor
spectroscop
character
igg
isol
ra
patient
raigg
reveal
structur
chang
comparison
igg
healthi
human
subject
nhigg
hyperchrom
uv
absorb
spectroscopi
quench
fluoresc
spectroscopi
decreas
sheet
content
faruv
cd
spectroscop
analysi
shift
amid
ii
band
ftir
spectroscopi
induc
damag
raigg
evalu
antibodi
gener
femal
rabbit
use
competit
bind
immunoassay
compar
nhigg
raigg
observ
specif
toward
immunogen
result
confirm
igg
ra
patient
prone
glycoxid
induc
structur
damag
lead
gener
neoepitop
render
protein
immunogen
byssu
intrigu
collagenbas
polym
secret
mussel
use
secur
anim
harsh
marin
condit
matur
filament
uniqu
mechan
adhes
properti
therefor
potenti
applic
bioinspir
materi
consid
mechan
byssogenesi
yet
fulli
understood
highresolut
tandem
mass
spectrometri
hrmsm
studi
perform
identifi
potenti
byssu
relat
protein
foot
organ
three
mytilida
mussel
mussel
foot
mantl
tissu
homogen
mechan
sonic
probe
prior
protein
precipit
extract
digest
complementari
enzym
trypsin
pepsin
separ
fraction
perform
protein
peptid
level
use
offlin
chromatographi
lcmsm
analysi
perform
hybrid
quadrupoletimeofflight
platform
protein
exclus
found
mussel
foot
mine
biolog
physicochem
inform
solubilis
issu
advers
affect
proteinlevel
fraction
therefor
give
satisfactori
result
differenti
analysi
foot
mantl
control
dataset
yield
list
protein
exclus
found
mussel
foot
total
number
uniqu
foot
protein
strong
cation
exchang
scx
reversephas
rp
peptid
fraction
compar
prefraction
scx
rp
fraction
gave
similar
result
protein
respect
wherea
less
half
identifi
nonfraction
sampl
protein
coverag
also
much
better
fraction
strategi
biolog
investig
thirti
candid
reveal
crucial
protein
secur
adhes
tough
promot
transcript
promot
effici
multidimension
lcmsm
approach
develop
analysi
mussel
tissu
strong
cation
exchang
revers
phase
fraction
demonstr
similar
protein
identif
perform
constanc
jefferi
wangfei
wang
univers
illinoi
chicago
usa
cell
surfac
protein
bacteri
pathogen
play
key
role
invas
virul
colon
requir
adhes
bacterium
host
tissu
surfac
protein
bind
extracellular
matrix
host
cell
other
bind
plasminogen
convert
activ
proteas
plasmin
aid
degrad
invas
host
tissu
surprisingli
dozen
cell
surfac
protein
bind
host
cell
extracellular
matrix
plasminogen
previous
identifi
intracellular
enzym
chaperon
refer
intracellularsurfac
moonlight
protein
known
protein
secret
possess
signal
peptid
motif
secret
sec
secret
system
noncanon
secret
system
contain
sequenc
motif
known
involv
attach
cell
surfac
secret
cell
surfac
attach
may
involv
novel
version
known
mechan
yet
unknown
mechan
project
involv
identifi
addit
intracellularsurfac
moonlight
protein
mechan
involv
secret
cell
surfac
attach
increas
problem
antibiot
resist
new
target
inhibit
bacteri
infect
need
understand
intracellularcel
surfac
moonlight
protein
target
surfac
pathogen
might
lead
method
decreas
abil
bacteria
bind
degrad
host
tissu
could
provid
new
target
develop
therapeut
treat
infect
kind
synthes
ferul
acid
deriv
made
halogen
ferul
acid
deriv
properti
like
matrix
matrixassist
laser
desorptionion
time
flight
mass
spectrometri
particularli
seem
usabl
identif
protein
structur
analysi
peptid
properti
compar
gener
matric
acid
chca
acid
dhba
ferul
acid
ferul
acid
show
unexpect
good
qualiti
mass
spectrum
mass
finger
print
pmf
analysi
transferrin
gave
higher
intens
chca
molecular
weight
region
therefor
halogen
matric
seem
avail
detect
rel
larg
molecular
peptid
moreov
test
matrix
msm
analysi
carri
rapid
amino
acid
sequenc
use
matrixassist
laser
desorptionion
quadrupol
ion
trap
time
flight
mass
spectrometri
gener
ion
cluster
reflect
cleavag
peptid
bond
score
mascot
databas
search
rel
better
dhba
tryptic
peptid
transferrin
synthes
peptid
therefor
deriv
appli
actual
identif
protein
prepar
mous
brain
sampl
seem
advantag
analyz
bigger
size
peptid
addit
suggest
effect
matric
peptid
includ
prolin
cyclooxygenas
dual
function
enzym
catalyz
sequenti
cyclooxygenaseperoxidas
reaction
lipid
substrat
mammal
cyclooxygenas
convert
arachidon
acid
prostaglandin
precursor
synthesi
biolog
activ
prostaglandin
exampl
cyclooxygenas
report
mani
lower
eukaryot
includ
coral
red
alga
gracilaria
bioinformat
analys
identifi
eleven
structur
homolog
eukaryot
cyclooxygenas
bacteri
origin
studi
describ
clone
express
character
put
cyclooxygenas
three
differ
bacteri
speci
enzym
express
ntermin
tag
purifi
greater
homogen
two
three
enzym
exhibit
hemedepend
peroxidas
activ
lack
third
previous
character
linol
assay
explor
lipid
oxid
progress
result
lipid
substrat
specif
oxid
product
present
comparison
predict
structur
enzym
three
speci
use
help
understand
observ
differ
activ
eph
famili
receptor
tyrosin
kinas
ephr
regul
wide
rang
cellcel
commun
event
cell
adhes
migrat
tissu
boundari
format
howev
molecular
mechan
ephr
mediat
process
far
understood
address
question
aim
identifi
new
ephr
downstream
effector
protein
determin
requir
eph
function
first
unravel
ephrdepend
signal
complex
appli
mass
spectrometrybas
bioid
approach
obtain
proxim
network
four
ephr
name
identifi
protein
major
previous
link
eph
signal
bioinformat
analysi
reveal
core
signal
network
protein
share
four
ephr
next
start
explor
effect
lossoffunct
bioididentifi
candid
ephdepend
cell
sort
repuls
assay
preliminari
experi
show
deplet
block
segreg
cell
cell
demonstr
could
downstream
mediat
ephr
overal
research
lead
better
understand
ephr
signal
pathway
provid
invalu
insight
mechan
ephr
affect
cell
behavior
illumin
specif
landscap
hcv
proteas
use
comput
next
gener
sequenc
manasi
peth
aliza
rubenstein
sagar
khare
dmitri
zorain
chemistri
chemic
biolog
rutger
univers
new
jersey
usa
cbmb
rutger
univers
new
jersey
usa
proteas
central
process
transfer
biolog
inform
viral
system
encod
proteas
need
precis
cleavag
polyprotein
replic
viral
assembl
eg
hcv
proteas
hcv
proteas
multifunct
proteas
like
result
posit
select
pressur
maintain
cleavabl
five
nativ
substrat
ie
known
site
polyprotein
neg
select
pressur
avoid
cleavag
site
polyprotein
map
specif
landscap
hcv
proteas
obtain
comprehens
understand
proteasesubstr
interact
network
use
vivo
yeast
surfac
display
assay
order
isol
popul
cleav
partial
cleav
uncleav
substrat
use
fluoresc
assist
cell
sort
popul
analyz
use
nextgen
sequenc
technolog
comput
model
use
rosetta
amber
packag
gener
forc
direct
graph
librari
discov
partial
cleav
sequenc
act
pit
stop
evolutionari
trajectori
function
substrat
nonfunct
substrat
abl
reconstruct
entir
million
sequenc
hcv
substrat
landscap
learn
sequenc
identifi
experi
use
svm
base
approach
predict
valid
sequenc
lie
network
explor
influenc
preval
drug
resist
proteas
mutant
tripl
mutant
substrat
specif
landscap
studi
deepen
understand
robust
proteasesubstr
landscap
also
pave
way
creat
design
proteas
sea
anemon
produc
varieti
peptid
protein
contain
biolog
activ
pharmacolog
biotechnolog
interest
compon
isol
crude
extract
whole
bodi
tentacl
mucou
secret
cover
entir
bodi
marin
organ
describ
analysi
proteom
transcirptom
profil
mucu
tentacl
sampl
obtain
sea
anemon
anthopleura
dowii
verril
mexican
pacif
use
proteom
approach
profil
protein
compon
adowii
verril
total
protein
identifi
protein
involv
variou
biolog
function
secret
adhes
neurotox
regul
enzym
activ
antioxid
structur
prolifer
cell
death
metabol
process
other
use
rnaseq
allow
identif
quantif
bioactiv
compound
biotechnolog
import
transcriptom
dowii
verril
raw
read
illumina
technolog
sequenc
transcirptom
read
assembl
triniti
pipelin
result
contig
bp
averag
length
bp
work
provid
first
transcriptom
proteom
sea
anemon
dowii
verril
inform
present
may
use
identifi
new
molecul
biotechnolog
pharmaceut
relev
work
support
consejo
nacion
de
ciencia
tecnolog
conacyt
grant
number
dna
damag
respons
ddr
reli
special
protein
sensor
detect
signal
repair
dna
lesion
therebi
maintain
genom
stabil
singlestrand
dna
ssdna
bind
complex
rpa
critic
ddr
factor
detect
persist
stretch
ssdna
induc
dna
break
replic
impedi
rpassdna
act
platform
recruit
larg
number
genom
mainten
factor
includ
atr
checkpoint
kinas
signal
replic
problem
repair
genom
recent
identifi
ubiquitin
ligas
key
player
pathway
rapidli
recruit
onto
rpassdna
function
ubiquitin
ligas
enhanc
atr
activ
dna
repair
replic
fork
restart
specif
ubiquityl
substrat
regul
process
still
unclear
use
labelfre
proteom
approach
systemat
identifi
constitut
dna
damageinduc
interactor
show
interact
critic
dna
helicas
rpassdna
platform
respons
dna
damag
use
immunofluoresc
assay
establish
regul
accumul
specif
dna
helicas
rpassdna
also
regul
ubiquityl
helicas
replic
stress
promot
genom
stabil
data
provid
comprehens
landscap
interactor
provid
much
need
insight
mani
role
genom
mainten
great
lake
fisheri
provid
bounti
sourc
protein
indigen
peopl
howev
concern
fish
consumpt
contamin
exposur
popul
sera
fish
consum
great
lake
basin
analyz
legaci
chemic
polychlorin
biphenyl
organochlorin
pesticid
assess
differenti
accumul
contamin
respect
fish
consumpt
proteom
relat
contamin
enrich
current
studi
doubleblind
studi
legaci
contamin
residu
analyz
random
order
sera
exhibit
lowest
level
adopt
control
parallel
sera
also
analyz
blindli
proteom
method
controlexpos
sampl
segreg
base
contamin
level
sampl
with
lowest
level
pcb
consid
control
elev
level
denot
expos
legaci
chemic
analysi
perform
use
cdc
method
employ
isotop
dilut
mass
spectrometri
proteom
analysi
perform
albumin
deplet
separ
sdspage
follow
ingel
trypsin
digest
nanolcmsm
analysi
nanoacqu
uplc
coupl
qtof
ultima
api
mass
spectromet
water
addit
sera
also
digest
trypsin
insolut
follow
nanolcm
ms
analysi
two
method
ingel
insolut
digest
complement
initi
scout
run
insolut
digest
nanolcmsm
analysi
complet
addit
indepth
analys
current
underway
obstruct
sleep
apnea
osa
affect
adult
popul
associ
sever
atrial
diseas
character
transient
cessat
respir
last
second
due
narrow
occlus
upper
airway
sleep
although
clinic
evid
link
osa
proarrhythma
atrial
chang
well
known
molecular
mechan
osa
caus
atrial
diseas
remain
elus
initi
recent
develop
rat
model
close
recapitul
characterist
osa
studi
osainduc
cardiac
chang
male
spragu
dawley
rat
age
day
receiv
surgic
implant
tracheal
balloon
inflat
caus
transient
airway
obstruct
apnea
group
experienc
apnea
per
hour
either
second
moder
apnea
second
sever
apnea
week
hour
per
day
control
rat
receiv
surgeri
inflat
proteom
analysi
done
rat
atria
homogen
identifi
dysregul
protein
moder
sever
apnea
compar
control
sdspage
perform
gel
band
trypsin
digest
obtain
peptid
mixtur
peptid
analyz
nano
acquiti
uplc
coupl
xevo
mass
spectromet
proteom
analysi
reveal
enzym
glycolysi
protein
relat
oxid
phosphoryl
downregul
sever
apnea
group
contrast
sever
structur
prohypertroph
protein
upregul
chronic
osa
data
suggest
chronic
osa
caus
protein
chang
lead
cessat
glycolysi
diminish
capac
gener
reduc
equival
ie
nadh
well
promot
cardiac
hypertrophi
sever
key
point
plasmidencod
nicotin
catabol
pathway
soil
bacterium
arthrobact
nicotinovoran
still
miss
data
regul
nicotin
catabol
gene
nicotinetransport
protein
requir
pathway
could
success
use
detoxif
nicotinecontain
wast
andor
product
use
nicotinederiv
current
work
attempt
provid
data
identifi
nicotinecatabol
relat
protein
nicotinovoran
use
nanolcmsm
cell
free
extract
nicotinovoran
grown
without
nicotin
separ
sdspage
maxi
gradient
gel
stain
commasi
brilliant
blue
protein
current
digest
trypsin
result
peptid
mixtur
analyz
nanoacqu
uplc
coupl
qtof
ultima
api
mass
spectromet
data
process
analysi
achiev
inhous
protein
lynx
global
server
mascot
server
scaffold
softwar
simpl
examin
coomassiestain
gel
reveal
differ
proteom
nicotineuntr
nicotinetr
bacteria
sever
extra
band
rang
kda
could
identifi
nicotinegrown
bacteria
extract
one
nicotinerel
band
identifi
kata
chromosom
hemebind
catalas
kata
might
help
protect
bacteri
cell
reactiv
oxygen
speci
gener
oneelectron
reduct
nicotin
endproduct
comprehens
proteom
analysi
current
way
experi
allow
us
identifi
nicotinecatabol
relat
protein
better
understand
pathway
integr
gener
metabol
cell
nicotin
catabol
enzym
might
also
find
applic
biotechnolog
bone
tissu
hold
inform
regard
physiolog
statu
individu
cellular
compon
miner
extracellular
matrix
particip
homeostat
event
despit
specif
protein
express
profil
differ
skelet
compon
unknown
aim
identifi
organspecif
protein
marker
bone
tissu
skull
rib
obtain
inform
regard
premortem
event
patholog
caus
death
perform
analysi
bone
piec
skull
rib
obtain
postmortem
individu
admit
institut
forens
scienc
incifo
mexico
citi
protein
extract
perform
follow
deminer
protocol
recov
protein
associ
bone
matrix
protein
separ
sdspage
express
pattern
determin
densitometr
analysi
mass
spectrometri
final
western
blot
assay
perform
determin
presenc
protein
marker
extract
method
allow
recoveri
protein
two
type
bone
differ
structur
physiolog
characterist
analysi
electrophoret
pattern
protein
marker
indic
differ
protein
express
two
analyz
bone
type
result
suggest
express
protein
bone
tissu
event
depend
physiolog
mechan
requir
bone
subject
identifi
protein
could
use
establish
possibl
premortem
condit
addit
strategi
identif
biomark
could
appli
forens
anthropolog
purpos
project
submit
approb
ethic
research
institut
committe
fmunam
rddm
support
scholarship
dgapaunam
postdoctor
scholarship
program
oncoprotein
frequent
mutat
pancreat
colon
lung
cancer
local
cytoplasm
membran
requir
farnesyl
proteolyt
cleavag
carboxymethyl
ctermin
cy
residu
inactiv
kra
process
enzym
genet
small
molecul
inhibit
may
result
gener
differ
form
kra
lack
complet
set
ctermin
modif
prenyl
proteolysi
andor
methyl
develop
method
would
allow
us
identifi
protein
form
proteolysi
mass
spectrometri
express
purifi
gkekmskdgkkkkkksktkc
farn
peptid
peptid
express
fusion
protein
baculovirusinsect
cell
express
system
engin
coexpress
human
farnesyl
transferas
protein
affin
purifi
imac
via
tag
follow
cex
cleavag
proteas
final
step
purif
remov
histag
protein
final
imac
step
peptid
cleav
gluc
proteas
gener
kmskdgkkkkkksktkc
farn
gkkkkkksktkc
farn
purifi
hplc
quantifi
amino
acid
analysi
use
standard
target
proteom
peptid
correspond
cterminu
unprocess
kmskdgkkkkkksktkcvim
purifi
gluc
digest
peptid
use
develop
target
proteom
method
detect
quantif
kra
ctermin
peptid
shimadzu
system
consist
hplc
pump
tripl
quadrupol
mass
spectromet
method
allow
studi
state
cterminu
cell
express
wild
type
mutant
kra
well
differ
tag
kra
support
nci
contract
moham
abufarha
preethi
cherian
irina
alkhairi
jehad
abubak
recent
shown
induc
betacel
prolifer
regul
triglycerid
tg
fatti
acid
metabol
show
increas
sequenc
variant
gene
associ
higher
fbg
level
kuwaiti
object
identifi
protein
regul
function
vitro
identifi
new
target
protein
might
involv
function
lipid
regul
cross
section
studi
design
examin
level
nondiabet
arab
identifi
sequenc
variant
use
sanger
sequenc
associ
variou
clinic
paramet
studi
conform
principl
outlin
declar
helsinki
approv
ethic
review
committe
dasman
diabet
institut
ddi
inform
written
consent
obtain
particip
enrol
studi
data
show
first
time
arab
heterozygot
form
higher
level
fast
blood
glucos
fbg
wild
type
variant
flag
tag
express
test
use
flag
antibodi
overexpress
cell
result
chang
number
protein
express
select
number
differenti
express
protein
identifi
lcm
famili
member
involv
lipid
metabol
ajay
wagh
kakoli
bose
background
object
serin
proteas
high
temperatur
requir
proteas
involv
apoptosi
protein
qualiti
control
howev
one
murin
inact
mutant
aka
associ
motor
neuron
degener
similarli
conserv
mutat
human
also
render
proteas
inact
implic
pathogen
howev
structur
determin
inactiv
yet
elucid
therefor
object
understand
structur
correl
inact
pathogen
associ
mutat
use
multidisciplinari
approach
method
secondari
tertiari
structur
character
wildtyp
mutant
done
use
cd
fluoresc
spectroscopi
chromatographi
dynam
light
scatter
employ
compar
oligomer
properti
structur
comparison
atom
resolut
perform
use
xray
crystallographi
result
enzym
kinet
show
inact
spectroscop
probe
identifi
major
structur
chang
mutant
structur
analys
resolut
show
subtl
yet
critic
structur
chang
ctermin
regulatori
domain
residu
critic
oxyanion
hole
format
crystallograph
data
also
highlight
import
water
molecul
might
play
critic
role
mediat
intermolecular
interact
maintain
function
ensembl
proteas
conclus
overal
crystallograph
data
along
ongo
function
studi
help
deciph
structur
basi
inact
implic
neurodegener
also
shed
light
residu
import
complex
alloster
mechan
activ
program
protein
degrad
via
ubiquitinproteasom
system
import
control
signal
regulatori
pathway
specif
target
substrat
perform
ligas
human
complex
parallel
transcript
translat
regul
recent
work
highlight
role
protein
structur
disord
regul
substrat
turnov
experiment
literatur
first
collect
dataset
ligasesubstr
pair
order
studi
degrad
signal
degron
trigger
protein
turnov
base
systemat
bioinformat
analysi
propos
multilevel
degron
architectur
tightli
control
decisionmak
protein
degrad
primari
degron
specifi
substrat
recognit
cognat
short
peptid
motif
constitut
import
class
primari
degron
almost
exclus
present
within
disord
region
primari
degron
sequenc
strongli
conserv
among
ortholog
occur
disord
segment
undergo
foldinguponbind
posttransl
modif
switch
primari
degron
state
therebi
integr
degrad
signal
pathway
secondari
degron
compris
singl
multipl
neighbor
ubiquitin
substrat
lysin
often
locat
proxim
primari
degron
therefor
part
disord
segment
final
experi
predict
show
initi
degrad
proteasom
requir
partial
disord
region
tertiari
degron
facilit
substrat
entri
proteasom
core
distribut
natur
degron
ensur
specif
regulatori
control
degrad
furthermor
sinc
disord
segment
may
accommod
multipl
bind
partner
enabl
degron
mask
via
overlap
bind
site
partner
involv
trigger
degrad
balanc
compet
interact
determin
spatiotempor
control
protein
degrad
daniel
kraut
mari
cundiff
william
dewey
eden
reichard
nichola
nassif
villanova
univers
pennsylvania
usa
eukaryot
cell
protein
target
proteasom
degrad
polyubiquitin
protein
bind
ubiquitin
receptor
engag
unfold
proteasom
atpas
process
degrad
factor
determin
extent
proteasom
success
unfold
degrad
substrat
still
poorli
understood
previous
found
architectur
polyubiquitin
chain
attach
substrat
affect
proteasom
abil
unfold
degrad
substrat
mixedlinkag
chain
lead
greater
process
chain
ubiquitinindepend
target
substrat
proteasom
gave
substanti
lower
process
degrad
ubiquitindepend
target
thu
even
though
ubiquitin
chain
remov
earli
degrad
substrat
engag
remark
dramat
affect
later
unfold
protein
domain
ubiquitin
chain
differenti
activ
proteasom
one
attract
candid
ubiquitin
receptor
mutat
prevent
ubiquitin
bind
led
drastic
unfold
defect
earli
degrad
process
use
destabil
substrat
allow
initi
degrad
occur
easili
found
process
defect
depend
ubiquitin
chain
linkag
substrat
similar
result
found
ubiquitin
receptor
doubl
mutant
essenti
elimin
ubiquitinbas
activ
proteasom
conclud
linkagebas
differ
allow
substrat
interact
one
ubiquitin
receptor
activ
proteasom
unfold
abil
structur
yeast
trna
ligas
reveal
competit
nonconvent
mrna
splice
rna
decay
peter
jirka
peter
walter
ucsf
california
usa
yeast
trna
ligas
essenti
trifunct
enzym
consist
cyclic
phosphodiesteras
polynucleotid
kinas
atpdepend
rna
ligas
catalyz
exonexon
ligat
trna
halfmolecul
trna
splice
also
requir
mrna
splice
unfold
protein
respons
upr
upr
intracellular
signal
network
monitor
protein
fold
capac
endoplasm
reticulum
er
upon
sens
protein
fold
perturb
er
kinaseendonucleas
initi
upr
signal
uniqu
mechan
nonconvent
cytoplasm
splice
reaction
remov
intron
mrna
follow
exonexon
ligat
allow
product
transcript
factor
drive
transcript
respons
splice
reaction
orchestr
fidel
ensur
stress
signal
remain
outstand
question
report
crystal
structur
rna
ligas
domain
thermophil
fungu
chaetomium
thermophilum
resolut
molecular
architectur
activ
site
reveal
principl
rna
substrat
recognit
mutant
variant
uncoupl
function
output
vivo
allow
us
identifi
competit
rna
ligat
degrad
mrna
splice
result
show
function
import
mrna
decay
pathway
ribosomeassoci
qualiti
control
maintain
fidel
nonconvent
splice
reaction
furthermor
enzym
found
human
fungal
pathogen
potenti
drug
target
differ
mammalian
trna
splice
enzym
find
provid
structur
insight
ligand
bind
enabl
chemic
inhibit
trna
ligas
pathogen
fungi
teleostei
includ
salmonid
fish
indetermin
grower
maxim
growth
rate
observ
first
year
young
salmonid
northern
lowproduct
watercours
white
sea
basin
character
decreas
growth
rate
river
period
life
increas
smoltif
age
compar
conspecif
lowerlatitud
watercours
fish
growth
mostli
determin
accumul
skelet
muscl
protein
reli
balanc
protein
synthesi
degrad
although
proteolysi
limit
rate
muscl
growth
fish
role
proteolyt
system
respons
degrad
myofibrillar
protein
well
defin
among
proteindegrad
system
calciumdepend
proteolysi
domin
total
muscl
protein
degrad
teleost
fish
proteasom
digest
play
minor
role
neg
correl
proteas
activ
fish
muscl
growth
increment
shown
atlant
salmon
salar
brown
trout
trutta
signific
decreas
calpain
proteasom
activ
well
continu
decreas
growth
increment
show
first
year
salmonid
life
lowest
level
calpain
proteasom
activ
detect
larger
individu
salmon
trout
enter
smoltif
stage
common
specif
mechan
control
proteolysi
salmonid
growth
growth
hormon
endogen
inhibit
evalu
research
support
russian
scientif
foundat
project
aggregationinduc
proteotox
proteostasi
collaps
link
progress
number
protein
misfold
disord
includ
huntington
diseas
hd
caus
expans
trinucleotid
repeat
sequenc
huntingtin
gene
result
misfold
aggreg
mutant
huntingtin
associ
variou
deleteri
effect
cellular
phenotyp
studi
aggreg
mutant
huntingtin
use
yeast
model
hd
dietari
restrict
dr
report
benefici
effect
surviv
mani
lower
organ
although
benefit
higher
anim
clear
dr
induc
mild
stress
activ
cellular
stress
respons
machineri
consequ
advantag
cell
studi
show
dr
offer
benefit
fact
detriment
cell
proteotox
challeng
find
although
cell
activ
stress
respons
pathway
challeng
individu
protein
aggreg
dr
combin
two
factor
huntingtin
aggreg
drinduc
cell
dampen
cellular
stress
respons
work
also
show
level
two
compon
heat
shock
respons
viz
chemic
chaperon
trehalos
heat
shock
protein
fine
tune
cell
express
aggreg
huntingtin
level
one
compon
exceed
threshold
level
respons
aggregationinduc
stress
even
absenc
compon
conclud
variou
arm
proteostasi
tightli
regul
uncontrol
stress
lead
unregul
respons
mitochondri
process
peptidas
mpp
metallopeptidas
cleav
mitochondri
target
signal
major
nuclearencod
mitochondri
protein
mutat
mpp
substrat
implic
variou
neurodegen
diseas
includ
parkinson
diseas
pd
nonprogress
cerebellar
ataxia
one
implic
substrat
kinas
whose
mutat
known
caus
earlyonset
autosom
pd
healthi
mitochondria
constitut
import
cleav
first
mpp
retrotransloc
cytosol
proteasom
degrad
regard
mpp
act
key
junction
import
proteolysi
overal
mitochondri
qualiti
control
howev
mpp
cleavag
site
bind
conform
remain
unknown
gain
insight
proteolyt
mechan
concern
diseaseimpl
substrat
begun
character
human
mpp
heterodim
demonstr
human
mpp
dimer
success
purifi
coexpress
system
e
coli
also
develop
proteomicsbas
method
monitor
mpp
activ
use
synthet
presequ
malat
dehydrogenas
posit
control
research
cleavag
site
mechan
cleavag
current
ongo
laboratori
probe
determin
collagen
flexibl
use
atom
forc
microscopi
aaron
lyon
nanci
ford
naghmeh
rezaei
nanci
ford
depart
physic
simon
fraser
univers
vancouv
canada
primari
loadand
tensionbear
protein
mammal
mechan
properti
collagen
signific
biomed
interest
virtu
high
aspect
ratio
flexibl
collagen
monom
kda
tripl
helic
structur
nm
length
nm
diamet
describ
tool
polym
physic
howev
experiment
estim
collagen
rigid
span
nearli
order
magnitud
leav
mechan
properti
protein
unresolv
address
dispar
develop
method
extract
quantit
metric
collagen
flexibl
atom
forc
microscop
afm
imag
result
demonstr
collagen
flexibl
strongli
influenc
environment
condit
includ
ph
ionic
strength
surprisingli
find
minim
variat
rigid
differ
form
collagen
despit
differ
physiolog
context
new
tool
futur
goal
includ
extens
method
sequencedepend
analysi
collagen
flexibl
phosphatas
regener
liver
prl
highli
oncogen
yet
mechan
action
remain
controversi
recent
studi
propos
prl
oncogen
mediat
regul
famili
magnesium
transport
cnnm
present
xray
crystal
structur
three
differ
prlcnnm
complex
reveal
molecular
basi
complex
format
zhang
et
al
scientif
report
show
prl
function
pseudopseudophosphatas
bind
cnnm
protein
control
prl
phosphoryl
catalyt
cystein
residu
gulerez
et
al
embo
report
vivo
prl
endogen
phosphoryl
cystein
high
level
phosphoryl
chang
respons
magnesium
level
studi
suggest
prl
act
molecular
switch
combin
properti
pseudophosphatas
true
phosphatas
use
hydrogen
deuterium
exchang
mass
spectroscopi
hdxm
small
angl
xray
scatter
sax
engin
minim
complex
consist
eed
activ
amen
crystal
crystal
structur
inhibitorbound
wildtyp
reveal
surpris
ligand
bind
mode
structur
illumin
import
role
play
stretch
amino
acid
residu
ntermin
region
call
activ
loop
stimul
enzym
activ
inhibitor
recognit
potenti
develop
mutat
mediat
drug
resist
crystal
structur
inhibitor
wt
nearli
ident
consist
sensit
inhibitor
hdxm
analysi
oncogen
mutant
suggest
substitut
far
reach
consequ
protein
dynam
rather
creat
spaciou
substrat
bind
site
work
present
provid
new
avenu
design
develop
next
gener
inhibitor
establish
structurebas
drug
design
platform
offer
key
insight
interplay
activ
pyridon
base
inhibitor
recognit
ivi
yeuk
wah
chung
legionella
pneumophila
intracellular
pathogen
caus
legionnair
diseas
human
l
pneumophila
found
fresh
water
environ
freeliv
organ
also
intracellular
parasit
protozoa
l
pneumophila
becom
infecti
human
aerosol
pathogen
inhal
come
contact
alveolar
mucosa
l
pneumophila
primarili
replic
macrophag
macrophag
amoeba
defens
bacteri
pathogen
phagocytosi
subsequ
fusion
phagosom
endosom
compart
kill
pathogen
interestingli
l
pneumophila
enter
host
cell
phagocytosi
l
pneumophila
contain
phagosom
segreg
phagocyt
matur
pathway
instead
fuse
erderiv
secretori
vesicl
membran
result
format
legionella
contain
vacuol
l
pneumophila
replic
intracellularli
l
pneumophila
achiev
subvert
mani
host
cellular
process
eg
apoptosi
transcript
secretori
transport
ubiquitin
secret
effector
molecul
doticm
type
iv
secret
system
present
structur
function
studi
l
pneumophila
effector
rava
much
known
carboxyl
termin
glutam
rich
sequenc
report
import
transloc
express
ravagfp
cell
show
juxtanuclear
local
local
depend
ctermin
region
structur
analysi
reveal
ntermin
region
consist
four
structur
repeat
like
involv
interact
host
protein
potenti
rava
target
present
investig
yeast
twohybrid
system
proteom
approach
nonribosom
peptid
synthetas
nrpss
true
macromolecular
machin
use
modular
assemblylin
logic
complex
catalyt
cycl
move
part
multipl
activ
site
make
structur
divers
small
molecul
determin
seri
crystal
structur
initi
modul
antibioticproduc
nrp
linear
gramicidin
synthetas
modul
includ
special
tailor
formyl
domain
captur
state
repres
everi
major
step
assemblylin
synthesi
initi
modul
structur
illustr
formyl
domain
incorpor
nrp
architectur
evolv
act
concert
domain
initi
process
substanti
conform
chang
occur
sequenti
step
synthet
cycl
peptidyl
carrier
protein
adenyl
subdomain
undergo
immens
movement
shuttl
substrat
distal
activ
site
structur
highlight
great
versatil
nrpss
small
domain
repurpos
recycl
limit
interfac
interact
variou
bind
partner
togeth
publish
unpublish
work
present
holist
view
function
eleg
nrp
initi
modul
univers
michigan
usa
cytochrom
membran
bound
protein
vital
regul
cytochrom
metabol
capabl
electron
transfer
mani
redox
partner
use
cyt
c
surrog
report
effect
membran
interact
fulllength
cyt
c
first
time
shown
stoppedflow
kinet
experi
electron
transfer
capabl
cyt
c
complex
form
incorpor
isotrop
bicel
lipid
nanodisc
chemic
shift
perturb
differenti
line
broaden
data
measur
nmr
experi
use
map
bind
interfac
cyt
c
experiment
result
identifi
differ
bind
epitop
presenc
absenc
membran
notabl
presenc
membran
engag
cyt
c
lower
upper
cleft
membranefre
also
use
distal
region
use
restraint
gener
cyt
c
complex
structur
gener
electron
transfer
pathway
identifi
result
demonstr
import
studi
membran
proteinprotein
complex
format
nativ
lipid
environ
result
also
demonstr
success
prepar
novel
peptidebas
lipid
nanodisc
system
detergentfre
possess
size
flexibl
use
nmr
structur
studi
membran
protein
topoisomeras
essenti
function
prevent
hyperneg
supercoil
dna
topoisomeras
mycobacterium
tuberculosi
essenti
viabil
organ
surviv
murin
model
pursu
novel
target
discoveri
new
therapeut
agent
treatment
drugresist
tuberculosi
structur
toroidshap
ntermin
domain
e
coli
topoisomeras
report
ten
year
ago
structur
even
domain
arrang
ctermin
region
topoisomeras
remain
elus
recent
studi
past
two
year
determin
fulllength
structur
e
coli
topoisomeras
unveil
ctermin
domain
includ
three
zinc
ribbon
domain
two
zinc
ribbonlik
domain
bind
ssdna
primarili
stack
interact
also
analyz
domain
arrang
ctermin
region
success
obtain
first
crystal
structur
includ
four
ntermin
domain
first
ctermin
domain
first
ctermin
domain
expect
repres
four
ctermin
domain
reveal
novel
fold
key
potenti
dnabind
residu
nonribosom
peptid
synthetas
nrpss
larg
multimodular
enzym
produc
interest
bioactiv
product
typic
modul
contain
three
domain
requir
peptid
chain
elong
adenyl
condens
c
peptidyl
carrier
protein
pcp
domain
modul
activ
amino
acid
substrat
attach
pcp
domain
add
grow
peptid
condens
c
domain
process
occur
everi
modul
product
releas
final
modul
nrpss
c
domain
replac
heterocycl
cy
domain
domain
first
perform
condens
ad
modul
cystein
threonin
serin
substrat
peptid
chain
perform
second
reaction
intramolecular
cyclodehydr
side
chain
backbon
carbonyl
form
thiazolin
methyl
oxazolin
ring
bacillamid
synthetas
bmdb
thermoactinomyc
vulgari
nrp
includ
cy
domain
catalyz
peptid
bond
format
alaninepcp
cysteinepcp
follow
thiazolin
ring
format
afterward
next
c
domain
perform
condens
reaction
free
tryptamin
form
bacillamid
e
addit
transact
protein
identifi
within
biosynthet
cluster
bmda
decarboxyl
tryptophan
produc
tryptamin
bmdc
oxid
thiazolin
ring
bacillamid
e
make
bacillamid
goal
elucid
time
detail
bacillamid
biosynthesi
crystallographi
biochem
assay
reconstitut
entir
bacillamid
biosynthet
pathway
vitro
determin
structur
cy
domain
bmdb
bmdc
oxidas
protein
provid
valuabl
insight
bacillamid
synthesi
choic
membran
mimet
studi
integr
membran
protein
critic
experiment
success
deterg
often
easiest
mimet
implement
extens
deterg
screen
may
need
find
suitabl
proteindeterg
pair
nonion
deterg
becom
key
tool
studi
challeng
multicompon
unstabl
membran
protein
dodecyl
melibios
ddmb
novel
nonion
deterg
whose
apt
membran
protein
work
investig
dynam
light
scatter
ddmb
reveal
micel
stabl
wide
rang
common
biochem
condit
membran
protein
ddmb
result
high
qualiti
trosyhsqc
spectra
often
equal
slightli
better
previous
use
ionic
deterg
unlik
deterg
ddmb
possess
abil
protect
diacylglycerol
kinas
dagk
thermal
inactiv
ddmb
capabl
solubil
multipl
lipid
raft
compon
mixtur
form
bilay
micel
given
stabl
micel
abil
dissolv
lipid
raft
compon
high
qualiti
spectra
protect
natur
ddmb
includ
initi
screen
membran
protein
work
sophi
gobeil
leonard
spicer
ben
bobay
ron
venter
duke
univers
biochemistri
depart
north
carolina
usa
duke
univers
nmr
center
north
carolina
usa
invas
fungal
infect
remain
lead
caus
death
immunocompromis
patient
current
antifung
agent
multitud
issu
includ
limit
efficaci
host
toxic
alarm
increas
resist
current
research
laboratori
focus
target
calcineurin
signal
pathway
shown
requir
fungal
pathogenesi
calcineurin
key
regul
signal
transduct
network
requir
surviv
common
pathogen
fungi
human
make
ideal
target
fungal
drug
develop
calcineurin
also
target
immunosuppress
function
inhibitor
first
complex
peptidylprolyl
cistran
isomeras
immunophilin
complex
subsequ
bind
calcineurin
inhibit
activ
although
fungal
calcineurin
target
drug
also
target
mammalian
calcineurin
thu
immunosuppress
host
order
improv
therapeut
efficaci
undertaken
uniqu
effort
util
structur
biolog
molecular
dynam
molecular
mycolog
aim
identifi
biophys
featur
complex
might
confer
fungal
specif
inhibit
calcineurin
activ
object
design
novel
drug
treat
invas
fungal
diseas
reduc
human
immunosuppress
nmr
studi
focus
determin
reson
assign
solut
structur
inhibitor
bind
dynam
protein
human
pathogen
fungi
c
albican
fumigatu
c
glabrata
circinelloid
without
bound
inhibitor
importantli
studi
alreadi
determin
specif
residu
affect
differenti
human
pathogen
fungal
protein
present
earli
result
life
scienc
xray
scatter
lix
beamlin
nation
synchrotron
light
sourc
ii
lix
beamlin
support
sever
method
investig
structur
biolog
macromolecul
solut
experi
carri
high
throughput
mode
data
collect
microlit
sampl
two
minut
sampl
contain
multipl
speci
particl
eg
coexist
complex
subunit
may
contain
aggreg
instrument
instantan
switch
inlin
size
exclus
chromatographi
mode
essenti
use
beamlin
one
detector
purif
system
instrument
equip
xray
fluoresc
detector
facilit
anomal
scatter
measur
also
explor
timeresolv
solut
scatter
measur
base
flow
mixer
measur
scatter
data
record
three
detector
cover
wide
rang
scatter
vector
typic
lix
beamlin
part
lsbr
research
resourc
jointli
fund
nih
doeber
togeth
pair
macromolecular
crystallographi
beamlin
fmx
amx
beamlin
current
oper
access
flexibl
regular
gener
user
rapid
access
block
alloc
group
propos
presenc
tailor
domain
nonribosom
peptid
synthetas
nrpss
dramat
increas
chemic
space
nonribosom
peptid
access
linear
gramicidin
synthetas
evolv
includ
formyl
f
domain
start
initi
modul
f
domain
respons
formyl
first
residu
valin
formyl
event
crucial
linear
gramicidin
bioactiv
earlier
bioinformat
studi
suggest
f
domain
origin
sugar
formyltransferas
ft
fuse
nrp
horizont
gene
transfer
identifi
gene
sugar
ft
anoxybacillu
kamchatkensi
like
similar
pretransf
gene
transfer
ft
ancestor
f
domain
ft
locat
gene
cluster
like
cmppseudamin
acid
pathway
involv
glycosyl
flagellin
cmppseudamin
acid
pathway
udpglcnac
process
seri
pse
enzym
third
enzym
pseh
nacetyltransferas
acetyl
group
kamchatkensi
gene
cluster
pseh
substitut
put
ft
pseft
use
biophys
techniqu
xray
crystallographi
show
pseft
replac
pseh
bind
formyl
sugarnucleotid
substrat
exhibit
remark
structur
resembl
linear
gramicidin
f
domain
togeth
experi
display
compel
evid
pseft
repres
precursor
sugar
ft
prior
incorpor
nrp
enzym
udpglucos
glycoprotein
glucosyltransferas
uggt
specif
recogn
misfold
glycoprotein
catalyz
attach
glucos
nglycan
order
regener
glucosyl
form
addit
cycl
calnexin
calreticulin
assist
refold
process
qualiti
sensor
function
uggt
ensur
er
target
glycoprotein
adopt
proper
threedimension
fold
thu
avoid
cell
malfunt
damag
result
misfold
protein
accumul
howev
structur
uggt
mechan
select
misfold
protein
unknown
sinc
identifi
year
ago
express
drosophila
melanogast
uggt
character
physic
properti
besid
character
interact
uggt
wellknown
bind
partner
hydrogendeuterium
exchangemass
spectrometri
hdxm
analysi
bind
site
uggt
reveal
smallangl
xray
scatter
sax
provid
us
model
full
length
uggt
furthermor
full
length
structur
uggt
solv
refin
singl
particl
construct
neg
stain
electron
microscopi
em
structur
uggt
indic
advantag
uggt
screen
accommod
varieti
substrat
propos
model
one
big
central
bind
pocket
uggt
udpglucos
misfold
portion
glycosubstr
seat
simultan
upon
well
posit
uggt
substrat
precis
glucosyl
end
identifi
domain
organ
penicillium
chrysogenum
uggt
intern
label
strategi
singl
particl
em
model
big
step
uncov
mysteri
uggt
famili
human
cytidin
deaminas
renown
provid
first
line
defens
mani
exogen
endogen
retrovirus
recent
howev
discov
abil
protein
deamin
cytidin
ssdna
made
doubleedg
sword
overexpress
mutat
endogen
genom
dna
result
varieti
cancer
although
sequenc
context
mutat
dna
vari
among
known
time
mechan
substrat
sequenc
specif
well
understood
character
substrat
specif
systemat
approach
use
quantifi
affin
substrat
function
sequenc
context
ph
substrat
secondari
structur
cocryst
structur
bound
ssdna
abl
develop
model
explain
molecular
mechan
underli
sequenc
specif
result
work
provid
key
insight
mechan
benefici
role
cell
especi
viral
restrict
also
deleteri
activ
role
develop
cancer
lipid
play
vital
role
energi
sourc
structur
compon
cell
also
serv
signal
molecul
mani
lipid
identifi
ligand
nuclear
receptor
ppar
regul
transcript
howev
nt
understood
insolubl
lipid
deriv
membran
organel
transport
nucleu
lipid
bind
protein
lbp
discov
solubil
lipid
transport
nucleu
serv
integr
role
lipidsign
pathway
lipid
bind
protein
highli
express
fat
storag
tissu
caenorhabd
elegan
c
elegan
recent
discov
bind
lipid
gener
lysosom
acid
lipas
lysosom
shuttl
nucleu
serv
ligand
nuclear
hormon
receptor
homolog
ppar
prolong
lifespan
worm
fig
recombinantli
express
escherichia
coli
purifi
crystal
determin
first
highresolut
structur
allow
us
identifi
structur
conserv
nuclear
local
signal
amino
acid
necessari
lipid
bind
mutat
residu
confirm
reduct
lipid
bind
current
transgen
express
mutant
form
c
elegan
observ
effect
lifespan
worm
order
elucid
mechan
shuttl
lipid
cell
mcgill
univers
canada
univers
louisvil
usa
univers
saskatchewan
usa
ankyrin
b
ankb
bacteri
protein
play
essenti
role
intracellular
prolifer
legionella
pneumophila
caus
agent
legionnair
diseas
collect
protein
target
degrad
free
amino
acid
gener
sourc
carbon
energi
prevent
starvat
respons
ankb
contain
two
eukaryoticlik
domain
combin
never
found
eukaryot
protein
ntermin
fbox
domain
allow
mimicri
host
fbox
protein
interact
host
ubiquitin
pathway
via
scf
ubiquitin
ligas
complex
ctermin
ankyrin
repeat
allow
ankb
select
bind
target
degrad
report
crystal
structur
full
length
ankb
complex
host
found
ankb
contain
enlarg
substratebind
site
three
ankyrin
repeat
rather
two
expect
base
sequenc
structur
analys
mutat
studi
identifi
key
residu
respons
decor
legionellacontain
vacuol
ubiquitin
replic
pathogen
infect
studi
provid
first
structur
insight
structur
mimicri
allow
bacteri
virul
factor
ankb
associ
host
ubiquitin
complex
select
substrat
sinc
discoveri
late
antibiot
extens
use
misus
human
anim
husbandri
consequ
effect
wane
resist
increas
aminoglycosid
broadspectrum
class
antibiot
use
treatment
infect
caus
gramneg
posit
bacteria
preval
mode
aminoglycosid
resist
coval
enzymat
modif
two
medic
import
aminoglycosid
tobramycin
gentamicin
target
sever
differ
resist
factor
includ
aminoglycosid
nucleotidyltrasferas
ant
describ
two
crystal
structur
one
widespread
antibiot
resist
enzym
ant
complex
nucleotid
two
clinic
relev
aminoglycosid
tobramycin
gentamicin
structur
complet
character
medic
import
enzym
within
tobramycin
gentamicin
resistom
analysi
tobramycin
gentamicin
bind
resistom
enzym
well
intend
target
ribosom
asit
reveal
extens
similar
crucial
differ
observ
differ
antibiot
bind
interact
princip
exploit
develop
nextgener
aminoglycosid
select
reduc
affin
resistom
enzym
present
analysi
viabl
avenu
nextgener
aminoglycosid
antibiot
develop
base
structur
data
tobramycin
gentamicin
clinic
resistom
nonribosom
peptid
synthetas
nrpss
famili
multimodular
enzym
synthes
structur
function
divers
peptid
mani
interest
secondari
metabolit
central
chemic
step
peptid
synthesi
amid
bond
format
typic
catalyz
condens
c
domain
nrpss
c
domain
replac
heterocycl
cy
domain
cy
domain
perform
amid
bond
format
well
intramolecular
cycliz
serin
cystein
threonin
sidechain
form
thiazolin
oxazolin
methyloxazolin
ring
ring
import
form
function
peptid
product
present
crystal
structur
nrp
cy
domain
resolut
despit
share
fold
activ
site
c
cy
domain
import
differ
structur
allow
us
assess
role
activ
site
residu
subsequ
probe
bacillamid
biosynthesi
assay
via
mutat
analys
drastic
differ
effect
interpret
use
structur
bioinformat
result
provid
insight
catalyt
mechan
cy
domain
suggest
critic
role
previous
unexamin
aspthr
dyad
cyclodehydr
reaction
tolou
golkar
albert
berghui
major
mechan
resist
clinic
relev
bacteri
strain
enzymemedi
alter
antibiot
macrolid
phosphotransferas
ii
mphi
mphii
group
enzym
target
macrolid
antibiot
inactiv
transfer
aphosph
group
gtp
research
focus
design
inhibitor
two
antibiot
resist
enzym
order
restor
antibiot
sensit
use
librari
identifi
fragment
binder
use
ligandbas
nmr
methodssatur
transfer
differ
std
waterlogsi
wl
differenti
scan
fluorimetri
dsf
use
orthogon
differenti
strong
weak
binder
lead
compound
competit
assay
use
preferenti
select
hit
bound
nucleotidebind
pocket
select
ligand
subject
isotherm
titrat
calorimetri
itc
studi
determin
bind
affin
subsequ
studi
establish
hit
use
lead
optim
structur
studi
mphi
mphii
util
establish
bind
mode
compound
hope
join
merg
grow
initi
hit
effect
inhibitor
enzym
smallangl
xray
scatter
sax
appli
protein
solut
becom
accept
rapidli
grow
structur
biolog
techniqu
measur
done
nativ
condit
vari
concentr
ph
ionic
strength
temperatur
data
provid
inform
molecular
weight
size
shape
stabil
biomolecul
ultim
allow
low
resolut
molecular
shape
envelop
reconstruct
inform
complementari
obtain
xrd
nmr
cryoem
although
setup
sax
easi
theori
practic
demand
respect
instrument
recent
requir
dedic
costli
lab
instrument
usag
synchrotron
beam
line
techniqu
readili
avail
home
laboratori
recent
develop
econm
solut
allow
easi
configur
multipurpos
xrd
platform
empyrean
panalyt
protein
sax
measur
empyrean
wide
use
lab
gener
materi
research
character
show
gener
xrd
platform
configur
sax
experi
demonstr
perform
number
protein
new
fast
probe
methodolog
studi
disord
protein
region
use
nuclear
magnet
reson
spectroscopi
understand
protein
structur
dynam
properti
govern
cellular
process
crucial
basic
appli
research
particular
interest
intrins
disord
protein
idp
region
display
altern
transient
conform
enabl
multitud
function
idp
particularli
hard
timeconsum
studi
classic
approach
develop
globular
protein
welldefin
conform
new
method
requir
given
idp
role
diseas
mechan
employ
dengu
viru
capsid
protein
possess
structur
disord
region
develop
fast
nuclear
magnet
reson
nmr
spectroscopi
method
immedi
determin
nh
group
solvent
access
amino
acid
residu
resolut
protein
region
dynam
first
residu
ahelic
also
readili
determin
method
base
minim
ph
chang
use
wellestablish
heteronuclear
singl
quantum
coher
hsqc
puls
sequenc
simpl
interpret
manner
use
technolog
studi
contrast
idp
region
dengu
viru
capsid
protein
hydrophob
wellstructur
section
allow
gain
insight
flaviviru
capsid
protein
biolog
function
use
dengu
also
relat
flavivirus
westnil
zika
virus
show
dengu
ntermin
specif
residu
within
key
c
protein
biolog
activ
line
previou
find
therefor
approach
complement
data
importantli
methodolog
easili
implement
current
protein
nmr
routin
provid
structur
dynam
inform
fast
manner
gener
interest
structur
biolog
natur
product
long
known
sourc
complex
molecul
molecul
exhibit
medicin
benefit
develop
antimicrobi
antitumor
antivir
drug
due
versatil
flavinbind
enzym
ubiquit
found
numer
pathway
synthes
natur
product
high
interest
exampl
includ
piee
xiai
piee
involv
hydroxyl
posit
piericidin
pyridinol
core
xiai
catalyz
creation
cyclic
core
structur
xiamycin
play
catalyt
role
oxid
reaction
hexos
moieti
necessari
glycopeptid
matur
project
determin
structur
enzym
use
xray
crystallographi
enzym
belong
differ
class
flavoprotein
structur
insight
studi
shed
light
respect
cofactor
recruit
cofactorsubstr
bind
regioselect
catalysi
insight
contribut
potenti
use
enzym
semisynthet
strategi
cyclic
depsipeptid
small
bioactiv
molecul
consist
altern
sequenc
amino
acid
hydroxyl
acid
produc
massiv
enzym
call
depsipeptid
synthetas
belong
famili
nonribosom
peptid
synthetas
depsipeptid
synthetas
employ
sixti
enzymat
reaction
linear
fashion
gener
singl
cyclic
product
work
focus
first
step
biosynthet
mechan
consist
select
alphaketoacid
reduct
hydroxyl
acid
action
three
protein
domain
adenyl
ketoreduct
thiolat
domain
addit
catalyz
specif
enzymat
reaction
domain
also
requir
interact
commun
success
synthet
cycl
address
interact
take
place
aim
obtain
highresolut
structur
protein
construct
contain
three
domain
sever
catalyt
conform
abl
obtain
crystal
intact
construct
diffract
resolut
furthermor
evalu
adenyl
thiolat
reduct
activ
construct
biochem
assay
final
abl
perform
intact
protein
lcm
analysi
kda
protein
data
obtain
shed
light
onto
sever
novel
strategi
captur
differ
depsipeptid
synthetas
conform
xray
crystallographi
improv
resolut
current
crystal
sinc
introduct
aminoglycosid
extens
use
clinic
agricultur
led
select
bacteri
strain
capabl
evad
action
aminoglycosid
current
use
bacteria
employ
sever
mechan
confer
aminoglycosid
resist
preval
mode
enzymat
modif
antibiot
aac
ieaph
ia
enzym
capabl
modifi
virtual
aminoglycosid
confer
high
level
resist
clinic
relev
strain
domain
capabl
activ
modifi
aminoglycosid
aac
ie
domain
nacetyl
aph
ia
domain
ophosphoryl
detail
structur
exist
domain
separ
howev
fulllength
structur
despit
extens
effort
yet
elucid
studi
describ
use
puls
electronelectron
doubl
reson
peldor
techniqu
order
obtain
orient
two
domain
respect
one
anoth
within
aac
ieaph
ia
observ
obtain
studi
may
provid
insight
enzym
bifunt
natur
includ
mechanist
function
potenti
conform
chang
surviv
challeng
complex
environ
microb
reli
power
bioactiv
compound
mani
compound
synthes
use
molecular
machin
call
polyketid
synthas
pk
megaenzym
organ
repeat
function
modul
work
assembl
line
fashion
repetit
assemblylin
synthesi
pk
produc
fulllength
polyketid
attach
transport
domain
pk
acyl
carrier
protein
acp
final
step
consist
releas
polyketid
cycliz
hydrolysi
perform
enzymat
domain
pk
call
thioesteras
te
domain
action
te
domain
extrem
import
hydrolysi
produc
linear
compound
cycliz
produc
cyclic
compound
proper
form
compound
essenti
bioactiv
cycliz
vs
hydrolysi
decis
depend
individu
te
domain
natur
present
substrat
polyketideacp
aim
research
elucid
control
mechan
cycliz
vs
hydrolysi
decis
fungal
te
domain
two
te
domain
found
radicicol
dehydrocurvularin
polyketid
synthas
differenti
control
cycliz
hydrolysi
heterolog
express
purifi
protein
crystal
produc
aim
achiev
high
resolut
structur
xray
crystallographi
structur
provid
enhanc
knowledg
crucial
step
polyketid
synthesi
could
facilit
ongo
effort
use
pkss
synthesi
novel
design
chemic
legionella
pneumophila
gramneg
pathogen
bacterium
caus
sever
pneumonia
human
establish
replic
nich
call
legionella
contain
vacuol
lcv
allow
bacteria
surviv
replic
insid
pulmonari
macrophag
order
hijack
host
cell
defens
system
legionella
inject
effector
protein
host
cell
cytosol
effector
protein
interfer
signal
pathway
caus
signific
chang
host
cell
phosphoproteom
aim
deciph
structur
mechan
action
two
effector
directli
interfer
cellular
phosphoryl
bacteri
protein
kinas
one
sever
effector
directli
modifi
host
cell
phosphoproteom
determin
structur
nonkinas
domain
map
autophosphoryl
site
moreov
identifi
human
protein
stimul
activ
base
structur
function
data
found
anoth
effector
protein
might
potenti
affect
phosphoryl
state
host
cell
yeast
twohybrid
screen
msbase
phosphoproteom
vitro
phosphopeptid
array
use
identifi
interact
partner
well
phosphoryl
site
modifi
effector
northeastern
collabor
access
team
necat
focus
design
oper
synchrotron
xray
beamlin
solut
technic
challeng
structur
biolog
problem
provid
import
resourc
nation
intern
research
commun
current
necat
oper
two
undul
beamlin
kev
tunabl
energi
beamlin
kev
singl
energi
beamlin
beamlin
equip
stateoftheart
instrument
microdiffractomet
instal
beamlin
provid
clean
beam
micron
diamet
capabl
visual
microns
crystal
larg
area
pixel
array
detector
provid
fast
noiseless
data
collect
make
possibl
resolv
larg
unit
cell
beamlin
equip
custombuilt
alsstyl
robot
sampl
automount
dewar
capabl
hold
puck
rapd
local
develop
softwar
suit
rapd
provid
data
collect
strategi
quasir
time
data
integr
scale
simpl
autom
mrsad
pipelin
comput
cluster
user
beamlin
support
experienc
resid
crystallograph
fund
necat
provid
grant
nigm
necat
member
institut
guennadi
kozlov
irina
gulerez
huizhi
zhang
howi
wu
kall
gehr
phosphatas
regener
liver
prl
highli
overexpress
metastat
cancer
yet
mechan
action
poorli
understood
recent
cnnm
protein
famili
membran
protein
involv
magnesium
homeostasi
identifi
prlbind
partner
disrupt
prlcnnm
interact
promot
tumor
format
invas
anim
cellular
model
strongli
suggest
physiolog
function
prl
regul
cnnm
magnesium
transport
determin
crystal
structur
bound
cbspair
domain
structur
cbspair
domain
present
dimer
headtohead
arrang
typic
cbspair
domain
cbspair
domain
contain
long
loop
extend
away
dimer
interfac
contact
prl
catalyt
site
side
chain
aspart
acid
sit
pocket
form
phosphatas
ploop
wpfdd
motif
like
mimic
neg
charg
phosphat
bound
substrat
use
isotherm
titrat
calorimetri
itc
experi
extens
mutagenesi
probe
import
prl
residu
cnnm
bind
comparison
bind
activ
vitro
phosphatas
activ
show
strongli
correl
result
suggest
prl
function
pseudophosphatas
regul
action
cnnm
protein
cancer
paramyxovirus
infect
mani
organ
includ
mammal
bird
reptil
fish
common
human
pathogen
measl
mump
parainfluenza
virus
belong
larg
famili
despit
preval
virus
structur
understand
machineri
respons
rna
synthesi
remain
incomplet
therefor
investig
rnadepend
rna
polymeras
rdrp
menangl
viru
menv
bat
born
zoonot
pathogen
close
relat
mump
viru
two
protein
subunit
compris
viral
rdrp
known
larg
protein
l
protein
phosphoprotein
p
protein
catalyt
function
hous
l
protein
p
protein
act
chaperon
facilit
bind
l
protein
replic
templat
p
protein
known
selfassoci
central
locat
coiledcoil
figur
use
rang
biophys
techniqu
shown
selfassoci
menv
p
protein
form
tetramer
speci
structur
analysi
p
protein
use
nuclear
magnet
reson
nmr
spectroscopi
xray
crystallographi
small
angl
xray
scatter
sax
show
structur
domain
within
ctermin
region
connect
highli
dynam
sequenc
conform
transit
within
tetramer
p
protein
like
import
facilit
transloc
viral
polymeras
replic
without
dissoci
templat
pmra
twocompon
respons
regul
manag
gene
polymyxin
resist
phosphorylationdepend
regul
recent
report
resolut
crystal
structur
phosphoryl
analog
pmra
complex
promot
dna
reveal
activ
pmra
induc
format
twofold
symmetr
dimer
ntermin
receiv
domain
rec
promot
ctermin
dnabind
domain
dbd
recogn
pmra
box
locat
posit
promot
nmr
dynam
experi
suggest
rec
dbd
domain
tumbl
separ
divers
orient
togeth
dbddbd
interfac
may
facilit
pmra
search
best
interact
rna
polymeras
holoenzym
rnaph
transcript
activ
primari
sigma
factor
control
transcript
direct
rnaph
promot
compos
element
recogn
domain
respect
henc
possibl
pmra
transcript
activ
achiev
interact
pmra
domain
promot
element
replac
pmra
box
chimera
protein
fuse
short
betaflap
tip
helix
artifici
linker
design
improv
solubl
stabil
solut
structur
chimera
show
adopt
similar
conform
within
rnaph
interact
among
chimera
protein
pmra
box
promot
dna
pmra
investig
reveal
rnaph
recruit
pmra
box
promot
pmra
human
neuroendocrin
enzym
glutam
decarboxylas
gad
catalys
synthesi
inhibitori
neurotransmitt
gaba
use
cofactor
gad
exist
two
isoform
name
accord
respect
molecular
weight
preval
autoantigen
autoantibodi
detect
high
frequenc
patient
autoimmun
type
diabet
certain
autoimmun
disord
use
small
angl
xray
scatter
mutagenesi
comput
method
describ
structur
complex
recombin
fab
fragment
deriv
human
monoclon
antibodi
structur
provid
insight
patientderiv
autoantibodi
engag
diseaseassoci
epitop
ultim
molecular
determin
gad
autoantigen
pha
synthas
phac
key
enzym
polymer
polyhydroxyalkano
pha
biodegrad
polym
produc
wide
rang
bacteria
report
crystal
structur
catalyt
domain
phac
chromobacterium
sp
phaccscat
atom
resolut
crystal
structur
contain
two
molecul
form
dimer
pseudo
dyad
symmetri
catalyt
domain
adopt
hydrolas
fold
compris
core
subdomain
cap
subdomain
dimer
interfac
contain
two
patch
contact
residu
first
display
hydrophob
contact
five
residu
molecul
close
ntermin
end
second
compris
two
salt
bridg
two
aromat
stack
interact
near
catalyt
catalyt
triad
cover
cap
subdomain
face
water
channel
buri
insid
protein
comparison
recentlyreport
structur
catalyt
domain
phaccn
cupriavidu
necat
reveal
sharp
contrast
conform
cap
subdomain
dimer
arrang
phaccn
display
rel
loosen
conform
allow
narrow
path
activ
site
phacc
tighter
close
conform
structur
impli
pingpong
mechan
unlik
activ
site
distant
apart
clear
product
egress
observ
either
structur
infer
dynam
conform
chang
essenti
catalyt
action
conclus
threedimension
structur
catalyt
domain
phac
provid
invalu
clue
understand
catalyt
mechan
industri
import
enzym
killer
protein
ltype
calcium
channel
use
novel
ltype
calcium
channel
inhibitor
character
ltype
calcium
channel
structur
function
voltag
depend
transmiss
gene
regul
longlast
vgcc
also
known
ltype
ubiquit
express
throughout
bodi
found
cardiomyocyt
smooth
muscl
brain
pancrea
adren
gland
canon
structur
ltype
vgcc
consist
transmembran
pore
domain
calcium
enter
cell
extracellular
regul
domain
respons
traffick
cell
surfac
ensur
channel
sensit
physiolog
membran
potenti
cytosol
kinet
modul
interact
intracellular
intermedi
messeng
protein
calmodulin
multipl
inhibitor
ltype
calcium
channel
discov
inhibitori
either
via
direct
interact
pore
domain
interact
domain
regul
channel
traffick
stabil
previous
known
channel
inhibitor
oper
increas
necessari
voltag
requir
depolar
open
channel
recent
novel
ltype
inhibitor
discov
viral
encod
secret
protein
deriv
persist
infect
strain
fungu
ustilago
maydi
inhibit
calcium
entri
cell
without
alter
voltag
requir
open
channel
across
kingdom
follow
propos
mechan
interact
specif
region
extracellular
subunit
contain
dival
cation
bind
site
respons
promot
proteinprotein
interact
character
interact
result
better
understand
calcium
channel
structur
function
voltag
depend
alec
fraser
petr
leiman
process
protein
dna
transloc
across
lipid
membran
central
function
organ
larg
class
larg
multicompon
organel
bacteriophag
tail
type
vi
secret
system
rtype
pyocin
serratia
antifeed
prophag
other
transloc
substrat
use
rigid
tubecontractil
sheath
mechan
function
structur
contractil
inject
system
resembl
stretch
spring
sheath
wound
around
noncontractil
tube
system
lock
highenergi
metast
state
basepl
structur
play
import
role
sheath
assembl
contract
trigger
upon
interact
basepl
target
cell
membran
sheath
contract
drive
tube
cell
envelop
full
atom
model
sheath
tube
extend
contract
state
avail
rtype
pyocin
one
simplest
repres
contractil
inject
system
structur
suggest
contract
accomplish
rigid
bodi
rearrang
sheath
subunit
transform
driven
energi
store
extend
conform
sheath
assembl
data
show
contract
start
basepl
propag
sheath
wave
individu
subunit
trajectori
howev
unknown
discuss
deriv
trajectori
energet
consider
find
import
understand
substrat
transloc
contractil
inject
system
pkgia
central
regul
smooth
muscl
tone
nocicept
activ
pkgia
nocicept
neuron
induc
longterm
hyperexcit
caus
chronic
pain
recent
studi
show
balanollik
compound
inhibit
pkgia
high
potenc
select
attenu
thermal
hyperalgesia
osteoarthrit
pain
rat
understand
molecular
basi
high
potenc
select
measur
inhibit
constant
pkgia
catalyt
domain
determin
structur
complex
resolut
structur
reveal
bind
activ
site
extern
phenyl
ring
specif
interact
glycinerich
loop
ab
helix
structur
align
campdepend
protein
kinas
pka
ca
show
glycinerich
loop
replac
pkaca
may
caus
steric
hindranc
reduc
interact
ab
helix
pkgia
interact
analog
residu
pkaca
may
summari
structur
explain
high
potenc
select
pkgia
provid
start
point
structureguid
design
select
inhibitor
incred
stabil
postfus
hcmv
glycoprotein
b
ellen
white
yuhang
liu
senguil
han
ekaterina
heldwein
tuft
univers
school
medicin
massachusett
usa
pfizer
inc
usa
human
cytomegaloviru
hcmv
infect
major
popul
worldwid
commonli
caus
lifelong
latent
infect
individu
healthi
immun
system
howev
hcmv
caus
seriou
ill
individu
compromis
immun
system
develop
fetu
current
vaccin
hcmv
enter
host
cell
hcmv
util
sever
conserv
glycoprotein
express
virion
surfac
includ
glycoprotein
b
gb
viral
fusogen
gb
must
undergo
conform
rearrang
metast
prefus
form
stabl
postfus
form
bring
togeth
viral
envelop
host
cell
membran
fusion
occur
structur
postfus
gb
determin
prefus
form
remain
elus
know
gb
structur
prefus
conform
allow
us
better
understand
hcmv
entri
process
engin
gb
construct
design
stabil
prefus
conform
andor
destabil
postfus
conform
negativestain
electron
microscopi
em
small
angl
xray
scatter
sax
use
determin
conform
construct
result
show
despit
variou
modif
construct
far
adopt
postfus
conform
demonstr
incred
stabil
postfus
gb
also
found
use
sax
critic
accur
observ
gb
conform
fragmentbas
screen
repres
potenti
mean
smaller
institut
meet
need
identifi
seed
futur
medic
fragmentbas
lead
discoveri
fbld
becom
viabl
complement
altern
tradit
highthroughput
screen
discov
seed
futur
drug
fbld
involv
screen
librari
fragment
search
binder
target
protein
binder
use
chemic
biolog
probe
function
modul
scaffold
custom
design
potent
inhibitor
central
fbld
qualiti
screen
librari
fbld
valid
strategi
led
compound
clinicmarket
seriou
issu
remain
limit
practic
applicationthi
work
describ
practic
process
employ
creat
new
fragment
librari
combin
theoret
cheminformat
experiment
nmr
filter
employ
remov
undesir
compound
reactiv
toxic
unstabl
aggreg
etc
priorit
desir
compound
dimension
biocor
solubl
substructur
approach
includ
introduct
sensit
simplifi
nmrbase
screen
method
softwar
assist
identif
fragment
binder
followup
strategi
help
filter
problemat
promiscu
ligand
overal
screen
time
reduc
deconvolut
effort
semiautom
medicin
chemist
focu
promis
drug
seed
use
stringent
criteria
start
set
compound
reduc
enrich
subset
compound
ensembl
new
librari
distinct
commerci
librari
individu
compound
readili
avail
along
nmr
spectra
buffer
furthermor
intellig
pool
strategi
introduc
enabl
higherthroughput
screen
chemotaxi
toward
environment
cue
mediat
membraneembed
chemoreceptor
fundament
phenomenon
play
major
role
roottip
colon
pseudomona
fluorescen
p
fluorescen
chemotact
transduc
amino
acid
type
ctaa
mediat
taxi
toward
natur
occur
amino
acid
periplasm
ligand
bind
domain
lbd
ctaa
belong
cach
superfamili
structur
analysi
ctaa
lbd
complex
cognat
ligand
ctaa
adopt
doubl
domain
typic
ntermin
long
ahelix
two
subdomain
membranedist
proxim
biophys
structur
bioinformat
analysi
ctaa
allow
us
identifi
crucial
residu
compris
ligand
bind
pocket
membran
distal
subdomain
isotherm
titrat
calorimetri
analysi
show
bind
affin
ligand
micromolar
rang
studi
highlight
import
confirm
chang
phenol
side
chain
two
aromat
residu
contribut
determin
substrat
specif
molecular
basi
signal
transduct
mechan
receptor
protein
dynam
conform
diseas
multitimescal
characteris
nmr
alistair
jagger
christoph
waudbi
lisa
cabrita
john
christodoul
jame
irv
david
loma
univers
colleg
london
uk
kda
serin
proteas
inhibitor
found
high
concentr
human
plasma
z
mutat
occur
northern
european
caus
format
long
polym
chain
retain
site
synthesi
hepatocyt
accumul
polym
lead
liver
cirrhosi
reduc
antiproteas
activ
lung
predispos
individu
earli
onset
emphysema
ration
design
therapeut
treatment
defici
requir
detail
understand
polymeris
pathway
polymeris
thought
progress
nativ
monomer
speci
unknown
conform
recent
crystal
structur
z
mutant
reveal
differ
wildtyp
variant
suggest
chang
aggreg
behaviour
due
differ
structur
dynam
variant
address
use
solut
state
nuclear
magnet
reson
nmr
togeth
biophys
biochem
approach
characteris
structur
dynam
polymeris
particular
methyltrosybas
nmr
observ
label
allow
us
studi
dynam
across
rang
time
scale
ps
ms
addit
show
possibl
acquir
high
qualiti
nmr
correl
spectra
patientderiv
wt
natur
isotop
abund
data
begin
probe
impact
mammalian
posttransl
modif
structur
structur
dynam
consequ
z
mutat
open
new
possibl
rapid
structur
characteris
clinic
relev
variant
ahmad
gebai
bhushan
nagar
alexei
gorelik
katalin
ill
acid
ceramidas
acdas
catalyz
convers
lysosom
membran
resid
ceramid
sphingosin
backbon
sphingolipid
regul
divers
cellular
process
essenti
housekeep
role
abnorm
function
acdas
lead
patholog
like
farber
diseas
spinal
muscular
atrophi
progress
myoclon
epilepsi
increas
activ
acdas
accumul
ceramid
link
diseas
alzheim
diseas
type
diabet
cancer
make
attract
target
therapeut
intervent
present
first
crystal
structur
mammalian
acdas
proenzym
inact
form
autocleav
activ
form
inact
form
catalyt
center
protect
solvent
slightli
perturb
like
slow
autocleavag
reaction
still
allow
take
place
optim
condit
autocleavag
intern
peptid
bond
stabli
align
activ
site
residu
catalysi
concomitantli
creat
surfac
expos
bind
pocket
allow
entri
ceramid
substrat
unusu
larg
hydrophob
surfac
adjac
activ
site
suggest
site
lysosom
membran
attach
posit
optim
substrat
deliveri
accessori
protein
saposin
final
map
farber
diseas
mutat
onto
structur
reveal
variant
like
destabil
protein
fold
result
inactiv
diseas
onset
structur
analysi
clarifi
molecular
mechan
acdas
function
inform
develop
ration
design
acdas
inhibitor
use
recombin
acdas
diseas
therapeut
nucleocapsid
protein
n
protein
coronaviru
cov
essenti
rnabind
human
cell
requir
replic
transcript
viral
rna
recent
studi
suggest
human
cov
n
protein
valid
target
antivir
drug
develop
recent
demonstr
crystal
structur
ntermin
domain
merscov
n
protein
nntd
dimer
dimer
conform
confirm
solut
crosslink
assay
current
studi
util
structurebas
virtual
screen
interfac
two
merscov
nntd
dimer
avail
zinc
databas
dock
vari
precis
comput
intens
identifi
sever
potenti
compound
also
determin
crystal
structur
nntdligand
complex
although
dimer
interfac
site
might
directli
involv
rna
bind
bind
small
molecul
compound
site
could
promot
oligomer
n
protein
allosteri
could
altern
target
antivir
drug
develop
find
provid
better
insight
develop
new
therapeut
could
potenti
affect
interact
two
individu
nntd
human
cov
discoveri
new
compound
could
bind
interfac
nntd
dimer
would
imper
design
novel
n
protein
inhibitor
human
cov
futur
maintain
control
homeostat
plastic
synapt
scale
requir
rapid
synthesi
mobil
receptor
protein
involv
underli
regulatori
function
arc
abstract
immedi
earli
gene
express
directli
dendrit
compart
upon
neuron
activ
appar
function
regul
pathway
control
ltd
ltp
bidirect
manner
arc
display
sequenti
partial
structur
similar
retrovir
gag
protein
belong
retrotransposon
famili
determin
solut
structur
twolob
ctermin
capsid
like
domain
arc
rel
arrang
two
lobe
similar
seen
sever
member
famili
includ
capsid
protein
show
arc
elev
temperatur
transient
undergo
structur
transit
welldefin
oligomer
state
final
arc
interact
synapt
protein
extend
character
ligand
bind
site
consensu
recognit
motif
demonstr
bind
subunit
nmda
receptor
hypoxia
induc
factor
hif
heterodim
compos
pair
regul
hifalpha
constitut
arnt
subunit
bhlhpa
basic
helixloophelixperiodarntsingl
mind
transcript
regul
hif
essenti
normal
physiolog
respons
low
oxygen
level
higher
eukaryot
misregul
hif
abund
activ
correl
onset
progress
sever
cancer
proteinprotein
interact
hif
arnt
well
variou
downstream
compon
import
proper
function
dysfunct
pathway
small
molecul
inhibitor
interact
serv
potenti
new
anticanc
therapi
previous
demonstr
discoveri
nanomolar
affin
artifici
ligand
bind
larg
hydrat
caviti
buri
within
pasb
domain
address
question
small
molecul
access
caviti
affect
hif
function
use
biophys
biochem
approach
examin
linkag
protein
dynam
intern
ligand
bind
current
data
use
highpressur
nmr
cpmg
carrpurcellmeiboomgil
relax
dispers
experi
suggest
small
molecul
access
intern
regulatori
caviti
rapid
protein
dynam
propos
presenc
ligand
within
caviti
perturb
betasheet
surfac
lead
destabil
interact
arnt
better
understand
protein
ligand
interact
regul
protein
function
critic
deciph
root
caus
diseas
develop
novel
research
tool
pharmacolog
lead
phenol
acid
decarboxylas
pad
enzym
present
bacteria
notabl
bacillu
pumilu
protein
character
ten
strand
betabarrel
adopt
lipocalinlik
fold
flank
three
alpha
helic
fold
mainli
known
bind
small
hydrophob
molecul
pad
share
high
similar
ferul
acid
decarboxylas
fad
involv
detoxif
process
decarboxyl
small
aromat
molecul
ferul
pcoumar
caffeic
acid
organ
chemistri
decarboxyl
import
process
elimin
carboxyl
acid
mostli
achiev
use
progress
heat
degre
c
process
simpl
high
temperatur
may
detriment
complex
molecul
achiev
decarboxyl
biocatalysi
thu
interest
goal
exampl
previous
fulfil
one
substrat
sinap
acid
green
chem
use
engin
pad
protein
develop
larger
varieti
substrat
reli
ultim
understand
enzymat
mechan
report
structur
pad
mutant
analogu
ferul
acid
present
catalyt
site
interestingli
bind
mode
pocket
differ
previous
report
literatur
base
result
herebi
suggest
altern
mechan
decarboxyl
reaction
enzym
develop
e
coli
bandpass
assay
proteinprotein
interact
use
discov
protein
tune
interact
strength
assay
base
genet
circuit
link
proteinprotein
interact
strength
betalactamas
activ
interact
weak
select
show
resist
given
concentr
ampicillin
interact
strong
lead
excess
betalactamas
activ
caus
repress
essenti
gene
growth
combin
posit
neg
select
pressur
limit
cell
growth
concentr
rang
ampicillin
type
select
pressur
satisfi
betalactamas
activ
level
turn
betalactamas
activ
level
dictat
interact
strength
express
protein
pair
result
bandpass
indic
strength
proteinprotein
interact
function
assay
demonstr
analyz
seri
synthet
coiledcoil
interact
partner
bandpass
function
enabl
pure
cultur
separ
mixtur
cell
express
differ
coiledcoil
base
interact
strength
protein
pair
system
appli
develop
protein
inhibitor
coexpress
inhibitor
imped
interact
protein
pair
system
demonstr
analyz
seri
inhibitor
target
bzip
basic
leucin
zipper
protein
creb
expect
bandpass
assay
facilit
evalu
inhibitor
librari
design
develop
inhibitor
tune
interact
strength
precis
spatiotempor
regul
protein
synthesi
essenti
mani
cellular
process
includ
synapt
fire
embryon
develop
tumour
format
tradit
method
use
studi
protein
synthesi
offer
crude
spatiotempor
control
protein
express
limit
timescal
day
week
optogenet
method
contrast
could
control
protein
synthesi
noninvas
within
minut
spatial
scale
small
singl
synaps
present
develop
new
optogenet
tool
downregul
protein
synthesi
fusion
circularli
permut
avena
sativa
vari
length
human
inhibitor
translat
identifi
activ
construct
design
yeast
growth
assay
screen
structurebas
design
vivo
screen
slow
growth
yeast
express
human
key
translat
initi
factor
inhibit
blue
light
dark
nonbind
growth
restor
wildtyp
level
vitro
studi
use
sec
show
lightstat
bound
blue
light
darkstat
bind
bind
revers
repeat
use
yeast
growth
assay
librari
structurebas
design
screen
increas
lightdark
differ
activ
sever
candid
show
stronger
inhibit
low
level
blue
light
thu
develop
new
set
optogenet
tool
downregul
protein
synthesi
blue
light
optogenet
tool
advanc
studi
protein
synthesi
exampl
neurodevelopment
disord
embryo
morphogenesi
notch
cellsurfac
receptor
facilit
celltocel
signal
mechan
requir
mechan
forc
receptor
activ
upon
transcellular
bind
target
ligand
induc
success
proteolyt
cleavag
liber
intracellular
transcript
effector
transloc
nucleu
describ
develop
set
synthet
notch
synnotch
receptor
engin
bind
recogn
small
molecul
includ
fluorescein
deriv
show
engin
receptor
proteolyt
cleav
upon
bind
surfaceimmobil
target
ligand
receptor
activ
lead
induct
specifi
target
gene
overal
system
serv
power
probe
studi
natur
mechan
notch
activ
addit
serv
power
synthet
biolog
tool
reprogram
sens
capabl
mammalian
cell
futur
work
appli
receptor
detect
specif
cell
type
label
cellsurfac
bind
ligand
moham
nasr
david
kwan
vincent
martin
centr
appli
synthet
biolog
depart
biolog
concordia
univers
canada
synthet
biolog
techniqu
aim
construct
artifici
metabol
pathway
genet
modifi
microorgan
emerg
import
sustain
method
product
biofuel
pharmaceut
commod
chemic
reach
industri
relev
scale
howev
challeng
relat
bottleneck
system
optim
must
address
direct
evolut
offer
solut
limit
yet
lack
highthroughput
detect
method
product
reaction
remain
disadvantag
purpos
work
util
transcript
factorbas
biosensor
particularli
tetr
famili
repressor
link
product
substanc
signal
fluoresc
antibiot
resist
transcript
repressor
protein
regul
gene
bind
specif
effector
molecul
condit
bind
dna
project
aim
expand
toolbox
repressor
avail
ration
engin
effectorbind
domain
respond
altern
effector
molecul
proof
principl
use
combin
comput
direct
evolut
approach
engin
biosensor
protein
respond
intermedi
engin
metabol
pathway
adip
acid
deriv
shikim
pathway
adip
acid
precursor
nylon
plastic
current
produc
unsustain
petrochem
worldwid
annual
demand
million
tonn
optim
biorenew
altern
product
adip
acid
design
biosensor
use
part
within
genet
circuit
pathway
dynam
control
tool
direct
evolut
pathway
enzym
ultim
improv
yield
induc
gene
express
control
use
antivir
proteas
inhibitor
elliot
tagu
john
ngo
boston
univers
massachusett
usa
drug
induc
gene
express
wide
use
studi
control
biolog
functionshowev
mani
drug
use
present
avail
system
possess
endogen
cellular
target
caus
undesir
sideeffect
make
incompat
use
therapeut
applic
increas
prospect
use
gene
modul
human
therapi
ie
gene
therapi
cellbas
therapi
etc
orthogon
druginduc
system
use
safe
ligand
molecul
need
present
novel
method
druginduc
gene
express
control
use
exist
fdaapprov
antivir
drug
compound
abl
bind
inhibit
cisproteolyt
activ
hepat
c
viru
hcv
proteas
show
proteas
use
render
artifici
transcript
factor
base
subject
drug
control
via
insert
viral
enzym
scaffold
ctermin
transactiv
domain
absenc
drug
proteas
serv
selfimmol
linker
lead
dismember
chimera
upon
exposur
drug
intact
copi
protein
abl
enter
nucleu
activ
express
sgrnaspecifi
target
gene
overal
result
demonstr
versatil
use
hcv
domain
drugsensit
modul
regul
activ
local
engin
transcript
factor
mani
pharmaceut
activ
small
molecul
natur
product
contain
sugar
moieti
play
import
role
bioactiv
exampl
one
class
molecul
anthracyclin
includ
anticanc
doxorubicin
natur
product
glycosid
biosynthes
action
glycosyltransferas
gt
modifi
improv
bioactiv
molecul
alter
glycosyl
vitro
enzymat
method
could
circumv
multistep
laborintens
rout
organ
synthesi
aim
facilit
screen
engin
gt
produc
modifi
glycosid
thu
develop
highthroughput
screen
assay
gt
enabl
rapid
isol
detect
chromophor
fluoresc
glycosyl
natur
product
valuabl
tool
discov
engin
gt
direct
evolut
epirubicin
semisynthet
deriv
doxorubicin
high
valu
anticanc
drug
fewer
side
effect
parent
convent
produc
replac
sugar
moieti
doxorubicin
sever
organ
synthet
step
genet
modifi
bacteria
engin
biosynthesi
demonstr
produc
limit
amount
epirubicin
low
yield
effort
like
due
poor
activ
exogen
enzym
artifici
biosynthet
pathway
address
engin
improv
gt
enzym
direct
evolut
toward
aim
use
novel
vitro
enzymat
synthesi
produc
modifi
sugar
donor
substrat
gtcatalyz
synthesi
anthracyclin
result
librari
sugar
donor
use
highthroughput
screen
engin
gt
direct
evolut
includ
product
epirubicin
activ
mechan
involv
mechan
forc
notch
receptor
contain
neg
regulatori
region
nrr
serv
forceactiv
mechan
switch
regul
local
notch
intracellular
domain
nicd
transcript
effector
cleav
plasma
membran
transport
nucleu
upon
receptor
activ
receptor
rest
state
nrr
adopt
autoinhibit
conform
activ
cleavag
site
steric
block
receptor
activ
forcemedi
unravel
nrr
reveal
site
occur
respons
pn
pull
forc
goal
use
notch
scaffold
engin
new
mechanoreceptor
respond
vari
degre
forc
initi
design
strategi
integr
nrrbind
domain
receptor
stabil
nrr
increas
forc
requir
expos
present
data
demonstr
chimer
receptor
exhibit
increas
forc
resist
cellbas
assay
furthermor
show
receptor
use
program
cell
abil
discrimin
ligand
bound
stiff
versu
soft
surfac
also
show
nrrbind
domain
suscept
engin
tunabl
mechan
sensit
futur
work
mechanoreceptor
invalu
studi
protein
abl
transmit
inform
regard
mechan
properti
microenviron
nucleu
synthet
twocompon
system
redirect
oncogen
signal
therapeut
output
hokyung
kay
chung
michael
lin
stanford
univers
california
usa
mani
cancer
driven
constitut
activ
signal
promot
cell
growth
prolifer
surviv
pharmacolog
approach
aim
block
aberr
signal
often
suffer
resist
narrow
therapeut
window
present
novel
approach
signal
drive
oncogenesi
instead
coopt
trigger
therapeut
respons
via
rewir
synthet
signal
transduct
pathway
system
queri
whether
specif
oncogen
signal
exist
select
trigger
therapeut
program
purpos
conceiv
idea
oncogen
signalinduc
proteolysi
inhibitori
motifteth
effector
liber
upon
activ
term
gener
approach
rewir
aberr
signal
effector
releas
raser
studi
describ
engin
applic
compact
twocompon
system
sens
constitut
erbb
phosphoryl
trigger
therapeut
respons
modular
sens
actuat
domain
raser
system
allow
facil
optim
sens
versatil
program
therapeut
output
mathemat
model
entir
system
enabl
silico
optim
sever
biochem
paramet
enhanc
system
respons
result
system
erbbras
respond
specif
constitut
activ
erbb
sensit
constitut
erbb
signal
nativ
growthand
survivalpromot
pathway
program
induc
varieti
output
includ
direct
induct
apoptosi
transcript
apoptosisinduc
gene
result
repres
knowledg
first
success
attempt
use
comput
model
design
synthet
pathway
mammalian
cell
therapeut
effect
raser
system
generaliz
variou
cancer
custom
sensoractu
modul
specif
oncogen
signal
hold
potenti
novel
synthet
approach
cancer
treatment
activ
met
receptor
tyrosin
kinas
rtk
link
tumor
growth
surviv
metastasi
drug
resist
result
poor
patient
prognosi
met
overexpress
trigger
ligandindepend
selfactiv
commonli
caus
transcript
upregul
met
howev
mechan
met
regul
remain
unclear
use
phenotyp
select
fluoresc
activ
cell
sort
fac
coupl
function
genet
screen
use
pool
crispr
librari
identifi
bona
fide
modul
met
rtk
use
met
express
colorect
cancer
cell
line
sort
two
subpopul
base
met
intens
cell
infect
pool
crispr
librari
crispr
target
popul
identifi
use
next
gener
sequenc
modelbas
analysi
genomewid
knockout
mageck
use
rank
gene
compar
rel
abund
metlow
methigh
popul
crispr
target
top
rank
gene
caus
strongest
shift
cell
toward
metlow
methigh
popul
result
identifi
essenti
protein
transcript
translat
peptid
process
well
novel
regul
includ
transcript
factor
compon
ubiquitin
kinas
complex
conclud
combin
pool
crispr
librari
fac
robust
tool
identifi
regul
met
protein
abund
identif
novel
regul
met
may
lead
novel
target
companion
diagnost
sever
cancer
gener
alloster
chaperon
treat
dehydrogenas
defici
sunhe
hwang
stanford
univers
school
medicin
california
usa
dehydrogenas
catalyz
first
step
pentos
phosphat
pathway
reduc
nadph
nicotinamid
adenin
dinucleotid
phosphat
gener
nadph
use
maintain
reduc
state
glutathion
gsh
play
critic
role
regul
antioxid
balanc
thu
protect
cell
oxid
damag
particularli
erythrocyt
lack
mitochondria
reli
gener
antioxid
defici
caus
loss
enzymat
activ
structur
integr
due
point
mutat
disrupt
physiolog
antioxid
balanc
signific
decreas
nadph
gsh
level
thu
increas
vulner
cell
oxid
stress
current
treatment
avail
defici
given
defici
lead
hemolyt
crisi
follow
sequala
press
need
develop
therapeut
plan
correct
defici
toward
end
character
common
mutant
enzym
canton
xray
crystallographi
identifi
structur
distort
area
enzym
lead
decreas
enzym
activ
use
enzym
screen
molecul
chaperon
activ
identifi
potenti
molecul
refer
hereaft
activ
enzym
significantli
increas
enzym
stabil
cell
activ
mutant
enzym
well
suggest
gener
treatment
defici
furthermor
allevi
lossoffunct
phenotyp
zebrafish
model
taken
togeth
studi
provid
novel
insight
develop
therapeut
strategi
defici
reduc
deficiencyassoci
patholog
affect
world
popul
sanela
martic
oakland
univers
michigan
usa
tau
protein
regul
neuron
cell
function
posttransl
modif
tau
lead
microtubul
instabl
cell
death
neurodegener
current
neurodegener
remain
without
abstract
cure
immunotherapi
anim
model
shown
reduct
clearanc
tau
patholog
mechan
antibodybas
inhibit
current
unclear
main
object
determin
role
antitau
antibodi
nonphosphoryl
phosphoryl
tau
phosphoryl
tubulin
polymer
vitro
phosphoryl
carri
presenc
glycogen
synthas
kinas
microtubuleaffin
regul
kinas
specif
antibodi
ad
phosphoryl
evalu
role
phosphoryl
residu
extent
phosphosphoryl
determin
use
western
blot
tubulin
polymer
microtubul
measur
use
fluoresc
spectroscopi
tau
antibodi
tauantibodi
introduc
prior
polymer
tubulin
antibodi
target
domain
induc
turnon
phosphoryl
microtubuleaffin
regul
kinas
turnoff
phosphoryl
observ
antibodi
glycogen
synthas
kinas
tubulin
polymer
microtubul
inhibit
antibodi
test
howev
tau
effect
rescu
microtubul
even
presenc
antibodi
substrat
epitopetarget
phosphoryl
proteinprotein
interact
may
regul
cocryst
structur
tubulin
novel
auristatin
analogu
improv
cell
potenc
alison
varghes
kevin
parri
jayvarthan
pandit
suman
shanker
cynthia
song
andrea
maderna
pfizer
inc
usa
antibodydrug
conjug
adc
combin
potenc
highli
cytotox
small
molecul
payload
conjug
highli
specif
monoclon
antibodi
mab
result
cancer
therapi
target
diseas
cell
leav
healthi
cell
intact
date
two
fdaapprov
adc
market
kadcylav
r
adcetrisv
r
current
clinic
trial
mani
payload
develop
antimitot
agent
disabl
mitosi
addit
alter
cytoskelet
structur
lead
cell
death
one
seri
potent
antimitot
agent
auristatin
act
inhibit
polymer
tubulin
protein
crystal
structur
tubulin
bound
auristatin
previous
report
resolut
disord
residu
cterminu
present
crystal
structur
tubulin
bound
novel
auristatin
significantli
improv
resolut
provid
detail
examin
auristatin
prefer
bind
mode
along
excel
potenc
improv
adm
properti
structur
inform
serv
tool
enabl
design
develop
safer
effect
adc
chemotherapeut
use
antibodi
fragment
product
pichia
pastori
highli
attenu
oglycosyl
pattern
without
addit
pure
alexandr
di
paolo
nathali
pirlot
laurent
jost
rudi
piedboeuf
jean
guda
david
ho
green
zhang
kaneka
eurogentec
belgium
imaginab
usa
kaneka
eurogentec
develop
effici
pichia
pastori
express
platform
product
antibodi
fragment
protein
produc
high
titer
gl
singl
copi
clone
without
addit
pure
oxygen
ferment
product
show
limit
oglycosyl
pattern
cours
studi
develop
antibodi
fragment
product
condit
eurogentec
test
bind
properti
imaginab
variou
type
fragment
fab
cysdiabodi
minibodi
deriv
antibodi
oxford
biomedica
plc
human
engin
imag
therapeut
purpos
total
diabodi
minibodi
fab
studi
present
ferment
oglycosyl
optim
result
obtain
two
cysdiabodi
name
cysdiabodi
display
low
level
oglycosyl
also
share
ident
bind
properti
equival
produc
mammalian
cell
dissect
catalyt
fragment
pseudomona
exotoxin
john
weldon
earl
brook
kaleem
coleman
victor
eromosel
olubunmi
olakunl
kavisha
schroff
alec
ahearn
jack
sanford
rodrigo
montoro
towson
univers
maryland
usa
pseudomona
exotoxin
pe
bacteri
toxin
halt
protein
synthesi
eukaryot
archaea
inhibit
action
translat
elong
factor
matur
nativ
pe
function
domain
respons
receptor
bind
intracellular
traffick
catalysi
catalyt
fragment
toxin
monoadpribosyltransferas
exert
toxic
effect
cytosol
attach
adpribosyl
group
deriv
nad
specif
residu
pe
adapt
use
cancer
therapeut
develop
recombin
immunotoxin
rit
fusion
protein
produc
combin
antibodi
protein
toxin
rit
show
promis
treatment
cancer
suffer
sever
limit
includ
patient
immunogen
nonspecif
toxic
untarget
cell
ineffici
cell
kill
cell
type
effort
improv
therapeut
potenti
rit
studi
catalyt
domain
pe
determin
minimum
essenti
sequenc
use
seri
delet
substitut
mutat
catalyt
domain
pe
purifi
studi
structur
function
variant
observ
chang
occur
work
perform
primarili
student
part
biochemistri
lab
cours
towson
univers
design
give
experi
common
biochemistri
laboratori
techniqu
improv
stabil
bovin
secretori
iga
nanobodi
ration
design
fragment
crystallis
chain
adam
chinfatt
rima
menassa
western
univers
agricultur
agrifood
canada
secretori
iga
nanobodi
modular
molecul
compris
two
highli
order
constant
domain
collect
term
fragment
crystallis
fc
significantli
conserv
fuse
antigen
bind
partner
variabl
heavi
chain
fragment
vhh
compris
spectrum
sequenc
depend
correspond
bind
partner
consid
fc
may
confer
stabil
variou
vhh
partner
ration
design
fc
enabl
bioinformat
analysi
molecular
model
predict
key
amino
acid
substitut
may
induc
format
either
surfac
salt
bridg
disulfid
bond
predict
stabil
mutat
enabl
site
direct
mutagenesi
nativ
bovin
fc
sequenc
screen
protein
accumul
thermost
follow
transient
express
leav
nicotiana
benthamiana
result
far
identifi
seven
candid
show
better
accumul
enhanc
thermost
determin
seven
fc
mutant
confer
enhanc
stabil
whole
secretori
iga
molecul
current
fuse
variabl
heavi
chain
vhh
bind
clostridium
difficil
coexpress
join
chain
bind
togeth
vhhfc
dimer
pair
secretori
compon
wrap
around
join
tetram
goal
project
develop
stabil
bovin
fc
chain
could
potenti
gener
stabil
scaffold
variou
vhh
correspond
secretori
iga
reaction
present
studi
evalu
protein
express
lipoxygenas
lox
signal
follow
cpt
challeng
possibl
preserv
role
inhibitor
zileuton
zt
renal
tissu
wistar
rat
anim
challeng
cpt
mgkg
ip
treat
zt
mgkgday
po
start
week
cpt
challeng
protein
express
lox
signal
enzym
product
quantifi
western
blot
includ
lox
enzym
activ
protein
flap
hydrolas
synthas
cysteinyl
cy
lt
receptor
type
kidney
cpt
significantli
provok
express
lox
signal
inhibit
zt
attenu
alter
improv
express
lox
enzym
product
conclus
primari
studi
indic
contribut
lox
signal
cpt
mediatednephrotox
inhibit
zt
could
establish
novel
therapeut
approach
paclitaxel
ptx
one
effect
anticanc
agent
treat
variou
cancer
includ
breast
cancer
howev
clinic
use
ptx
limit
poor
solubl
aqueou
solut
henc
clinic
formul
ptx
taxol
contain
cremophor
elv
r
improv
solubl
ptx
caus
seriou
side
effect
hypersensit
reaction
neurotox
nephrotox
previous
report
lipocalintyp
prostaglandin
synthas
lpgd
could
bind
solubil
poorli
watersolubl
anticanc
drug
complex
show
high
antitumor
activ
vitro
vivo
studi
attempt
develop
safe
drug
deliveri
system
ptx
use
lpgd
estim
bind
capabl
lpgd
ptx
perform
dock
simul
use
autodock
vina
dock
model
ptx
molecul
locat
hydrophob
caviti
lpgd
predict
free
energi
chang
kjmol
next
investig
effect
lpgd
solubl
ptx
ptx
insolubl
mm
trishcl
buffer
ph
solubil
mm
mm
lpgd
solut
investig
cytotox
activ
ptxlpgd
complex
human
breast
cancer
cell
line
assay
valu
ptxlpgd
complex
growth
cell
nm
respect
indic
ptxlpgd
complex
high
anticanc
activ
result
taken
togeth
demonstr
lpgd
suitabl
drug
deliveri
vehicl
ptx
sickl
cell
diseas
scd
monogen
hereditari
diseas
gene
therapi
scd
introduc
antisickl
hb
insid
rbc
consid
promis
approach
cure
diseas
globin
chain
chosen
gene
therapi
present
includ
mutant
achain
inhibit
polymer
transdim
locat
even
though
inhibit
polymer
complet
suggest
increas
delay
time
polymer
enough
afford
therapeut
benefit
howev
recent
studi
transgen
mous
model
demonstr
antisickl
hb
consid
adequ
suffici
normal
high
cerebr
blood
flow
cbf
present
scd
besid
seen
least
scd
therapeut
approach
induc
oxygen
debt
brain
reduc
cbf
hand
antianemia
therapeut
high
oxygen
affin
peghb
afford
good
scd
therapeut
activ
protect
brain
oxygen
debt
normal
cbf
new
insight
cerebr
patholog
scd
prompt
us
advanc
combin
antisickl
antianemia
therapi
scd
antianemia
therapeut
gener
higher
nitrit
reductas
activ
thu
vasodilatori
base
experiment
structur
model
result
suggest
swine
humanswin
chimer
canin
achain
complet
neutral
polymer
exert
activ
cisand
transdim
locat
antisickl
antianemia
antiischem
activ
therapeut
activ
achain
synerg
achain
enhanc
therapeut
activ
protect
possibl
athalassemia
towson
univers
maryland
usa
elong
factor
gtpase
requir
translat
transloc
ribosom
along
mrna
contain
uniqu
posttransl
modif
call
diphthamid
found
protein
diphthamid
singl
posttransl
modifi
histidin
mammal
central
target
sever
bacteri
toxin
diphtheria
toxin
pseudomona
exotoxin
pe
cholix
toxin
arrest
inhibit
translat
transfer
adpribosyl
group
nad
diphthamid
residu
toxin
util
antibodytoxin
conjug
cancer
therapeut
term
recombin
immunotoxin
investig
pe
resist
cell
express
mutat
diphthamid
histidin
pe
resist
determin
treat
cell
pebas
recombin
immunotoxin
preliminari
data
indic
none
mutant
test
toxin
resist
futur
experi
explor
toxin
resist
endogen
substitut
mutat
use
genom
edit
evalu
addit
cell
line
structur
basi
parkinmedi
mitochondri
qualiti
control
marta
vrana
tremp
mutat
parkin
gene
caus
famili
form
parkinson
diseas
pd
parkin
work
togeth
mitochondri
qualiti
control
pathway
essenti
prevent
neurodegener
kinas
sens
damag
mitochondria
accumul
depolar
membran
phosphoryl
ubiquitin
phosphoubiquitin
pub
recruit
activ
ubiquitin
ligas
parkin
parkin
ubiquitin
outer
mitochondri
membran
protein
mark
proteasom
degrad
recruit
autophagi
machineri
along
other
previous
shown
parkin
adopt
autoinhibit
conform
tremp
et
al
releas
inhibit
initi
pub
bind
domain
parkin
alloster
displac
ubl
domain
sauv
e
et
al
promot
phosphoryl
ubl
increas
ubiquitin
ligas
activ
howev
molecular
mechan
underli
conform
chang
substrat
specif
mitochondria
remain
unclear
dissect
mechan
parkin
activ
combin
biophys
measur
mitochondri
ubiquitin
cellular
mitophagi
assay
mutat
anchor
repressor
element
parkin
rescu
phosphodead
mutant
indic
phosphoryl
releas
rep
enabl
tang
vrana
et
al
transthiol
ubiquitin
parkin
effect
specif
substrat
ubiquitin
orchestr
experi
pave
way
novel
therapeut
approach
could
restor
activ
impair
parkin
noncanon
smc
protein
play
critic
role
epigenet
regul
includ
x
chromosom
inactiv
genom
imprint
regul
autosom
gene
express
recent
mutat
implic
facioscapulohumer
muscular
dystrophi
fshd
rare
craniofaci
disord
call
bosma
arhinia
microphthalmia
syndrom
bam
import
welldescrib
protein
function
molecular
level
mediat
epigenet
control
still
unclear
perform
structuralfunct
characteris
two
recognis
domain
name
smc
hing
domain
respons
nucleic
acid
bind
put
ghkl
atpas
domain
demonstr
hing
domain
assembl
unconvent
dimer
arrang
flank
intermolecular
coiledcoil
solv
crystal
structur
core
hing
domain
investig
structur
basi
nucleic
acid
interact
furthermor
show
ntermin
region
encapsul
atpas
domain
grossli
resembl
crystal
structur
fulllength
protein
importantli
found
atpas
domain
catalyt
activ
therefor
similar
atpbind
depend
conform
chang
envisag
dimer
may
undergo
energydepend
conform
chang
engag
chromatin
addit
ongo
characteris
recombin
protein
incorpor
patientderiv
mutat
provid
potenti
explan
underli
pathogenesi
studi
provid
import
insight
understand
protein
elicit
epigenet
control
molecular
level
form
basi
explor
activ
potenti
therapeut
treatment
fshd
aaspart
acid
isomer
acid
wellknown
peptid
modif
isoaspart
contain
protein
play
signific
role
age
process
could
lose
structur
becom
biolog
inact
even
harm
thu
high
sensit
method
malditof
ms
could
appli
determin
aand
ratio
aspart
acid
peptid
peptid
contain
could
note
biomark
alzheim
diseas
diagnost
peptid
good
model
system
improv
isoaspart
acid
detect
method
experi
perform
model
system
contain
normal
isoform
synthet
peptid
use
bruker
ultraflextrem
mass
spectromet
use
fragment
spectra
obtain
use
collisioninduc
dissoci
differ
collis
gase
binari
mixtur
synthet
fragment
investig
fragment
spectra
analyz
find
marker
ion
normal
isoform
target
peptid
rel
intens
ratio
shown
fragment
spectra
differ
intens
fragment
form
dissoci
bond
near
asparticisoaspart
acid
group
correl
rel
intens
marker
ion
isoform
percentag
mixtur
allow
determin
amount
peptid
refer
normal
one
malditof
measur
allow
use
small
amount
sampl
less
concentr
sampl
without
addit
sampl
prepar
step
shown
detect
limit
nmol
could
improv
concentr
sampl
directli
target
plate
simpl
method
could
also
adapt
peptid
protein
prone
aspart
acid
isomer
process
work
support
russian
scienc
foundat
grant
lysin
acetyl
import
posttransl
modif
found
ubiquit
throughout
cell
lysin
acetyl
occur
thousand
human
nuclear
nonnuclear
protein
regul
wide
varieti
dynam
cellular
process
acetyl
eras
histon
deacetylas
hdac
attract
therapeut
target
due
aberr
activ
diseas
rang
cancer
neurodegen
disord
hdac
compris
famili
enzym
hdac
wellstudi
crystal
structur
solv
littl
known
divis
deacetyl
role
among
isozym
creat
hdac
toolbox
contain
varieti
methodolog
use
combin
allow
us
unravel
complex
hdac
substrat
specif
toolbox
includ
comput
substrat
predict
vitro
peptid
protein
deacetyl
assay
protein
librari
deacetyl
screen
hdacinteractor
photocrosslink
cell
lysat
vivo
acetyl
analysi
hdac
knockout
use
simplest
beststudi
hdac
develop
toolbox
toolbox
compat
hdac
identifi
sever
dozen
novel
put
substrat
includ
heat
shock
protein
beta
isocitr
dehydrogenas
well
previous
identifi
substrat
structur
mainten
chromosom
use
method
gain
better
understand
substrat
specif
moreov
identifi
potenti
physiolog
relev
substrat
inform
ration
drug
design
allow
effect
drug
develop
